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Kurzfassung 
Enantioselektive Interaktionen zwischen Molekülen spielen in vielen biologischen Vorgängen 
eine entscheidende Rolle. Sind diese Wechselwirkungen von nicht-kovalenter Natur, bilden sie 
häufig die Grundlage für Vorgänge der molekularen Erkennung, des Chiralitätstransfers oder 
der Selbstorganisation. Es wird vermutet, dass solche Mechanismen an der Entstehung der Ho-
mochiralität in der Natur beteiligt waren.[1-4] Das Verständnis darüber, wie solche nicht-kova-
lenten Interaktionen ausgenutzt werden können, um die stereochemische Kontrolle über asym-
metrische Reaktionen zu erlangen, verspricht weitreichende Möglichkeiten für das zukünftige 
Design neuer Katalysatoren in der Chemie.  
Die vorliegende Dissertation beschreibt die Synthese und Untersuchung stereodynamischer Lig-
anden und Komplexe sowie ihre Anwendung in asymmetrischen Reaktionen. Im Zentrum stand 
die Beeinflussung der Chiralität axial chiraler Liganden durch nicht-kovalente Wechselwirkun-
gen zwischen am Ligandenrückgrat befestigten Bindungsstellen (Selektoren) und anderen Mo-
lekülen. Die Dissertation ist in vier Themengebiete untergliedert.  
Das erste Themengebiet in Kapitel 2 beinhaltet die Untersuchung chiraler, L-Aminosäure-ba-
sierter Interaktionsstellen mit sekundären Amiden, deren Natur von Interaktionsstellen der 
Hochleistungs-Gaschromatographiesäule CHIRASIL VAL abgeleitet wurde (Abbildung 1a). 
Verschiedene 5,5‘-selektormodifizierte, 2,2‘-biphenyl-basierte Liganden wurden synthetisiert 
und es konnte gezeigt werden, dass eine derartige Substitution im Rückgrat eine spontane, mit-
unter quantitative Anreicherung eines Ligandrotamers bewirkt. In detaillierten strukturellen Un-
tersuchungen konnte nachgewiesen werden, dass ein intermolekulares Netzwerk aus Wasser-
stoffbrückenbindungen zwischen Selektoreinheiten zur diastereoselektiven Ausbildung von 
Ligand-Dimerstrukturen führt, welche im Folgenden die Anreicherung nach sich zieht. Die ver-
schiedenen Ligandtypen konnten abschließend erfolgreich in enantioselektiven Hydrierungs- 
und Alkylierungsreaktionen eingesetzt werden. 
Im darauffolgenden Kapitel 3 wird die Thematik auf achirale Bindungsstellen ausgeweitet (Ab-
bildung 1b). Nach dem Vorbild „schaltbarer“ Katalysatoren sollte die gezielte Deracemisierung 
von racemischen Liganden mittels chiraler Additive durchgeführt werden.  Hierbei wurden unter 
anderem, aufbauend auf Erkenntnissen aus dem vorangegangenen Kapitel, racemische Bisphos-
phinite mit Glycin- sowie racemischen Phenylalanin-basierten Selektoren modifiziert. Durch 
Wechselwirkung mit chiralen Additiven konnte das Rotamerverhältnis der Liganden entspre-
chender Rhodiumkomplexe selektiv beeinflusst werden und somit Katalysatoren für enantiose-
lektive Hydrierungsreaktionen erzeugt werden.  
Kapitel 4 behandelt die Entwicklung eines autoinduktiven Katalysatorsystems (Abbildung 1c). 
In Anlehnung an eine von Trapp et al. beschriebene enantioselektive Reaktion mit autoindukti-
ven, selbstamplifizierenden Eigenschaften wurde ein komplementäres System entwickelt, bei 
dem der Selektivität einer Reaktion ein selbstinhibierender Ablauf zugrunde liegt. In einem 
zweistufigen Prozess wurde zunächst ein neuartiges Phenylalanin-basiertes Amidoester-Se-
lektormotiv auf sein Potential der Stereoinduktion hin untersucht. Durch stereoselektive Inter-
aktion mit einer Reihe chiraler L-Aminosäurederivate, die gleichzeitig potentielle Hydrierpro-
dukte darstellten, gelang es, eine signifikante Rotameranreicherung bei einem der untersuchten 
Bisphosphinitliganden und seinem Rhodiumkomplex herbeizuführen. Dies führte gleichzeitig 
zu einer signifikanten Selektivitätssteigerung in nachfolgenden Hydrierreaktionen, wobei ver-
stärkt das (R)-Produktenantiomer gebildet wurde. Basierend auf diesen Ergebnissen wurden im 
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zweiten Schritt ein hochdynamischer, selektormodifizierter Phosphoramiditligand und verschie-
dene Olefine synthetisiert, wobei letztere sich von einem der chiralitätsinduzierenden Amino-
säurederivate ableiten. In folgenden Hydrierreaktionen konnte gezeigt werden, dass ein ur-
sprünglich bevorzugt gebildetes Produktenantiomer durch Interaktion mit dem Katalysator seine 
eigene Entstehung im weiteren Verlauf der Reaktion inhibiert und so eine Selektivitätsumkehr 
herbeiführt.   
Der letzte Teil der Arbeit in Kapitel 5 beschreibt das Konzept und initiale Studien eines neuar-
tigen, aliphatischen Ligandengrundkörpers für selektormodifizierte tropos Liganden, der auf 
meso-Weinsäure basiert (Abbildung 1d). Die Erprobung von Synthesen für einen Bisphosphin- 
und einen Bisphosphinitliganden und Untersuchungen zur Konformerverteilung werden be-
schrieben. 
 
Abbildung 1: Übersicht der in der vorliegenden Dissertation beschriebenen Forschungsprojekte. Im Zentrum steht 
das Bestreben mittels nicht-kovalenter Wechselwirkungen Einfluss auf die Stereochemie der untersuchten, stereody-
namischen Liganden und Katalysatoren zu nehmen, um so Enantioselektivität in asymmetrischen Reaktionen zu er-
zeugen. 
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Abstract 
Enantioselective interactions between molecules play a crucial role in a wide range of biological 
transformations. Where these interactions are of non-covalent nature, they can form the basis 
for molecular recognition, chirality transfer and self-organization, processes believed to be 
deeply involved in the origin of natural homochirality.[1-4] Understanding how non-covalent in-
teractions can be utilized to exert stereochemical control over chemical reactions promises far-
reaching opportunities for the prospective design of novel chiral catalysts in chemistry. The 
strive to harness this potential has sparked great efforts to find pathways that allow for enantio-
control on a molecular level.  
In this dissertation, the synthesis and study of stereodynamic ligands and respective complexes 
as well as their application in asymmetric reactions is described. The focus is on investigating 
possibilities to influence the axial chirality of tropos ligands through non-covalent interactions 
between binding sites (selectors), covalently attached to the ligand backbone, and other chiral 
and achiral molecules, thus inducing enantioselectivity in subsequent asymmetric reactions. The 
dissertation is divided into four topics.  
The first topic in chapter 2 covers investigations on chiral L-amino acid-based interaction sites 
with secondary amides, derived from selector sites of the gas chromatography CSP CHIRASIL 
VAL. Different 2,2’-biphenyl-based ligands with interaction sites in 5,5’-position were devised 
and it was found that such a substitution entails spontaneous enrichment of one ligand rotamer 
(Figure 1a). Detailed structural investigations revealed an intermolecular network of hydrogen 
bonds between selector units to cause diastereoselective formation of ligand dimers. Lastly, the 
ligands could successfully be employed in transition metal-mediated asymmetric hydrogenation 
and alkylation reactions yielding products in very high enantioselectivities. 
In chapter 3, investigations are extended to achiral binding sites for non-covalent interaction. 
Inspired by the model of "switchable" catalysts, hydrogen-bond driven deracemization of race-
mic catalysts was examined (Figure 1b). Based on the findings in the previous chapter, bisphos-
phinite ligands with glycine- and racemic phenylalanine-based diamide selectors were devised. 
By interaction with chiral additives, the rotational distribution of the ligands in corresponding 
rhodium complexes could be selectively influenced and catalysts for enantioselective hydro-
genation reactions could be obtained.  
Chapter 4 deals with the development of an autoinductive catalyst system. Based on a “by de-
sign” self-amplifying reaction previously described by Trapp et al., a complementary system 
was developed in which the selectivity of a reaction is based on enantioselective self-inhibiting 
properties (Figure 1c). In a two-stage process, a novel, phenylalanine-based amidoester selector 
motif was first investigated for its potential of non-covalent stereoinduction. Using a series of 
chiral amino acid derivatives, all of them representing potential hydrogenation products, it was 
possible to induce significant rotameric enrichment in one investigated ligand and its respective 
rhodium complex. A concomitant increase in selectivity for the R product enantiomer in subse-
quent hydrogenation reactions was detected. In the second stage of the project, a highly dynamic, 
selector-modified phosphoramidite ligand and different olefins were synthesized, the latter be-
ing structurally based on one of the amino acid derivatives that had earlier exhibited strong ste-
reoinducing capabilities. In subsequent hydrogenation reactions, it could be shown that over the 
course of the reaction, an originally preferential product enantiomer inhibited its own production 
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by changing the catalyst’s selectivity through non-covalent interaction, thus inducing a reversal 
of the catalyst’s enantioselectivity.   
The last part of the dissertation in chapter 5 describes initial studies concerning a novel ligand 
motif for selector-modified tropos ligands that is based on an aliphatic ligand backbone derived 
from meso-tartaric acid (Figure 1d). The synthetic outline and initial syntheses for a bisphos-
phine and a bisphosphinite ligand as well as preliminary studies on ligand conformers and inter-
action behaviour are described. 
 
Figure 1: Overview of the research projects described in this dissertation. The investigations focused on influencing 
the stereochemistry of stereodynamic ligands and catalysts by means of non-covalent interaction in order to generate 
enantioselectivity in asymmetric reactions. 
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1 Introduction 
Nature provides us with countless patterns illustrating the importance of a stereochemical infor-
mation for the successful functioning of biochemical processes. One example is provided by the 
fact that in some processes only the correct stereoisomer produces the desired effect, while other 
isomers have reduced to no effect. One example is the herbicide metolachlor for which four 
different stereoisomers exist, only two of which are biologically active (see Figure 1-1, left).[5] 
 
Figure 1-1: Four diastereomers of the herbicide Metolachlor and both enantiomers of Thalidomide. 
Another example can be found in cases where two enantiomers have opposite biological effects. 
One of the most prominent examples is thalidomide, a immunomodulatory drug which became 
infamous during the Contergan scandal.[6] While (R)-thalidomide successfully countered nausea 
and alleviated morning sickness for expecting mothers, tragically, the corresponding S enantio-
mer was found to have a teratogenic effect on the unborn child (see Figure 1-1, right). It was 
also observed that both enantiomers can interconvert[7,8] under physiological conditions[9], 
strongly limiting the medical applicability of the compound. These examples illustrate that the 
optical purity of chiral compounds is of vital importance for the pharmaceutical, cosmetic and 
agrochemical industries, among others.[10-12] 
In general, this is achieved by employing enantiomerically pure catalysts, whose preparation 
requires enantioselective syntheses or the cumbersome separation of a racemate themselves. The 
best-known examples are the synthesis of L-menthol, developed by BASF, in which neral is 
reduced to D-citronellal using a Chiraphos-Rh catalyst,[13] the JosiPhos-Ir-catalyzed imine re-
duction during the preparation of the aforementioned metolachlor[14] and the enantioselective 
hydrogenation using DIPAMP- or BINAP-Rh complexes for the synthesis of the Parkinson's 
drug L-DOPA ((S)-3,4-dihydroxyphenylalanine) that was originally established by 
Knowles.[14,15] The fact that the development of optically pure catalysts is so time-consuming 
and expensive is the underlying reason for present trends to investigate alternative approaches 
to generate optically enriched compounds. Naturally, interest arises to understand and imitate 
underlying mechanisms nature has developed for this purpose. 
The stereochemical specialisation of biological processes in nature is generally summarised un-
der the term homochirality. At the very center of this concept are amino acids and sugars, with 
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few exceptions naturally only found in their L-form and in their D-form, respectively, and mak-
ing up the essential building blocks for the most important molecules of life. The question of the 
origin of homochirality is a heavily discussed topic among experts.[16-19] As early as 1953, Frank 
published a theoretical model dealing with the spontaneous emergence of asymmetric reactions. 
[20] Todays consensus assumes a two-stage procces. In the first stage, a local deviation from 
racemic equilibrium is assumed. While Frank's model uses statistical, locally limited fluctuation 
as the original trigger, it has been shown that irradiation of racemic amino acids with circularly 
polarized light leads to enantioselective degradation.[1] Furthermore, it was found that spontane-
ous deracemization can occur during the crystallization of racemic compounds.[21,22] In the sec-
ond stage, stereochemical fluctuations must be amplified, leading to an enantiomerically pure 
final state. In this context, non-linear effects play a decisive role, because they allow for an 
enlargement of initially small enantiomeric excesses. [23] It has already been achieved to transfer 
this concept to reactions catalysed by biologically relevant compounds such as amino acids.[24,25] 
A special case is auto induction or self-amplification, where a chiral reaction product influences 
the enantioselectivity of its own production. If the product serves as the catalyst itself, this is 
also referred to as autocatalysis.[26]
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2 Cooperative chiral induction in stereodynamic catalysts 
2.1 State of knowledge 
Asymmetric reactions using chiral, organometallic catalysts is one of the most versatile and 
widely applied methods for the preparation of enantioenriched compounds.[27] The most com-
mon approach is to employ optically pure ligands for which a number of privileged structures 
have emerged following the diligent research in the past decades.[28] Among the most popular 
examples are bidentate ligands like BINAP,[29] where the chiral information is stored in a rigid, 
atropisomeric axis and widespread research has been conducted to understand how this infor-
mation can efficiently be transferred onto a given substrate.[30-32] Since the enantiopure synthesis 
of these ligands can be quite challenging to begin with, numerous strategies have emerged that 
allow employment of racemic ligands in asymmetric reactions. 
Yamamoto et al. were the first to employ a strategy now referred to as chiral poisoning, when 
they treated racemic BINOL-Al complexes with chiral ketones to reduce catalytic activity of 
one catalyst enantiomer in hetero-diels-alder reactions (see Figure 2-1).[33] 
 
Figure 2-1: a) Schematic illustration of enantioselective reactions with racemic catalysts where a chiral agent (chiral 
poison) selectively decreases the reactivity of one catalyst isomer. b) Reaction schemes for the enantioselective de-
activation of a rac-BINOL-Al catalyst using (d)-3-bromocamphors as chiral poison for enantioselective hetero-diels-
alder reactions by Yamamoto and Maruoka[33] and for the kinetic resolution of allylic alcohols using a rac-BINAP-
RuCl2 catalyst and (-)-ephedrine as deactivator, published by Faller and Tokunaga.[34] 
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This effect was also studied by Faller and Parr, among other, who could employ racemic Chira-
phos-Rh complexes in the presence of (S)-methophos for the enantioselective hydrogenation of 
olefins[35] and by Faller and Tokunaga, who achieved the asymmetric kinetic resolution of allylic 
alcohols with a racemic BINAP-Ru catalyst in presence of (-)-ephedrine.[34] In the complemen-
tary approach of “chiral activation”, Mikami and Noyori used (S,S)-diphenylethylendiamine 
(DPEN) as co-ligand for rac-TolBINAP-Ru complexes to selectively enhance the reactivity of 
one catalyst enantiomer, allowing for the highly enantioselective reduction of various ketones 
(see Figure 2-2).[36]  
This concept, too, was widely adopted and further developed.[37] It bears the intrinsic advantage, 
that – unlike in the case of chiral poisoning – the activated catalyst species can have a higher 
selectivity and reaction rate than a comparable enantiopure catalyst. A general drawback in both 
concepts results from the fact that either one relies on only half of the catalyst stock to conduct 
the reaction.  
Stereolabile, biphenyl-based tropos ligands offer a substantially different approach. The term 
“tropos” generally refers to chiral ligands where the two chiral ligand states have a low barrier 
of interconversion and isomerize readily.[38] The overwhelming majority of these ligands is 
based on 2,2’-biphenol (BIPOL) and a relevant selection of ligand types is shown in Figure 2-3. 
 
Figure 2-2: a) Schematic illustration of enantioselective reactions using a chiral activator, which selectively enhances 
the catalytic performance of one catalyst isomer to generate enantiomeric excess in an asymmetric transformation. b) 
Reaction schemes for the enantioselective activation of a rac-TolBINAP-Rh catalyst using (S,S)-DPEN during enan-
tioselective hydrogenations of prochiral ketones by Mikami and Noyori[36] and for an enantioselective carbonyl-ene 
reaction using a rac-BINOL-Ti(OiPr)2 catalyst and (R)-BINOL as activator, published by Mikami and Matsukawa.[39]  
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Figure 2-3: Relevant selection of biphenyl-based tropos ligands or their respective Rh complex. Rotational barrier 
increases from left to right and references for the values for the rhodium-phosphoramidite complex,[40] the rhodium-
bisphosphinite complex[41] and the BIPHEP ligand[42,43] can be found in the respective reference(s). In general, com-
plexated ligands have an increased barrier of rotation in comparison to the uncoordinated ones.  
To generate enantioselectivity, a stereochemical bias on the dynamic chiral axis is needed to 
trigger the enrichment of one ligand rotamer. This can be accomplished by interaction of the 
racemic catalyst with a chiral molecule. The energetic difference between the resulting diastere-
omeric complexes leads to concomitant adaptation of the rotamer distribution. This was impres-
sively pioneered by the groups of Gagné, Mikami and Noyori, who used enantiopure diamines 
and amino alcohols as co-ligands to generate diastereomerically enriched 2,2’-bis(diphe-
nylphosphinyl)biphenyl (BIPHEP) transition metal complexes for the use in asymmetric trans-
formations (see Figure 2-4).[44-47] Similarly, Brown and Faller employed chiral diene ligands, 
while Klankermayer, Leitner and Franciò used proline-based ionic liquids that coordinate to a 
metal center across from the tropos ligand to achieve similar degrees of stereoinduction.[48-51] 
Because of the dynamic nature of the ligand, this approach demands suitable conditions to pre-
serve the chiral enrichment, if the stereoinducing co-ligand is displaced during the catalytic re-
action cycle. To circumvent this issue, RajanBabu und Parquette et al. designed a system where 
stereodirecting, chiral oxazoline substituents were covalently attached in the 3,3’-position of a 
biphenol-based 2,2’-bisphospinite to allow for spontaneous rotameric enrichment of the ligand 
based on central-to-axial chirality transfer.[52] Similarly, Trapp et al. modified a BIPHEP-core 
with chiral esters in the 3,3’-position to obtain diastereoenriched catalysts for the enantioselec-
tive hydrogenation of olefins, whose selectivities could be changed by temperature treat-
ment.[53,54] 
In a more recent development, supramolecular chemistry has emerged as a new pillar in asym-
metric synthesis. However, as with original atropos catalysts, many systems reported rely on 
employment of established ligand motives such as BINOL, which bear a static chiral information 
and need to be provided in high enantiomeric purity. Enhanced enantioselectivity is subse-
quently achieved through rigidification of the complex geometry based on non-covalent inter-
action between ligands or ligand parts.[55,56] The share of published examples, where the chiral 
information in the ligand or catalyst is defined by intermolecular interaction itself (e. g. a chiral 
axis or a helical structure) is much smaller. Inspired by the well-defined geometry of DNA base 
pairs, Breit et al. devised chiral, nucleobase-derived ligands with complementary binding mo-
tives to form supramolecular, out-of-plane ligand dimers that were used in enantioselective hy-
drogenation reactions.[57,58] Both groups of Breit and Kirin employed peptidyl-substituted phos-
phines that formed PhanePhos-like complexes with helical chirality (see Figure 2-7, page 8).[59-
61] Reek and co-workers developed a “cofactor”-controlled catalyst, where a chiral guest binds 
to the pocket of an achiral ligand to determine its helical conformation.[62]  
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Figure 2-4: a) Schematic illustration of an enantioselective reaction using tropos ligands. The previously racemic 
catalyst experiences a stereochemical bias rendering the two rotamers unequal in energy. The low rotational barrier 
allows for an equilibrium shift generating a diastereomerically enriched catalyst. b) The rotameric enrichment of the 
ligand can be achieved using a chiral co-ligand coordinating across the metal center (left)[45,49-51] or by covalently 
attaching a chiral auxiliary group to the ligand core achieving central-to-axial chirality transfer (right).[52-54] 
The interplay of chiral and achiral components in supramolecular systems became of particular 
interest with the development of the “sergeant-soldier principle”, also known as the “majority 
rule effect”, where a chiral moiety, the “sergeant”, aligns an achiral neighbour, the “soldier”, 
who conveys this bias further down the line.[63] Most prevalent approaches are implementations 
in larger self-assembling systems[63-67] or helical polymers.[68-70] Suginome et al. published sev-
eral examples where such helices were employed in a number of different stereoselective trans-
formations .[71-74] 
Trapp and co-workers combined the concept of previously discussed tropos biphenyl-based lig-
ands with that of non-covalent interactions on a molecular level. They modified ligands with 
interaction sites (selectors) and succeed to change the rotamer distribution of the ligand, solely 
relying on non-covalent interactions between the ligand’s selector moieties and its chiral envi-
ronment. This requires formation of well-defined, transient diastereomeric associates between 
the two ligand rotamers and surrounding, chiral molecules. Selector-modified BIPHEPs were 
successfully employed in on-column deracemization experiments using chiral HPLC columns 
to achieve an equilibrium shift in the previously racemic ligand that could later be used in enan-
tioselective double aldol reactions.[75] In other examples, strong additive-selector interaction was 
achieved by modifying stereodynamic ligands with HPLC column selector-derived interaction 
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groups, such as 3,5-dichlorobenzoyl amide from Chiralpak® IC and IE[41,76] or (S)-N-pivaloylpro-
line,[40] originally employed on a high-performance stationary phase reported by Pirkle and Mur-
ray.[77,78] In both cases, a shift of the equilibrium ration of the catalyst species was observed in 
the presence of amino acid-derived additives and enantiomerically enriched products were ob-
tained in asymmetric hydrogenation experiments (see Figure 2-5). 
 
Figure 2-5: Example of a stereodynamic phosphoramidite ligand developed by Trapp et al. with interaction sites 
derived from HPLC column selectors, originally developed by Pirkle and Murray.[77,78] The catalyst shows structural 
change in presence of specifically designed additives, which alters its selectivity and was featured in self-amplifying 
reactions which will be discussed in a later chapter (see chapter 4, page 49).[40] 
The design of such stereodynamic systems requires careful consideration of the ligands rota-
tional barrier and of the strength of molecular interaction between the ligand’s selector and the 
chirality-inducing agent. If the selector moiety contains a chiral information, the stereoselectiv-
ity of the interaction has to be taken into account as well (see also chapter 7.9, page 176). This 
is relevant if the selector is simultaneously serving as stereoinducing unit or if autoinductive 
reactions – which will be covered in a later chapter – are considered. It appears self-evident to 
derive interaction sites from state-of-the-art chromatography selectors, such as the HPLC col-
umn selector-based examples mentioned above.  
 
Figure 2-6: Different examples of CSP’s that incorporate the motive of (S)-valine with two secondary amide func-
tionalities and that allow for the simultaneous separation and enantiodiscrimination of a wide range of amino acid 
derivatives and amino alcohols.[79-81]  
Most promising, yet unexamined as selectors for tropos biphenyl-based ligands, are amino acid-
derived diamides such as the one found in the chiral high-performance CSP CHIRASIL-Val for 
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GC (see Figure 2-6).[82,83] This selector is highly appreciated for its versatility and its excellent 
chiral separation capabilities which are based on strong and well defined hydrogen bonding.[81,84-
87] The number of hydrogen bond acceptor and donor sites allow for a multitude of possible 
interaction modes which appears promising for broad applicability and particularly selective 
interaction with other amino acid-derived additives. Chiral amino acid-derived diamide interac-
tion sites have previously been used in combination with other stereodynamic frameworks. 
Apart from earlier mentioned peptidyl-modified phosphine ligands by the groups of Breit and 
Kirin (see Figure 2-7a),[59-61] Herradón et al. published findings of crystallization-induced dy-
namic resolution of axial isomers of 2,2’-peptidyl-modified biphenyls, a process based on the 
stereoselective formation of a network of intra- and intermolecular hydrogen bonds (see Figure 
2-7b).[88,89] Similarly, it was found that chiral 1,1’-disubstituted ferrocenyl dipeptides, who exist 
in interconverting rotamers based on the twist around the Cp-Fe-Cp axis, undergo spontaneous 
transformation into one single species due to a -turn-like interaction between the opposite pep-
tidyl chains (see Figure 2-7c).[90-92] 
 
Figure 2-7: Illustration of previously published stereodynamic systems with amino acid-derived interaction sites. a) 
m-peptidyl-substituted bisphosphine ligand as “PhanePhos” analogue published by Kirin et al.[60] b) Diastereoselec-
tive crystallization of 2,2’-peptidyl-substituted biphenyls based on stereoselective formation of intra- and intermolec-
ular hydrogen bonds published by Herradón et al.[88,89] c) Bis(peptidyl)-substituted ferrocene molecules exhibit dia-
stereoselective -turn-like interaction between the amide chains forcing the two cyclopentadienyl rings into a prefer-
ential conformation.[90-92] 
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2.2 Objective 
The objective was the preparation and investigation of stereodynamic 2,2’-biphenol-based lig-
ands bearing amino acid-derived selector moieties, which are based on selector sites from the 
high-performance GC column CHIRASIL-Val. Selectors were placed in 5,5’-position of the lig-
and core in order to enable efficient chirality transfer onto the ligand while maintaining rota-
tional flexibility. Attachment of the selectors in 6,6’-position would render the ligand atropos. 
Sterically demanding substituents in 3,3’ position are expected to strongly increase the rotational 
barrier (buttressing effect)[93] and potentially affect coordination of the ligand to the metal center. 
Little information is available in literature on substitution effects at the 4,4’-position, however, 
a rather minor influence on the axial stereochemistry of the ligand was assumed.[94]  
A very short linking group between selector and ligand backbone would enhance rigidity and, 
consequently, improve chirality transfer onto the ligand axis. Methoxy groups in the 3,3’-posi-
tion were included as stereodirecting groups to enhance the ligand’s performance in enantiose-
lective catalytic reactions through increased steric hindrance around the catalyst metal center.[95] 
 
Figure 2-8: Schematic illustration of targeted tropos biphenyl-based ligands of different types bearing amino acid-
derived selector sites in 5,5’-position and stereodirecting groups in 3,3’-position. Chiral interaction sites are derived 
from those found in the stationary GC phase Chirasil-Val. 
Accordingly, a synthetic scheme was to be devised to synthesize a set of ligand bearing (S)-
amino acid-derived, secondary diamide moieties, with different isomerization barriers, namely 
a biphenol, a bisphosphine, a bisphosphinite and a phosphoramidite ligand. Following successful 
syntheses, ligands were to be studied for their stereodynamic behaviour. The investigated selec-
tor sites were believed to be particularly capable of engaging in strong and stereoselective inter-
action with surrounding hydrogen bond donors and acceptors, which was thought to allow for 
increased stereocontrol over the chiral axis of the biphenyl backbone. Finally, ligands were to 
be tested for their performance in asymmetric aldol reactions (biphenol ligand) and in enanti-
oselective hydrogenation reactions (the phosphorus-based ligands). 
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2.3 Investigation of a selector-modified bisphosphine ligand 
2.3.1 Synthesis 
Initial synthetic attempts to synthesize the ligand were based on modification of a corresponding 
2,2’-biphenol with appropriate triflate leaving groups and subsequent transition metal-mediated 
C-P cross coupling. This approach failed, however, supposedly due to increased steric demand 
around the triflate groups. In a more successful approach, shown in Figure 2-9, 3-bromo-5-hy-
droxybenzoic acid 1 was reacted in a Fischer esterification and subsequently treated with chlo-
rodiphenylphosphine oxide to give phosphinate 2. Reaction with LDA induced an anionic phos-
phorous Fries rearrangement,[96,97] that gave the desired product 3 where the diphenylphosphine 
oxide moiety had migrated to the position adjacent to the bromine substituent. Subsequent meth-
ylation of the newly formed hydroxy group gave diphenylphosphine oxide 4. The biphenyl back-
bone was constructed by a pyridine-free Ullmann coupling[98] to yield bis(diphenylphosphine 
oxide) 5, which was reduced in phenylsilane yielding the free bisphosphine 6. To attach the 
selector moieties, the methyl esters in 5,5’-position where saponificated and tBuNH-(S)Val-NH 
selector groups were attached employing standard peptide coupling reagents EDCI·HCl/HOBt 
under inert conditions yielding the desired bisphosphine 7 as a white powder. With the Phospho-
Fries rearrangement as an exception, good yields were obtained for all transformations, espe-
cially at the end of the sequence, where compound value increases. 
 
 
Figure 2-9: Synthesis of bisphosphine ligand 7, i) MeOH, H2SO4, 84%, ii) POPh2Cl, 4-dimethylaminopyridine, NEt3, 
83%, iii) lithium diisopropylamine, 29%, iv) MeI, 98%, v) Cu, 91%, vi) PhSiH3, 95%, vii) KOH, 99%, viii) tBuNH-
(S)Val-NH3Cl, EDCI·HCl, HOBt, DIPEA, 63%. 
2.3.2 Structural investigations 
Bisphosphine ligand 7 was obtained as a mixture of two species with a ratio of 16:84, as detected 
by 31P NMR analysis. While the minor species showed no unexpected characteristics with regard 
to its NMR data, the major compound exhibited a two-fold set of signals of identical intensity 
in 1H, 13C{1H} and 31P{1H} NMR spectra. For the phosphorus atoms, the two signals addition-
ally split due to mutual coupling which indicates that both observed signal sets belong to the 
same C1 symmetric molecular scaffold. The two species of bisphosphine 7 could be separated 
by precipitation and were individually characterized. Both compounds gave identical HR-ESI+-
MS spectra with a signal at m/z = 979.4666. Heating a pure sample of either species in CDCl3 
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to 60 °C for 14 hours resulted in complete re-equilibration to the same previously observed 
diastereomeric ratio of both species, indicating their conformational relationship, i.e. intercon-
version of the two diastereomeric forms by rotation (see Figure 2-10).  
 
 Figure 2-10: 31P NMR spectra of isolated samples of both ligand species of 7 (top). Heating the samples for several 
hours yields identical distribution of both species, which indicates their conformational relationship.   
31P NMR spectra taken in steps of 20 °C between -40 and 80 °C revealed significant line broad-
ening for the major species with increasing temperature until the signal had completely vanished 
at 80 °C. The minor species, however, underwent no such change (for spectral data see chapter 
7.2.13, page 107). This indicates that the major rotamer experiences a dynamic change of its 
chemical environment with rising temperature, e.g. by dissociation of hydrogen bonds. 
A single crystal suitable for X-ray analysis was obtained from a purified sample of the major 
species. The obtained structure shows a C2 symmetric dimer comprising two Rax rotamers of 7 
that are connected through multiple hydrogen bonds (see Figure 2-11). The supramolecular com-
plex can be divided into two parts. In the inner sphere part, two selectors align in a Herrick 
conformation,[92] imitating a [²]-turn, by forming a C5:C5 associate.1 In the outer sphere part, 
two remaining selector moieties engage in a chelating, “tweezer”-like assembly by forming two 
additional hydrogen bonds each (C7:C5) with the backside of the inner sphere selector of the 
respective other ligand molecule.  
The inner sphere aromatic rings of the biphenyl units arrange spatially offset in parallel plane. 
The free electron pairs of the two diphenylphosphine groups in each molecule point towards the 
aromatic backbone on the respective other side of the same molecule. Assuming that these su-
pramolecular features are retained in solution, this data identifies the minor species as the rota-
tional isomer (Sax)-7 and the major species as (Rax)-7. It also provides a plausible explanation for 
the unexpected asymmetry of the latter, that was illustrated by NMR spectroscopic data.   
                                                     
1 Within the nomenclature CX:CY of cyclic two-component hydrogen bond networks, X and Y represent 
the number of atoms (= the length) of each chain that connect over two non-covalent bonds. 
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Figure 2-11: Representation of the single crystal X-ray structure of (Rax)-7 from different viewpoints (top). Two Rax 
molecules form a supramolecular C2-symmetric dimer of C1-symmetric subunits (indicated in beige and grey, bi-
phenyl core atoms are coloured darker). Nitrogen = blue, oxygen = red, phosphorus = orange. Hydrogen bonds are 
indicated as blue lines. Non-relevant hydrogen atoms and solvent molecules are omitted for clarity. Images were 
produced using UCSF Chimera.[99] Also shown are simplified model structures representing the “Front view” ar-
rangement (bottom left) and a detailed depiction of the selector interaction pattern (bottom right). 
 
 
 
 
 
front view top view 
side view bottom view 
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The supramolecular structure renders both halves of each molecular subunit diastereotopic, thus 
doubling the number of detectable NMR signals. Moreover, the spatial orientation of the free 
electron pairs on the phosphorus atoms provides a pathway for their coupling through * orbital 
interaction (through space coupling) through the adjacent backbone phenyl ring (TSJ(P,P) = 9.7 
Hz), which is a known phenomenon for bidentate ligands with diastereotopic phosphorus at-
oms.[100,101] 
1H NMR signal shifts of amide protons of (Rax)-7 were found to be 9.05, 8.34, 6.96 and 5.75 ppm. 
This this suggests that three out of four protons of each molecular subunit are strongly engaged 
in non-covalent interactions, the forth, unbonded one being one of the two terminal tBuNH pro-
tons, which is in agreement with bonding pattern found by single crystal X-ray analysis (see 
Figure 2-11 for comparison). It is unlikely that the minor rotamer (Sax)-7 does not engage in 
some sort of non-covalent interaction, however, these bonds seem to be much less stable. 1H 
NMR shifts of amide protons for this rotamer showed a comparably high field shift (6.38 and 
5.84 ppm), indicating much weaker bonding. At the same time, a higher molecular symmetry 
contradicts the formation of aggregates of the kind found for (Rax)-7 even at temperatures as low 
as -40 °C, as visible from the obtained NMR data. Also, since the formation of a hydrogen bond 
is accompanied by energetic stabilization, the strong enrichment of the Rax rotamer suggests that 
significant differences exist in the saturation level of hydrogen bond donor and acceptor sites 
between both rotamers. Moreover, heterodimeric species comprising both ligand isomers were 
not observed.  
From this can be concluded, that the key feature of the investigated ligand motif, which causes 
rotameric enrichment, is the diastereoselective and cooperative self-recognition process during 
selector interaction of two ligand molecules. The stereoinformation imbedded in the selector 
sites dictates the axial orientation of the biphenyl units during formation of the hydrogen bond 
network allowing only one rotamer to form dimers. In itself, this phenomenon can also be seen 
as a form of stereoselective narcissistic self-sorting,[102] which is a concept that has been found 
to govern non-covalent interaction in a variety of chiral systems.[3,103-108]  
To investigate the effect of hydrogen bonding on the rotational barrier, respective energies for 
bisphosphines 6 and 7 were compared. Ligand precursor 6 was previously investigated for its 
isomerization barrier of its enantiomers using dynamic HPLC[109] and was found to have a barrier 
of interconversion of ΔG298‡ = 97.8 kJ/mol. NMR-spectroscopically assisted kinetic measure-
ments of compound 7’s epimerization at 60 °C were conducted assuming an opposing reaction 
of first order. Rate constants of k(Rax-Sax) = 1.3692 x 10-5 s-1 and k(Sax-Rax) = 6.9798 x 10-5 s-1 
were found, which correspond to free enthalpies of ΔG333K‡(Rax-Sax) = 112.9 kJ/mol and 
ΔG333K‡(Sax-Rax) = 108.4 kJ/mol, respectively (correlation factor R2 = 0.978, see chapter 7.2.9, 
page 98 for experimental details). The increased energetic barriers of isomerization can be ex-
plained by additional sterical pressure of the larger diamide substituents compared to the smaller 
methyl esters. It is also plausible to assume that strong hydrogen bond stabilization of the ground 
state of (Rax)-7, that needs to be overcome for an epimerization, is responsible for the observed 
difference in transition state energies.  
2.3.3 Interaction studies 
Since stereoselective formation of hydrogen bonds was found to be the cause of the ligand’s 
self-enriching behaviour, interfering with its bonding pattern was expected to have a profound 
effect. Consequently, the effects of chiral and achiral hydrogen bond donors and acceptors on 
ligand 7 was investigated by adding them in excess to a solution of the equilibrated ligand (dr 
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14:86 Sax:Rax) in CDCl3. The re-equilibration of the resulting mixtures at 60 °C was monitored 
by 31P NMR spectroscopy. 
Given the excellent enantioselectivity of the GC stationary phase CHIRASIL Val in separating 
amino acid derivatives, compounds 8-10 from the same class, all with different steric and elec-
tronic properties, were employed as chiral additives. Because of the matching interaction pat-
tern[83] of the valine-based selector, these where believed to be effective competitors for the 
ligand’s self-interaction. As achiral additives, dicyclohexyl urea (11) and DMSO-d6 (as solvent 
instead of CDCl3) were used, both expected to unselectively interfere with hydrogen bonds of 
(Rax)-7 and diminish beneficiary stabilization effects. Intriguingly, mixing the bisphosphine lig-
and with amino acid-based additives (S)-8, (S)-9 and (S)-10, all of which have the same chirality 
as the ligand’s selector unit, immediately gave rise to a new singlet species, (Rax
C2)-7 at the 
expense of the two doublets of (Rax
C1)-7 (see Figure 2-12 and Table 2-1).  
 
Figure 2-12: Exemplary 31P NMR spectra of interaction studies between equilibrated ligand 7  (a) and (S)-amino acid 
derived additives 8-10 that shows formation of a new singlet species (b), which was assigned to a “re-symmetrized” 
monomer (RaxC2)-7 that forms at the expense of dimeric (RaxC1)-7 when the additives inhibit dimerization and occupy 
binding sites instead. Re-equilibration of these mixtures changes the ligand distribution (see Table 2-1). The exact 
stoichiometry of (RaxC2)-7 and the shown structure serves as an example. 
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Interactions between ligand and additive break the supramolecular dimer (Rax
C1)-7 and binding 
sites are instead occupied by excessive additive molecules, thus yielding a labile, “re-symme-
trized” additive-ligand hydrogen bond adduct (Rax
C2)-7 of unknown structure and stoichiometry. 
The process was found to be reversible. Placing a sample of ligand and poorly soluble diamide 
(S)-9 in the fridge led to crystallization of the additive. As a result, (Rax
C2)-7 vanished and (Rax
C1)-
7 reformed. The extent of re-symmetrisation was found to be depending on the type of substitu-
ents on the diamide additive (see Table 2-1, entries 2, 4 and 5). Apart from hydrogen bond donor 
and acceptor sites, bulky aromatic moieties for π-interactions or additional steric repulsion were 
found vital to maximize the effect, indicating a three-point interaction pattern.[110] After re-equi-
libration, a further increase of the diastereomeric excess (de) of 7 was observed for all samples 
mentioned above. The strongest enrichment was found to occur in presence of phenylalanine 
derivative (S)-8 (dr 7:93 Sax:Rax, de = +18%). When “mismatched” diamide (R)-8 was used, 
almost no re-symmetrisation was observed (Table 2-1, entry 3). This demonstrates the stereose-
lective nature of the interactions and is in line with the enantiodiscriminatory capacity of the 
tBuNH-(S)Val-NH moiety as a selector site in CSPs. Equilibration of this sample led to a slight 
decrease of the de of (Rax)-7 (dr 24:76 Sax:Rax, de = -16%). As expected, both achiral additives 
DMSO-d6 and 11 were also found to reduce the excess of the ligand’s major rotamer (Table 2-1, 
entries 6 and 7). While a high excess of DMSO-d6 lead to significant line broadening and unin-
terpretable NMR spectra, DCU, like compound (R)-8, only shifted the ligand’s equilibrium dis-
tribution without changing the unsymmetrical appearance of (Rax)-7. Beyond these differences, 
observations confirm the assumption that the rotameric enrichment of the bisphosphine is based 
Table 2-1: Distribution of ligand species of bisphosphine 7 after equilibration in presence 
in different chiral and achiral compounds. 
 
Entrya) Solvent/Additive (eq.) Ligand Species of 7 [%] 
  Sax RaxC2 RaxC1 ded) 
1 CDCl3/no additive 16 0 84 68 
2 CDCl3/(S)-8 (10 eq.) 7 82 11 86 
3 CDCl3/(R)- 8 (10 eq.) 24 5 71 52 
4 CDCl3/(S)-9 (5 eq.)b) 9 59 32 82 
5 CDCl3/(S)-10 (10 eq.) 11 38 51 78 
6 DMSO-d6 35 ndc) 65 30 
7 CDCl3/11 (10 eq.)b) 33 0 67 34 
a) Detailed experimental protocol can be found in the experimental section. b) Solute did not fully dissolve. c) Not 
determined. Measured in CDCl3 after equilibration to circumvent heavy line broadening.  
d) de = (Rax
C1+Rax
C2)-Sax 
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on non-covalent interactions of highly enantioselective nature, which is governed by the central 
chirality of the selector moieties. 
2.3.4 Enantioselective hydrogenation experiments 
Ligand 7 was subsequently employed in Rh-catalyzed hydrogenation experiments. Ligand pre-
cursor 6 was tested in the same context to assess the stereoselectivity provided by the ligand 
core during the asymmetric hydrogenation of methyl 2-acetamidoacrylate (12). Ligand (Sax)-6 
has been enantiomerically purified by preparative HPLC and isolated with 91 % ee Sax. In situ 
reaction with [Rh(COD)2]BF4 gave a catalyst that converted substrate 12 with 90 % ee in favour 
of the (S)-enantiomer, verifying that the ligand’s rotamer distribution closely correlates with the 
selectivity of the asymmetric transformation, as previously found for the 3,3’-methoxy substi-
tuted BINAP ligand.[95] Hereafter, equilibrated ligand 7 (dr 16:84 Sax:Rax, 68% de Rax) was em-
ployed under identical conditions generating (R)-13 with 65% ee (see Figure 2-13).  
 
Figure 2-13: Asymmetric hydrogenation of methyl 2-acetamidoacrylate 12 using bisphosphine ligands 5 and 7. The 
diagram shows the diastereomeric/enantiomeric ratio (er/dr) of ligand rotamers and the corresponding enantiomeric 
ratio of 13 (colored bars), as well as the enantiomeric excess (ee%) of the latter (black lines) and its change when the 
ligand was aligned by an additive (ee%). Additives were added to the ligand in a 10-fold excess and the mixture 
was equilibrated at 60 °C prior to complexation. In case of (S)-9, only a 5-fold excess was used and not all solids 
dissolved. All reactions showed full conversion. Detailed experimental procedure can be found in the experimental 
section in chapter 7.2.17  on page 121. 
Assuming the same degree of stereoinduction as ligand 6, given identical substituents on the 
ligand core in 3,3’-position,[95] these findings corroborate the assignment of ligand rotamers that 
was originally based on the crystal structure. Hydrogenation experiments of complexated lig-
ands previously pre-conditioned in presence of a chiral diamide gave product enantiomer distri-
butions of 13 that correlated with the change of the ligand rotamer equilibria mentioned above. 
While equilibration with (R)-8 led to a selectivity drop to 46% ee R (ee = -19%), all other 
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additives allowed for a conversion of 12 with higher selectivity. Best results were achieved with 
AcNH-(S)Ala-NH(3,5-dichlorophenyl) (S)-9, which increased the catalysts selectivity to 83% 
ee R (ee = +18%). 
2.4 Investigation of selector-modified bisphosphinite ligands  
2.4.1 Syntheses 
For the synthesis of stereodynamically flexible bisphosphinite ligands, a precursor derived from 
2,2’-biphenol (BIPOL) was found to be the most convenient approach (see Figure 2-14). Due to 
the ease of synthesis, it a was also decided to investigate changes in the selector structure. Apart 
from the previously employed selector (tBuNH-(S)Val-NH, a), a modified version with terminal 
1-adamantyl group, which was supposed to act as a more sterically demanding terminal substit-
uent, was devised (1-AdNH-(S)Val-NH, b). Moreover, a phenylalanine-based selector was syn-
thesized (tBuNH-(S)Phe-NH, c), to incorporate an aromatic moiety into the selector structure 
and potentially benefit from an additional π-interaction after those where found beneficial during 
interaction studies between bisphosphinite 7 and differently substituted additives. Lastly, a gly-
cine-derived bisphosphinite was synthesized (tBuNH-Gly-NH, d) to allow for investigation of 
achiral selector sites, as well (see chapter 3 for details). 
 
Figure 2-14: Synthesis of phosphinite ligands 19a-d, i) PhI(OAc)2, 51%, ii) KOH, 97%, iii) amide selector hydro-
chloride, EDCI·HCl, HOBt, DIPEA, then excess Me2NCH2CH2NH2, 89% a; 51% b, 91% c, 80% d, iv) PPh2Cl, 1,4-
diazabicyclo[2.2.2]octane, 49% a, 53% b, 83% c, 53% d. 
In a straightforward synthesis, methyl vanillate 14 was initially oxidatively dimerized using (di-
acetoxyiodo)benzene to build the biphenyl backbone (15).[111] Subsequent saponification gave 
dicarboxylic acid 16. Notably, introduction of the selectors by amide coupling could be con-
ducted without protection of the phenolic hydroxyl groups. After initial EDCI·HCl/HOBt-me-
diated amide coupling between compound 16 and 2.5 equivalents of the corresponding selector 
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amine hydrochloride, excess carbodiimide reacted with the free hydroxy groups on the phenol 
to form adduct 17. It was found that this addition could be reversed by treating 17 with an excess 
of N,N’-dimethylethylenediamine to aminolyse the isourea. Aqueous workup gave selector-
modified biphenols 18a-d without further purification in high purity. Final treatment of the BI-
POLs with chlorodiphenylphosphine in presence of DABCO[112] yielded the desired bisphos-
phinite ligands 19a-d as white solids. 
2.4.2 Structural investigations 
As structural similarities to bisphosphine 7 suggest, dimerization was also observed for bisphos-
phinite ligands 19a-d. Formation of the supramolecular hydrogen bond complexes could be ver-
ified by NMR spectroscopy, where two sets of signals could be detected in 1H, 13C{1H} and 
31P{1H} NMR spectra. In contrast to the bisphosphine, no coupling was observed between the 
two phosphorus atoms. However, strong cross peaks in two-dimensional 1H-13C HMBC spectra 
were found that link both signal sets to the same molecular scaffold (for spectral data see chapter 
7.2.11, page 102). Intriguingly, bisphosphinites 19a-c were found to exist as one diastereomer-
ically pure species and no minor rotamer was be detected for any of them. This indicates that 
the energy gap between the two rotamers is increased due to enhanced hydrogen bond-driven 
stabilization of the enriched species, which, in analogy to previous example of bisphosphine 7, 
was assigned to the Rax isomer. For ligand 19d, the achiral nature of the selector sites conse-
quently leads to formation of racemic Sax and Rax dimers. When ligands where complexated to a 
rhodium center, significant line broadening was observed, but the dimerization and the associ-
ated enrichment process were found not to be affected. 
Suitable crystals for X ray analysis were obtained of glycine-based ligand 19d. The resulting 
crystallographic data showed close resemblance the one obtained for (Rax)-7. The same supra-
molecular arrangement was found, where two ligands of the same axial chirality form a C2-
symmetric dimer that is stabilized by six hydrogen bonds and that renders the molecular halves 
of each subunit chemically and magnetically inequivalent, hence resulting in the additional set 
of NMR signals. (see Figure 2-15). 
1H NMR signals of amide protons were found to be strongly shifted to low fields. Signals for 
compound 19a were observed at 9.43, 9.12, 8.11 and 7.56 ppm, while ligands 19b-d showed 
shifts between 9.46 and 7.44 ppm, between 9.75 and 7.59 ppm and between 10.22 and 7.67 ppm, 
respectively. The stronger lowfield shift compared to bisphosphine (Rax)-7 is in line with the 
observation of complete diastereoenrichment, since a stronger shift represents stronger hydrogen 
bonding which, in turn, increases ground state stabilization of the dimer and is the driving force 
for the rotameric enrichment.  
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Figure 2-15: Representation of the single crystal X-ray structure of 19d, which closely resemble that of bisphosphine 
7 shows on page 12. Two Rax molecules form a supramolecular C2-symmetric dimer of C1-symmetric subunits (carbon 
atoms of different subunits are indicated in beige and grey). Hydrogen bonds are indicated with light blue lines. To 
improve clarity, OPPh2 moieties are abstracted as orange placeholder atoms and non-relevant hydrogen atoms as well 
as solvent molecules are omitted. Nitrogen = blue, oxygen = red. Images were produced using UCSF Chimera.[99] 
Temperature-dependant NMR spectra of 19a were collected in steps of 20 °C between -40 and 
100 °C. Shifts of the amide protons with rising temperature can be used to qualitatively asses 
the strength of hydrogen bonds. Protons shifting with 0 to -4 ppb K-1 are either strongly bonded 
or not bonded at all, hence insignificantly changing their chemical surrounding with increased 
temperature, while chemical shifts >4 ppb K-1 indicate weakly bonded hydrogen atoms.[113,114] 
The three amide protons, believed to be participating in the hydrogen bond network according 
to the established binding model, exhibit shifts of -0.84, -2.76 and -3.58 ppb K-1, whereas the 
forth, “unbonded” one shifts with -6.25 ppb K-1 (see chapter 7.2.13, page 107, page  for spectral 
data). Since absence of hydrogen bonds for the first three protons can be ruled out on the basis 
of previous experiments, the obtained values indicate a much stronger hydrogen bonding 
strength for those protons in comparison to the last one, which is in good agreement with the 
assumed arrangement of the ligand subunits. 
When respective 31P NMR spectra were compared, significant line broadening was observed at 
higher temperatures. At 40 °C, a new singlet species appeared and vanished again when another 
spectrum was collected at room temperature afterwards (see chapter 7.2.13, page 108 for spectral 
data). As with bisphosphine ligand 7, this indicates that the ligand loses a stabilizing force at 
elevated temperatures and regains structural flexibility due to breaking of weak non-covalent, 
intermolecular bonds. Formation of the new singlet species after very moderate heating addi-
tionally signifies that the dimeric complex retains enough dynamic at ambient temperatures to 
disengage and undergo chemical exchange with other complexes. This indicates that the state of 
rotameric enrichment is self-reinforced by dynamic exchange among the complex subunits, 
which is a form of stereocontrol that resembles that found in sergeant-soldier-type self-organ-
izing, supramolecular systems. Nonetheless, attempts to interfere with the dimeric hydrogen 
 
  side view     front view     side view 
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bond network by adding diamide 8 failed, and no re-symmetrisation was observed, which sup-
ports the assumption that a comparably stronger binding force is the cause of the quantitative 
rotational enrichment. 
In order to corroborate the supramolecular nature of the hydrogen bonding, a crossover experi-
ment was conducted by mixing ligands 19a and 19b, which only differ with respect to their 
terminal amide substituents. While each individual ligand gave two singlet signals in their re-
spective 31P NMR spectrum, a 1:1 mixture of both ligands immediately gave rise to new species 
represented by four additional singlet signals of identical intensity (see Figure 2-16). In accord-
ance with previous observations, the additional four signals were attributed to a heterodimeric 
ligand complex comprising both ligand types, where all four phosphorus atoms become diastere-
otopic. The ratio of the dimers was found to be 1:2:1 (19a²:19a∙19b:19b²) A 2:1 mixture of the 
same ligands resulted in formation of the same species in a 4:4:1 ratio (19a²:19a∙19b:19b²), 
signifying a statistical distribution of ligand species with no preferential interaction with respect 
to the two different selector types. Kinetic considerations as well as spectral data for the latter 
experiment can be found in chapter 7.2.12.1, page 105. 
Comparing the ligand mixtures to the respective pure ligand samples revealed a very similar 
behaviour. NMR signals of heterodimeric species showed similar signal patterns and, most no-
tably, all amide protons exhibited similarly strong downfield shifts. Also, when conduction 31P 
NMR measurements at elevated temperatures, similar line broadening and formation of a new 
singlet signal representing monomeric ligand molecules was observed, both of which was re-
versed when the same sample was re-measured at room temperature again afterwards.  
 
Figure 2-16: 31P NMR spectra of (a) individual ligands 19a and 19b and of (b) an equimolar mixture of two ligands 
where a total of eight signals could be observed and the four new signals were assigned to a supramolecular hetero-
dimer comprising both ligand types. Results for the experiment with a 2:1 mixture as well as kinetic considerations 
can be found in chapter 7.2.12.1, page 105.  
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Most crucially, as with the individual ligands, newly formed heterodimers where not affected 
by the presence of chiral diamides and no inhibition of the intermolecular interactions were ob-
served, when diamide (S)-8 was added to compete over hydrogen bonding sites. 
The swift formation of the mixed ligand dimer supports the assumption mentioned above that 
chemical exchange still occurs at room temperature and individual molecules change interaction 
partners rapidly despite strong hydrogen bonding. Furthermore, the findings provide definite 
proof for the formation of supramolecular structures in solution. Assuming that the investigated 
enrichment phenomenon and the C1-symmetric appearance could also be caused by intramolec-
ular selector interactions or other conformational changes (e.g. amide cis-trans isomer-
ism),[115,116] formation of a mixed ligands species clearly disproves these possibilities. 
To analyse the spatial atomic arrangement in a supramolecular structure, NOE-based two-di-
mensional spectroscopy is usually a convenient approach. NOESY experiments on hydrogen 
bonded structures with intrinsic symmetry are problematic, however, if the subunits retain suf-
ficient dynamic for chemical exchange on the NMR timescale. It results in the difficulty to dis-
tinguish proximity-based cross peaks from chemical exchange or dynamic TOCSY trans-
fer.[117,118] Conveniently enough, this was not the case for bisphosphinite 19a and NOESY spec-
tra could be collected without signs of chemical exchange. Since crystallographic data on 19a 
was unavailable, a model structure was generated in order to allow a qualitative comparison of 
NOE cross peaks with atomic distances within the ligand dimer. The structure model-19a was 
based on the crystallographic data obtained for glycine derivative 19d and the stability of the 
dimer was verified by geometry optimization using DFT calculations on the B3LYP/(aug)-cc-
pVDZ level (see chapter 7.2.14, page 109 for details). The most prominent atomic proximities 
extracted from the NOESY spectrum are illustrated in Figure 2-17 (see SI for spectral data). 
Cross peaks were found between protons H4 and H6’.2 Comparing atomic distances in model-
19a suggests that intramolecular coupling of corresponding atoms within the same molecule is 
not possible (d(H4,H6’, intra) = 5.818 Å). Intermolecular coupling, however, seems likely 
(d(H4,H6’, inter) = 2.703 Å). Coupling was also observed for protons H9 and H8’ and for H9 
and H10’, which both accounts for the interaction between inner and outer sphere selector and 
where atomic distances of d(H9,H8’, inter) = 2.543 Å and d(H9,H10’, inter) = 2.334 Å were 
found in the model structure. Respective atomic distances for the other halve of the dimer were 
found to be similar with a maximum deviation of 0.05 Å. 
                                                     
2 In the following notation, HX refers to an inner sphere proton and HX' to an outer sphere proton. 
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Figure 2-17: Calculated structure (Rax/Rax)-model-19a after geometry optimization on the theoretical level 
B3LYP/(aug)-cc-pVDZ (left). Initial guess of model-19a was based on the crystal structure of 19d (see chapter 
7.2.14, page 109 for details). To improve clarity, only annotated hydrogen atoms are shown and OPPh2 moieties are 
abstracted as orange placeholder atoms. Image was produced using UCSF Chimera.[99] The two molecular subunits 
of the dimer are coloured in light and dark grey. Nitrogen = blue, oxygen = red, OPPh2 moiety = orange. A simplified 
representation of the structure is also given (right). Atomic distances are depicted in green dashed lines. Respective 
atomic distances for the lower side of the dimer were found to be similar with a maximum deviation of 0.05 Å.  
2.4.3 Enantioselective hydrogenation experiments 
Diastereomerically pure ligands 19a-c were employed in Rh-catalyzed hydrogenation experi-
ments of prochiral olefins 12 and 20-22.3 Catalysts were formed by treating a solution of the 
ligand with [Rh(COD)2]BF4. All three ligands exhibited high to very high enantioselectivities. 
Phenylalanine derived ligand 19c performed slightly better than valine-based bisphosphinites. It 
allowed conversion of methyl 2-acetamidoacrylate 12 with an enantiomeric ratio of 4.0:96.0 
(S:R), methyl N-acetylcinnamate 20 with a ratio of 5.5:94.5 (S:R) and dimethyl-2-methyl suc-
cinate 21 with 94.9:5.1 (S:R). For enamide 22, a selectivity of 6.3:93.7 (S:R) was obtained. An 
overview over all hydrogenation experiments can be found in Figure 2-18. Conveniently 
enough, obtained selectivities were comparable to those found for enantiopure atropos ligands 
of similar built.[119] In a second set of experiments, substrate loadings and hydrogen pressure 
was varied yielding identical outcomes. These experiments were designed to prove that the cat-
alyst’s selectivity is independent of the turnover number (TON). Consequently, these findings 
exclude selective catalyst activation or structural change of the catalyst over time as a source of 
selectivity. Catalyses were also conducted in THF and MeOH to evaluate solvent effects. While 
THF, a weakly coordinating solvent, gave a similar product distribution for the hydrogenation 
                                                     
3 For experiments concerning glycine-based ligand 19d, see chapter 3.4.1, page 44. 
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of substrate 12 using ligand 19c (4.8:95.2, S:R) compared to CDCl3, employment of methanol 
as reaction solvent led to a significant drop in selectivity (19.2:80.8, S:R), which can be attributed 
to the solvent inhibiting ligand-ligand interaction that drive the rotameric enrichment. 
 
Figure 2-18: Overview over asymmetric hydrogenation experiments of prochiral olefins 12 and 20-22 using diastere-
omerically pure ligands 19a-c (left) and control experiments under differing reaction conditions to evaluate the origin 
of the catalyst’s selectivity (right). All reactions showed full conversion. Enantiomeric ratios were determined by 
chiral GC or HPLC. Detailed experimental procedures can be found in chapter 7.2.17 on page 121. 
2.4.4 Selector comparison 
Comparison of the ligands 19a-c with respect to their selector types shows no significant differ-
ence (for further investigations concerning ligand 19d, see chapter 3.4.1). Full rotameric enrich-
ment and very similar behaviour during structural investigations was observed in all three cases. 
Additional sterical pressure provided by the adamantyl moiety had no adverse effect on dimeri-
zation as evident from the crossover experiment, where distribution of species was found to be 
purely statistical. Strongest low-field shifts of amide protons were observed for phenylalanine 
derivative 19c, which is an indicator for increased binding strength. Accordingly, this ligand 
was found to exhibit the highest selectivities during asymmetric hydrogenation reactions, which 
might either be caused by higher supramolecular stability or by a change in the ligands dihedral 
angle[120,121] due to the difference in the selector’s substitution pattern.  
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2.5 Investigation of selector-modified phosphoramidite ligands  
2.5.1 Synthesis 
Stereodynamic phosphoramidite ligands could be conveniently synthesized from the same BI-
POL precursors as the respective bisphosphinite ligands (see Figure 2-19). Valine-based ligand 
23a was prepared by refluxing a suspension of biphenol 18a in toluene in the presence of 
tris(diethylamino)phosphine to give the desired phosphoramidite in good yields. Phenylalanine 
derivative 23b was synthesized by treating the corresponding diol with diethylphosphoramidous 
dichloride in presence of triethylamine. 
 
Figure 2-19: Synthesis of phosphoramidite ligands 23a,b. Diols 18a and 18c were prepared as shown in Figure 2-14, 
page 17. i) P(NEt2)3, 56%, ii) NEt2PCl2, NEt3, 74%.  
2.5.2 Structural investigations 
Based on structural similarites to previously discussed bisphosphine and bisphosphinite ligands, 
the synthesized phoshoramidites were expected to undergo the same dimerization process that 
entails cooperative chiral induction to yield diastereomerically pure ligands. Since this ligand 
type has a very low isomerization barrier, it is exceedingly difficult to distinguish between the 
two ligand rotamer states by means of NMR spectroscopy. Both ligands, however, were found 
to exhibit C1-symmety leading to a doubling of NMR signals in 1H and 13C NMR spectra and 
amide protons exhibited low field 1H NMR shifts between 10.64 and 7.63 ppm (23a) and be-
tween 10.72 and 7.32 ppm (23b), which proves very strongly engagement in hydrogen bonding. 
These findings have previously been identified as indicators for the supramolecular arrangement 
for these types of diamido-modified ligand structures (see chapter 2.3.2 and 2.4.2). Intriguingly, 
the reduction of symmetry for ligands 23a and b was found to have another consequence. Since 
the two sides of each ligand subunit within the hydrogen bonded complex are chemically non-
equivalent, the phosphorus atom becomes chiral. As a result, diastereomeric adducts with dif-
ferent chirality at the phosphorus atom form. In the resulting 31P NMR spectrum, the two C2-
symetric homomers (S,S,Rax,P*R)/(S,S,Rax,P*R) and (S,S,Rax,P*S)/(S,S,Rax,P*S) produce one singlet 
signal each while the C1-symmetric heteromer (S,S,Rax,P*R)/(S,S,Rax,P*S) gives two more singlet 
signals (see Figure 2-20). Consequently, another fourfold increase in signals is observed in 1H 
and 13C NMR spectra.  
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Figure 2-20: a) Reduction of symmetry renders phosphorus atoms in phosphoramidite ligands 23a und 23b chiral. b) 
Three different diastereomeric adducts form during dimerization that can be distinguished by NMR. For annotation 
of stereogenic phosphorus atoms, each inner sphere ligand half was given priority over the outer sphere half. 
Finally, assumptions that the observation of additional signals is related to the formation of hy-
drogen bond dimers comprising both Rax and Sax ligand isomers, instead, can be dismissed. Pre-
viously discussed geometrical considerations of the selector interaction patterns make Sax/Rax-
adducts unfeasible due to the divergent selector orientation (see crystal structures in Figure 2-11 
and Figure 2-15). 
2.5.3 Hydrogenation experiments 
Phosphoramidite ligands 23a and 23b were also employed in rhodium-catalyzed asymmetric 
hydrogenations of olefins 12 and 20-22. It is worth stressing that due to the monodentate nature 
of this ligand type, two molecules were needed to saturate a rhodium center. Since the ligands 
form supramolecular dimers, it is plausible that structurally dynamic oligomers or polymers with 
many catalytically active centers were formed during complexation. This is supported by the 
observation that complexes formed in situ using rhodium precursor [Rh(COD)2]BF4 gave base-
line-broadened 31P NMR signals ranging over multiple ppm along with intense line broadening 
in the corresponding 1H NMR spectra, both of which is common for polymeric, dynamic struc-
tures. 
Both catalysts, formed in situ, were found to be less selective in comparison to their bisphos-
phinite-based counterparts. Enantiomeric ratios ranged from 56.2:43.8 (S:R) for the reduction of 
1-phenyl-1-acetamidoethylene 22 using ligand 23a to 73.2:26.8 (S:R) when the same catalyst 
was employed with olefin 12. All other transformations were found to occur with similar selec-
tivities (see Figure 2-21). Most intriguingly, it was found that changing the selector motive from 
(S)-valine to (S)-phenylalanine was accompanied by an inversion of selectivity during later ca-
talysis for all tested substrates. While the former ligand exhibited selectivity for the generation 
of the S enantiomer during the reduction of substrates 12, 20 and 22 and for the R enantiomer in 
case of substrate 21, the latter proved to predominantly produce the opposite enantiomer in each 
case. Also, when both ligands were employed during reduction of olefin 22 in a ratio of 1:1, a 
very low er of 51.2:48.8 (S:R) was obtained. This clearly indicates that for these catalysts, the 
selectivity of the transformation is not exclusively based on the axial chirality of the ligands. 
Arguably, the diastereomeric distribution of the P*-chiral ligands might depend on the nature of 
the selector and cause this phenomenon. Another possible explanation is that the substitution 
pattern on the selector units affects the degree and dynamic of the catalyst oligomerization men-
tioned above. Lastly, it is also known that phosphoramidite complexes exist as a mixture of 
several different Rh-P rotamers, whose distribution might also affect the catalyst’s selectivity 
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and is possibly being affected by the structure of the ligand backbone. Still, it remains unclear, 
how such an inversion of selectivity can be evoked by a subtle change of the selector’s substitu-
tion pattern and without changing its chiral information. Clearly, an answer to this question ne-
cessitates further investigation on the exact structure and dynamics of the catalytic system.  
 
Figure 2-21: Overview over asymmetric hydrogenation experiments of benchmark olefins 12 and 20-22 using phos-
phoramidite ligands 23a and 23b. All reactions showed full conversion. Enantiomeric ratios were determined by 
chiral GC or HPLC. Detailed experimental procedures can be found in chapter 7.2.17 on page 121. 
2.6 Investigation of selector-modified BIPOL ligands  
2.6.1 Structural investigations 
BIPOL compounds 18a-c were observed to undergo the same transformation into diastereomer-
ically pure dimers that was identified for bisphosphinite ligands 18a-c and phosphoramidite lig-
ands 23a-b derived thereof. Formation of the supramolecular hydrogen bond complexes could 
be identified by NMR spectroscopy, where two sets of signals could be detected in both 1H and 
13C NMR spectra (see exemplary spectrum in Figure 2-22b) and again, strong cross peaks in 
two-dimensional HMBC spectra were found that link both signal sets to the same molecular 
scaffold (for spectral data see chapter 7.2.11, page 102). In all three cases, no minor species was 
observed.  
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Figure 2-22: a) Overview of investigated BIPOL compounds and synthesis of methylated biphenol 24. b) Aromatic 
section of the 1H NMR spectrum of BIPOL 18a at -20 °C. Two sets of signals of equal intensity were observed 
representing the inner sphere (green) and the outer sphere (orange) of the supramolecular dimer. 
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The dynamic of the tropos biphenols was found to depend on the substitution pattern of the 
selector. While NMR spectra for valine-based BIPOLs 18a and 18b needed to be collected at -
20°C to avoid excessive line broadening, phenylalanine-derived BIPOL 18c exhibited sharp, 
well-defined NMR signals at room temperature.  
To verify the dimeric structure of the biphenol compounds, BIPOL 18c was methylated with 
iodomethane to afford compound 24 from which single crystals suitable for X-ray analysis could 
be grown (see Figure 2-22a). The structure shows the same characteristics that were found for 
that of bisphosphine (Rax)-7 and bisphosphinite 19d (see Figure 2-23). 
 
Figure 2-23: Representation of the single crystal X-ray structure of 24. Two Rax molecules form a supramolecular C2-
symmetric dimer of C1-symmetric subunits (carbon atoms of different subunits are indicated in beige and grey). Hy-
drogen bonds are indicated with light blue lines. Non-relevant hydrogen atoms as well as solvent molecules are omit-
ted for clarity. Nitrogen = blue, oxygen = red. Images were produced using UCSF Chimera.[99] 
The stability of the diols towards oxygen, moisture and protic solvents subsequently allowed to 
conduct additional experiments to verify that the structural arrangement found in the solid state 
is identical to that in solution. In analogy to previous experiments with bisphosphinite ligands 
19a and 19b, formation of a heterodimeric species was observed, when BIPOLs 18a and 18b 
were mixed in solution (see Figure 7-14, page 106 for spectral data). In a subsequent titration 
experiment, phenylalanine-based BIPOL 18c was dissolved in mixtures of CDCl3 and CD3OD 
with ratios of 99:1, 90:10, 50:50 and 0:100 (v:v) and 1H NMR spectra were collected in order to 
investigate the impact of solvent molecules capable of hydrogen bonding on the amide protons 
of the BIPOL dimer (see Figure 2-24).  
In accordance with previously suggested bonding patterns, proton Ha, which is part of the C5:C5 
interaction in the inner sphere of the dimer, and protons Ha’ and Hb, that form the outer sphere 
C7:C5 interaction, show very subtle overall shift differences between  = -0.18 ppm for NHa 
and NHa’ and  = +0.20 ppm for NHb. The “unbonded” and exposed amide proton NHb’, how-
ever, underwent a downfield shift of  = +1.97 ppm due to increased solvent interaction. 
  
 side view   front view   side view 
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Figure 2-24: 1H NMR spectra showing the titration experiment of BIPOL 18c. Dissolving the compound in different 
mixtures of CDCl3 and CD3OD gave different shifts for amide protons corresponding to their exposure to solvent as 
predicted by the structural model shown in the top right corner.  
In a follow-up experiment, HD exchange rates of the amide protons were investigated. These 
are reliable indicators for non-covalent interactions of amide groups as these rates are strongly 
influenced by proton fixation through hydrogen bonding. The speed of exchange also depends 
on both substitution pattern and electronics of the amide moiety.[122,123] To obtain reference val-
ues, model compound (S)-25 was synthesized, which provides exchangeable protons in the same 
electronic and steric environment compared to the selector moieties of 18c, but which was con-
sidered not to engage in strong self-interaction due to the lack of a comparable chelating effect. 
Solutions in freshly opened, deuterated methanol were prepared (20 mM 18c, 40 mM (S)-25) 
and spectra were collected periodically to monitor the decrease of the amide proton signals. Due 
to high excess in methanol, exchange kinetics were calculated based on a pseudo-first order 
reaction (see chapter 7.2.16, page 119 for details). Half-life times t1/2 and corresponding ex-
change rates kex are shown in Table 2-2. As expected, amide protons of model compound (S)-25 
were found to undergo deuterium exchange significantly faster. Proton Ha25 had already fully 
exchanged before the first measurement could be conducted and the signal for Hb25 had vanished 
after two hours. For BIPOL 18c, however, exchange took place on a different timescale. Amide 
protons Ha18c and Ha’18c took roughly 20 hours while Hb18c and Hb’18c took about nine weeks to 
undergo complete deuterium exchange. Evidently, hydrogen bonding immobilizes amide pro-
tons, which greatly decreases the rate of deuteration. In order to analyse the bonding pattern, 
retardation factors were calculated to normalize exchange rates of 18c with those of diamide (S)-
25 allowing for a direct comparison of the deceleration for each individual amide proton of the 
BIPOL ligand (see Table 2-2). Exchange rate constants decreased by a factor of 2554 and 2402 
for Ha18c and Ha’18c, respectively. For the terminal amide protons Hb18c and Hb’18c, retardation 
factors of 917 and 731 were found. These values are in good agreement with the proposed bind-
ing model: Amide proton Ha18c, located in the inner sphere center of the complex, profits from 
a strong and stabilizing chelating effect of the surrounding hydrogen bonds and shows the 
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strongest exchange slowdown. Proton Ha'18c benefits to a similar extent but is deuterated slightly 
faster because of its peripheral position. In comparison, exchange of terminal amide proton Hb18c 
is decelerated 2.5 times less since only one hydrogen bond needs to be broken. Finally, proton 
Hb'18c experiences the smallest exchange retardation due to the exposed position on the outside 
of the complex and the measured slowdown can be attributed to chemical exchange of the sub-
units within the dimer. 
2.6.2 Enantioselective alkylation of aromatic aldehydes  
2,2’-biphenols have found successful application as ligands in homogeneous catalysis.[124,125] 
Among the most prominent examples is the Ti-catalyzed alkylation of aromatic aldehydes. Chan 
et al. pioneered the use of atropos (S)-BINOL and diethyl zinc to convert a range of substrates 
with excellent selectivities.[126,127] Using these studies as a starting point, stereodynamic BIPOLs 
18a-c were employed for the same reaction type.  
Prior to catalytic experiments, formation of the BIPOL-titanium complex and the interplay with 
ZnEt2 was investigated. When ligand 18c was mixed with an equimolar amount of Ti(O
iPr)4 in 
dichloromethane, yellow solids formed and almost quantitative precipitation of the ligand was 
confirmed by 1H NMR spectroscopy (see chapter 7.2.18.1, page 122 for spectroscopic data). 
When the solids were treated with another six equivalents of the titanium precursor, a clear, 
yellow solution was produced and formation of a variety of complex species comprising dimer-
ized ligands was spectroscopically observed. These findings suggest that stoichiometric employ-
ment of biphenol 18c and titanium tetraisopropoxide gives hardly soluble complexes of un-
known composition. Their dissolution upon addition of more titanium precursor implies coordi-
Table 2-2: Half-life times and exchange rates for HD exchange in deuterated methanol. 
 
Compounda) 
Diol 18c Diamide (S)-25 
Ha Hb Ha’ Hb’ Ha Hb 
t1/2 
[102 min] 
1.91 253.3 1.80 201.6 0.0008b) 0.28 
kex 
[sec-1] 
6.0 · 10-5 4.6 · 10-7 6.4 · 10-5 5.7 · 10-7 1.5 · 10-1 4.2 · 10-4 
Retardation 
Factorc) 
2554 - 2402 - 1 - 
- 917 - 731 - 1 
a) Experiments were conducted at room temperature with a 20 mM solution of 18c and a 40 mM solution of (S)-25 in deuterated 
methanol. b) Complete exchange was observed already after 30 seconds when the first spectrum was measured. Half-life time was 
therefore estimated (see chapter 7.2.16, page 119). c) Retardation Factor = kex(HX
25) / kex(HX
18c) 
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nation of two or more BIPOL units to the same titanium atom. Combined with the self-aggre-
gating behaviour of the BIPOL compounds, formation of larger clusters or MOF-like oligomers 
is assumed that fragment when the titanium concentration is increased. Subsequent addition of 
diethyl zinc resulted in additional line broadening but did not impair the integrity of the dimer-
ized diol complexes.  
In a first set of screening reactions with benzaldehyde as a benchmark substrate and diethyl zinc 
as alkylating agent, all three ligands were employed and the reaction conditions such as temper-
ature, solvent and reagent ratios were varied (see Table 2-3). Differences in the diols’ dynamics 
that were initially identified by comparison of their NMR spectra are reflected in their enanti-
oselectivities as ligands (entries 1-3). More dynamic valine-based compounds 18a and 18b al-
kylated benzaldehyde at 0°C with selectivities of 37.4% ee R and 29.4% ee R, respectively, and 
conversions below 62% after 16 hours. In contrast, phenylalanine-based ligand 18c gave 75.6% 
ee R and a conversion of 92.7% after the same amount of time. Consequently, further screening 
experiments were limited to this diol. When the reaction was run under identical conditions and 
stopped after eight hours, the same ee and reduced conversion was observed, which indicates 
Table 2-3: Reaction screening for the enantioselective alkylation of aromatic aldehydes using 
BIPOL ligands 18a-c. 
 
Entrya) Solvent Ligand Ratio Temp. Product analysis [%]e) 
   Ti/Ligand  Conv. ee  
1 DCM 18a 1.4/0.2 0 °C 61.8 37.4 R 
2 DCM 18b 1.4/0.2 0 °C 41.4 29.4 R 
3 DCM 18c 1.4/0.2 0 °C 92.7 75.6 R 
        
4b) DCM 18c 1.4/0.2 0 °C 76.2 75.4 R 
        
5 DCM 18c 1.4/0.2 25 °C 98.0 66.0 R 
6 DCM 18c 1.4/0.2 -20 °C 22.1 57.9 R 
        
7c) DCM 18c 1.4/0.2 0 °C 16.0 77.2 R 
8d) DCM 18c 1.4/0.2 0 °C 98.5 37.8 R 
9 DCM 18c 1.4/0.4 0 °C 65.1 79.8 R 
10 DCM 18c 1.4/0.05 0 °C 57.7 32.2 R 
        
11 THF 18c 1.4/0.2 0 °C 11.5 12.4 R 
12 Toluene 18c 1.4/0.2 0 °C 86.4 27.6 R 
13 Et2O 18c 1.4/0.2 0 °C 78.1 34.5 R 
14 MeCN 18c 1.4/0.2 0 °C 36.3 18.5 R 
15 EtOAc 18c 1.4/0.2 0 °C 35.0 77.2 R 
a) Benzaldehyde/Ti(OiPr)4/ZnEt2 = 1.0/1.4/3.0 (molar ratio) and 125 mM solution with respect to substrate. All reactions were 
stopped after 16 hours by quenching with NH4Cl solution. Detailed experimental procedure can be found in chapter 7.2.18.2, 
page 122. b) Reaction was stopped after eight hours. c) 20.0 mM solution with respect to substrate. d) 375 mM solution with 
respect to substrate. e) Conversion and ee were determined using chiral GC (Chirasil -Dex). Benzylic alcohol was found to 
only form in traces and is not considered. 
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that the catalyst does not change selectivity over time (entry 4). Variation of the reaction tem-
perature to 25 °C or -20 °C slightly in- or significantly decreased the yield but both changes 
resulted in a drop in enantioselectivity to 66.0% ee R or 57.9% ee R, respectively (entries 5 and 
6). Similar outcomes were observed when the reaction was run at higher concentrations (entry 
8), while a 6.5 times more diluted setup gave almost no conversion, but a slight increase in 
selectivity (entry 7). While the change in conversion along with in- or decreased concentration 
seems plausible, a lower selectivity at higher ligand concentration seems counterintuitive since 
the dimerization of a supramolecular ligand should be positively affected by this. These findings 
suggest that aside from the ligand’s diastereopurity, selectivity of the reaction is profoundly 
influenced by the interplay of the complex network of equilibria that is also affected by the 
change in concentration. As previously demonstrated, the ratio of titanium tetraisopropoxide and 
diol ligand also has a strong impact on the course of the catalysis, based on various reversible 
ligand exchange steps during the reaction cycle.[128] A decreased ligand loading (5 mol% to sub-
strate, 28:1 Ti:ligand) negatively affected both conversion and selectivity, while an increased 
amount of diol (40 mol% to substrate, 3.5:1 Ti:ligand) gave an equally reduced conversion, but 
slightly increased the enantiomeric excess to 79.8% ee R (entries 9 and 10). Varying solvents 
led to significantly smaller yields in all instances and only ethyl acetate gave enantioselectivities 
comparable to those of DCM (35.0% conversion and 77.2% ee R, entry 15). In total, conditions 
found optimal for the investigated catalytic system were found to match those previously iden-
tified by Chan et al. for the employment of BINOL for the same purpose. Moreover, a high 
selectivity for the formation of the product was observed and benzylic alcohol, which can be 
found as side product of this reaction, formed only in traces.  
In a second set of experiments, the origin of enantioselectivity during the catalytic cycle was 
investigated. Apart from diol-titanium complexes of various kinds, zinc complexes of small, bi-
functionalized molecules such as amino alcohols or bis(sulphonamides) are also well known to 
selectively catalyze the reaction.[129-131] For this reason, control experiments were conducted to 
ensure that selectivity was indeed induced by the axial orientation of diastereoenriched biphenol 
ligands and not simply by coordination of chiral diamide selector groups to a transition metal 
center (Table 2-4). A strong, inhibiting effect was found when selector-type diamide (S)-8 was 
added resulting in a drop of conversion and selectivity (entry 2). When a catalytic solution from 
racemic 2,2’-biphenol 26 and two equivalents of diamide (S)-8 was prepared, a very low enan-
tiomeric excess of 5% in favour of the R enantiomer was obtained indicating involvement of the 
diamide as ligand (entry 3). Indeed, when the incubation time prior to substrate addition was 
increased from 10 minutes to two hours, the same catalyst showed an increased enantioselectiv-
ity of 11.3% ee R along with greatly reduced activity (entry 4). Employment of diamide (S)-8 as 
sole ligand led to an even higher enantiomeric excess of 38.5% ee R, but only in the presence of 
the titanium precursor (entries 5 and 6). These experiments illustrate, that amino acid-derived 
diamides can coordinate to a titanium center in the presence of strong bases such as diethyl zinc, 
forming a less active and less selective catalyst for the alkylation reaction that can compete with 
the BIPOL-Ti complex. Since acidity of amide protons is affected by hydrogen bond formation, 
it seems plausible to assume that dimerization reduces the availability of the selector units on 
the investigated BIPOL ligand 18c to be deprotonated by a strong base and act as coordination 
units themselves. To verify this, the “capped” version of the ligand (24) was employed as ligand 
and the resulting catalytic mixture gave a full racemate (entry 7). These experiments allow for 
the conclusion that enantioselectivities of experiments with diol ligands 18a-c solely originate 
from the axial chirality of the self-assembling diol ligand.  
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Finally, a variety of different aromatic aldehydes were tested under standard reaction conditions 
(see Table 2-5). Most noticeable was the significant variation in conversion. While m-nitro-, 2-
methoxy- and -naphthaldehyde (entries 7, 9 and 10) gave good yields (94.7%, 79.5% and 
77.0%), 4-substituted aldehydes generally performed worse with yields ranging from 19.3% for 
4-methoxybenzaldehyde (entry 5) to 56.7% for 4-fluorobenzaldehyde (entry 4). When compar-
ing the enantiomeric distribution of the products, selectivity was found to scale inversely with 
sterical pressure around the aldehyde moiety. While most 4-substituted aldehydes were alkylated 
with enantiomeric excesses that were similar to that of benzaldehyde, substitution of the 1-posi-
tion caused a significant deterioration of selectivity. As an exception, 4-acetylbenzaldehyde was 
converted with a selectivity of 49.8% ee R (entry 6) similar to the more sterically crowded sub-
strates. Best selectivity was achieved for 4-fluorobenzaldehyde being alkylated with 76.9% ee 
R (entry 4), which slightly exceeded the benchmark value. Altogether, the observed trends re-
flect those previously found for atropos ligand (S)-BINOL by Chan et al. The lower selectivity 
can be attributed to the ligand’s residual stereodynamic or to a differing dihedral angle compared 
to BINOL. Furthermore, the spatial arrangement of the ligand dimer brings the transition metal 
centers of two interlinked titanium complexes closely together, which results in increased steri-
cal pressure when large substrates coordinate during the catalytic cycle. All of these issues could 
potentially be addressed by optimizing selector and biaryl substituents on the diol in order to 
Table 2-4: Investigation of the origin of chiral induction during the  
asymmetric alkylation. 
 
Entrya) Ligand Solute Reagents Product analysis [%]
d) 
 0.2 eq. 0.4 eq. Ti/Zn Conv. ee.  
1 18c - 1.4/3.0 92.7 75.6 R 
2 18c (S)-8 1.4/3.0 52.7 54.0 R 
       
3 26 (S)-8 1.4/3.0 82.7 5.0 R 
4b) 26 (S)-8 1.4/3.0 52.4 11.3 R 
5c) - (S)-8 1.4/3.0 33.0 38.5 R 
6 - (S)-8 0.0/3.0 9.1 3.8 R 
7 24 - 1.4/3.0 38.9 0.3 R 
a) Benzaldehyde/Ti(OiPr)4/ZnEt2 = 1.0/1.4/3.0 (molar ratio) and 0.125 M solution with respect to sub-
strate. All reactions were stopped after 16 hours. Detailed experimental procedure can be found in chap-
ter 7.2.18.2, page 122. b) Biphenol, diamide and titanium precursor were incubated in presence of ZnEt2 
for two hours prior to catalysis. c) 0.375 M solution of diamide with respect to substrate. d) Conversion 
and ee were determined using chiral GC (Chirasil -Dex). 
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further strengthen the hydrogen bond network and tune sterical hindrance around the cata-
lytically active center.  
2.7 Results 
This chapter details the investigation of a novel core motif for tropos biphenyl-based ligands. 
These were equipped with (S)-amino acid-based diamido groups (selectors) in the 5,5' position, 
that are inspired by selector units in the high-performance CSP for GC CHIRASIL VAL. Based 
on this motif, synthetic routes for bisphosphine 7 and for BIPOLs 18a-c, bisphosphinites 19a-d 
and phosphoramidites 23a-b were developed.  
The investigated substitution pattern was found to trigger a process of spontaneous rotamer en-
richment of the Rax isomer. The phenomenon was investigated, inter alia, by NMR spectroscopy, 
X-ray structure analysis and HD exchange experiments. It was found that highly diastereoselec-
tive, intermolecular non-covalent interactions of the selector groups lead to formation of well-
ordered ligand dimers. The central chirality of the amino acid-based selector units thereby dic-
tates the axial chirality of the ligand’s biphenyl backbones within the supramolecular structure. 
It allows only for Rax rotamers to dimierise causing selective stabilization of one rotamer that 
drives the ensuing rotameric enrichment. The entire process is controlled by cooperative chiral 
Table 2-5: Enantioselective alkylation of different aromatic aldehydes. 
 
Entrya) Substrate 
Conversion  
and eeb) 
Entry Substrate 
Conversion 
and eeb) 
1 
 
92.7% 
75.6% R 
6 
 
25.3% 
49.8% R 
2 
 
41.5% 
63.3% R 
7c) 
 
94.7% 
49.8% R 
3 
 
24.9% 
62.4% R 
8 
 
67.0% 
55.9% R 
4 
 
56.7% 
76.9% R 
9 
 
79.5% 
46.5% R 
5 
 
19.3% 
69.4% R 
10c) 
 
77.0% 
53.7% R 
a) Benzaldehyde/Ti(OiPr)4/ZnEt2/Ligand = 1.0/1.4/3.0/0.2 (molar ratio) and 0.125 M solution with respect to substrate. All reac-
tions were stopped after 16 hours. Detailed experimental procedure can be found in the 7.2.18.2, page 122. b) Unless stated 
otherwise, conversion and ee were determined using chiral GC (Chirasil -Dex). c) ee was determined by chiral HPLC (Chiralcel 
OD-H).  
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induction that results from the self-recognition properties of the selector units. It evokes a stere-
oconvergent response from the dynamic ligand core that can be described as a form of diastere-
oselective narcissistic self-sorting and the state of rotameric enrichment is self-reinforced by 
dynamic exchange among the complex subunits, which is a form of stereocontrol that resembles 
that found in sergeant-soldier-type self-organizing, supramolecular systems. 
The strength of the supramolecular hydrogen bonds was found to be slightly influenced by the 
substitution pattern of the selector. A much greater influence was exerted by the ligand-defining 
substituents in 2,2’-position of the biaryl backbone, which was found to affect the degree of 
rotameric enrichment. For bisphosphine 7, a strongly weighted equilibrium between a mono-
meric Sax rotamer and a dimeric Rax rotamer with a ratio of 16:84 (Sax:Rax) was found. This ratio 
could be influenced by interfering with the ligands self-interaction by addition of various chiral 
and achiral hydrogen bond donors and acceptors that would occupy the interaction sites. BIPOL 
ligands 18a-c, phosphinite ligands 19a-c and phosphoramidite ligands 23a-b were found to un-
dergo complete transformation into one diastereomerically pure Rax species each.  
All ligands were subsequently investigated for their potential as ligands in asymmetric reactions. 
BIPOL ligands were used in titanium-mediated enantioselective alkylation reactions of aromatic 
aldehydes. The path of chiral induction was examined and a variety of different alcohols could 
subsequently be generated with selectivities of up to 79.8% ee R.  
All phosphorus-based ligands were employed in asymmetric, rhodium-catalyzed hydrogenation 
reactions. Enantioselective reduction of methyl 2-acetamidoacrylate 12 with bisphosphine 7 pro-
duced methyl 2-acetamidoalanate 13 with an enantiomeric distribution of 17.4:82.6 (S:R), which 
closely corresponds to the previously determined rotamer distribution and indicates high selec-
tivity for each individual ligand rotamer. The enantiomeric excess of the product could subse-
quently be influenced by employing ligand mixtures whose rotameric distribution had previ-
ously been adapted by equilibration in presence of chiral amino acid derivatives. The best selec-
tivity was obtained by using Ac-(S)Ala-NH(3,5-dichorophenyl) (9) as an additive, which ena-
bled hydrogenation of 12 with a selectivity of 8.6:91.4 (S:R, ee = +18%). Diastereomerically 
pure phosphinite ligands 19a-c were used for the rhodium-catalyzed hydrogenation of bench-
mark substrates 12 and 20-22 where all ligands were found to reduce these substrates with high 
to very high selectivities. Best results were obtained with the phenylalanine-based ligand 19c, 
which reduced olefin 12 with a selectivity of 4.0:96.0 (S:R). Enantiomeric product distributions 
were additionally shown to be independent of the catalyst’s turnover number proving that ligand 
selectivity is solely governed by the stereodynamic enrichment of the energetically stabilized 
Rax rotamer, whose enrichment occurs prior to catalysis. 
Phosphoramidite ligands 23a and 23b were found to perform less selectively and the highest 
enantiomeric ratio of 73.2:26.8 (S:R) was achieved with ligand 23a in the reduction of 12. Inter-
estingly, a reversal in selectivity was observed when the valine-based selector was replaced by 
a phenylalanine-based one indicating a more complex path of stereoinduction for this ligand 
type.
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3 Deracemization of selector-modified tropos ligands 
3.1 State of knowledge 
Nature has developed eloquent methods to exert comprehensive control over the path of a cata-
lytic chemical reaction by modulating participating enzymes or other small, catalytically active 
molecules in manifold ways.[132] Of particular importance in this context is the concept of allo-
stery, which allows to create complex, switchable systems with various ligand states.[133-135] The 
versatility of such catalysts creates a great incentive to develop artificial, bio-mimetic systems 
that copy those mechanisms. As result, a variety of catalysts have been developed[136,137] that can 
undergo structural changes in response to external stimuli such as light,[138,139] pH changes[140,141] 
or redox-based electron transitions[142-144] to simultaneously change selectivity or reactivity.  
One field of particular interest is that of enantioselective reactions, where asymmetric catalysts 
change their selectivity in response to an external influence.[145] Feringa and colleagues devel-
oped a light- and temperature-controlled system, based on the core structure of a molecular mo-
tor, where an alkene with catalytically active substituents can be sequentially switched between 
helical states of different selectivity (see Figure 3-1, top).[146-148] Yu et al. realized a photo-
switchable helicene containing a 4-aminopyridine unit for enantiodivergent Steglich rearrange-
ments.[149] 
A heat-controlled system for enantioselective hydrogenation reactions, developed by Trapp and 
co-workers has already been mentioned in the previous chapter. They modified Rh- and Ir-
BIPHEP complexes with chiral esters as auxiliary groups in 3,3’-position. The resulting catalyst 
underwent heat-driven conversion of the previously major ligand rotamer into the minor one 
changing the selectivity of the catalyst as a result (see Figure 3-1, bottom).[53,54] In other exam-
ples, helical polymer structures were equipped with catalytically active centers that gave high 
enantioselectivities in a number of different transformations. Controlling the helicity of the pol-
ymer by solvent change allowed for a reversal of selectivity.[73,150]  
In nature, many allosteric systems are controlled by co-factors and system change is evoked by 
non-covalent interaction. This requires a stereodynamic element within the catalyst structure 
that responds to interaction with a chiral or achiral molecule. In a system where exchange occurs 
between two enantiomeric conformers of the catalyst, this interaction produces two diastereo-
meric, energetically different states of which the more energetically favourable one subsequently 
accumulates. This concept of deracemization as a result of chirality transfer was employed in 
the context of chiral sensing, where chiral analytes interact with a stereodynamic sensor (see 
Figure 3-2). Canary and Anslyn developed copper complexes that could be used to determine 
the enantiomeric composition of different coordinating compounds in solution.[151] Wolf and co-
workers developed stereodynamic phosphine-palladium complexes for the same purpose.[152] 
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Figure 3-1: Top: Light- and heat-driven switch by Feringa et al. that serves as organocatalyst in asymmetric 1,4-
addition reactions between thiols and ,-unsaturated ketones.[146] Changing the ligand state alters selectivity of the 
reaction. Bottom: Example for temperature-controlled selectivity during asymmetric hydrogenation reactions by 
Trapp et al. Naproxene-based auxiliary groups on a bisphosphine ligand yield thermodynamically unfavourable rota-
mer as major species, whose isomerization is kinetically inhibited.[53] Thermal treatment allows for reversal of catalyst 
selectivity. 
 
Figure 3-2: Chiral sensors for determination of enantiomeric compositions of small molecules in solution including 
a) biaryl ether developed by Wolf et al. for sensing of bidentate diamines or amino alcohols,[152] b) quinoline-based 
copper complex coordinating chiral carboxylic acids by Canary and Anslyn[151] and c) tropos BIPHEP ligand for 
sensing of chiral, amino acid-derived diamides by Trapp et al.[76] A suggested interaction patterns is shown.  
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Regarding enantioselective catalysts, some examples of tropos catalysts that were enantiomeri-
cally enriched by employing chiral co-ligands have already been covered in the previous chapter 
(see page 6). Furthermore, Suginome et al. presented the deracemization of helical polymer 
structures in presence of chiral additives[153]. Supramolecular structures could be realized in 
which enantioselective self-aggregation of achiral ligands takes place in the presence of a chiral 
co-monomer to yield a supramolecular, helical copper catalyst for enantioselective ketone re-
duction.[154]  
In all these systems, a fundamental requirement is strong and diastereoselective non-covalent 
interaction between the stereoinducing additive and the two enantiotopic catalyst structures in 
order to generate a large energy gap between the two catalyst states. As already set out in the 
previous chapter, it serves the purpose to lent structural elements from interaction sites of estab-
lished HPLC and GC phases. Originally developed by Okamoto et al. as selectors in cellulose-
based CSPs,[155,156] Trapp and Storch implemented 3,5-dichlorocarbamate-derived moieties into 
stereodynamic Rh complexes to act as non-covalent interaction sites.[157,158] The respective ra-
cemic 5,5’-substituted BIPHEP complex could be used as a chiral sensor to determine the enan-
tiomeric composition of different amino acid derivatives in solution.[76] In addition, a similar 
racemic phosphinite ligand was devised whose Rh complex H-32 undergoes rotamer enrichment 
of the ligand in the presence of a chiral amino acid-derived additive (see Figure 3-3). Employing 
AcNH-Phe-NHMe (8) as additive, a deracemization of the complex to 10% ee could be achieved 
at room temperature, which increased up to 38% ee when the mixture was cooled to -38 °C. Due 
to the achiral nature of the ligand, the Sax rotamer and the Rax rotamer could be enriched by 
employing either the S or the R additive. Stereo-enriched catalyst mixtures could subsequently 
be employed in enantioselective hydrogenation experiments to give up to 12 % ee during reduc-
tion of methyl 2-acetamido cinnamate.[41] 
 
Figure 3-3: Stereodynamic ligand developed by Trapp et al. bearing interaction sites derived from high-performance 
HPLC column selectors. Phosphinite ligand undergoes rotameric enrichment in the presence of amino acid-derived 
diamides generating optically active hydrogenation products in subsequent asymmetric transformations.[41] 
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3.2 Objective 
The first part of this project was set around the attempt to increase the selectivity of the previ-
ously investigated, racemic complex H-32. Since non-covalent interactions between the selector 
site and various additives had already been extensively investigated in the previous study, pre-
sent efforts focused on modification of the ligand core by introducing stereodirecting groups in 
the 3,3' position of the ligand. Very little detailed information is available on how substitution 
of the ligand core of tropos biphenyl-based bisphosphinite ligands affects the stereodynamic 
behaviour. Unquestionably, large substituents increase the barrier of rotation due to the buttress-
ing-effect,[93] which could impede de-racemization at lower temperatures. It was thus decided to 
modify the racemic bisphosphinite developed by Trapp et al. with small methyl groups. A syn-
thetic strategy was to be developed and the impact of the 3,3’-substituens on the deracemization 
process as well as the improvement of selectivity during subsequent catalysis was to be investi-
gated. 
By extending the ligand spectrum, the second part of the project was built on knowledge gained 
on diamido-substituted bisphosphinite ligands, presented in the previous chapter. In this context, 
it was to be investigated whether achiral, diamide-based selectors such as tBuNH-Gly-NH or 
racemic rac-tBuNH-Phe-NH are also suitable for generating racemic, switchable ligands whose 
stereoselectivity can be controlled by chirality transfer from chiral additives. 
 
Figure 3-4: Racemic bisphosphinite ligands with achiral or chiral, racemic selector moieties in 5,5’-position to be 
investigated for their capacity in chirality transfer experiments to give enantiomerically enriched catalysts for asym-
metric hydrogenation reactions. 
3.3 Investigation of tropos ligands with achiral 3,5-dichlorobenzoyl selector sites 
3.3.1 Synthesis 
In the original approach, synthesis of the ligand was realized by nitration of biphenol in 
HNO3/AcOH, protection of the phenol groups with allyl bromide, subsequent reduction of nitro 
groups using SnCl2 and coupling of resulting amines with 3,5-dichlorobenzoic acid chloride. 
Final deprotection with a palladium catalyst and treatment of the diol with chlorodiphe-
nylphosphine yielded the desired ligand. Unfortunately, implementation of a reaction step to 
methylate the biaryl backbone in 3,3’-position into this reaction sequence was unsuccessful due 
to insolubility of intermediates or compound decomposition under previously employed reaction 
conditions. 
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Consequently, an alternative reactions sequence was developed (see Figure 3-5). According to 
a known procedure by Pfaltz and co-workers, biphenol was methylated in 3,3’-position.[159] At-
tempts to nitrate compound 28 using nitric acid repeatedly failed due to product decomposition. 
Employing a slightly modified procedure from Gaude, Le Goaller and Pierre allowed for the 
synthesis of 29 in a biphasic system under mild conditions.[160] Subsequent reduction of the nitro 
groups and introduction of the achiral selector moieties was done using the previously estab-
lished protocol by Trapp et al., which was slightly adapted.[41] Finally, treatment of the resulting 
biphenol 30 with PPh2Cl in presence of DABCO yielded the desired bisphosphinite ligand 31 
which was complexated to a rhodium precursor to give the final catalyst 32.  
A phosphoramidite-based catalyst was also synthesized. The respective ligand could easily be 
prepared from diol precursor 30 by refluxing in toluene in presence of P(NEt2)3 to yield com-
pound 33. Subsequent complexation gave catalyst 34 (see Figure 3-6). 
 
Figure 3-5: Synthesis of bisphosphinite complex 32, i) CH3OCH2Cl, NaH, 61%, ii) BuLi, MeI, then HCl in isopro-
panol 38%, iii) NaNO3, HCl, 64%, iv) SnCl2, HCl, Cl2C6H3COCl, triethylamine, then H2NCH2CH2NMe2, 83%, v) 
PPh2Cl, 1,4-diazabicyclo[2.2.2]octane, 73%, vi) [Rh(COD)2]BF4, 71%. 
 
Figure 3-6: Synthesis of phosphoramidite complex 34: i) P(NEt2)3, 91 %, ii) [Rh(COD)2]BF4, in situ. 
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3.3.2 Ligand deracemization and hydrogenation experiments 
To compare complex 32 to previously investigated catalyst H-32, the same chirality transfer 
experiment was conducted. Catalyst 32 and diamide (S)-8 were dissolved in dry and degassed 
chloroform and their interaction was monitored by 1H NMR spectroscopy. In similar observa-
tions to those made by Trapp and co-workers, the amide protons of the selector moiety under-
went significant splitting in presence of the chiral additive which is owed to formation of dia-
stereomeric, supramolecular complexes between the diamide and the two enantiomeric rotamers 
of the complex (see Figure 3-7). The splitting increases at lower temperatures indicating an even 
stronger differentiation between the two ligand states. Interaction with the chiral additive re-
moves energetic degeneration of the two ligand isomers leading to rotameric enrichment of the 
energetically favoured Sax species. Assignment of rotamer species was done on the basis of re-
sults for the unmethylated catalyst H-32, where identical behaviour was assumed. At 22 °C, a 
distribution of 56:44 (Sax:Rax, 12% ee) and a signal splitting of 381 ppb was observed, which is 
about 80 ppb above of what was observed for H-32. A similar result had been obtained with the 
unmethylated system previously investigated by Trapp et al. and cooling the mixture to -38 °C 
had been found to significantly increase deracemization. Disappointingly, no significant im-
provement of the enantiomeric excess of complex 32 could be achieved, when the sample was 
cooled, but signal splitting increased to 510 ppb. Accordingly, hydrogenation of methyl 2-acet-
amidocinnemate 20 using stereo-enriched complex mixtures at -20 °C gave only a slight enan-
tiomeric excess of 4 % ee S for the respective product and a complete racemate was obtained 
when the reaction was repeated at room temperature.  
 
Figure 3-7: a) Section of 1H NMR spectrum of 32 shows superimposed signals of the amide protons of both rotamers. 
b) Interaction studies with phenylalanine-derived diamide (S)-8 (in dry and degassed CDCl3, 6.5 mM in complex with 
5 eq. diamide) show strong signal splitting of the two rotamers for the amide proton due to diastereotopic, non-
covalent interaction of additive and selector sites along with minor enrichment of the energetically favoured Sax rota-
mer. 
Since increased signal splitting of the catalyst’s amide proton in the 1H NMR spectrum with 
lower temperature (510 ppb at -38 °C) contradicts a decrease of interaction strength and enan-
tiodifferentiation compared to un-methylated complex H-32, the increased rotational barrier was 
believed to inhibit deracemization at lower temperatures. Consequently, it was attempted to use 
phosphoramidite ligand 33, which bears the same ligand backbone, but is believed to have a 
much lower barrier of inversion. Changing the ligand type, however, did not lead to an improve-
ment of selectivity for the subsequent catalysis. Using catalyst 34 and additive (S)-8 and only 
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racemates were obtained when hydrogenation reactions were run at room temperature or at -20 
°C. 
3.4 Investigation of tropos ligands with amino acid-based-selector sites 
3.4.1 Deracemization and hydrogenation experiments with a glycine-based bisphosphinite lig-
and 
To enlarge the spectrum of investigated racemic, “switchable” ligands, further investigations 
were performed on ligand 19d, which has already been introduced in chapter 2.4.1, page 17. As 
all investigated tropos bisphosphinite ligands, compound 19d undergoes spontaneous, quantita-
tive dimerization yielding a C2-symmetric, hydrogen bonded complex with unsymmetrical sub-
units. Since the glycine-based selector sites do not contain a stereochemical bias, a racemic mix-
ture of (Sax/Sax)-19d and (Rax/Rax)-19d is formed. Given the high interaction strength of the dia-
mide selectors that is evident from the dimerization, it seemed promising to further investigate, 
if chirality transfer could be accomplished on this ligand. This seems especially true since NMR 
data of compound 19d, unlike those of compounds 19a-c, show significant line broadening at 
room temperature and spectra had to be recorded at -20°C to be interpretable, indicating en-
hanced dynamic and chemical exchange. As stereo-aligning agents, different amino acid deriv-
atives were chosen. In accordance with literature[83] and with previously observed interaction 
patterns between ligand selector moieties in the dimeric ligand structure, a pincer-like coordina-
tion of small diamide derivatives was expected (see Figure 3-8). 
 
Figure 3-8: Expected interaction pattern between ligand 19d and chiral, amino acid-derived diamides that can induce 
ligand deracemization. 
When interaction of racemic ligand 19d with (S)-8 was investigated by 31P NMR spectroscopy 
in dry and degassed THF-d8, formation of a new singlet signal was observed at -20 °C, which 
had a relative intensity of 1:8 compared to the dimerized ligand. However, treatment of the lig-
and with [Rh(COD)2]BF4, before or after alignment, yielded a very unselective catalyst and 5% 
ee R were obtained for product 13 during subsequent hydrogenation of methyl 2-acetamidoacry-
late 12 (see Table 3-1, entry 2). Intriguingly, repeating the experiment with selector-like additive 
(S)-25 yielded intensely broadened, uninterpretable 31P NMR spectra and hydrogenation af-
forded the product with 14% ee R (entry 3). As expected, employment of (R)-25 gave the oppo-
site selectivity (entry 4). Strong dependency of the alignment on additive’s substitution pattern 
was confirmed in following experiments where dichlorophenyl-substituted (S)-9 could induce 
34% ee R (entry 5), while methyl amide 10 gave a much less selective catalyst (7% ee R, entry 6) 
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and 3-nitrophenyl analogue 35 failed to induce any selectivity at all (entry 8).  In a final experi-
ment, the catalyst was treated with tetraamide 24, which has the ability to undergo the same form 
of dimerization as the catalyst itself and was thus considered to be a much better competitor to 
the catalysts self-interaction. Employing this catalytic mixture, prochiral olefin 12 could be hy-
drogenated with 41% ee R.  
3.4.2 Deracemization and hydrogenation experiments with a bisphosphinite ligand bearing ra-
cemic phenylalanine selector units 
Due to the self-sorting behaviour of the catalyst, it seems plausible to investigate if the ligand’s 
self-interaction adversely affects the level of alignment that is reached using additives mentioned 
above. Consequently, it was attempted to further destabilize supramolecular catalyst structure in 
order to enhance competitiveness of these additives over the ligand’s interaction sites. To main-
tain the selectors interaction strength, both secondary amide functionalities were to be preserved. 
Therefore, the effect of implementing racemic phenylalanine-based selector moieties into the 
ligand backbone was investigated. This substitution pattern would lead to a formally achiral, 
racemic ligand meso-19c and it was expected that opposing chiral information in the ligand se-
lector units would form a “mismatch” during dimerization and destabilize the supramolecular 
structure.  
Table 3-1: Asymmetric hydrogenation of methyl 2-acetamidoacrylate 12 using racemic catalyst 
with ligand 19d after pre-alignment with different additives. 
 
Entrya) Additive ee %b)  Entry Additive ee % 
1 - rac  5c) 
 
(S)-9 34 R 
2 
 
(S)-8 5 R  6 
 
(S)-10 7 R 
3 
 
(S)-25 14 R  7c) 
 
(S)-35 1 R 
4 
 
(R)-25 14 S  8d) 
 
24 41 S 
a) Complex was allowed to equilibrate in presence of additive for 16 hours at room temperature before addition of substrate and 
subsequent hydrogenation. Detailed experimental protocol can be found in chapter 7.3.11, page 131. All reactions showed full 
conversion. b) Enantiomeric excess was determined using chiral GC. c) Only 5 eq. of the additive were used and additive did 
not fully dissolve. d) Only 5 eq. of the additive were used. 
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The desired catalyst could conveniently be synthesized by the same procedure as all previous 
bisphosphinites of similar structure. Since a stereoselective attachment of selector groups ap-
peared too laborious, the respective diol precursor meso-19c was synthesized by coupling a ra-
cemic mixture of the selector groups. A mixture of stereoisomers (S,S)-19c:meso-19c:(R,R)-19c 
in a ratio of 1:2:1 was obtained and the desired meso diastereomer could be isolated by flash 
chromatography. Intriguingly, no second set of signals was observed for meso-19c in the 1H 
NMR spectrum (see Figure 3-9)  
This is a clear sign that the compound does not form the same stable, dimeric structure observed 
for compounds with homochiral selectors and instead retains a much higher dynamic leading to 
a C2-symmetric state in solution. The subsequently formed bisphosphinite ligand meso-19c ex-
hibited similar characteristics of internal symmetry and signal broadening through increased 
molecular dynamic as evident from the broad singlet signal observed in the respective 31P NMR 
spectrum. Complexation of the ligand to a rhodium precursor lead to signal splitting caused by 
Rh-P coupling, as well as, P-P coupling of non-equivalent halves of the molecule as a result of 
slower rate of isomerization.  
 
Figure 3-9: Left: Section of 1H NMR spectrum showing tBu protons of all three stereoisomers of X, which can be 
separated by flush chromatography. Homochiral diols form dimers represented by two singlet signals. Meso-19c did 
not readily dimerize, hence, only one singlet was detected. Top right: 31P NMR spectrum of meso-19c shows a single, 
broad singlet. Bottom right: 31P NMR spectrum of the respective Rh complex. 
 
Addition of chiral diamides to the ligand or its complex did not lead to a visible change in the 
31P or 1H NMR spectra and intense line broadening was still observed even at -40 °C.  Ligand 
meso-19c was subsequently employed in asymmetric hydrogenation reactions of olefin 12 (see 
Table 3-2). A racemate was obtained, when no chiral additive was present. Once more, pre-
aligning the catalyst for 16 hours using a range of chiral diamides gave enantioenriched hydro-
genation products. Similar trends and selectivities compared to those previously found for gly-
cine-based compound 19d were obtained. Among diamide additives, the highest selectivity 
could be induced with alanine derivative (S)-9 (23% ee R, entry 3). When tetraamide 24 was 
employed as stereoinducing agent, the enantiomeric excess of the reduction could be increased 
to 46% ee R (entry 10).  
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3.4.3 Ligand comparison 
The similar extent of chirality transfer compared to glycine-based ligand 19d suggests, that lig-
and dimerization does not adversely affect the level of chiral induction. It can be assumed that 
fast chemical exchange among supramolecular structures, previously also observed for similar 
compounds with chiral, enantiopure selectors (see page 20), still allows for chiral additives to 
intervene and occupy bonding sites. The subtle differences in selectivity that were achieved be-
tween both ligand types can be understood by acknowledging that ligand meso-19c bears addi-
tional phenyl groups that might be beneficial for certain non-covalent interaction modes. How-
ever, the individual chiral selector sites can be expected to have a greatly reduced level of inter-
action with additives of the opposite chirality, meaning that only one out of two selectors on 
each molecule effectively bonds with stereoinducing additives during alignment. This clearly 
reduces the overall extent of the interaction, something that is not to be expected for ligand 19d 
which that bears achiral selector sites. 
Table 3-2: Asymmetric hydrogenation of methyl 2-acetamidoacrylate 12 using a racemic cat-
alyst with ligand meso-19c after pre-alignment with different additives. 
 
Entrya) Additive ee %b) 
 
Entry Additive ee % 
1 - rac 
 
6 
 
(S)-25 14 R 
2 
 
(S)-8 1 R 
 
7 
 
(S)-S5 3 R 
3c) 
 
(S)-9 23 R 
 
8c) 
 
(S)-35 1 R 
4 
 
(S)-10 6 R 
 
9 
 
(S)-36 5 R 
5 
 
(R)-25 14 S 
 
10d) 
 
24 46 R 
a) Complex was allowed to equilibrate in presence of additive for 16 hours at room temperature before addition of the substrate 
and subsequent hydrogenation. Detailed experimental protocol can be found in chapter 7.3.11, page 131. All reactions showed 
full conversion. b) Enantiomeric excess was determined using chiral GC. c) Additive did not completely dissolve. d) Only 5 
eq. of the additive were used. 
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3.5 Results 
In this chapter, a number of different, racemic ligands have been investigated for their potential 
as switchable catalysts, that deracemize due to non-covalent interactions with chiral amino acid 
derivatives in solution. 
In the first part, a bisphosphinite ligand bearing 3,5-dichlorobenzoyl moieties as selector sites, 
previously investigated by Trapp et al., has been modified with methyl groups in 3,3’-position 
to investigate potential improvements of chirality transfer onto the ligand and of selectivity in 
subsequent asymmetric hydrogenation reactions of prochiral substrates. Unfortunately, the sub-
stitution was found to inhibit deracemization of the Rh complex of ligand 31 at lower tempera-
tures, presumably due to an increased rotational barrier, and only a maximum deracemization to 
a dr of 57:43 (Sax:Rax) could be achieved.  
Based on these results, highly stereodynamic phosphoramidite ligand 33 was subsequently syn-
thesized from the same ligand precursor. Attempts to generate a stereoselective catalyst through 
non-covalent interaction with chiral additives failed and yet again subsequent hydrogenation 
reactions gave only racemates. 
In the second part of the project, racemic ligands bearing 5,5’-diamido selector moieties were 
investigated.  Self-aggregating ligand 19d with glycine-derived selector sites could successfully 
be aligned by allowing the respective Rh complex to interact with different amino acid-derived 
diamide additives. The switchable nature of the catalyst was verified by employing both enanti-
omers of phenylalanine derivative 25 separately as aligning agents where subsequent hydro-
genation of 12 gave products in 14% ee S or R when the R or the S additive was used. Among 
other diamides, alanine-derived compound (S)-9 showed the biggest alignment potential allow-
ing for reduction to proceed with 34% ee R. When ligand-mimicking tetraamide 24 was em-
ployed selectivity could be increased further to 41% ee R due to a higher stability of the ligand-
additive adduct.  
To reduce ligand-ligand interaction by employing “mismatching” selector units, bisphosphinite 
ligand meso-19c bearing racemic phenylalanine-derived interaction sites was devised. The lig-
and was found not to form stable supramolecular dimers and again, significant chirality transfer 
could be achieved. Selectivities were similar to those obtained with catalyst 19d. Best results 
using diamide additives were again achieved with alanine-derived compound (S)-9 yielding me-
thyl 2-acetamidoalanate 13 with 23% ee R. As with ligand 19d, selectivity could be further in-
creased by deracemization of meso-19c with tetraamide 24 where a selectivity of 46% ee R was 
obtained. 
The similar extent of alignment found to occur with both achiral ligand types suggests, that 
ligand dimerization does not adversely affect the degree of chirality transfer, potentially due to 
fast chemical exchange among supramolecular compounds that allows chiral additives to inter-
vene and occupy bonding sites. 
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4 Development of a reaction with enantioselective self-inhibiting 
properties 
4.1 State of knowledge 
Among the most intriguing phenomena that occurred during the evolution of life is the adapta-
tion of homochirality and nature’s ability to maintain this state of enantiopurity. The chemical 
pathway that led to this state is yet unidentified and various aspects such as the initiating impulse 
that caused deviation from a racemic state and the subsequent increase of the initial enantiomeric 
surplus are controversially discussed on a practical[18,161-165] as well as on a theoretical 
level.[19,20,166-168] An often proposed scenario concerning the augmentation of an enantiomeric 
excess is a self-reinforcing system, where an initial deviation from a racemic state is sustained 
and extended by its own involvement. The strive for a better understanding of the various aspects 
of such systems on a molecular level has sparked great interest in the studies of asymmetric, 
autoinductive, self-amplifying reactions. 
At its core, an autoinductive asymmetric reaction is based on the participation of a chiral reaction 
product in the production of itself. Different scenarios include catalytical activity of the product 
molecules as such or the incorporation of the product into a more complex catalyst. Considering 
a self-amplifying reaction adds an additional layer of complexity. Long ahead of the first exper-
imental realization of such a reaction, Frank described the crucial, underlying principle of "mu-
tual antagonism".[20] The desired reaction must be assisted by the inducing product species and 
the undesired reaction must simultaneously be suppressed in order to prevent a drop in selectiv-
ity. This fundamental process manifests in the emergence of non-linear effects (NLE) which 
signify an increased optical purity (positive NLE) or a decreased optical purity (negative NLE) 
of the reaction product compared to the purity of the initially employed catalyst. Such non-line-
arities root in the different properties of racemates compared to optically pure compounds, which 
is a long known phenomenon that has been studied – inter alia – in the context of the NMR 
spectroscopic non-equivalence of enantiomers,[169-171] the enantiomeric separations in liquid 
chromatography using an achiral stationary phase[172-174] or other physical properties.[175-177] Non-
linear effects in asymmetric catalysis have been intensely studied, among others, by Kagan and 
Noyori.[23,26,178-180] A famous example is the asymmetric alkylation of aldehydes that is catalysed 
by 3-exo-(dimethylamino)isoborneol (DAIB) zinc complexes discovered by Noyori et al.[181] 
When a mixture of both ligand enantiomers is employed, formation of catalyst dimers leads to 
artificial increase in the ligands enantiopurity, which is caused by the higher stability of the 
inactive meso catalyst complex (see Figure 4-1).  
4.1  State of knowledge 
____________________________________________________________________________ 
- 50 - 
 
Figure 4-1: Asymmetric alkylation of benzaldehyde with enantioenriched DAIB by Noyori et al. shows positive non-
linear effects on the enantiomeric distribution of produced benzylic alcohol.[181] Formation of catalyst dimers of which 
the meso form was found to have a greater stability than the two homochiral complexes artificially increases enanti-
omeric excess of the catalytically active monomer.  
The first experimental example that incorporated these principles to achieve a self-amplifying 
reaction was delivered by Wynberg and Alberts, who demonstrated autoinductive effect during 
the reaction of benzaldehyde and ethyl lithium by employing deuterated reaction products as 
chiral initiators.[182] Wynberg and Feringa later took advantage of intermolecular interactions 
during the oxidative coupling of chiral phenols and camphor to obtain homochiral dimers.[183] 
Danda et al. and Shvo et al.[184] reported NLEs and self-amplifying properties during enantiose-
lective hydrocyanation reactions on aldehydes catalysed by cyclic diamides.[185] Similarly, 
Figadère and co-worker realized an autoinductive aldol reaction where 2-trimethylsilyloxyfuran 
reacts with prochiral aldehydes in the presence of a BINOL-Ti catalyst that gradually imple-
ments generated alcohol molecules into its structure.[186] An electro-cyclic, autoinductive reac-
tion was reported by Wulff et al., who employed an aluminium complex of VAPOL (“vaulted 
biphenanthrol ligand”) as catalyst for the Diels-Alder reaction between cyclopentadiene and me-
thyl acrylate (see Figure 4-2).[187]  
The most prominent example for a self-amplifying reaction is the Soai reaction in which substi-
tuted 5-pyrimidylaldehydes react with diisopropylzinc to form the corresponding pyrimidyl al-
cohols.[188] The reaction is catalyzed by zinc complexes of the produced pyrimidyl alcohol and 
governed by a strong positive NLE which is based on the kinetics of the complex reaction net-
work for the formation of the different catalyst stereoisomers. A small initial enantiomeric ex-
cess of the pyrimidyl alcohol is sufficient to alkylate aldehydes with high enantioselectivities 
and re-employment of the enantioenriched product as ligand for following catalytic reaction 
allows for the generation of enantiopure compounds from almost racemic mixtures in only three 
consecutive runs (see Figure 4-3).[189] Initial dis-symmetrisation has also been achieved by using 
other small, chiral molecules or even chiral surfaces of organic or inorganic crystals.[190]  
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Figure 4-2: a) Concept of autocatalytic, self-amplifying reactions. A substrate is converted in presence of a catalyst, 
whose selectivity changes upon stereoselective incorporation of product molecules to increase selectivity of the cat-
alyst overtime. b) Examples by Danda,[185] Wulff[187] and Figadère[186] and co-workers are shown. 
 
Figure 4-3: Illustration of the potential for self-amplification in the Soai reaction.[189] 5-Pyrimidylaldehyde is alkylated 
by diisopropylzinc. Addition of the reaction product in very low ee and consecutive recovery of newly formed alcohol 
as initiator for consecutive runs allows to obtain enantiopure product within two repetitions.  
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Trapp and Storch recently succeeded to develop a “by-design” catalyst system for the self-am-
plifying, asymmetric hydrogenation of prochiral olefins using a rhodium catalyst bearing tropos 
phosphoramidite ligands (see Figure 4-4).[40] During the hydrogenation reaction, the structure of 
the rhodium catalyst could be altered by strong, non-covalent interactions between the chiral 
reaction products and the interaction sites (selectors) on the ligands influencing the selectivity 
of the catalyst. In order to accomplish this, an interaction motive between (S)-N-pivaloylproline-
3,5-dimethylanilide and (S)-N-(3,5-dinitrobenzoyl)leucine dimethylamide, developed by Pirkle 
and Murray,[77,78] was abstracted and structural elements were implemented into the hydrogena-
tion product and the stereodynamic phosphoramidite ligand. During the design of the targeted 
system a number of crucial requirements were identified: 1) The dynamic nature of non-covalent 
interaction between the catalyst and the reaction products would allow for a constant adaptation 
to a changing product distribution, altering the selectivity of the catalyst as the reaction pro-
gresses. 2) Rapid chirality transfer from the chiral reaction product to the ligands should occur 
much faster than the hydrogenation of the substrate. 3) The interaction between the chiral selec-
tor sites and product molecules needs to be stereoselective in order to enhance the catalyst’s 
selectivity for one particular product stereoisomer, while simultaneously supressing further for-
mation of the other one (“mutual antagonism”). A number of different designed substrates where 
hydrogenated. As the catalyst’s selectivity was found to be positively correlated to the level of 
interaction with product molecules, an increased enantiopurity of the reaction product was ob-
tained at lower catalyst loadings. 
 
Figure 4-4: a) Chiral recognition model for the interaction pair investigated by Pirkle and Murray.[77,78] b) Illustration 
of self-amplifying catalysis developed by Trapp and Storch.[40] Stereoselective interaction of the reaction product with 
the phosphoramidite catalyst changes the selectivity of the reaction affording higher enantiomeric excesses when the 
turnover number increases. 
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4.2 Objective 
It seems evident that an "inverse" model of an autoinductive, self-inhibiting reaction could be 
based on the same prerequisites as the ones identified by Trapp and Storch that were discussed 
above. Moreover, it would be of interest due to its complementary.  
As before, utilizing chiral diamides as stereoinducing agent was believed to be a promising and 
convenient method, since these can be readily generated from suitable olefinic precursors by 
asymmetric hydrogenation. Catalyst alignment, driven by non-covalent interaction, and ensuing 
change of enantioselectivity during the reduction of the olefin would close the loop to an auto-
inductive cycle. 
Studies detailed in chapters 2 have shown that appropriately substituted 2,2’-biphenyl ligands 
with phenylalanine-derived, diamide-based selectors in the 5,5'-position exhibit strong, enanti-
oselective interaction with chiral amino acid-derived diamide residues or molecules bearing the 
same chiral information aligning the ligand to induce the opposite stereoinformation during the 
subsequent asymmetric hydrogenation of substituted olefins. Selectors bearing two secondary 
amide groups were thereby found to interact in a highly enantioselective manner, but efficient 
binding and an additional chelate effect led to formation of stable ligand dimers and a loss of the 
ligand’s stereodynamics. Consequently, ligands bearing phenylalanine-derived amidoester se-
lector moieties were chosen to be investigated, which were believed to have better balanced 
binding strength (see Figure 4-5). 
 
Figure 4-5: Ligands bearing phenylalanine-derived amidoester selectors in 5,5’-position to be investigated for their 
isomerization dynamics and their potential to align in presence of chiral amino-acid derived diamides.  
In a two-step development process (1) interaction studies between each selector type a and b 
and different chiral additives were to be conducted in order to evaluate the capability of each 
selector unit to transfer chiral information from a chiral solute onto the tropos ligand and subse-
quently, (2) these insights were to be utilized to realize an asymmetric hydrogenation reaction 
that shows chiral, autoinductive self-inhibition, i.e. a reactions where a chiral hydrogenation 
product supresses its own formation. 
4.3 Investigation of amidoester-based selector units for chiral induction 
4.3.1 Ligand syntheses 
Initial interaction studies on the potency of the selectors were performed on tropos bisphos-
phinite ligands, as their Rh complexes have a rotational barrier high enough to allows for a clear 
NMR spectroscopic differentiation of the two axial isomers, while equilibration and structural 
change of the ligand still readily occurs at room temperature. Moreover, the relationship between 
4.3  Investigation of amidoester-based selector units for chiral induction 
____________________________________________________________________________ 
- 54 - 
the ligand’s rotamer distribution and its enantioselectivity in asymmetric hydrogenation reac-
tions is known and can be directly correlated. Syntheses of the ligands is depicted in Figure 4-6. 
Oxidative dimerization[111] of methyl 4-hydroxy-3-methoxybenzoate 14 and subsequent allyl 
protection of the hydroxy groups[191] gave diester 37 that was saponificated into dicarboxylic 
acid 38. The selector attachment was achieved by two-fold coupling of (S)-phenylalanine tert-
butyl ester hydrochloride to the corresponding bis(acid chloride) (39a) or by Steglich esterifica-
tion of with (S)-2-hydroxy-3-phenylpropionic acid tert-butyl amide (39b). After removal of the 
phenol protecting groups to obtain BIPOLs 40a und 40b, these were treated with chlorodiphe-
nylphosphine to yield the bisphosphinite ligands 41a and 41b. The corresponding Rh complexes 
42a and 42b were prepared by reaction with [Rh(COD)2]BF4. 
 
Figure 4-6: Synthesis of bisphosphinite complexes 42a,b i) PhI(OAc)2, 51%, ii) allyl bromide, K2CO3, 97%, iii) KOH, 
99%, iv) 39a: SOCl2, then NH3Cl-(S)Phe-OtBu, diisopropylethylamine, 91%; 39b: HO-(S)Phe-NHtBu, DMAP, 
EDCI·HCl, 50%, v) Pd(OAc)2, PPh2(C6H4NMe2), HCOOH, 40a: 71%; 40b: 93% vi) 41a: PPh2Cl, 1,4-diazabicy-
clo[2.2.2]octane, 20%; 41b: PPh2Cl, triethylamine, 69%, vii) 42a,b [Rh(COD)2]BF4, in situ  (EDCI·HCl = 1-ethyl-
3-(3-dimethylammoniumpropyl)carbodiimide hydrochloride, DMAP = 4-dimethylaminopyridine, DIPEA= diisopro-
pylethylamine) 
4.3.2 Chirality transfer and hydrogenation experiments 
Regarding the choice of additives used to influence the stereodynamic behaviour of the ligands, 
similar concepts to those developed by Trapp and Storch for a self-amplifying hydrogenation 
reaction were applied.[40] Amide derivatives of different amino acids were chosen, since these 
were expected to effectively interact with the ligands’ amino acid-based selector units through 
their various hydrogen bond donor and acceptor sites or through π-π interactions. A greater num-
ber of attachment points would rigidify the transient adducts and facilitate the transmission of a 
chiral information onto the ligand backbone. Furthermore, the highly enantioselective nature of 
interactions between amino acid-derived additives and selector units, which has been established 
in previous chapters and which is also recorded in literature,[192] is necessary for the observation 
of non-linear effects. As discussed above, the latter serve as a basis for the envisioned stereose-
lective, self-inhibiting reaction. Finally, amino acids and their derivatives can conveniently be 
generated through enantioselective rhodium-catalyzed hydrogenation of suitable olefins which 
makes them ideal products for an asymmetric, autoinductive reaction.  
When the different selector types were compared, a significant difference with regard to the 
ligand behaviour was observed. Ligand 41b and its Rh complex 42b were found to form a close 
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to racemic mixture. Addition of various chiral additives had negligible influence on the rotamer 
distribution and employment of those rhodium complex 42b in hydrogenation reactions of me-
thyl 2-acetamidoacrylate 12 gave exclusively racemates (see chapter 7.4.20, page 149 for spec-
tral data). For compound 41a, however, the selector moieties evoked a very different behaviour. 
The 31P{1H} NMR spectrum of the bisphosphinite contained a sharp singlet representing a minor 
species, while the major isomer appeared as two broad singlet signals. The two-fold set of sig-
nals, also found in corresponding 1H and 13C NMR spectra, is indicative for the dimerization 
phenomenon which has already been observed for similar diamide selector-modified ligands and 
has been extensively investigated in chapter 2. It signifies strong, rotamer-specific interaction 
between selector moieties allowing for retrospective assignment of the minor compound as the 
Sax rotamer and the major, dimierized compound as the Rax rotamer. 
When ligand 41a was treated with (S)-amino acid-derived additive PhCO-(S)Phe-NHtBu 25, re-
symmetrisation along with an rotameric enrichment of Rax-41a was observed (see chapter 7.4.18, 
page 144 for spectral data). The resulting ligand de was found to be dependent both on the ad-
ditive:ligand ratio and the ligand concentration. When ligand 41a was complexated to form Rh 
complex 42a, no dimeric behaviour could be detected any more. Yet again, significant confor-
mational change was observed in presence of chiral diamides (see Figure 4-7).  
 
Figure 4-7: Exemplary 31P{1H} NMR spectra depicting interactions studies between bisphosphinite complex 42a and 
amino acid-derived diamides. a) Equilibrated complex shows equilibrium between two rotamers. b) Addition of chiral 
diamide (S)-8 leads to signal sharpening/broadening and shift of Rax-42a, exclusively, indicating stereoselective en-
gagement in non-covalent interaction. c) Ligand-additive interaction results in significant enrichment of the more 
stabilized isomer Rax-42a. 
Significant downfield shift, signal sharpening or broadening and a significant rotameric enrich-
ment of Rax-42a over a period of several hours was observed by 31P NMR spectroscopy. The 
minor species Sax-42a did not seem to significantly interact with additives and no change signal 
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shape or position was observed in any case. A comprehensive overview of the spectroscopic 
data for all interaction experiments can be found in chapter 7.4.19, page 145.  
At this point it should be highlighted, that all additives employed for stereoinduction represent 
potential products of a preceding hydrogenation reaction and are thus candidates for autoinduc-
tive hydrogenation experiments. Due to massive signal overlap and broadening in most cases, 
the degree of enrichment could not unambiguously be determined. Since the ligand rotamer ratio 
is correlated to the enantiomeric distribution of products from asymmetric hydrogenation exper-
iments, however, those could be used in order to quantitatively asses the structural change of the 
catalyst. Catalyst mixtures of 42a, aligned after interaction with various additives, was conse-
quently employed for the reduction of olefin 12 (see Figure 4-8).  
The untreated complex was found to hydrogenate the substrate with 27% ee R. Almost all addi-
tives proved capable of significantly enhancing the catalyst’s selectivity. In the presence of 
AcNH-(S)Phe-NHMe (S)-8, which had evoked a strong 31P NMR signal shift as well as signifi-
cant enrichment for Rax-7a, selectivity of the hydrogenation increased to 56% ee R (ee = 29%). 
The enantiomer AcNH-(R)Phe-NHMe (R)-8, however, was unable to significantly align the cat-
alyst to increase its selectivity (29% ee R, ee = 2%). This indicates that the tBuO-(S)Phe-NH 
selector, just like its diamide analogue, interacts with other amino acid-derived compounds in a 
highly enantioselective manner. The differentiability of chiral molecules in solution and ensuing 
selective chirality transfer from one enantiomer is a vital prerequisite for chiral amplification. 
 
Figure 4-8: Hydrogenation experiments using catalyst 42a that was pre-aligned using different amino acid-derived 
additives. Rh complex 42a and additive where dissolved in dry and degassed CDCl3 (4.3 mM in catalyst) and left 
standing for 16 hours until re-equilibration was completed. For additive 24 only 25 mol% where used. Compounds 
(S)-9 and (S)-35 did not fully dissolve. Detailed experimental procedure can be found in chapter 7.4.22, page 150.  
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The strongest catalyst alignment, observed for those additives that also caused the heaviest sig-
nal broadening for the enriched Rax isomer, was achieved with alanine derivatives (S)-9 and (S)-
35, which allowed for reduction of 12 with 84% ee R (ee = 57%) and 81% ee R ee = 54%), 
respectively, and with selector-imitating diamide (S)-25, which gave an increase in selectivity 
to 82% ee R (ee = 55%). 
4.4 Enantioselective self-inhibition in an asymmetric hydrogenation reaction 
4.4.1 Concept and syntheses 
Based on results from interaction studies with complex 42a, discussed in chapter 4.3.2, ligand-
substrate system was designed that would fulfil all prerequisites necessary to show autoinduc-
tive, self-inhibiting properties (see Figure 4-9). The most important ones where 1) a highly ste-
reodynamic catalyst with different, accessible ligand states that is each selective for the for-
mation of one enantiomer, 2) a prochiral substrate that can be converted into a reactions product, 
which is capable of swiftly altering the catalyst’s ligand state through non-covalent interaction 
and 3) stereoselective interaction between formed reaction product and selector sites of the cat-
alyst.  
  
Figure 4-9: Conceptualization for a self-inhibiting reaction. A prochiral substrate is converted by a stereodynamic 
ligand. Stereoselective incorporation of one product enantiomer into the catalyst through non-covalent interaction 
changes selectivity of the catalyst and supresses further formation of the same stereoisomer. 
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Catalyst 42a bearing amidoester selector sites was found to be most strongly affected by the 
presence of diamides (S)-9, (S)-25 and (S)-35, where over the course of several hours, a strong 
rotameric enrichment of one catalyst epimer was observed. To decrease the time required for 
catalyst alignment, it was instead decided to employ corresponding phosphoramidite ligand, as 
previously done by Trapp and Storch, where a much lower inversion barrier of the ligand would 
lead to immediate equilibration. As for the substrate design, important qualities include strong, 
enantioselective interaction capabilities of the hydrogenated product, as well as good solubility 
of both product and respective substrate. Among the diamides in question, compounds (S)-9 and 
(S)-35 were only sparingly soluble. Since dehydrogenation generally tends to reduce solubility 
of diamides even further, it was decided to rely on the substitution pattern of diamide 25 for the 
substrate design. 
Syntheses are shown in Figure 4-10. Treating BIPOL 40a with diethylphosphoramidous dichlo-
ride in presence of triethylamine afforded phosphoramidite ligand 44, which was added to 
[Rh(COD)2]BF4 in two-fold excess to give catalyst 45. The envisioned substrate could conven-
iently synthesized through an Erlenmeyer azlactone synthesis by reacting glycine with benzoic 
acid chloride and benzaldehyde to afford azlactone 46, from which olefins 47a-c were obtained 
through aminolysis. 
 
Figure 4-10: a) Synthesis of phosphoramidite complex 45 i) Cl2PNEt2, TEA, 77%, ii) [Rh(COD)2]BF4, quant. b) 
Synthesis of olefinic substrates 47a-c: i) PhCOCl, PhCHO, ii) 47a: tBuNH2, 68%, 47b: iPrNH2, 69%, 47c: EtNH2, 
73%. 
4.4.2 Asymmetric hydrogenation and enantioselective self-Inhibition 
As previously found for similar compounds, complex 45 produced a complex 31P NMR spectrum 
comprising various species that presumably form when phosphoramidite ligands rotate around 
the Rh-P bond (see this reference[40] and supplementary information therein). Testing the stere-
odynamic behaviour of the catalyst, a notable change in the distribution of species was observed 
by 31P NMR spectroscopy in presence of (S)-25, which did not occur when only the enantiomer 
(R)-25 was present (see Figure 4-11a).  
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Figure 4-11: a) 31P NMR spectra of phosphoramidite complex 45 depicting structural change of the ligand mixture if 
the S enantiomer of 25 is present. b) Employing mixtures of catalyst 45 and additive 25 during asymmetric hydro-
genation of olefin 12 shows that observed structural change is linked to a change in selectivity if the S enantiomer of 
the additive is present. Reactions were run in dry and degassed chloroform with a 3.2 mM solution with respect to 
the catalyst. Detailed experimental procedures can be found in chapter 7.4.22, page 150. 
This change could be linked to a change in selectivity when mixtures of complex and S and/or 
R additive were used for the asymmetric hydrogenation of prochiral olefin 12. A change in prod-
uct ee was found whenever the S enantiomer of the additive was present (see Figure 4-11b). 
These results indicate, that insights about stereoselective interactions and resulting stereoinduc-
tions obtained for bisphosphinite ligand 41a can be transferred to its more dynamic phospho-
ramidite analog 44. 
In order to investigate autoinductive effects during the hydrogenation of olefin 47, catalytic runs 
with different catalyst loadings at the same catalyst concentrations were conducted, which is 
tantamount to a change of the turnover number (TON) 4. A decreased catalyst loading leads to 
an increase in catalytic cycles, eventually resulting in higher levels of interaction between the 
catalyst and the reaction product by increasing the relative amount of the latter. This conse-
quently causes the catalyst structure to change to a greater extent over time. When olefin 47a 
was converted at 3.2 mM catalyst concentration with 5 bar hydrogen and a catalyst loading of 
100 mol%, which equates to an average TON of one, the S enantiomer of 25 was found to form 
with 19% ee. The same selectivity was found, when the reaction was re-run under the same 
conditions, but with 100 bar H2 gas. This affirms that the obtained selectivities are dictated by 
the specific distribution of the catalyst’s different conformers and not by selective catalyst acti-
vation, i.e. kinetically favoured hydrogenation of the COD co-ligand for one catalyst species. 
Increasing the TON led to a significant change in the enantiomeric distribution of the product 
towards the R enantiomer. When experiments were conducted with 10, 2.5 and 1 mol% catalyst 
(TON of 10, 40 and 100), selectivities of 10% ee S, 12% ee R and 41% ee R were obtained (see 
Figure 4-12). This accounts for an overall change in enantiomeric excess of ee = 60%.  
Since it has been established that only the S product enantiomer is capable of interacting with 
the catalyst to change its selectivity, the rising formation of (R)-25 with increased turnover num-
ber is a clear sign that the initially predominant enantiomer promotes the formation of its mirror 
image at its own expense, classifying this reaction as autoinductive and self-inhibiting. When 
                                                     
4 TON is referred to here as the quotient n(substrate)/n(catalyst). Partial catalyst activation was experi-
mentally addressed, but is formally not considered. 
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similar experiments were performed using weakly interacting substrate 12, a reaction with 10 
mol% catalyst and 100 mol% catalyst had similar outcomes yielding the product with selectivi-
ties of 50% ee and 49% ee. This shows that diamide 25 is vital to change of selectivity that was 
observed for the reduction of 47a. Constitution of the substrate was found to have a significant 
influence on the extent of the autoinductive effect. When substrates 47b was tested, a much less 
pronounced change in selectivity was observed and for substrate 47c, enantiomeric distribution 
did not change at all, when the catalyst loading was altered.  
 
Figure 4-12: Results for the asymmetric hydrogenation of olefin 47a using phosphoramidite complex 45. The cata-
lyst’s selectivity was found to be dependent on its concentration. Moreover, characteristics of auto induction and self-
inhibition for the enantioselective formation of (S)-25 were detected, when the turnover number of the reaction was 
varied. Increased interaction between the catalyst and formed product led to a reversal of selectivity. A detailed ex-
perimental description can be found in chapter 7.4.22, page 150. 
Due to the fact that a decreased catalyst loading at constant catalyst concentration is restricted 
by the solubility of the substrate, it appeared desirable to run reactions with lower catalyst con-
centrations in order to reach higher turnover numbers. As studies of bisphosphinite ligand 41a 
bearing an identical ligand backbone had established that the ligand’s rotamer distribution was 
found out to be concentration dependent, the same was assumed to be true for Rh complex 45. 
Consequently, a second set of reactions was carried out, where olefin 47a was reduced using a 
constant catalyst loading of 10 mol% and varying concentrations. When reactions were run at 
8.0 mM, 3.2 mM, 0.4 mM and 0.2 mM, an increasing selectivity for the S enantiomer of 25 (1%, 
11%, 23% and, again, 23% ee S) was observed accounting for an overall difference of ee = 
22%. This is in line with previous observations of weak ligand-ligand interaction for ligand 41a 
and suggests that an increased presence of the selector moiety influences other catalyst mole-
cules selectivity in favour of (R)-25. Given the structural similarities between selector and reac-
tion product, it comes to no surprise, that both are similarly capable of exerting influence over 
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surrounding catalyst molecules and that identical trends of enhanced production of (R)-25 were 
observed when either the catalyst or the product concentration was increased.  
Finally, attempts to run reactions with increased TONs at lower temperatures were found to be 
limited by catalyst deactivation. Although the presumed trends were identified, reactions at 0.4 
mM catalyst concentration and 0.5 mol% catalyst loading repeatedly failed to give full conver-
sion: First run finished with 19% ee R and about 25% conversion, second run finished with 4% 
ee R at about 10% conversion. When catalysis was repeated with 1 mol% catalyst at 0.4 mM 
catalyst concentration, however, full conversion with a selectivity of 1% ee R was observed, 
which is a considerable shift of selectivity towards the R enantiomer of diamide 25 and is thus 
in line with the previously established self-inhibiting nature of the reaction.  
4.5 Resume 
This chapter describes the development of an asymmetric autoinductive, self-inhibiting hydro-
genation reaction. It serves as a complementary system to the self-amplifying hydrogenation 
reaction recently developed by Trapp and Storch[40] and relies on the same principles: 1) a highly 
stereodynamic catalyst with different enantioselective states, 2) a chiral reactions product, which 
is capable of swiftly altering the catalyst’s ligand state through strong non-covalent interaction 
leading to concurrent increase in production of one enantiomer on the expense of the other one 
and 3) preferential interaction between the selector sites of the catalyst and one enantiomeric 
reaction product over the other one. 
A two-stage process was devised. In the first step, a novel (S)-phenylalanine-based amidoester 
selector was investigated for its ability to serve as coordination site for non-covalent interaction 
with chiral, amino acid-derived additives. Using a variety of differently substituted (S)-amino 
acid-derived additives as alignment agents, all of them representing potential hydrogenation 
products, the rotamer ratio of stereodynamic bisphosphinite 41a and its Rh complex 42a could 
successfully be manipulated. In subsequent asymmetric reductions of methyl 2-acetamidoacry-
late 12 significantly increase in selectivity for the (R)-product enantiomer was observed. While 
the untreated complex 42a converted the substrate with 27% ee R, selectivity could be improved 
to up to 84 % ee R (ee = +57%) after incubating the catalyst with (S)-9 for several hours.  
Building on these results, highly dynamic phosphoramidite complex 45 bearing the same ami-
doester selector sites was synthesized along with the olefins 47a-c, which constitute the unsatu-
rated analogues of strongly interacting diamide (S)-25. When olefin 47a was hydrogenated using 
phosphoramidite complex 45, it could be shown that (S)-25, initially produced in excess, suc-
cessfully supressed its own production during subsequent catalyst turnovers by altering the cat-
alyst selectivity. When catalyst loadings were decreased, ongoing enantioselective self-inhibi-
tion lead to a change in selectivity form 19% ee S (100 mol% catalyst) to 41% ee R (1 mol% 
catalyst) which accounts for an overall difference of ee = 60%. Self-inhibition was found to be 
strongly affected by the substitution pattern of the substrate and a much weaker autoinductive 
effect was observed for compounds 47b and 47c. Another factor found to influence the product 
distribution was the concentration of the catalyst. This was linked to previously observed, weak 
intermolecular interaction of ligand molecules which is an attenuated form of the diastereose-
lective narcissistic self-sorting previously found for ligands with a similar structure (see chapter 
2) and that can be understood as a different manifestation of the same in inhibition process when 
considering the structural similarity between the selector sites and compound (S)-25. 
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5 Tropos ligands based on meso-tartaric acid 
5.1 State of knowledge 
A number of stereodynamic ligands have been discussed and different pathways outlined, that 
allow to exert influence over the rotameric distribution of these ligands. These include - among 
others - use of chiral co-ligands,[193,194] covalently attached chiral auxiliary groups,[52-54] ligand 
isomerization through light and temperature[146,148,149] and chirality transfer through no-covalent 
interaction between the stereodynamic ligand and a chiral molecule.[40,41,62,153,154,195]  
Most widely applied tropos ligands bear a stereochemical axis that allows interconversion be-
tween the Sax and the Rax isomer (see Figure 5-1). Prevalent examples are biphenyl-based biden-
tate ligands, such as BIPOL or BIPHEP. Others include oxazoline based BiphBOX,[196] 2,2’-
bipyridyl-based ligands,[197] or corresponding monodentate ligands such biphenol-based phos-
phoramidites or phosphites. Closely related are compounds with small bridging unit between 
two backbone aryl rings such as benzophenone (DBPB),[198-200] diaryl ether (DPEPhos)[201] or 
bisphenylmethane (MBP).[202] A different type of rotation is encountered with ligands based on 
ferrocene, such as dppf, whose conformers interconvert through rotation of the cyclopentadienyl 
anion around the cp-Fe-cp axis, or PhanePhos-type ligands,[203] where both aryl groups have to 
rotate for enantiomeric interconversion. Apart from chiral axes, helicity of polymeric structures 
can also be influenced under certain conditions forcing them to switch between M- and P-
state.[204]  
 
Figure 5-1: A variety of bidentate, stereodynamic ligands with stereodynamic axes is shown. 
Examples for tropos ligands where interconversion of the two ligands state occurs by rotation 
around an sp3-sp3 bond, on the other hand, are scarce. Privileged ligands containing a C(sp3)-
C(sp3) backbone include DIOP[205] and Chiraphos.[206] Since rotation around an aliphatic C-C 
single bond is very fast, ethane having a barrier of rotation as low as 12.5 kJ/mol,[207] stabilization 
of one rotamer needs to be provided by steric repulsion of the backbone substituents in order for 
the ligands to be selective. For both ligands above, this is caused by the spatial arrangement of 
the substituents that form two stereocenters. A respective stereodynamic tropos ligand with an 
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aliphatic ligand backbone requires interconversion of two enantiomeric synclinal (gauche) con-
formations. If the complexity of the ligand backbone exceeds that of simple ethane, substituents 
have to be attached so that the meso compound is formed in order to retain the equivalence of 
both synclinal (sc) conformers. A comparison with the rotamer ligand states of a biaryl ligand is 
depicted in Figure 5-2. In both cases, two enantiomeric, ligand rotamers (Sax and Rax or +sc and 
–sc) can be found that can be interconverted through an achiral planar/synperiplanar state.  
 
Figure 5-2: Comparison of different rotational states of a biphenyl-based ligand (left) to those of a meso-1,2-disubsti-
tuted DPPE-type ligand (right). In both cases, two enantiomorphic rotamers are found, that interconvert through an 
achiral conformer. 
Previously attributed to internal compensation, the optical inactivity of meso-tartaric acid was 
found to be the caused by the existence of a racemic mixture of both enantiomeric sc forms.[208] 
Unlike homochiral (R,R)- or (S,S)-tartaric acid, which is known to be predominantly exist in 
antiperiplanar conformation (ap), meso-tartaric acid was found to primarily adapt one of these 
two conformers in both solid and in solution state instead.[209,210] 
Walsh and co-workers used meso-1,2-diamies and their respective imines as achiral ligands to 
enhance selectivity in reactions with chiral co-ligands (see Figure 5-3).[211] This can be consid-
ered as an inverse analogue of the asymmetric activation strategy developed by Mikami and 
Noyori, where achiral BIPHEP ligands are stereochemically aligned by chiral diamines.[45] 
 
Figure 5-3: Asymmetric alkylation of aromatic aldehydes by Walsh and co-workers.[211] After coordination to a zinc 
atom, naphthol co-ligand forces the 1,2-diamine- or imine-based meso ligands I or II in one of two possible synclinal 
conformations, significantly increasing the selectivity of the reaction. 
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5.2 Objective 
Following the trend to build stereodynamic ligand systems with selector sites for non-covalent 
interaction, synthesis of a novel ligand type with an aliphatic backbone and amino-acid-derived 
selectors for non-covalent interaction was envisioned. Ease of accessibility with carboxylic acid 
groups as selector attachment points and stereocenters already in place made meso-tartaric acid 
the most convenient substrate to start from.  
Synthesis of a Chiraphos-type ligand and a bisphosphinite analogue was attempted. Focus was 
on the development of a synthetic strategy for each ligand along with investigation of their ste-
reodynamic behaviour. As selector sites, previously investigated phenylalanine-derived diamide 
residues were to be implemented. In this context, it was also to be examined, whether this kind 
of atomic arrangement would prohibit the ligand to form dimers, as previously observed for 
biaryl compounds that were modified with this type of selector. 
 
Figure 5-4: Ligands to be synthesized from meso-tartaric acid or a derivative include a Chiraphos-type bisphosphine 
48 (left) and a corresponding bisphosphinite 49 (right). 
5.3 Synthetic approaches 
5.3.1 Bisphosphine ligand 
The most common approach for the synthesis of alkylphosphines is treatment of a suitable pre-
cursor bearing a leaving group, such as bromine or triflate, with the respective metal phospha-
nide. Due to the generally observed air sensitivity of phosphines, their introduction in the last 
stage of the synthesis seemed sensible. The synthetic strategies that were attempted are outlined 
in Figure 5-5. 
Initial attempts to directly couple the hydrochloride of phenylalanine tert-butylamide to meso-
2,3-dibromotartaric acid 50 remained unsuccessful, potentially due to the instability of the acti-
vated dicarboxylic acid species. Instead, trans-alkene 51 was synthesized from fumaric acid with 
75% yield and subsequent stereoselective bromination was achieved at room temperature to af-
ford meso-2,3-dibromotetraamide 52 in quantitative yield. Unfortunately, final exchange of the 
halogen atoms with diphenylphosphine proved to be challenging. Treatment of compound 52 
under different conditions with PHPh2 in presence of KO
tBu,[212] with PPh2Li[213,214] or with 
PHPh2(BH3) and n-butyl lithium[215] led to full consumption of the phosphorous reagent, but no 
product could be isolated in either case. Among a number of different species identified by 31P 
NMR spectroscopy and HR mass spectrometry, some are believed to be vinyl phosphines sug-
gesting that after the first substitution, elimination of the remaining bromine atom is favoured 
due to sterical hindrance.  
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Figure 5-5: Synthetic attempts to synthesized Chiraphos analogue 48. More detailed experimental data for success-
fully synthesized compounds can be found in chapter 7.5, page 151. 
Consequently, other synthetic routes were tested, where attachment of the selector units would 
occur after previous introduction of the diphenylphosphine moieties. It was previously reported 
by Bookham and co-workers, that diarylphosphines add to diphenylacetylene and depending on 
the type of phosphine, some diphosphines were predominantly formed in meso-form.[216] Addi-
tion of arylphosphines to dimethyl acetylenedicarboxylate is similarly known.[217] Reaction of 
alkyne and diphenylphosphine occurred readily, however, no selective formation of the diphos-
phines could be observed. In a final attempt, the carboxylic acid groups of fumaric acid were 
transformed into oxazolines, which are known to withstand strongly basic organometallic rea-
gents. Subsequent introduction of leaving groups in meso-configuration would potentially allow 
for the substrate to withstand much harsher conditions during subsequent halogen-phosphine 
exchange. Fumaric acid was consequently treated with oxalyl chloride and 2,2-dimethylami-
noethanol. The resulting dialcohol could successfully be dehydrated using diethylamino sul-
furtrifluoride (DAST)[218,219] to give trans-bis(oxazoline) alkene 53. Treatment of this compound 
with bromine or tBu4NBr3 led to decomposition of the substrate, most likely due to faster side 
reactions with the oxazoline protecting groups. Attempts to use different, less aggressive rea-
gents such as PhI(OAc)2/KBr [220] or CuBr2/LiBr[221] gave no reaction at all. Iodination was found 
to be equally unsuccessful. 
5.3.2 Bisphosphinite ligand 
For the potential bisphosphinite ligand it seemed equally sensible to introduce the arylphospho-
rus groups in the last reaction step of the sequence to avoid having to handle moisture and oxy-
gen sensitive ligand precursors. The most convenient approach thus seemed to be coupling of 
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the selector moieties to meso-tartaric acid and subsequent treatment of the diol with PPh2Cl. The 
synthetic strategy for the ligand is outlined in Figure 5-6. 
 
Figure 5-6: Synthetic approach for the synthesis of bisphosphinite ligand 49 from meso-tartaric acid. More detailed 
experimental data can be found in chapter 7.5, page 151. 
In the first reaction step, meso-tartaric acid was treated with acetyl chloride to protect the hy-
droxy groups. The resulting anhydride was dissolved in water and THF to yield dicarboxylic 
acid 54.[222] Selector moieties could subsequently be introduced by coupling with phenylalanine 
tert-butylamide hydrochloride using oxalyl chloride and DMF as catalyst to give tetraamide 55 
in good yield.[223] When compound 55 was subsequently heated in methanol in the presence of 
potassium carbonate, full deprotection of the hydroxy groups was observed within 90 minutes. 
Intriguingly, racemization of the stereocenters occurred when the suspension was concentrated 
in presence of the base during workup. Pure diol 56 could finally be obtained by loading the 
fully deprotected crude mixture onto a plug of silica and eluating with ethanol. During the last 
reaction step, test reactions with chlorodiphenylphosphine or diethylamino diphenylphosphine 
in presence of different bases were conducted to analyse product formation. Reaction of diol 56 
with mildly reactive PPh2NEt2 in presence of N,N-dimethylaminopyridine at 70 °C was moni-
tored by 31P NMR spectroscopy over several days (see Figure 5-7). Formation of intermediate 
species represented by two singlet signals of equal size, which was assigned to the two possible 
mono-phosphorylated compounds, became visible within four hours. After longer reaction 
times, two additional singlet signals of equal intensity representing the desired bisphosphinite 
49 were detected. With longer reaction times, intensity of these signals increased while those 
assigned to the intermediate structures became weaker. Despite long reaction times, however, 
full conversion could not be reached. 
When 56 was reacted with an excess of highly reactive chlorodiphenylphosphine in presence of 
triethylamine, however, no intermediate was detected and full conversion to the desired bisphos-
phinite 49 was reached. Unfortunately, purification of the compound proved to be laborious due 
to its high solubility and sensitivity towards oxygen and moisture. No pure sample could be 
obtained within the timeframe of the project  
5.4  Conformational analysis 
____________________________________________________________________________ 
- 68 - 
 
Figure 5-7: Section of 31P NMR spectrum monitoring reaction progress for the synthesis of bisphosphinite 49 from 
diol 56 and PPh2NEt2 . Formation of mono-phosphorylated intermediate was also observed.  
 
5.4 Conformational analysis 
Since both desired ligands could not be synthesized in pure form within the timeframe of the 
project, an analysis of the ligands’ stereodynamics seems void. A brief investigation of the NMR 
data for all obtained ligand precursors, however, might reveal preliminary insights into the gen-
eral appearance of compounds of this sort.  
Compounds 52 (dibromo derivative), 55 (acetyl-protected diol), 56 (diol) and crude 49 (bisphos-
phinite) were compared. In all cases only one species was observed by NMR spectroscopy which 
indicates either complete immobilization of one fully enriched rotamer or rapid rotation around 
the central C-C bond where the NMR spectrum represents a weighted average between the stag-
gered conformers, which are the two synclinal conformers (-sc and +sc) and the antiperiplanar 
rotamer (ap) shown in Figure 5-8. Presence of additional stereocenters on the selector groups 
removes the energetic equivalence of the two sc conformers. Each of these rotamers are intrin-
sically diastereotopic, and if stable enough, orientation of both molecular halves can be esti-
mated with help of the Karplus equation, which connects the coupling constants of the two vic-
inal methin to their dihedral angle.[224] Maximal coupling (8-15 Hz) is observed for dihedral 
angles of 0° and 180°, where orbital overlap is maximized. A synclinal conformation results in 
smaller coupling constants (2-5 Hz) and no coupling is observed if a 90° angle is adapted.  
The 1H NMR spectrum of compound 51, however, exhibits intense line broadening, when col-
lected in CDCl3 suggesting the compound remains highly dynamic in aprotic solvents. Spectra 
of acetyl-protected diol 55 (collected in CDCl3), of deprotected compound 56 (CD3OD) and of 
in situ-formed bisphosphinite 49 (THF-d8) gave doublet signals for both methin protons of the 
tartaric acid moiety and a coupling constant of 3J(H,H) = 2.1 Hz, 2.1 Hz and 1.9 Hz, respectively, 
was observed which suggests that both compounds retain a synclinal conformation as their most 
stable form (see Figure 5-8).  
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Figure 5-8: Top: Schematic illustration of the staggered conformers of meso-tartaric acid derivatives bearing phenyl-
alanine derive selectors (Sel* = tBu-(S)Phe-NHCO). Bottom: Sections of 1H NMR spectra showing signals for methin 
protons of investigated compounds. 
Analysis of the amide protons revealed significant differences compared to those biaryl ana-
logues studied in chapter 2. Dimerization of these compounds led to a strong downfield 1H NMR 
shifts and signals for these protons were generally found between 10.7 and 7.3 ppm. In contrast, 
shifts for compound 55 were found to be much higher between 7.45 and 6.90 ppm for the inner 
and 6.06 and 4.83 ppm for the terminal amide groups. This indicates a much smaller hydrogen 
bond interaction with surrounding molecules. Also, when a sample of diol 55 was dissolved in 
deuterated methanol, complete deuteration of all amide protons was observed within a few 
hours. Unlike for diol 18c, where strong hydrogen bonding was found to significantly decelerate 
the exchange speed leading to a half-life of several days, this is another strong indicator, that 
inter- or intramolecular non-covalent self-interactions between selector moieties is significantly 
reduced in ligands that bear a backbone based on meso-tartaric acid. In conclusion, initial NMR-
based analysis of the ligand precursors suggests that changing the ligand backbone from a biaryl-
based to an aliphatic, ethane-based system strongly impairs the self-interaction capabilities that 
were previously observed to occur with this selector type. Further studies are needed to confirm 
these findings and to gain further insight into the stereodynamic properties of these ligands. 
5.5 Resume 
In this chapter, synthetic approaches to a new motif for stereodynamic ligands have been inves-
tigated. Meso-tartaric acid exists in two enantiomeric synclinal conformers (-sc and +sc), which 
serve as analogues to axial isomers of established biphenyl-based tropos ligands. The modifica-
tion of the carboxyl groups with previously investigated phenylalanine-based diamide selector 
moieties was pursued to yield a ligand motif for highly dynamic tropos ligands that could be 
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used as a blueprint for different ligand types. The geometric arrangement of selector and ligand 
backbone in this ligand type was also thought to inhibit ligand dimerization that was previously 
observed for biaryl-based ligands bearing the same selector sites. 
Different strategies for the synthesis bisphosphine 48 were attempted and synthesis of dibromo 
precursor 52 could be achieved, but the subsequent substitution reaction turned out to be prob-
lematic and the desired compound could not be obtained. 
Similarly, a synthetic strategy for the respective bisphosphinite 49 was devised. Starting from 
meso-tartaric acid, synthesis of respective diol precursor 56 could be achieved in three steps. 
Reaction to the bisphosphinite was also successful, full purification of the ligand, however, 
proved difficult and no pure ligand sample was obtained within the timeframe of the project.  
Conclusive NMR-assisted investigations of intermediates suggest that, unlike respective biaryl 
analogues, no ligand dimerization occurs. As with meso-tartaric acid, compounds 55, 56 and 49 
were found to adapt a synclinal arrangement as their predominant conformation, when dissolved 
in CDCl3 or CD3OD, respectively. Additional experiments, such as DHPCL- or NMR-based 
interaction studies are necessary to gain a deeper understanding for the stereodynamic behaviour 
of these types of compounds. 
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6 Summary and outlook 
In this dissertation, the synthesis and study of different stereodynamic ligands and complexes as 
well as their application in asymmetric reactions have been described. Investigations followed 
the intent to modify rotational behaviour of compounds through non-covalent interaction of lig-
and-bound interaction sites with other chiral molecules in order to alter selectivity in enantiose-
lective transformations. 
 
Chapter 2 describes investigations on chiral (S)-amino acid-based selector sites, derived from 
selector sites of high-performance gas chromatography CSP CHIRASIL VAL. Different 2,2’-
biphenol-based BIPOL, bisphosphine, bisphosphinite and phosphoramidite ligands with inter-
action sites in 5,5’-position were devised and it was found that such a substitution entails spon-
taneous enrichment of the Rax ligand rotamer (see Figure 6-1). Detailed investigations, inter alia, 
by NMR spectroscopy, X-ray structure analysis and HD exchange experiments revealed that 
intermolecular non-covalent interactions of the selector units lead to formation of well-ordered 
ligand dimers. The chiral information of the amino acid-based selector groups dictates the axial 
chirality of the ligand’s biphenyl backbones within the supramolecular structure through coop-
erative chiral induction, allowing only for Rax rotamers to dimierise. This causes selective stabi-
lization of one rotamer and drives the rotameric enrichment. The process can be described as a 
form of stereoselective, narcissistic self-sorting and the state of rotameric enrichment is self-
reinforced by dynamic exchange among the complex subunits, which is a form of stereocontrol 
that resembles that found in sergeant-soldier-type self-organizing, supramolecular systems. For 
selector-modified bisphosphine 7, a strongly weighted equilibrium between a monomeric Sax 
rotamer and a dimeric Rax rotamer with a ratio of 16:84 (Sax:Rax) was observed, which could be 
influenced by adding different chiral or achiral hydrogen bond donors and acceptors that would 
occupy the interaction sites. BIPOL ligands 18a-c, phosphinite ligands 19a-c and phospho-
ramidite ligands 23a-b, on the other hand, were found to undergo complete transformation into 
one diastereomerically pure Rax species each.  
BIPOL ligands were used in titanium-mediated enantioselective alkylation reactions of aromatic 
aldehydes. A variety of different alcohols could be generated with selectivities of up to 79.8% 
ee of the R enantiomer.  
All phosphorus-based ligands were employed in asymmetric, rhodium-catalyzed hydrogenation 
reactions. Methyl 2-acetamidoacrylate 12 was reduced using bisphosphine 7 to give the product 
with an er of 17.4:82.6 (S:R), which indicates high selectivity for each individual ligand rotamer. 
The enantiomeric excess of the product could be influenced by employing ligand mixtures 
whose rotameric distribution had previously been adapted by equilibration in presence of chiral 
or achiral additives and selectivity could be enhanced to an er of 8.6:91.4 (S:R, ee = +18%, 
additive Ac-(S)Ala-NH(3,5-dichlorophenyl) (S)-9). Diastereomerically pure bisphosphinite lig-
ands 19a-c were used for the hydrogenation of benchmark substrates 12 and 20-22 where all 
ligands were found to exhibit high to very high selectivities. Best results were obtained with the 
phenylalanine-based ligand 19c, which reduced olefin 12 with a selectivity of 4.0:96.0 (S:R).  
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Figure 6-1: Illustration of the diastereoselective self-interaction process. Modifying tropos biaryl ligands in 5,5’-
position with chiral diamide selectors induces formation of homochiral, energetically favoured dimers, which can be 
employed as ligands in asymmetric transformations. 
Phosphoramidite ligands 23a and 23b performed less selectively and the highest enantiomeric 
ratio of 73.2:26.8 (S:R) was achieved with ligand 23a in the reduction of 12. Interestingly, a 
reversal in selectivity was observed when the valine-based selector was replaced by a phenylal-
anine-based one indicating a more complex path of stereoinduction for this ligand type. 
With regard to future research, it should be highlighted that this ligand motive yields a predict-
able structure that can be used to design of self-recognizing enantioselective catalysts for a wide 
range of reactions. The question arises whether self-assembly-driven enrichment of this type of 
tropos ligands can be realized with other ligand structures. Different interaction modes should 
be tested in order to identify more specific prerequisites for this process to occur.  
 
In chapter 3, investigations were extended to achiral binding sites for non-covalent interaction. 
Inspired by the model of "switchable" catalysts, hydrogen-bond driven deracemization of race-
mic catalysts was examined (see Figure 6-2). A bisphosphinite ligand with 3,5-dichlorobenzoyl 
selector moieties, previously investigated by Trapp et al.[41], was modified with stereodirecting 
groups in 3,3’-position in order to analyze potential improvement of catalyst selectivity. How-
ever, decreased deracemization at lower temperatures was observed and no improvement in se-
lectivity could be achieved. In addition, racemic ligands with 5,5’-diamido selector moieties 
were investigated.  The rhodium complex of dimerizing ligand 19d with glycine-derived selector 
sites could successfully be deracemized in presence of different amino acid-derived diamide 
additives. The switchable nature of the catalyst was verified by employing both enantiomers of 
compound PhCO-Phe-NHtBu 25 separately as aligning agents. Subsequent hydrogenation of 12 
gave products in 14% ee S or R when the R or the S additive was used. Ac-(S)Ala-NH(3,5-
dichlorophenyl) (S)-9 showed the biggest alignment potential among employed diamides allow-
ing for the reduction to proceed with 34% ee R. When ligand-mimicking tetraamide 24 was 
employed, selectivity could be further increased to 41% ee R. In order to investigate adverse 
6  Summary and outlook 
____________________________________________________________________________ 
- 73 - 
effects of ligand dimerization on the deracemization process, ligand interaction was reduced by 
employing racemic phenylalanine-derived interaction sites as “mismatching” selector units.  
The ligand meso-19c was found not to form stable supramolecular dimers and again, significant 
chirality transfer was observed. As with ligand 19d, best selectivities were achieved with dia-
mide (S)-9, which induced a selectivity of 23% ee R for the reduction of 12 and with tetraamide 
24 where a selectivity of 46% ee R was obtained. Similar selectivities for both catalysts 19d and 
meso-19c in combination with different aligning agents indicate that ligand self-assembly has 
no adverse effect on the deracemization process, most likely due to fast molecular exchange 
between ligand subunits, which allows for stereoinducing additives to compete for the interac-
tion sites. 
 
Figure 6-2: Simplified illustration of racemic bisphosphinite catalyst systems described in chapter 3. Deracemization 
was achieved through non-covalent interactions between the ligands and chiral amino acid derivatives yielding a 
catalyst for enantioselective hydrogenation.  
Prospective research should focus on extending the library of investigated chiral additives in 
order to correlate substitution patterns to increased ligand deracemization. Detailed mechanistic 
studies would permit a more directed improvement of the systems. Moreover, it seems desirable 
to transfer the design to other racemic stereodynamic catalysts to access a wider range of reaction 
types. 
 
Chapter 4 covers the development of an autoinductive catalyst system. Based on a “by design” 
self-amplifying reaction previously described by Trapp et al.,[40] a complementary system was 
developed in which the selectivity of a hydrogenation reaction is based on self-inhibiting prop-
erties. In a two-stage process, a novel, (S)-phenylalanine-based amidoester selector motif was 
first investigated for its potential to interact with chiral additives. Using a variety of differently 
substituted (S)-amino acid-derived additives as alignment agents, all of them representing po-
tential hydrogenation products, the rotamer ratio of stereodynamic rhodium complex 42 could 
successfully be manipulated. In subsequent asymmetric reductions of 12 significantly increase 
in selectivity for the (R)-product enantiomer was achieved from 27% ee R with the untreated 
complex to up to 84 % ee R (ee = +57%), after incubating the catalyst with PHCO-(S)Phe-
NHtBu (S)-25 for several hours (see Figure 6-3a).  
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Figure 6-3: Illustration of the two-stage process for the development of an autoinductive, self-inhibition reaction 
described in chapter 4. a) Investigation of chiral induction between potential hydrogenation products and phenylala-
nine-derived selector sites. b) Findings were used to devise a system that shows self-inhibiting properties.  
Building on these results in the second stage of the project, highly dynamic phosphoramidite 
complex 45 bearing the same amidoester selector sites was synthesized along with olefin 47a, 
among others, which constitutes the unsaturated analogue of strongly interacting diamide (S)-
25. When olefin 47a was hydrogenated using phosphoramidite complex 45, it could be shown 
that (S)-25, initially produced in excess, successfully supressed its own production during sub-
sequent catalyst turnovers by altering the catalyst selectivity (see Figure 6-3b). When catalyst 
loadings were decreased, ongoing chiral self-inhibition lead to a reversal in selectivity from 19% 
ee S (100 mol% catalyst) to 41% ee R (1 mol% catalyst). The catalyst concentration was found 
to be another important factor and increasing the catalyst concentration at constant catalyst load-
ings led to a selectivity shift from 23% ee S (0.2 mM in catalyst) to 1% ee S (8 mM in catalyst). 
This was linked to weak intermolecular interaction of ligand molecules, which is an attenuated 
form of the stereoselective self-sorting process previously found for ligands of similar structure. 
Considering the structural similarities between the selector sites of catalyst 45 and (S)-25, this 
concentration dependency can also be understood as a different manifestation of the enantiose-
lective self-inhibition process. Ultimately, these findings illustrate how the process of self-inhi-
bition, a mechanism prevalent in nature, can be recreated on a molecular level. The process also 
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forms a complementary addition to the previously published example of chiral self-amplification 
and can be used as foundation to device new concepts for enantioselective transformations. It 
also demonstrates how a small deviation from the racemic state can transform into a state of high 
enantiomeric enrichment as it is presumed to have happened during the emergence of homochi-
rality.  
 
In the last part of the dissertation in Chapter 5 initial studies concerning a novel ligand motive 
for selector-modified tropos ligands with an aliphatic ligand backbone derived from meso-tar-
taric acid are presented. Meso-tartaric acid predominantly exists in two enantiomeric synclinal 
conformers (-sc and +sc), which serve as analogues to axial isomers of biphenyl-based tropos 
ligands and modification with selector sites for non-covalent interaction was believed to yield a 
novel motif for highly dynamic tropos ligands that could be used as a blueprint for different 
ligand types (see Figure 6-4). Strategies for the synthesis of a bisphosphine were attempted and 
different precursor compounds could be obtained. 
 
Figure 6-4: Illustration of the conceptual similarity between rotamer species from biphenyl-based tropos ligands to 
ones that are based on meso-tartaric acid. 
Similarly, a synthetic strategy for the respective bisphosphinite was devised. Starting from meso-
tartaric acid, synthesis of the diol precursor could be achieved in three steps and reaction to 
bisphosphinite ligand 49 could successfully be conducted in situ. Conclusive NMR-assisted in-
vestigations of the ligand and different precursors suggest that no ligand dimerization occurs 
and compounds were found to adapt a synclinal arrangement as their predominant conformation.  
Aside from improvement of the synthetic protocols, additional experiments will be necessary to 
gain a deeper understanding of the stereodynamic behaviour of these types of compounds, which 
will determine their applicability in subsequent enantioselective reactions. 
 
In conclusion, this dissertation describes a variety of different stereodynamic catalysts, whose 
selectivity in asymmetric transformations can be manipulated by enantioselective hydrogen 
bonding. These examples illustrate how non-covalent interactions can become a strong driving 
force for the transmission of a chiral bias and they can serve as starting points for the investiga-
tion of other stereodynamic systems. Moreover, these findings can be used to understand path-
ways for the transfer of chiral information in nature, which is particularly interesting in the con-
text of auto induction and homochirality. They can also be a basis for the development of novel 
catalyst systems.
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7 Experimental section 
7.1 General remarks  
Materials: 
All reactions involving the use of oxygen or moisture sensitive substances were carried out in 
dried glassware under an atmosphere of nitrogen or argon using standard Schlenk techniques. 
All chemicals were used as received from suppliers without further purification. Column chro-
matography was done using silica gel (technical grade, pore size 60 Å, 70-230 mesh, 63-200 
µm) produced by Sigma-Aldrich Chemie GmbH. Thin layer chromatography was performed on 
coated aluminium sheets (Machery-Nagel POLYGRAM ® SIL G/UV 254). Components were 
visualized by fluorescence quenching during irradiation with UV light (254 nm) or by using 
appropriate staining agents. Dry solvents were taped from solvent purification system MB SPS-
800 and used immediately. Manual degassing of solvents, if needed, was done by performing 
three consecutive freeze-pump-thaw cycles. Dry, oxygen-free solvents were then stored in J. 
Young ampules over molecular sieves and under an atmosphere of argon. Dry and degassed 
THF was purchased containing 250 ppm BHT as stabilizer. 
 
Analytics: 
NMR spectra were recorded at the NMR Spectroscopy Facilities of the Institute of Organic 
Chemistry, University of Heidelberg (Head: Dr. Jürgen Graf) and of the Faculty of Chemistry 
and Pharmacy, LMU Munich (Head: Dr. David Stephenson) on Varian NMR-Systems (300, 400 
and 600 MHz) and Bruker Avance III HD and DRX (300, 400, 600 and 800 MHz). NMR shifts 
are given in parts per million (ppm) and are referenced to the residual proton or carbon solvent 
signals.[225] Couplings are termed as follows: s (singlet), bs (broad singlet), d (doublet), t (triplet), 
sept (septet), dd (doublet of a doublet), dt (doublet of triplet) and tt (triplet of triplet), m (multi-
plet). Assignment was done by means of two-dimensional experiments (1H-1H-COSY, 1H-13C-
HSQC, 1H-13C-HMBC). The numbering is depicted in the respective figure shown above each 
procedure. If two halves of a formally symmetric molecule are represented by different signal 
sets, respective atoms are denoted with numbers X and X’.  
Mass spectra were acquired at the Mass Spectrometry Facilities of the Institute of Organic 
Chemistry, University of Heidelberg (Head: Dr. Jürgen H. Gross) and of the Faculty of Chem-
istry and Pharmacy, LMU Munich (Head: Dr. Werner Spahl) on JEOL JMS-700 magnetic sector 
(EI), Thermo Finnigan MAT 95/Jeol MStation sector field (FAB), Bruker ApexQe hybrid 9.4 T 
FT-ICR (DART), Thermo Q Exactive Hybrid Quadrupole Orbitrap and on Thermo Finnigan 
LTQ FT Ultra FT-ICR (ESI).  
For solid state IR analysis, Thermo Fisher Nicolet 6700 FT-IR-Spectrometer was employed and 
the wavenumber of reflectance was measured with signals being denoted as s (strong), m (me-
dium), w (weak) and b (broad signal).  
Crystallographic data was collected at the X-Ray Crystallography Laboratories of the Institute 
of Organic Chemistry, University of Heidelberg (Head: Dr. Frank Rominger) and of the Faculty 
of Chemistry and Pharmacy, LMU Munich (Head: Dr. Peter Mayer) on Bruker APEX-II Quazar 
area detector and on a STOE-IPDS system with Mo Kα radiation (λ = 0.71073 Å). 
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Elemental analysis was conducted at the combustion analysis laboratories of the Faculty of 
Chemistry and Pharmacy, LMU Munich (Head: Dr. Bernhard Kempf) on a Elementar vario 
micro cube equipped with a thermal conductivity detector. 
UPLC-MS analysis was conducted on Waters UPLC-SQD2 (DAD/APCI-MS) equipped with 
reversed-phase BEH C18 using different gradients of acetonitrile and water as mobile phase. 
HPLC and HPLC-MS measurements were performed on Agilent Technologies 1200 HPLC ma-
chines equipped with DAD and quadrupole mass spectrometer. All columns with chiral station-
ary phases were obtained from Chiral Technologies. HPLC-grade solvents were obtained for 
Sigma-Aldrich.  
GC analysis was done on Thermo Trace GC ULTRA, equipped with autosampler, split/splitless 
injector (20 mL/min splitflow, 250 °C injector temperature) and FID detector. Chiral columns 
(25 m, i.d. 250 µm, film thickness 250 nm) were prepared and coated in the Trapp group. 
In order to improve comprehensibility, most compounds are described with simplified names 
instead of IUPAC names. 
 
7.2 Experimental data for chapter 2 
1.1.1 Methyl-3-bromo-5-hydroxybenzoate (1i)  
 
3-Bromo-5-hydroxybenzoic acid (2.90 g, 13.4 mmol, 1.00 eq.) was dissolved in methanol (25.0 
mL). Concentrated sulfuric acid (3.54 g, 1.92 mL, 36.1 mmol, 2.70 eq.) was added and the clear 
solution was refluxed for five hours. The solution was then allowed to cool to room temperature 
and sodium hydroxide solution (2M, 20.0 mL) was added until pH 8 was reached. Water (40.0 
mL) was added and white solids precipitated. The suspension was stirred for 15 min to complete 
the crystallization. Afterwards, solids were filtered off , washed with cold water and dried in 
vacuo yielding the product 1i as white crystals (2.60 g, 11.2 mmol, 84%). 
1H-NMR (CDCl3, 600.24 MHz, 300 K): δ = 3.92 (s, 3H, CH3), 6.14 (s, 1H, OH), 7.24 (s, 1H, 
H2), 7.51 (s, 1H, H4), 7.73 (s, 1H, H6) ppm. 
13C{1H}-NMR (CDCl3, 150.93 MHz, 300 K): δ = 52.9 (CH3), 115.6 (C4), 123.0 (C1), 123.6 
(C2), 125.0 (C6), 132.7 (C5), 156.8 (C3), 166.3 (C=O) ppm. 
HRMS (EI): m/z calcd. for C8H7BrO3 where Br is 79Br [M]+: 229.9579; found: 229.9563. 
FTIR: ṽ = 763 (s), 1271 (s), 1425 (s), 1591 (s), 1706 (s), 2841 (w), 2958 (m), 3044 (w), 3096 
(m), 3392 (b) cm-1.  
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1.1.2 Methyl-5-bromo-3-(diphenylphosphinoyl)benzoate (2) 
 
An adaptation of the procedure published by Keay et al. was applied.[96] Phenol derivative 1i 
(3.34 g, 14.5 mmol, 1.00 eq.) and 4-(dimethylamino)pyridine (88.3 mg, 733 µmol, 0.05 eq.) 
were stirred in dry dichloromethane (40.0 mL). Solids dissolved upon addition of dry triethyla-
mine (2.05 g, 2.82 mL, 20.2 mmol, 1.40 eq.) and the clear solution was cooled in an ice bath. 
Diphenylphosphinic chloride (4.79 g, 3.86 mL, 20.2 mmol, 1.40 eq.) was added dropwise at 
0 °C. After warming to room temperature, the resulting orange solution was stirred for 20 hours. 
Upon subsequent addition of n-hexane, triethylammonium chloride precipitated and stirring was 
resumed for 15 min. The solids were filtered off and washed with more n-hexane. The combined 
organic layer was evaporated to give the crude mix as a clear oil, which was purified using 
column chromatography (silica, petrol ether: ethyl acetate 10:1 → 1:1, Rf = 0.49 in 2:1 petrol 
ether: ethyl acetate). The product 2 could be obtained as a white solid (5.17 g, 12.0 mmol, 83%). 
1H-NMR (CD2Cl2, 600.24 MHz, 300 K): δ = 3.87 (s, 3H, CH3), 7.51 (dt, 4H, 3J(H,H) = 5.00 Hz, 
4J(P,H) = 3.48 Hz, H9), 7.59 (t, 2H, 3J(H,H) = 7.43 Hz, H10), 7.63 (s, 1H, H2), 7.79 (s, 1H, H4), 
7.88 (dd, 4H, 3J(H,H) = 7.72, 3J(P,H) = 12.67 Hz, H8), 7.91 (s, 1H, H6) ppm. 
13C{1H}-NMR (CD2Cl2, 150.93 MHz, 300 K): δ = 52.9 (s, 1C, CH3), 121.0 (d, 1C, 3J(C,P) = 
5.16 Hz, C4), 122.9 (s, 1C, C1), 128.5 (d, 1C, 3J(C,P) = 4.78 Hz, C2), 129.1 (s, 1C, C6), 129.2 
(d, 4C, 3J(C,P) = 13.51 Hz, C9), 130.7 (d, 2C, 1J(C,P) = 137.59 Hz, C7), 132.0 (d, 4C, 2J(C,P) = 
10.42 Hz, C8), 133.2 (d, 2C, 4J(C,P) = 2.82 Hz, C10), 133.5 (s, 1C, C5), 151.9 (d, 1C, 2J(C,P) = 
7.92 Hz, C3), 165.1 (s, 1C, C=O) ppm. 
31P{1H}-NMR (CD2Cl2, 242.98 MHz, 300 K): δ = 31.84 (s) ppm. 
HRMS (ESI): m/z calcd. for C20H17BrO4P where Br is 79Br [M+H]+: 431.0042; found: 
431.0042. 
FTIR: ṽ = 724 (s), 1204 (s), 1428 (s), 1573 (s), 1725 (s), 2946 (w), 2993 (w), 3051 (m) cm-1.  
 
1.1.3 Methyl-3-bromo-4-(diphenylphosphoryl)-5-hydroxy (3) 
 
Phosphoric acid ester 2 (1.25 g, 2.90 mmol, 1.00 eq.) was dissolved in dry THF (25.0 mL) and 
the flask was placed in an acetone/dry ice cooling bath. LDA solution (342 mg, 1.59 mL, 3.19 
mmol, 1.10 eq.; 2M in THF/n-heptane/ethylbenzene) was added dropwise at -78 °C and the 
yellow solution was kept stirring in the cooling bath to warm to room temperature overnight. 
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After 15 hours, the solution was quenched with saturated ammonium chloride solution (25.0 
mL). The layers were separated and the aqueous layer was washed twice with ethyl acetate. 
Combined organic layers were washed with HCl solution (1M) and brine, dried over sodium 
sulfate and evaporated to afford the crude product as a yellow oil. Purification by column chro-
matography (silica, PE:EE 15:1 → 8:1, Rf = 0.46 in 4:1 PE:EE) gave a yellow solid. Washing 
with a mixture of petrol ether and ethyl acetate (20:1 v/v) removed the impurities and after dry-
ing in vacuo, the pure compound 3 was obtained as a white solid (360 mg, 835 µmol, 29%). 
1H-NMR (CDCl3, 600.24 MHz, 300 K): δ = 3.92 (s, 3H, CH3), 7.53 (dt, 4H, 3J(H,H) = 7.56 Hz, 
4J(P,H) = 2.76 Hz, H9), 7.61-7.62 (m, 1H, H4), 7.63 (t, 2H, 3J(H,H) = 7.32 Hz, H10), 7.66-7.68 
(m, 1H, H6), 7.85 (dd, 4H, 3J(H,H) = 7.68 Hz, 3J(P,H) = 12.93 Hz, H8), 13.12 (s, 1H, OH) ppm. 
13C{1H}-NMR (CDCl3, 150.93 MHz, 300 K): δ = 52.9 (s, 1C, CH3), 114.7 (d, 1C, 1J(C,P) = 
102.50 Hz, C2), 119.9 (d, 1C, 3J(C,P) = 6.82 Hz, C4), 125.2 (d, 1C, 3J(C,P) = 7.50 Hz, C6), 
125.3 (d, 1C, 2J(C,P) = 5.52 Hz, C1), 128.8 (d, 4C, 3J(C,P) = 13.10 Hz, C9), 130.2 (d, 2C, 1J(C,P) 
= 110.01 Hz, C7), 132.7 (d, 4C, 2J(C,P) = 10.85 Hz, C8), 133.0 (d, 2C, 4J(C,P) = 2.78 Hz, C10), 
136.4 (d, 1C, 4J(C,P) = 1.63 Hz, C5), 165.2 (s, 1C, C=O), 167.7 (d, 1C, 2J(C,P) = 3.52 Hz, C3) 
ppm. 
31P{1H}-NMR (CDCl3, 242.98 MHz, 300 K): δ = 45.07 ppm. 
HRMS (ESI): m/z calcd. for C20H14BrO4P where Br is 79Br [M-H]-: 429.9897; found: 428.9888. 
FTIR: ṽ = 694 (s), 1118 (s), 1398 (s), 1551 (s), 1722 (s), 2653 (b), 2955 (w), 3062 (w) cm-1. 
 
1.1.4 Methyl-3-bromo-4-(diphenylphosphoryl)-5-methoxy benzoate (4) 
 
A slightly adapted procedure introduced by Brown et al. was employed.[49] Phosphine oxide 3 
(360 mg, 835 µmol, 1.00 eq.) was suspended in acetone (15.0 mL) at 0 °C. After adding caesium 
carbonate (544 mg, 1.67 mmol, 2.00 eq.) the suspension became highly viscous and turned yel-
low. Iodomethane (1.18 g, 510 µL, 8.34 mmol, 10.0 eq.) was added dropwise via syringe and 
after warming to room temperature, the mixture was stirred for nine hours. Subsequently, evap-
oration of the colorless suspension yielded a white solid residue which was dissolved in a mix-
ture of water and dichloromethane (20.0 mL, 1:1 v/v). The layers were separated, the aqueous 
phase was extracted with dichloromethane twice more and the combined organic layer was 
washed with water and brine. Drying over sodium sulfate and evaporation of the solvent gave 
the pure product 4 as a white solid (362 mg, 835 µmol, 98%). 
1H-NMR (CD2Cl2, 600.24 MHz, 300 K): δ = 3.25 (s, 3H, CH3a), 3.91 (s, 3H, CH3b), 7.43-7.48 
(m, 5H, H6 and H9), 7.53 (t, 2H, 3J(H,H) = 7.38 Hz, H10), 7.66 (dd, 4H, 3J(H,H) = 7.50 Hz, 
3J(P,H) = 12.93 Hz, H8), 7.95 (s, 1H, H4) ppm. 
13C{1H}-NMR (CD2Cl2, 150.93 MHz, 300 K): δ = 53.0 (s, 1C, CH3b), 55.9 (s, 1C, CH3a), 112.1 
(d, 1C, 2J(C,P) = 5.30 Hz, C6), 125.9 (d, 1C, 1J(C,P) = 98.4 Hz, C2), 128.7 (d, 4C, 3J(C,P) = 
12.7 Hz, C9), 128.7 (s, 1C, C1), 129.2 (d, 1C, 3J(C,P) = 7.83 Hz, C4), 131.3 (d, 4C, 2J(C,P) = 
10.17 Hz, C8), 131.8 (d, 2C, 4J(C,P) = 2.79 Hz, C10), 134.1 (d, 2C, 1J(C,P) = 110.20 Hz, C7), 
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135.7 (d, 1C, 4J(C,P) = 1.71 Hz, C5), 162.6 (d, 1C, 2J(C,P) = 3.26 Hz, C3), 165.3 (s, 1C, C=O) 
ppm. 
31P{1H}-NMR (CD2Cl2, 242.98 MHz, 300 K): δ = 25.72 ppm. 
HRMS (ESI): m/z calcd. for C21H19BrO4P where Br is 79Br [M+H]+: 445.0199; found: 
445.0199. 
FTIR: ṽ = 698 (s), 1240 (s), 1546 (s), 1717 (s), 2953 (w), 2984 (w), 3048 (w) cm-1. 
 
1.1.5 3,3’-Dimethoxy-5,5’-bis(methoxycarbonyl)-[1,1’-biphenyl]-2,2’-bis(diphenylphosphine 
oxide) (5) 
 
Phosphine oxide 4 (350 mg, 786 µmol, 1.00 eq.) was stirred in dry dimethylformamide (6 mL). 
Copper powder (125 mg, 1.97 mmol, 2.50 eq.) was added at once and the mixture was heated to 
80 °C. After two hours, the mixture was filtrated and the remaining solids were washed with 
dichloromethane. The organic layer was collected and the green solution was washed with sat-
urated ammonium chloride solution to remove copper salts. It was then washed with water and 
brine, dried over sodium sulfate and evaporated to give the crude product as a white foam. Pu-
rification by column chromatography (silica, dichloromethane:methanol 200:1 → 50:1, Rf = 0.05 
in 100:1 dichloromethane:methanol) gave the pure bis(phosphine oxide) 5 as a white solid (262 
mg, 358 µmol, 91%). 
1H-NMR (CD3OD, 600.24 MHz, 300 K): δ = 3.41 (s, 6H, CH3a), 3.81 (s, 6H, CH3b), 7.30-7.35 
(m, 6H, H6 and H9), 7.43 (dt, 2H, 3J(H,H) = 7.44 Hz, 5J(P,H) = 0.96 Hz, H10), 7.55 (dd, 2H, 
4J(H,H) = 4.56 Hz, 4J(P,H) = 0.90 Hz, H4), 7.58 (dt, 4H, 3J(H,H) = 7.65 Hz, 4J(P,H) = 2.88 Hz, 
H13), 7.64-7.72 (m, 6H, H8 and H14), 7.85 (dd, 4H, 3J(H,H) = 8.18 Hz, 3J(P,H) = 12.26 Hz, 
H12) ppm. 
13C{1H}-NMR (CD3OD, 150.93 MHz, 300 K): δ = 52.9 (s, 2C, CH3b), 55.8 (s, 2C, CH3a), 112.4 
(d, 2C, 3J(C,P) = 6.10 Hz, C4), 123.5 (d, 2C, 1J(C,P) = 102.10 Hz, C2), 126.8 (d, 2C, 3J(C,P) = 
10.00 Hz, C6), 129.0 (d, 4C, 3J(C,P) = 13.08 Hz, C9), 129.6 (d, 4C, 3J(C,P) = 12.61 Hz, C13), 
132.3 (d, 2C, 4J(C,P) = 2.62 Hz, C10), 132.4 (d, 4C, 2J(C,P) = 11.19 Hz, C8), 133.2 (s, 2C, C14), 
133.8 (d, 2C, 1J(C,P) = 106.37 Hz, C11), 134.7 (d, 2C, 4J(C,P) = 1.66 Hz, C5), 136.4 (d, 2C, 
1J(C,P) = 112.32 Hz, C7), 150.3 (t, 2C, 2J(C,P) = 3.95 Hz, C1), 162.1 (d, 2C, 2J(C,P) = 5.81 Hz, 
C3), 167.2 (s, 2C, C=O) ppm. 
31P{1H}-NMR (CD3OD, 121.65 MHz, 300 K): δ = 30.61 ppm. 
HRMS (ESI): m/z calcd. for C42H37O8P2 [M+H]+: 731.1958; found: 731.1962. 
FTIR: ṽ = 693 (s), 1280 (s), 1384 (s), 1433 (s), 1558 (s), 1715 (s), 2851 (w), 2925 (m), 3051 
(w) cm-1. 
 
1.1.6 3,3’-Dimethoxy-5,5’-bis(methoxycarbonyl)-[1,1’-biphenyl]-2,2’-bis(diphenylphosphine) 
(6)  
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Diphenylphosphine oxide 5 (52.0 mg, 71.2 µmol, 1.00 eq.) was placed under an atmosphere of 
nitrogen, and phenylsilane (0.50 mL) was added. The suspension was heated to 120 °C and 
stirred for 40 hours. After cooling to room temperature, the crude mix was directly placed on a 
short pad of silica under an inert atmosphere. Silanes were removed first by washing with dry 
and degassed n-pentane (50.0 mL). Subsequently, the product was eluated using dry and de-
gassed dichloromethane (70.0 mL). Upon removal of the solvent in vacuo, bisphosphine 6 could 
be obtained as a waxy white solid. (47.0 mg, 67.3 µmol, 95%). The compound is oxygen-sensi-
tive and must be stored under argon.  
Enantiomeric separation of a sample for subsequent hydrogenation experiments was performed 
on Chiralpak® IA (250 mm, i.d. 20 mm, particle size 5 µm) using n-hexane and 2-propanol 
(95:5) as eluent with a solvent flow of 19.7 mL/min. Fractions of the pure enantiomers, collected 
automatically by slope analysis, were immediately combined and cooled to -10 °C to avoid rac-
emization. Removal of solvent afforded the separated enantiomers as white solids with an enan-
tiomeric excess of 91% ee, as determined by HPLC. 
Note: Due to the complexity of the phosphorous coupling, only phosphorous decoupled spectra 
are being reported. Signals are denoted as multiplets if coupling occurs.  
1H-NMR (CDCl3, 600.24 MHz, 300 K): δ = 3.36 (2, 6H, CH3a), 3.79 (s, 6H, CH3b), 7.05-7.10 
(m, 6H, H9 and H10), 7.14-7.17 (m, 4H, H8), 7.30-7.33 (m, 6H, H13 and H14), 7.44-7.45 (m, 
2H, H6), 7.47-7.50 (m, 6H, H4 and H12) ppm. 
13C{1H}-NMR (CDCl3, 150.93 MHz, 300 K): δ = 52.3 (s, 2C, CH3b), 55.3 (s, 2C, CH3a), 111.8 
(s, 2C, C4), 124.7 (m, 2C, C6), 127.0 (s, 2C, C10), 127.6 (m, 4C, C9), 128.1 (m, 4C, C13), 128.3 
(s, 2C, C14), 129.0 (m, 2C, C2), 131.7 (m, 4C, C8), 131.8 (s, 2C, C5), 133.8 (m, 4C, C12), 136.0 
(m, 2C, C11), 137.4 (m, 2C, C7), 151.7 (m, 2C, C1), 162.2 (s, 2C, C3), 166.8 (s, 2C, C=O) ppm. 
31P{1H}-NMR (CDCl3, 242.98 MHz, 300 K): δ = -15.47 ppm. 
HRMS (ESI): m/z calcd. for C42H37O6P2 [M+H]+: 699.2060; found: 699.2063. 
FTIR: ṽ = 689 (s), 790.4 (s), 1259 (s), 1553 (s), 1717 (s), 2962 (m), 3036 (w) cm-1. 
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1.1.7 6,6'-bis(diphenylphosphaneyl)-5,5'-dimethoxy-[1,1'-biphenyl]-3,3'-dicarboxylic acid (6i)  
 
Compound 6 (10.0 mg, 14.3 µmol, 1.00 eq.) was placed under an atmosphere of nitrogen. A 
degassed solution of potassium hydroxide in water and THF (12.1 mg, 2145 µmol, 10.0 eq.; 
3.00 mL solvent, 4:1 v/v) was added by syringe and the resulting clear solution was stirred vig-
orously at 55 °C for 5 hours. THF was then removed under reduced pressure and the aqueous 
layer was washed twice with degassed water (1.50 mL). Subsequent addition of hydrochloric 
acid in diethyl ether (0.45 mL, 0.45 mmol; 1M) and evaporation of all solvents gave yellow 
solids. They were slurried twice in water (1.50 mL each) to remove inorganic salts. Final extrac-
tion with methanol gave an orange solution. Its evaporation afforded the free acid 6i as a yellow 
solid (9.50 mg, 14.2 µmol, 99%). The compound is oxygen-sensitive and must be stored under 
argon. 
Note: Due to the complexity of the phosphorous coupling, only phosphorous decoupled spectra 
are being reported. Signals are denoted as multiplets if coupling occurs. 
1H-NMR (CD3OD, 600.24 MHz, 300 K): δ = 3.36 (s, 6H, CH3), 7.04-7.09 (m, 6H, H9 and H10), 
7.12-7.15 (m, 4H, H8), 7.30-7.34 (m, 6H, H13 and H14), 7.38 (s, 2H, H6), 7.45-7.47 (m, 4H, 
H12), 7.53 (s, 2H, H4) ppm. No COOH signal was observed due to rapid HD exchange. 
13C{1H}-NMR (CD3OD, 150.93 MHz, 300 K): δ = 55.5 (s, 2C, CH3), 112.7 (s, 2C, C4), 125.7 
(m, 2C, C6), 128.0 (s, 2C, C10), 128.5 (m, 4C, C9), 129.2 (m, 4C, C13), 129.5 (s, 2C, C14), 
129.9 (s, 2C, C5), 130.1 (m, 2C, C2), 132.4 (m, 4C, C8), 134.8 (m, 4C, C12), 137.0 (m, 2C, 
C11), 138.9 (m, 2C, C7), 153.1 (m, 2C, C1), 163.5 (m, 2C, C3), 169.2 (s, 2C, C=O) ppm. 
31P{1H}-NMR (CD3OD, 242.98 MHz, 300 K): δ = -15.99 ppm. 
HRMS (ESI): m/z calcd. for C40H31O6P2 [M-H]-: 669.1601; found: 669.1598. 
FTIR: ṽ = 691 (s), 1034 (s), 1247 (s), 1552 (s), 1685 (s), 2552 (b), 2849 (w), 2933 (w), 2961 
(w) cm-1.  
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7.2.1 tBuNH-(S)Val-NH bisphosphine (7) 
 
Deprotected bisphosphine precursor 6i (119 mg, 177 µmol, 1.00 eq.) and HOBt (47.9 mg, 354 
µmol, 2.00 eq.) were placed in a dried Schlenk flask and stirred in dry and degassed DCM (3 
ml). In a separate flask, the amine hydrochloride S2 (81.5 mg, 390 µmol, 2.20 eq.) was stirred 
in dry and degassed DCM and DIPEA (68.0 µl, 390 µmol, 2.20 eq.) was added. Both mixtures 
were cooled in an ice bath. Subsequently, EDCI.HCl (74.8 mg, 390 µmol, 2.20 eq.) was added 
to the suspended bisphosphine. Within 15 min, a bright yellow solution had formed, the depro-
tonated amine from the second flask was added dropwise using a syringe and its flask rinsed 
twice (1 ml solvent each). The mixture was kept stirring at low temperatures for one hour and 
then at room temperature for another 17 hours. For workup, the resulting turbid solution was 
stirred vigorously after addition of hydrochloric acid in diethyl ether (1 ml, 2 M) and degassed 
water (8 ml) for several minutes. The aqueous layer was subsequently removed via syringe. This 
was repeated twice. The organic layer was finally washed with water (3 ml) and evaporated to 
give the crude as a white solid. It was further purified by inert column chromatography (neutral 
alumina, DCM as forerunning, DCM:MeOH 125:1 as eluent) to give the product 7 as a white 
solids (110 mg, 112 µmol, 63%). The compound is oxygen-sensitive and has to be stored under 
argon.  
 
The product was obtained as a mixture of a minor and a major diastereomer A and B, which was 
heated in dry and degassed CDCl3 for 16 hours to ensure equilibration. For analytic purposes, 
pure samples of both rotamers were prepared and individually analysed (see page 100). 
Note: Due to the complexity of the phosphorus coupling, only phosphorus decoupled spectra are 
being reported. Signals are denoted as multiplets if coupling occurs.  
 
31P{1H}-NMR (CDCl3, 242.98 MHz, 300 K): δ = -15.85 (s, A), -17.80 (d, TSJ(P,P) = 9.7 Hz, 
B1), -18.24 (d, TSJ(P,P) = 9.7 Hz, B2) ppm.  
1H-NMR (CDCl3, 600.24 MHz, 300 K): δ = 0.70 (s, H9, B/H16’), 0.83 (d, 6H, 3J(H,H) = 6.66 
Hz, A/H11), 0.94 (d, 6H, 3J(H,H) = 6.75 Hz, A/H12), 0.96 (d, 3H, 3J(H,H) = 6.50 Hz, B/H11’), 
1.07 (d, 6H, 3J(H,H) = 6.5 Hz, B/H11 and H12’), 1.33 (d, 3H, 3J(H,H) = 6.5 Hz, B/H12), 1.35 
(s, 18H, A/H16), 1.41 (s, 9H, B/H16), 1.99-2.06 (m, 2H, 3J(H,H) = 6.94 Hz, A/H10), 2.21 (s, 
3H, B/H17’), 2.29-2.39 (m, 1H, B/H10), 2.41-2.51 (m, 1H, B/H10’), 3.38 (s, 3H, B/H17), 3.93 
(dd, 1H, 3J(H,H) = 6.6 Hz, 3J(H,H) = 9.7 Hz, B/H9), 4.43 (s, 6H, A/H17), 4.13 (t, 2H, 3J(H,H) = 
8.00 Hz, A/H9), 5.22 (dd, 1H, 3J(H,H) = 5.04 Hz, 3J(H,H) = 9.78 Hz, B/H9’), 5.75 (s, 1H, 
B/H14), 5.84 (bs, 2H, A/H14), 6.38 (d, 2H, 3J(H,H) = 7.8 Hz, A/H8), 6.51 (s, 1H, B/H4’), 6.79-
6.91 (m, 6H, B/HmPh,c and HmPh,d and HpPh,c and HpPh,d), 6.96 (s, 1H, B/H14’), 6.96-7.07 (m, 5H, 
B/HoPh,c and HoPh,d and HpPh,b), 6.97-7.00 (m, 2H, A/H6), 7.07-7.18 (m, 5H, B/HmPh,b and HmPh,a 
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and HpPh,a), 7.08-7.10 (m, 6H, A/HmPh,a and HpPh,a), 7.16 (m, 4H, A/HoPh,a), 7.287.32 (m, 4H, 
A/H4 and HpPh,b), 7.33-7.37 (m, 4H, A/HmPh,b), 7.34-7.40 (m, 2H, B/HoPh,a), 7.41-7.47 (m, 2H, 
B/HoPh,b), 7.45-7.49 (m, 4H, A/HoPh,b), 7.57 (s, 1H, B/H4), 7.60 (bs, 1H, B/H6’), 7.87 (bs, 1H, 
B/H6) 8.34 (d, 1H, 3J(H,H) = 6.6 Hz, B/H8), 9.05 (d, 1H, 3J(H,H) = 10.05 Hz, B/H8’) ppm.  
13C{1H}-NMR (CDCl3, 150.93 MHz, 300 K): δ = 17.6 (s, 1C, B/C11’ or C12’), 18.7 (s, 2C, 
A/C12), 19.6 (s, 2C, A/C11), 19.8 (s, 1C, B/C11’ or C12’), 20.0 (s, 1C, B/C11 or C12), 20.5 (s, 
1C, B/C11 or C12), 28.5 (s, 1C, B/C16’), 29.0 (s, 1C, B/C16), 29.0 (s, 6C, A/C16), 30.3 (s, 1C, 
B/C10), 31.4 (s, 2C, A/C10), 33.0 (s, 1C, B/C10’), 50.6 (s, 1C, B/C15’), 51.8 (s,2C, A/C15), 
51.8 (s, 1C, B/C15), 53.4 (s, 1C, B/C17’), 55.2 (s, 1C, B/C17), 55.4 (s, 2C, A/C17), 57.7 (s, 1C, 
B/C9’), 60.0 (s, 2C, A/C9), 62.9 (s, 1C, B/C9), 110.0 (s, 1C, B/C4’), 110.6 (s, 1C, B/C4), 110.8 
(s, 2C, A/C4), 120.7 (m, 1C, B/C6’), 121.1 (m, 2C, A/C6), 121.3 (m, 1C, B/C6), 125.4 (m, 1C, 
B/C2’), 126.4 (s, 1C, B/CpPh,c or CpPh,d), 126.5 (s, 1C, B/CpPh,c or CpPh,d), 127.0 126.4 (m, 1C, 
B/CmPh,c), 127.1 (s, 2C, A/CpPh,a), 127.1 (m, 1C, B/CmPh,d), 127.3 (m, 2C, A/C2), 127.3 (s, 1C, 
B/CpPh,b), 127.5 (m, 1C, B/CmPh,a), 127.6 (m, 4C, A/CmPh,a), 127.7 (s, 1C, B/CpPh,a), 127.8 (m, 1C, 
B/CmPh,b), 127.9 (m, 1C, B/C2), 128.4 (m, 4C, A/CmPh,b), 128.5 (s, 2C, A/CpPh,b), 131.6 (m, 4C, 
A/CoPh,a), 131.6 (m, 1C, B/CoPh,c), 132.0 (m, 1C, B/CoPh,d), 132.9 (m, 1C, B/CoPh,b), 133.7 (m, 4C, 
A/CoPh,b), 133.9 (m, 1C, B/CoPh,a), 134.0 (m, 1C, B/CiPh,d), 134.7 (s, 1C, B/C5), 135.3 (m, 1C, 
B/CiPh,c), 135.8 (m, 2C, A/CiPh,b), 136.2 (s, 1C, B/C5’), 136.5 (s, 2C, A/C5), 137.2 (m, 1C, 
B/CiPh,a), 137.7 (m, 2C, A/CiPh,a), 138.4 (m, 1C, B/CiPh,b), 151.7 (m, 2C, A/C1), 162.6 (m, 2C, 
A/C3), 151.9 (m, 1C, B/C1), 153.1 (m, 1C, B/C1’), 161.6 (m, 1C, B/C3’), 162.5 (m, 1C, B/C3), 
166.2 (s, 1C, B/C7), 166.5 (s, 1C, B/C7’), 167.4 (s, 2C, A/C7), 170.1 (s, 2C, A/C13), 171.6 (s, 
1C, B/C13’), 172.1 (s, 1C, B/C13) ppm.  
HRMS (DART): m/z calcd. for C58H68N4O6P2 [M+H]+: 979.4687; found: 979.4666 (A), 
979.4656 (B). 
FTIR: ṽ = 692 (s), 1026 (s), 1533 (b), 1632 (s), 2961 (m), 3053 (w), 3070 (w), 3307 (b) cm-1. 
 
7.2.2 Dimethyl 6,6’-dihydroxy-5,5’-dimethoxy-[1,1’-biphenyl]-3,3’-dicarboxylate (15)  
 
This compound was synthesized according to a known protocol.[111] Methyl vanillate 14 (7.65 
g, 42.0 mmol, 1.00 eq.) was dissolved in acetonitrile (150.0 mL) and the solution was cooled in 
an ice bath. (Diacetoxyiodo)benzene (6.83 g, 21.2 mmol, 0.51 eq.) was added in portions. The 
mixture was warmed to room temperature and stirred for 18 hours in the dark. Subsequently, all 
solids were filtered off , washed with fresh, cool acetonitrile (3 x 30 ml) and dried in vacuo to 
yield the product 15 as a white, fluff y solid (3.89 g, 21.0 mmol, 51%). 
 
1H-NMR (DMSO-d6, 400.33 MHz, 300 K): δ = 3.81 (s, 6H, H8), 3.90 (s, 6H, H9), 7.45 (d, 2H, 
4J(H,H) = 1.54 Hz, H6), 7.47 (d, 2H, 4J(H,H) = 1.54 Hz, H4), 9.49 (bs, 2H, H10) ppm. 
13C{1H}-NMR (DMSO-d6, 100.66 MHz, 300 K): δ = 51.7 (C8), 56.0 (C9), 111.0 (C4), 119.5 
(C5), 124.4 (C1), 125.4 (C6), 147.5 (C3), 148.9 (C2), 166.1 (C7) ppm. 
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HRMS (ESI): m/z calcd. for C18H19O8 [M+H]+: 363.1074; found: 363.1074. 
FTIR: ṽ = 1420 (s), 1587 (s), 1706 (s), 2960 (w), 3011 (w), 3067.2 (w), 3404 (b) cm-1. 
 
7.2.3 6,6’-Dihydroxy-5,5’-dimethoxy-[1,1’-biphenyl]-3,3’-dicarboxylic acid (16) 
 
Diester 15 (4.97 g, 13.7 mmol, 1.00 eq.) was suspended in a mixture of THF and water (150 ml, 
1:1 v:v) and KOH pellets (7.70 g, 137 mmol, 10.0 eq.) were added in portions. The resulting 
clear, two-phased solution was heated to 70°C and stirred vigorously for 16 hours. After cooling 
to room temperature, the organic layer was removed and the aqueous layer was acidified with 
HCl solution (6M) until pH 1 was reached and white solids formed. The precipitate was collected 
and washed with water to neutrality. Subsequent lyophilisation gave product 16 as a white solid 
(4.45 g, 13.7 mmol, 97%). 
 
1H-NMR (DMSO-d6, 400.33 MHz, 300 K): δ = 3.90 (s, 6H, H9), 7.42 (d, 2H, 4J(H,H) = 2.00 
Hz, H6), 7.46 (2, 2H, 4J(H,H) = 2.00 Hz, H4), 9.37 (bs, 2H, H10), 12.5 (bs, 2H, H8) ppm. 
13C{1H}-NMR (DMSO- d6, 100.66 MHz, 300 K): δ = 56.0 (C9), 111.2 (C4), 120.6 (C1), 124.4 
(C5), 125.5 (C6), 147.3 (C2), 148.5 (C3), 167.3 (C7) ppm. 
HRMS (ESI): m/z calcd. for C16H13O8 [M-H]+: 333.0616; found: 333.0616. 
FTIR: ṽ = 768 (s), 1046 (s), 1202 (s), 1591 (s), 1685 (s), 1711 (m), 2839 (w), 2939 (w), 2972 
(w), 3245 (bs) cm-1. 
 
7.2.4 General procedure for peptide couplings to diamido-modified BIPOLs 
Dicarboxylic acid 16 (1.00 eq.) and HOBt (85%, 2.50 eq.) were placed in a heat-gun dried 
Schlenk tube and dry DMF (10 ml/mmol acid) was added. Addition of DIPEA (2.50 eq.) gave a 
slightly yellow solution. The mixture was cooled in an ice bath and EDCI.HCl (2.50 eq.) was 
added. After 15 min of incubation, the amine hydrochloride (2.50 eq.) was added as a solid, the 
mixture was slowly warmed to room temperature and stirring was continued for 16 hours. To 
quench existing O-isoaryl urea side product 17, N,N-dimethylethylenediamine (50.0 eq.) was 
added in portions and stirring was continued for another six hours. For work-up, the solution 
was diluted with ethyl acetate (20 times the volume of DMF), washed with HCl solution (3M, 
three times, careful when quenching excess of diamine), saturated NaHCO3 solution (three 
times) and brine (once). The organic layer was finally dried over sodium sulfate and evaporated 
to give the BIPOL 18 as an amorphous solid. 
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7.2.4.1 tBuNH-(S)Val-NH diol (18a) 
 
The compound was synthesized according to the procedure described above using dicarboxylic 
acid 16 (800 mg, 2.39 mmol) and valine-based amine hydrochloride (S)-S2a (1.25 g, 5.98 mmol) 
to give the product as an off-white solid (1.37 g, 2.13 mmol, 90%). 
 
1H-NMR (CDCl3, 600.243 MHz, 253 K): δ = 0.84 (s, 9H, H16), 1.00 (m, 6H, H12 and H12’), 
1.05 (d, 3H, 3J(H,H) = 5.9 Hz, H11’), 1.11 (d, 3H, 3J(H,H) = 5.9 Hz, H11), 1.40 (s, 9H, H16’), 
2.23-2.34 (m, 1H, H10’), 2.34-2.46 (m, 1H, H10), 3.67 (s, 3H, H17), 3.95 (s, 3H, H17’), 4.04 
(m, 1H, H9’), 4.72 (m, 1H, H9), 5.90 (s, 1H, H18), 6.00 (s, 1H, H18’), 6.37 (bs, 1H, H14’), 7.07 
(s, 1H, H4), 7.23 (s, 1H, H6), 7.76 (s, 1H, H4’), 8.04 (s, 1H, H6’), 8.09 (s, 1H, H14), 9.36 (d, 
1H, 3J(H,H) = 5.1 Hz, H8’), 10.02 (d, 1H, 3J(H,H) = 7.9 Hz, H8) ppm. 
13C{1H}-NMR (CDCl3, 150.93 MHz, 253 K): δ = 19.9 (2C, C11 and C11’), 20.5 (C12’), 20.6 
(C12), 27.9 (C16), 28.9 (C16’), 30.0 (C10), 30.1 (C10’), 51.0 (C15), 51.5 (C15’), 55.7 (C17), 
56.3 (C17’), 60.4 (C9), 62.5 (C9’), 109.9 (C4), 110.9 (C4’), 120.4 (C6), 122.3 (C1), 123.1 (C1’), 
123.4 (C6’), 125.3 (C5’), 126.3 (C5), 144.5 (C2), 145.4 (C3), 145.9 (C3’), 146.2 (C2’), 165.1 
(C7), 166.3 (C7’), 145.9 (C13’) 146.2 (C13) ppm. 
HRMS (ESI): m/z calcd. for C34H49N4O8 [M-H]-: 641.3556; found: 641.3554. 
FTIR: ṽ = 679 (m), 1044 (m), 1221 (s), 1488 (m) 1624 (m), 2873 (w), 2930 (w), 2961 (w), 3077 
(bw), 3275 (bs), 3535 (bw) cm-1. 
 
7.2.4.2 1-AdNH-(S)Val-NH diol (18b)  
 
The compound was synthesized according to the procedure described above using dicarboxylic 
acid 16 (200 mg, 0.60 mmol) and valine-based amine hydrochloride (S)-S2b (429 mg, 1.50 
mmol) to give the product as an off -white solid (246 mg, 0.31 mmol, 51%). 
 
1H-NMR (CDCl3, 600.24 MHz, 253 K): δ = 0.90-1.06 (m, 9H, H12 and H11’ and H12’), 1.09 
(d, 3H, 3J(H,H) = 4.5 Hz, H11), 1.16-1.30 (m, 3H, H16), 1.30-1.41 (m, 3H, H18), 1.41-1.51 (m, 
3H, H18), 1.67 (s, 9H, H16 and H18’), 1.73 (s, 3H, H17), 2.08 (s, 9H, H16’ and H17’), 2.20-
2.30 (m, 1H, H10’), 2.30-2.43 (m, 1H, H10), 3.68 (s, 3H, H19), 3.95 (s, 3H, H19’), 4.02-4.18 
(m, 1H, H9’), 4.55-4.65 (m, 1H, H9), 5.83 (s, 1H, H20), 5.91 (s, 1H, H20’), 6.22 (bs, 1H, H14’), 
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7.12 (s, 1H, H4), 7.21 (1H, H6), 7.79 (s, 1H, H4’), 7.88 (s, 1H, H14), 8.11 (s, 1H, H6’), 9.38 (d, 
1H, 3J(H,H) = 4.5 Hz, H8’), 10.03 (d, 1H, 3J(H,H) = 6.8 Hz, H8) ppm. 
13C{1H}-NMR (CDCl3, 150.93 MHz, 253 K): δ = 19.9 (C12’), 20.0 (C11), 20.1 (C11’), 20.6 
(C12), 29.3 (C17’), 29.4 (C17), 29.7 (C10), 29.9 (C16), 30.1 (C10’), 36.3 (C18), 36.5 (C16’), 
40.1 (C16), 41.6 (C16’), 51.7 (C15), 52.2 (C15’), 55.7 (C16), 56.2 (C16’), 60.8 (C9), 62.3 (C9’), 
110.1 (C4), 110.9 (C4’), 120.5 (C6), 122.3 (C1), 123.2 (C1’), 123.5 (C6’), 125.6 (C5’), 126.3 
(C5), 144.5 (C2), 15.3 (C3), 146.0 (C2’), 146.1 (C3’), 164.9 (C7), 166.3 (C7’), 172.2 (C13’), 
173.2 (13) ppm. 
HRMS (ESI): m/z calcd. for C46H61N4O8 [M-H]-: 797.4495; found: 797.4497. 
FTIR: ṽ = 758 (m), 1043 (s), 1223 (s), 1486 (s), 1534 (s), 1590 (s), 1628 (s), 2848 (s), 2904 (s), 
3077 (bw), 3277 (bs), 3525 (bw) cm-1. 
 
7.2.4.3 tBuNH-(S)PheNH diol (18c) 
 
The compound was synthesized according to the procedure described above using dicarboxylic 
acid 16 (500 mg, 1.50 mmol) and phenylalanine-based amine hydrochloride (S)-S2c (960 mg, 
3.74 mmol) to give the product as an off -white solid (1.00 g, 1.36 mmol, 91%). 
 
1H-NMR (CDCl3, 600.24 MHz, 298 K): δ = 1.01 (s, 9H, H18), 1.32 (s, 9H, H18’), 3.02 (dd, 1H, 
2J(H,H) = 13.7 Hz, 3J(H,H) = 8.9 Hz, H10a’), 3.15-3.28 (m, 2H, H10b and H10b’), 3.52 (dd, 1H, 
2J(H,H) = 12.5 Hz, 3J(H,H) = 12.4 Hz, H10a), 3.67 (s, 3H, H19), 3.97 (s, 3H, H19’), 4.50-4.59 
(m, 1H, H9’), 5.34 (s, 1H, H16’), 5.58-5.68 (m, 1H, H9), 5.79 (s, 1H, H20), 5.89 (s, 1H, H20’), 
6.99 (s, 1H, H4’), 7.09-7.16 (m, 1H, H14), 7.17-7.24 (m, 3H, 4H, H13 and H13’), 7.26-7.31 (m, 
2H, H12’), 7.35 (d, 1H, 4J(H,H) = 1.1 Hz, H6), 7.66-7.68 (m, 2H, H12), 7.77 (s, 1H, H4’), 7.85 
(s, 1H, H6’), 8.33 (s, 1H, H16), 9.42 (d, 1H, 3J(H,H) = 5.6 Hz, H8’), 10.10 (d, 1H, 3J(H,H) = 
8.77 Hz, H8) ppm. 
13C{1H}-NMR (CDCl3, 150.93 MHz, 289 K): δ = 28.1 (C18), 28.9 (C18’), 38.3 (C10’), 39.0 
(C10), 51.1 (C17), 51.6 (C17’), 55.8 (C19), 56.5 (C9), 56.6 (C19’), 58.5 (C9’), 110.3 (C4), 111.3 
(C4’), 121.0 (C6), 122.9 (C1), 123.5 (C1’), 123.5 (C6’), 125.4 (C5’), 126.0 (C14), 126.3 (C5), 
126.8 (C14’), 128.1 (C13’), 128.5 (C13), 129.7 (C12’), 130.1 (C12), 138.1 (C11’), 139.3 (C11), 
145.2 (C2), 145.8 (C3), 146.5 (C2’), 146.7 (C3’), 166.2 (C7), 166.5 (C7’), 172.8 (C15’), 174.0 
(C15) ppm. 
HRMS (ESI): m/z calcd. for C42H49N4O8 [M-H]-: 737.3556; found: 737.3546. 
FTIR: ṽ = 697 (s), 1042 (m), 1220 (s), 1487 (s), 1487 (s), 1547 (s), 1627 (m), 2929 (w) 2965 
(w), 3064 (w), 3276 (bs), 3502 (bw) cm-1. 
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7.2.4.4 tBuNH-Gly-NH diol (18d) 
 
The compound was synthesized using dicarboxylic acid 16 (500 mg, 1.50 mmol) and glycine-
based amine hydrochloride S2d (623 mg, 3.74 mmol) according to the procedure described 
above, but with a modified work-up procedure: After N,N-dimethylethylenediamine had been 
added and the mixture had been stirred of another 18 hours, it was diluted with DCM (120 ml) 
and HCl solution (6M, 40 ml) was added carefully under formation of fumes. Subsequent addi-
tion of deionized water (80 ml) gave a white precipitate that was filtered off. The solids were 
washed with water (2x10 ml) and DCM (2x 10 ml) and finally dried in vacuo to give the product 
as an off -white solid (666 mg, 1.19 mmol, 80%). 
 
1H-NMR (DMSO-d6, 600.24 MHz, 295 K): δ = 1.25 (s, 9H, H13), 3.77 (d, 2H, 3J(H,H) = 5.8 
Hz, H9), 3.88 (s, 3H, H14), 7.37 (d, d, 4J(H,H) = 2.0 Hz, H6), 7.44 (s, 1H, H11), 7.47 (d, 1H, 
4J(H,H) = 1.9 Hz, H4), 8.41 (t, 1H, 3J(H,H) = 5.9 Hz, H8), 9.09 (s, 1H, H15) ppm. 
13C{1H}-NMR (DMSO-d6, 150.93 MHz, 295 K): δ = 28.6 (C13), 42.8 (C9), 50.1 (C12) 56.0 
(C14), 109.8 (C4), 123.0 (C6), 124.1 (C5), 124.9 (C1), 147.1 (C3), 147.2 (C2), 166.0 (C7), 168.4 
(C10) ppm. 
HRMS (ESI): m/z calcd. for C28H37N4O8 [M-H]-: 557.26169; found: 557.26229. 
FTIR: ṽ = 673 (m), 1043 (m), 1219 (s), 1486 (s), 1543 (s), 1584 (s), 2872 (w), 2934 (w) 2967 
(bm), 3076 (bm), 3235 (bs) cm-1. 
 
7.2.5 General procedure for bisphosphinite syntheses 
The compounds were synthesized according to a known protocol, which was slightly modi-
fied.[112] The respective biphenol 18a-d (1.00 eq.) and DABCO (4.00 eq., freshly sublimated) 
were placed in a heat-gun dried Schlenk and suspended in dry and degassed DCM (10ml/mmol 
biphenol). The mixture was cooled in an ice bath and PPh2Cl (4.00 eq.) was added dropwise 
yielding a clear solution. The ice bath was removed after 15 min and stirring was continued at 
room temperature for another three hours. The solvent was then removed and the residue diluted 
with dry, degassed and stabilized THF (about 1/4 of the original volume). The suspension was 
passed through a pad of dry, neutral alumina under inert conditions and was eluated with more 
THF (4x, same volume). Combined fractions were evaporated in vacuo using an external cooling 
trap. The resulting residue was re-precipitated three times from dry DCM/n-pentane (1:10 ml) 
and the supernatant solution removed using a filter-tipped cannula. Finally, drying in vacuo gave 
the desired bisphosphinite as a white solid. 
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7.2.5.1 tBuNH-(S)Val-NH bisphosphinite (19a) 
 
The compound was synthesized according to the procedure described above using biphenol 18a 
(300 mg, 0.47 mmol) and was obtained as a white solid (230 mg, 0.23 mmol, 49%). 
 
1H-NMR (THF−d8, 600.24 MHz, 295 K): δ = 0.85 (s, 9H, H16), 1.01 (d, 3H, 3J(H,H) = 6.5 Hz, 
H12), 1.11 (d, 3H, 3J(H,H) = 6.8 Hz, H11), 1.19 (d, 3H, 3J(H,H) = 6.8 Hz, H12’), 1.35 (d, 3H, 
3J(H,H) = 6.6 Hz, H11’), 1.44 (s, 9H, H16’), 2.36-2.45 (m, 1H, H10), 2.48-2.56 (m, 1H, H10’), 
3.06 (s, 3H, H17), 3.64 (s, 3H, H17’), 4.27 (dd, 1H, 3J(H,H) = 9.3, 3J(H,H) = 7.4 Hz, H9’), 4.71 
(dd, 1H, 3J(H,H) = 10.3, 3J(H,H) = 8.7 Hz, H9), 6.60 (d, 1H, 4J(H,H) = 1.6 Hz, H6), 6.78-6.82 
(m, 2H, Hmd), 6.83 (d, 1H, 4J(H,H) = 1.6 Hz, H4), 6.87-6.91 (m, 1H, Hpd), 6.92-7.00 (m, 4H, Hoc 
and Hod), 7.03-7.10 (m, 5H, Hmc and Hob and Hpc), 7.10-7.16 (m, 4H, Hmb and Hma), 7.17-7.21 
(m, 1H, Hpb), 7.22-7.26 (m, 1H, Hpa), 7.29-7.35 (m, 2H, Hoa), 7.56 (s, 1H, H14’), 7.74 (d, 1H, 
4J(H,H) = 1.8 Hz, H4’), 7.97 (d, 1H, 4J(H,H) = 1.8, H6’), 8.11 (s, 1H, H14), 9.12 (d, 1H, 3J(H,H) 
= 7.4 Hz, H8’), 9.43 (d, 1H, 3J(H,H) = 8.7 Hz, H8) ppm. 
13C{1H}-NMR (THF-d8, 150.93 MHz, 295 K): δ = 20.4 (s, C11), 20.5 (s, C11’), 21.5 (s, C12), 
21.5 (s, C12’), 28.6 (s, C16), 29.3 (s, C16’), 31.0 (s, C10), 31.2 (s, C10’), 51.8 (s, C15’), 51.9 
(s, C15), 55.4 (s, C17), 55.7 (s, C17’), 61.3 (s, C9), 62.3 (s, C9’), 112.7 (s, C4’), 112.9 (s, C4), 
120.6 (s, C6), 122.6 (s, C6’), 128.1 (d, 3J(C,P) = 5.1 Hz, CmC), 128.2 (d, 3J(C,P) = 8.4 Hz, Cmd), 
128.3 (s, Cpc), 128.4 (d, 3J(C,P) = 7.4 Hz, Cma), 128.4 (d, 3J(C,P) = 7.1 Hz, Cmb), 128.6 (s, Cpb), 
129.4 (s, C5), 129.7 (s, Cpa), 129.7 (d, 2J(C,P) = 22.0 Hz, Cob), 129.8 (s, Cpd), 130.2 (d, 2J(C,P) 
= 19.0 Hz, Coc), 130.3 (s, C5’), 131.3 (d, 2J(C,P) = 2.3 Hz, C1), 131.9 (d, 2J(C,P) = 24.2 Hz, Coa), 
132.3 (d, 2J(C,P) = 26.5 Hz, Cod), 133.2 (d, 3J(C,P) = 2.2 Hz, C1’), 143.2 (d, 1J(C,P) = 23.3 Hz, 
Cid), 144.3 (d, 1J(C,P) = 16.2 Hz, Cic), 144.3 (d, 1J(C,P) = 15.2 Hz, Cib), 145.0 (d, 1J(C,P) = 21.1 
Hz, Cia), 147.6 (d, 2J(C,P) = 8.4 Hz, C2), 148.8 (d, 2J(C,P) = 7.6 Hz, C2’), 150.8 (d, 4J(C,P) = 
1.9 Hz, C3), 152.9 (d, 4J(C,P) = 2.4 Hz, C3’), 165.7 (s, C7), 166.4 (s, C7’), 174.3 (s, C13), 174.4 
(s, C13’) ppm. 
31P{1H}-NMR (THF-d8, 202.47 MHz, 295 K): δ = 112.8 (s, 1P), 122.5 (s, 1P) ppm. 
HRMS (ESI): m/z calcd. for C58H69N4O8P2 [M+H]+: 101.4585; found: 1011.4619. 
FTIR: ṽ = 691 (s), 847 (m), 1093 (m), 1217 (s), 1433 (m), 1534 (m), 1624 (s), 1653 (s), 2838 
(w), 2962 (w), 3055 (w), 3286 (bm), 3417 (bw) cm-1. 
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7.2.5.2 1-AdNH-(S)Val-NH bisphosphinite (19b) 
 
The compound was synthesized according to the procedure described above using biphenol 18b 
(300 mg, 0.38 mmol) and was obtained as a white solid (234 mg, 0.20 mmol, 53%). 
 
1H-NMR (THF-d8, 600.24 MHz, 295 K): δ = 1.03 (d, 3H, 3J(H,H) = 6.6 Hz, H11), 1.14 (d, 3H, 
3J(H,H) = 6.8 Hz, H12), 1.21 (d, 3H, 3(H,H) = 6.8 Hz, H11’), 1.28-1.35 (m, 3H, H16), 1.35 (d, 
3H, 3J(H,H) = 6.5 Hz, H12’), 1.45-1.57 (m, 6H, H18), 1.66-1.71 (m, 3H, H16), 1.75-1.79 (m, 
6H, H18’), 1.91-2.00 (m, 3H, H17), 2.06-2.13 (m, 3H, H17’), 2.14-2.26 (m, 6H, H16’), 2.33-
2.41 (m, 1H, H10), 2.49-2.56 (m, 1H, H10’), 3.05 (s, 3H, H19), 3.69 (s, 3H, H19’), 4.27 (dd, 
1H, 3J(H,H) = 8.8 Hz, 3J(H,H) = 8.1 Hz, H9’), 4.64 (dd, 1H, 3J(H,H) = 9.8 Hz, 3J(H,H) = 9.1 Hz, 
H9), 6.54 (d, 1H, 4J(H,H) = 1.5 Hz, H6), 6.78-6.82 (m, 2H, Hmd), 6.83 (d, 1H, 4J(H,H) = 1.6 Hz, 
H4), 6.86-6.92 (m, 3H, Hoc and Hpd), 6.95-7.00 (m, 2H, Hod), 7.01-7.10 (m, 5H, Hob and Hmc and 
Hpc), 7.12-7.16 (m, 4H, Hmb and Hma), 7.19-7.23 (m, 1H, Hpb), 7.23-7.27 (m, 1H, Hpa), 7.30-7.35 
(m, 2H, Hoa), 7.44 (s, 1H, H14’), 7.79 (d, 1H, 3J(H,H) = 1.7 Hz, H4’), 7.95 (s, 1H, H14), 7.98 
(d, 1H, 4J(H,H) = 1.7 Hz, H6’), 9.11 (d, 3J(H,H) = 7.5 Hz, H8’), 9.46 (d, 1H, 3J(H,H) = 8.6 Hz, 
H8) ppm. 
13C{1H}-NMR (THF-d8, 150.93 MHz, 295 K): δ = 20.5 (s, C12), 20.5 (s, C12’), 21.5 (s, C11), 
21.6 (s, C11’), 30.4 (s, C17), 30.8 (s, C17’), 30.9 (s, C10) 31.1 (s, C10’), 37.4 (s, C18), 37.5 (s, 
C18’), 41.3 (s, C16), 42.6 (s, C16’), 52.7 (s, C15’), 52.7 (s, C15), 55.3 (s, C19’), 55.4 (s, C19), 
61.4 (s, C9), 62.4 (s, C9’), 112.2 (s, C4’), 112.8 (s, C4) 120.6 (s, C6), 122.5 (C6’), 128.1 (d, 
3J(C,P) = 4.6 Hz, Cmc), 128.3 (s, Cpc), 128.3 (d, 3J(C,P) = 7.6 Hz, Cmd), 128.4 (d, 3J(C,P) = 7.4 
Hz), Cma), 128.5 (s, Cpb), 129.5 (s, C5), 129.6 (d, 2J(C,P) = 23.5 Hz, Cob), 129.7 (s, Cpa), 129.9 
(s, Cpd), 130.2 (d, 2J(C,P) = 18.2 Hz, Coc), 130.5(s, C5’), 131.3 (d, 4J(C,P) = 1.7 Hz, C1), 131.9 
(d, 2J(C,P) = 24.1 Hz, Coa), 132.5 (d, 2J(C,P) = 26.6 Hz, Cod), 133.4 (d, 3J(C,P) = 2.1 Hz, C1’), 
143.1 (d, 1J(C,P) = 24.2 Hz, Cid), 144.3 (d, 1J(C,P) = 14.1 Hz, Cic), 144.4 (d, 1J(C,P) = 16.0 Hz, 
Cib), 145.0 (d, 1J(C,P) = 21.3 Hz, Cia), 147.5 (d, 2J(C,P) = 8.9 Hz, C2), 148.4 (d, 2J(C,P) = 7.8 
Hz, C2’), 150.7 (d, 3J(C,P) = 2.2 Hz, C3), 152.6 (d, 3J(C,P) = 2.3 Hz, C3’), 165.6 (s, C7), 166.4 
(s, C7’), 174.0 (s, C13), 174.1 (s, C13’) ppm. 
31P{1H}-NMR (THF-d8, 202.47 MHz, 295 K): δ = 114.5 (s, 1P), 125.2 (s, 1P) ppm. 
HRMS (MALDI): m/z calcd. for C70H81N4O8P2 [M+H]+: 1167.5524; found: 1167.5569. 
FTIR: ṽ = 693 (s), 1092 (s), 1217 (s), 1458 (s), 1627 (s), 2848 (m), 2904 (s), 3002 (w), 2053 
(w), 3282 (bm), 3416 (bw) cm-1. 
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7.2.5.3 tBuNH-(S)Phe-NH bisphosphinite (19c) 
 
The compound was synthesized according to the procedure described above using biphenol 18c 
(100 mg, 0.13 mmol) and was obtained as a white solid (125 mg, 0.11 mmol, 83%). 
 
1H-NMR (THF-d8, 600.24 MHz, 300 K): δ = 1.07 (s, 9H, H18), 1.47 (s, 9H, H18’), 3.04 (s, 3H, 
H19), 3.21-3.30 (m, 2H, H10a and H10’b), 3.41 (dd, 1H, 2J(H,H) = 14.1 Hz, 3J(H,H) = 8.9 Hz, 
H10’a), 3.58 (dd, 1H, 2J(H,H) = 25.0 Hz, 3J(H,H) = 11.9 Hz, H10b), 3.64 (s, 3H, H19’) 4.79-
4.84 (m, 1H, H9’), 5.70-5.77 (m, 1H, H9), 6.18-6.23 (m, 2H, Hmd), 6.45-6.50 (m, 1H, Hpd), 6.60 
(d, 1H, 4J(H,H) = 2.0 Hz, H4), 6.72-6.78 (m, 2H, Hod), 6.82 (d, 1H, 4J(H,H) = 2.0 Hz, H6), 6.97-
7.02 (m, 2H, Hoa), 7.03-7.09 (m, 5H, Hma and Hmb and Hpc), 7.09-7.16 (m, 5H, H14 and Hoc and 
Hmc), 7.16-7.21 (m, 3H, H14’ and Hpa and Hpb), 7.21-7.26 (m, 2H, Hob), 7.28-7.35 (m, 4H, H13 
and H13’), 7.59 (s, 1H, H16’), 7.61-7.64 (m, 2H, H12’), 7.68 (d, 1H, 4J(H,H) = 1.8 Hz, H4’), 
7.86-7.92 (m, 3H, H12 and H6’), 8.52 (s, 1H, H16), 9.28 (d, 1H, 3J(H,H) = 7.0 Hz, H8’), 9.75 
(d, 1H, 3J(H,H) = 8.7 Hz, H8’) ppm. 
13C{1H}-NMR (THF-d8, 150.93 MHz, 300 K): δ = 28.4 (s, C18), 29.1 (s, C18’), 39.2 (s, C10’), 
39.6 (s, C10), 51.6 (s, C17), 51.6 (s, C17’), 55.1 (s, C19), 55.6 (s, C19’), 57.3 (s, C9), 58.2 (s, 
C9’), 112.4 (s, C4), 112.4 (s, C4’), 121.0 (s, C6), 122.7 (C6’), 126.9 (s, C14), 127.1 (s, C14’), 
127.7 (d, 3J(C,P) = 8.0 Hz, Cmd), 127.9 (d, 3J(C,P) = 5.0 Hz, Cmb), 128.0 (s, Cpc), 128.2 (d, 3J(C,P) 
= 8.7 Hz, Cma), 128.2 (d, 3J(C,P) = 8.8 Hz, Cmc), 128.4 (s, Cpb), 128.6 (s, C5), 128.6 (s, C13’), 
128.8 (s, C13), 129.5 (s, Cpa), 129.6 (s, C5’), 129.7 (d, 2J(C,P) = 23.0 Hz, Coc), 129.7 (s, Cpd), 
129.9 (d, 2J(C,P) = 19.3 Hz, Coa), 130.7 (s, C12’), 130.9 (d, 3J(C,P) = 2.1 Hz, C1’), 131.0 (s, 
C12), 131.9 (d, 2J(C,P) = 24.3 Hz, Cob), 132.6 (d, 2J(C,P) = 25.8 Hz, Cod), 133.3 (d, 3J(C,P) = 2.9 
Hz, C1), 139.7 (s, C11’), 140.5 (s, C11), 142.4 (d, 1J(C,P) = 21.3 Hz, Cid), 144.1 (d, 3J(C,P) = 
16.1 Hz, Cic), 144.3 (d, 3J(C,P) = 15.0 Hz, Cib), 144.4 (d, 3J(C,P) = 20.9 Hz, Cia), 147.1 (d, 2J(C,P) 
= 8.4 Hz, C2), 149.1 (d, 2J(C,P) = 7.7 Hz, C2’), 150.4 (d, 3J(C,P) = 1.8 Hz, C3), 152.9 (d, 3J(C,P) 
= 2.6 Hz, C3’), 165.9 (s, C7’), 166.4 (s, C7), 174.8 (s, C15’), 175.0 (C15) ppm. 
31P{1H}-NMR (THF-d8, 202.47 MHz, 295 K): δ = 114.8 (s, 1P), 124.7 (s, 1P) ppm. 
HRMS (ESI): m/z calcd. for C66H69N4O8P2 [M+H]+: 1107.4585; found: 1107.4564. 
FTIR: ṽ = 692 (s), 860 (m), 1219 (s), 1360 (m), 1545 (m), 1626 (s), 2930 (w), 2966 (w) 3058 
(w), 3280 (bm) cm-1. 
  
7  Experimental section 
____________________________________________________________________________ 
- 93 - 
7.2.5.4 tBuNH-Gly-NH bisphosphinite (19d) 
 
The compound was synthesized according to the procedure described above using biphenol 18d 
(300 mg, 0.54 mmol) and was obtained as a white solid (261 mg, 0.28 mmol, 53%). 
 
1H-NMR (THF-d8, 600.24 MHz, 300 K): δ = 0.89 (s, 9H, H13), 1.40 (s, 9H, H13’), 3.02 (s, 3H, 
H14), 3.48 (dd, 1H, 2J(H,H) = 15.9 Hz, 3J(H,H) = 4.4 Hz, H9b), 3.54 (s, 3H, H14’), 3.70 (dd, 
1H, 2J(H,H) = 15.9 Hz, 3J(H,H) = 5.3 Hz, H9’b), 4.51 (dd, 1H, 2J(H,H) = 15.9 Hz, 3J(H,H) = 6.8 
Hz, H9’a), 4.88 (dd, 1H, 3J(H,H) = 15.9 Hz, 3J(H,H) = 8.8 Hz, H9a), 6.79 (d, 1H, 4J(H,H) = 1.7 
Hz, H4), 6.84-6.94 (m, 4H, HmAr and HoAr), 6.95 (d, 1H, 4J(H,H) = 1.6 Hz, H6), 6.96-7.02 (m, 
1H, HpAr), 7.05-7.20 (m, 12H, 2xHoAr and 3xHmAr and 2xHpAr), 7.21-7.30 (m, 3H, HoAr and HpAr), 
7.66 (s, 1H, H11), 7.70 (d, 1H, 4J(H,H) = 1.5 Hz, H4’), 7.75 (d, 1H, 4J(H,H) = 1.55 Hz, H6’), 
8.82 (s, 1H, H11), 9.36 (dd, 1H, 3J(H,H) = 6.5 Hz, 3J(H,H) = 5.3 Hz, H8’), 10.20 (dd, 1H, 3J(H,H) 
= 9.1 Hz, 3J(H,H) = 4.3 Hz, H8). 
13C{1H}-NMR (THF-d8, 150.93 MHz, 300 K): δ = 27.3 (s, C13), 28.0 (s, C13’), 42.3 (s, C9), 
42.9 (s, C9’), 50.6 (s, C12), 50.7 (s, C12’), 54.3 (d, 5J(C,P) = 6.0 Hz, C14), 54.5 (s, C14’), 110.9 
(s, C4), 111.4 (s, C4’), 120.1 (s, C6), 121.7 (C6’), 127.2 (s, CmAr), 127.3 (s, CpAr), 127.3 (s, CpAr), 
127.4 (s, CmAr), 127.5 (s, CmAr), 127.8 (s, CmAr), 128.4 (s, C5), 128.6 (s, CpAr), 128.7 (s, C5’), 
128.8 (d, 2J(C,P) = 24.1 Hz, CoAr), 128.9 (s, CpAr), 129.5 (d, 2J(C,P) = 21.4 Hz, CoAr), 130.5 (d, 
3J(C,P) = 2.8 Hz, C1’), 130.7 (d, 2J(C,P) = 24.6 Hz, CoAr), 131.2 (d, 2J(C,P) = 24.6 Hz, CoAr), 
131.8 (d, 3J(C,P) = 3.2 Hz, C1), 142.3 (d, 1J(C,P) = 21.3 Hz, CiAr), 143.1 (d, 1J(C,P) = 15.3 Hz, 
CiAr), 143.2 (d, 1J(C,P) = 16.9 Hz, CiAr), 143.3 (d, 1J(C,P) = 20.5 Hz, CiAr), 146.7 (d, 3J(C,P) = 
8.9 Hz, C2), 147.4 (d, 3J(C,P) = 7.9 Hz, C2’), 150.1 (d, 3J(C,P) = 2.1 Hz, C3), 151.7 (d, 3J(C,P) 
= 2.6 Hz, C3’), 165.1 (s, C7’), 166.0 (s, C7), 170.5 (s, C10), 170.7 (C10’) ppm. 
31P{1H}-NMR (THF-d8, 202.47 MHz, 295 K): δ = 115.1 (s, 1P), 123.0 (s, 1P) ppm. 
HRMS (ESI): m/z calcd. for C52H57N4O8P2 [M+H]+: 927.36461; found: 927.3672. 
FTIR: ṽ = 693 (s), 851 (s), 1219 (s), 1361 (m), 1477 (m), 1555 (m), 1627 (m), 2928 (w) 2967 
(w), 3073 (bw), 3267 (bm), 3336 (w), 3370 (w), 3392 (w) cm-1. 
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7.2.6 tBuNH-(S)Val-NH phosphoramidite (23a)  
 
Diol 18a (100 mg, 0.16 mmol, 1.00 eq.) was suspended in dry and degassed toluene (1.5 ml) 
and P(NEt2)3 (85.2 µl, 311 µmol, 2.00 eq.) was added. The suspension was refluxed for three 
hours and after all solids had dissolved, a thick gel formed. After cooling to room temperature, 
5 ml dry and degassed n-pentane was added to achieve full precipitation and all solvents were 
removed using a filter-tipped cannula. The crude product was subsequently slurried in dry and 
degassed DCM (1 ml), re-precipitated with n-pentane (5 ml) and the solvent was removed again. 
This was repeated another two times. Obtained solids were finally dried in vacuo to yield the 
product 23a as a white powder (65.0 mg, 87.4 µmol, 56%). The compound is oxygen-sensitive 
and has to be stored under argon. 
 
Note: The large number of species with very similar NMR shifts, due to dimer formation and the 
chirality of phosphorus atoms, made an exact assignment of all signal unreasonable. Therefore, 
no distinction is made between molecules with different chirality of phosphorus atoms. 
 
1H-NMR (THF-d4, 400.22 MHz, 300 K): δ = 0.97-1.26 (m, 104 H, H11/H11’ and H15/H15’ 
and H18/H18’), 1.39-1.50 (m, 40H, H15/H15’), 2.31-2.46 (m, 4H, H10’), 2.53-2.69 (m, 4H, 
H10), 2.72-2.94 (m, 8H, H17/H17’), 3.00-3.19 (m, 8H, H17/H17’), 3.48-3.51 (m, 6H, 
H16/H16’), 3.55 (s, 3H, H16/H16’), 3.61 (s, 3H, H16/H16’), 3.85-3.88 (m, 6H, H16/H16’), 
3.88-3.91 (m, 6H, H16/H16’), 4.15-4.28 (m, 4H, H9’), 4.97-5.13 (m, 4H, H9), 7.13 (s, 1H, 
H4/H4’), 7.27 (s, 1H, H4/H4’), 7.29 (s, 1H, H4/H4’), 7.36 (s, 1H, H6/H6’), 7.41-7.43 (m, 2H, 
H6/H6’), 7.45 (s, 1H, H6/H6’), 7.49 (s, 1H, H4/H4’), 7.61-7.70 (m, 4H, H13’), 7.80-7.87 (m, 
5H, H6/H6’ and H4/H4’), 7.90 (s, 1H, H6/H6’), 7.95 (s, 1H, H6/H6’), 8.04 (s, 1H, H6/H6’), 
8.60-8.81 (m, 4H, H13), 9.16-9.49 (m, 4H, H8’), 10.43-10.57 (m, 4H, H8) ppm. 
13C{1H}-NMR (THF-d4, 201.24 MHz, 300 K): δ = 14.4-14.7 (C8/C8’), 20.2-21.3 (C11/C11’), 
28.6-29.4 (C15/C15’), 31.0-31.3 (C10/C10’), 38.4-38.8 (C17/C17’), 51.9-52.2 (C14/C14’), 
55.5-56.2 (C16/C16’), 61.8-63.2 (C9/C9’), 112.9-113.9 (C4/C4’), 118.6-119.1 (C6/C6’), 121.7-
122.1 (C6/C6’), 130.4-131.9 (C5/C5’ and C1/C1’), 133.0-133.5 (C1/C1’), 142.7-143.2 
(C2/C2’), 151.9-153.1 (C3/C3’), 166.1-16.7 (C7/C7’), 174.4-174.8 (C12/C12’) ppm. 
31P{1H}-NMR (THF-d4, 161.98  MHz, 300 K): δ = 147.2 (s), 147.3 (s), 147.4 (s), 147.8 (s) ppm. 
HRMS (ESI): m/z calcd. for C38H59N5O8P [M+H]+: 744.4095; found: 744.4091. 
FTIR: ṽ = 668 (s), 826 (s), 1023 (s), 1176 (s), 1361 (s), 1458 (s), 1542 (s), 1624 (s), 2870 (w), 
2934 (w), 2966 (m), 3077 (bw), 3270 (bm) cm-1.  
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7.2.7 tBuNH-(S)Phe-NH phosphoramidite (23b)  
 
Diol 18c (150 mg, 0.20 mmol, 1.00 eq.) and triethylamine (70.7 µl, 507 µmol, 2.50 eq.) were 
mixed in dry, degassed and stabilized THF (5 ml). The mixture was cooled in an ice bath and a 
thick gel formed. NEt2PCl2 (32.5 µl, 223 µmol, 1.10 eq.) was added dropwise and stirring was 
continued at room temperature for 16 hours. All volatiles were evaporated and the residue was 
stirred again in THF (2 ml). The mixture was passed through a short, inert column of neutral 
alumina and eluted with more THF (30 ml). The collected fraction was evaporated, the white 
residue dissolved in dry and degassed DCM (1 ml) and the product was precipitated by adding 
dry and degassed n-pentane (10 ml). The supernatant solution was removed using a filter-tipped 
cannula. Re-precipitation was repeated another three times. Obtained solids were finally dried 
in vacuo to yield the product 23b as a white powder (54.1 mg, 64.4 µmol, 32%). The compound 
is oxygen-sensitive and has to be stored under argon. 
 
Note: The large number of species with very similar, overlapping NMR shifts, due to dimer 
formation and the chirality of phosphorus atoms, made an exact assignment of all signal unrea-
sonable. Therefore, no distinction is made between molecules with different chirality of phos-
phorus atoms. 
 
1H-NMR (THF-d4, 400.22 MHz, 300 K): δ = 0.94-1.00 (m, 12H, H17/H17’), 1.02-1.08 (m, 
12H, H17/H17’), 1.22 (s, 18H, H14/H14’), 1.27 (s, 9H, H14/14’), 1.28 (s, 9H, H14/H14’), 1.43 
(s, 18H, H14/H14’), 1.49 (s, 9H, H14/H14’), 1.50 (s, 9H, H14/H14’), 2.70-2.93 (m, 8H, H16 
and H16’), 3.00-3.23 (m, 16H, H10a’ and H10b’ and H16 and H16’), 3.54 (s, 3H, H15/H15’), 
3.56 (s, 3H, H15/H15’), 3.58 (s, 3H, H15/H15’), 3.60 (s, 3H, H15/H15’), 3.61 (s, 3H, 
H15/H15’), 3.89 (s, 3H, H15/H15’), 3.90 (s, 3H, H15/H15’), 3.91 (s, 3H, H15/H15’), 3.93 (s, 
3H, H15/H15’), 4.55 (m, 4H, H9’), 5.85-6.25 (m, 4H, H9), 7.10 (s 1H, H4/H4’), 7.12-7.30 (m, 
28H, H4/H4’ and HAr), 7.32-7.42 (m, 10H, HAr and H12’), 7.49-7.52 (m, 1H, H12’), 7.54-7.64 
(m, 4H, H6/H6’), 7.71-7.78 (m, 6H, H4/H4’ and H6/H6’), 7.79-7.88 (m, 10H, H6/H6’ and HAr), 
9.10 (s, 1H, H12), 9.12 (s, 1H, H12), 9.14 (s, 1H, H12), 9.20 (s, 1H, H12), 9.20-9.24 (m, 2H, 
H8’), 9.32-9.35 (m, 2H, H8’), 10.58-10.72 (m, 4H, H8) ppm. 
13C{1H}-NMR (THF-d4, 100.65 MHz, 300 K): δ = 13.4-13.6 (C17/C17’), 27.8-28.3 
(C14/C14’), 37.4-37.8 (C16/C16’), 38.3-38.7 (C10/C10’), 50.8-51.0 (C13/C13’), 54.4-55.3 
(C15/C15’), 56.9-57.0 (C9/C9’), 58.1-58.2 (C9/C9’), 111.6-112.1 (C4/C4’), 117.7-117.9 
(C6/C6’), 120.7-120.9 (C6/C6’), 126.0-126.1 (CArtert), 127.6-127.7 (CArtert), 128.9 (C1/C1’ or 
C5/C5’), 129.5-130.0 (CArtert and C1/C1’ and C5/C5’), 130.1-132.6 (C1/C1’ and C5/C5’), 138.2-
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139.2 (CArquart), 141.5-142.1 (C2/C2’), 143.3-144.0 (C2/C2’), 150.8-152.1 (C3/C3’), 165.6-
166.0 (C7/C7’), 173.5-174.4 /C11/C11’) ppm. 
31P{1H}-NMR (THF-d4, 161.98 MHz, 300 K): δ = 148.1 (s), 148.2 (s), 148.2 (s), 148.3 (s) ppm. 
HRMS (ESI): m/z calcd. for C46H59N5O8P [M+H]+: 840.40958; found: 840.40831. 
FTIR: ṽ = 698 (s), 860 (s), 1023 (s), 1090 (s), 1176 (s), 1362 (s), 1455 (s), 1541 (s), 1626 (s), 
2870 (w), 2931 (w), 3063 (w), 3081 (w), 3277 (bw) cm-1.  
 
7.2.8 Inversion barrier of compound 6 
Stereodynamics of BIPHEP 6 were investigated using dynamic HPLC measurements. Elution 
profiles were measured between 35 and 70 °C and evaluated using the Unified Equation which 
allows the determination of rate constants from first order reactions taking place in chromato-
graphic systems.[109] The Unified Equation was solved using the program DCXplorer.[226] Prep-
aration of the Eyring plot was done with Microsoft Excel 2013 and ChemOrganizer.[227] 
7.2.8.1 Chromatograms 
Conditions: Chiralpak® IA (250 mm, i.d. 4.6 mm, particle size 5 µm); 1,0 ml/min; n-hexane:2-propanol 95:5 (v/v); 
35 °C bis 70 °C with 5 °C interval, three measurements per temperature.  
 
Figure 7-1: Elution profiles for the inversion barrier determination of compound 6. 
 
7.2.8.2 Chromatographic data Eyring plot 
Table 7-1: Raw data of elution plots 
 
Retention time [min] FDHM [s] Height [%] # of theoretical plates 
T [°C] t1 t2 w1 w2 Peak 1 Plateau Peak 2 N1 N2 
          
35,0 5,522 10,529 9,4 17,3 100,00 0,13 50,44 4620 6056 
35,0 5,519 10,512 9,4 17,2 100,00 0,10 50,47 4614 6105 
35,0 5,517 10,502 9,4 17,3 100,00 0,10 50,57 4609 6022 
40,0 5,393 10,009 9,2 16,1 100,00 0,19 52,21 4551 6250 
40,0 5,389 9,995 9,2 16,1 100,00 0,19 52,27 4543 6231 
40,0 5,389 9,987 9,4 16,2 100,00 0,18 52,40 4352 6143 
45,0 5,281 9,561 9,2 15,3 100,00 0,30 54,47 4322 6250 
45,0 5,276 9,540 9,1 15,2 100,00 0,28 54,50 4408 6301 
45,0 5,277 9,535 9,2 15,2 100,00 0,28 54,60 4314 6294 
50,0 5,183 9,156 9,1 14,6 100,00 0,42 57,61 4218 6229 
50,0 5,180 9,144 9,1 14,6 100,00 0,43 57,63 4212 6211 
50,0 5,128 8,776 6,3 12,1 100,00 0,38 52,77 8570 8244 
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55,0 5,111 8,712 6,4 11,9 100,00 0,53 53,83 8236 8384 
55,0 5,110 8,702 6,4 11,9 100,00 0,53 53,27 8232 8362 
55,0 5,113 8,705 6,4 12,0 100,00 0,52 53,62 8244 8230 
60,0 4,981 8,208 6 10,9 100,00 0,80 58,75 8788 8729 
60,0 4,979 8,189 6 11,0 100,00 0,84 58,92 8779 8526 
60,0 4,981 8,19 6,1 10,9 100,00 0,83 58,99 8502 8686 
65,0 4,919 7,931 6 10,5 100,00 1,24 62,65 8516 8698 
65,0 4,919 7,921 6 10,5 100,00 1,55 62,28 8516 8673 
65,0 4,917 7,912 5,9 10,4 100,00 1,56 62,38 8798 8817 
70,0 4,866 7,689 5,9 10,2 100,00 1,92 65,32 8571 8585 
70,0 4,863 7,669 5,9 10,1 100,00 2,11 64,54 8558 8703 
70,0 4,863 7,657 5,9 10,0 100,00 2,08 64,54 8558 8846 
 
 
Table 7-2 Kinetic data 
T [°C] k1UE [1/s] Gapp [kJ/mol] 1/T [1/K] ln(k1UE/T) 
     
35,0 6,6470E-05 100,20 3,2452E-03 -15,3493 
35,0 5,1120E-05 100,87 3,2452E-03 -15,6119 
35,0 5,0920E-05 100,88 3,2452E-03 -15,6158 
40,0 9,3550E-05 100,98 3,1934E-03 -15,0237 
40,0 9,3390E-05 100,98 3,1934E-03 -15,0254 
40,0 8,6350E-05 101,19 3,1934E-03 -15,1038 
45,0 1,3860E-04 101,59 3,1432E-03 -14,6464 
45,0 1,3030E-04 101,76 3,1432E-03 -14,7082 
45,0 1,2890E-04 101,79 3,1432E-03 -14,7190 
50,0 1,8290E-04 102,49 3,0945E-03 -14,3847 
50,0 1,8630E-04 102,44 3,0945E-03 -14,3663 
50,0 2,1830E-04 102,01 3,0945E-03 -14,2078 
55,0 2,9560E-04 102,80 3,0474E-03 -13,9200 
55,0 2,9580E-04 102,80 3,0474E-03 -13,9193 
55,0 2,9080E-04 102,85 3,0474E-03 -13,9363 
60,0 4,1910E-04 103,45 3,0017E-03 -13,5860 
60,0 4,2890E-04 103,38 3,0017E-03 -13,5629 
60,0 4,1770E-04 103,46 3,0017E-03 -13,5893 
65,0 5,8830E-04 104,09 2,9573E-03 -13,2618 
65,0 7,1150E-04 103,55 2,9573E-03 -13,0716 
65,0 7,2120E-04 103,51 2,9573E-03 -13,0581 
70,0 8,4130E-04 104,65 2,9142E-03 -12,9187 
70,0 9,3080E-04 104,36 2,9142E-03 -12,8176 
70,0 9,2010E-04 104,39 2,9142E-03 -12,8292 
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Figure 7-2: Eyring plot for the determination of thermodynamic parameters. 
𝑌 =  −8.06738 ·  103 𝑥 +  1.06694 
∆G‡298 = 97,81 kJ·mol-1, ∆H‡ = 67,08 ± 0,50 kJ·mol-1, ∆S‡ = -103,10 ± 1,8 J·K-1·mol-1 
 
7.2.9 Determination of the inversion barrier of compound 7 
Pure samples of each rotamer were prepared by dissolving each compound in dry and degassed 
CDCl3 to give a 5.1 mM solution. Samples were heated to 60 °C and spectra were collected 
periodically until equilibrium was reached (for spectral data see page 100). 
 
Kinetic data and thermodynamic calculations 
  
Figure 7-3: NMR-based kinetic measurements for the interconversion of bisphosphine 7. 
 
For thermodynamic calculations, a model of first order kinetics with opposing reactions was 
assumed:  
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[𝐴(𝑡)] = 𝐴𝑒 + 𝑥𝑒 𝑒𝑥𝑝[−(𝑘1 + 𝑘−1)𝑡]  
 
𝑦 (𝑡) =  𝑙𝑛 (
𝐴(𝑡) − 𝐴𝑒
𝑥𝑒
) =  −(𝑘1 + 𝑘−1)𝑡 =   𝑎 ∗ 𝑡 
 
𝑎 =  −(𝑘1 + 𝑘−1)                     𝐵𝑒/𝐴𝑒  =  𝑘1/𝑘−1  =  𝐾𝑒 
 
𝑘−1  =  −
𝑎
𝐾𝑒 + 1
  
 𝑘1  =  𝑘 − 1 ∗  𝐾𝑒 
 
 
 
 
time  Rax Sax de A(t)-Ae (A(t)-Ae)/xe ln((A(t)-Ae)/xe) 
h min sec % % % 
   
0 0 0 100 0 100 16.4 1 0 
2 120 7200 91.7 8.2 83.5 8.1 0.493902439 -0.705417273 
4 240 14400 87.6 12.4 75.2 4 0.243902439 -1.410986974 
6 360 21600 84.8 15.2 69.6 1.2 0.073170732 -2.614959778 
8 480 28800 84.7 15.3 69.4 1.1 0.067073171 -2.701971155 
10 600 36000 84.4 15.6 68.8 0.8 0.048780488 -3.020424886 
12 720 43200 84.1 15.9 68.2 0.5 0.030487805 -3.490428515 
14 840 50400 83.8 16.2 67.6 0.2 0.012195122 -4.406719247 
16 960 57600 83.7 16.3 67.4 0.1 0.006097561 -5.099866428 
18 1080 64800 83.6 16.4 67.2 0 0 - 
         
 
Ae = 83.6 xe = 16.4 
 
a = -8.35E-05 s-1 
 
  
  
      
 
Ke = 0.19617225 
     
         
  k-1 =  6,97977E-05 s-1  k1 = 1,36924E-05 s-1  
 
𝑘(𝑇) =
𝑘𝑇
ℎ
𝑒𝑥𝑝 (−
𝛥𝐺‡
𝑅𝑇
)       →      𝛥𝐺‡  =  −𝑅𝑇 ∗ 𝑙𝑛 (
(𝑘(𝑇)ℎ)
𝑘 ∗ 𝑇
) 
  
𝑘 = 1.3806 ∗ 10−23
𝐽
𝐾
       ℎ =  6.62607 ∗ 10−34𝐽 ∗ sec       𝑅 = 8.314
𝐽
𝑚𝑜𝑙∗𝐾
        𝑇 = 333.15 °𝐶  
 
ΔG333K‡ (RaxSax) =112.9 kJ/mol   ΔG333K‡(Sax  Rax) =108.4 kJ/mol 
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Figure 7-4: Schematic energy profile of interconverting species of ligand 7. 
7.2.10 Ligand equilibration and seeding experiments of bisphosphine 7  
7.2.10.1 Ligand isomerization 
A mixture of both ligand diastereomers was precipitated from dry and degassed DCM/n-pentane 
(1:5, v:v) and the solids were collected and dried to give highly enriched (Rax)-7. The filtrate was 
evaporated and residual solids re-precipitated from dry and degassed diethyl ether/pentane (1:5, 
v:v) to obtain the respective rotamer (Sax)-7. Solutions in CDCl3 (5.1 mM) were prepared and 
heated to 60 °C. Spectra were collected periodically until equilibrium was reached. 
 
Figure 7-5: Equilibration of (Sax)- and (Rax)-7 at elevated temperatures leads to the same equilibrium distribution of 
rotamer species. 
 
7.2.10.2 Re-symmetrization 
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Strong hydrogen bond donors induce re-symmetrization the major rotamer (Rax)-7
C1 to form a 
new species (Rax)-7
C2.  
 
Figure 7-6: (a) Employing an un-equilibrated sample of the ligand with (Sax)-7 in excess. (b) Addition of the additive 
(S)-8 converts (Rax)-7asym into its symmetric equivalent. (c) Equilibration of the solution leads to significant enrich-
ment of the newly formed species at the expense of the less stable Sax rotamer due to thermal isomerization. 
 
7.2.10.3 Solute-dependent equilibrium distribution 
Ligand equilibrium distribution was found to be depending on the chemical environment. Lig-
and 7 was equilibrated in the presence of different chiral and achiral additives. For all experi-
ments, the ligand (2 mg) was placed in a J.Young-NMR tube and dissolved in dry and degassed 
CDCl3 (0.4 ml) to give a 5.1 mM solution. After addition of 10 equivalents of the respective 
additive, the mixture was equilibrated at 60 °C and the progress monitored by 31P{1H}-NMR 
spectroscopy. 
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Figure 7-7: Equilibrium distribution for ligand 7 under different conditions. Procedure as described above with ex-
ceptions as follows: Spectrum 4: Only 5 eq. Ac-(S)Ala-NH(3,5-dichlorophenyl) 9 were used and not all solids dis-
solved. Spectrum 6: For DMSO, ligand was equilibrated in pure and degassed DMSO-d6. Due to line broadening, 
final compound distribution was determined by evaporating the sample and measuring it in CDCl3 where (Rax)-7C2 
could not be determined. Spectrum 7: 10 eq. dicyclohexyl urea 11 were used, but not all solids dissolved. 
 
7.2.11 HMBC correlation data 
Two-dimensional 1H-13C-HMBC NMR data of ligand precursors 18a-c and ligand 19a show 
cross peaks between protons belonging to the two diff erent signal sets and quaternary carbons 
of the respective other set linking all signals in the spectrum to the same molecular scaffold. 
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Figure 7-8: Section of 1H-13C-HMBC spectrum of ligand precursor 18a with annotated cross peaks. 
 
Figure 7-9: Section of 1H-13C-HMBC spectrum of ligand precursor 18b with annotated cross peaks. 
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Figure 7-10: Section of 1H-13C-HMBC spectrum of ligand precursor 18c with annotated cross peaks. 
 
Figure 7-11: Section of 1H-13C-HMBC spectrum of ligand 19a with annotated cross peaks. 
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7.2.12 Crossover experiments 
7.2.12.1 Bisphosphinite ligands 19a and 19b 
From a stock solution in THF-d8, 2.55 mg 19a and 2.95 mg 19b were placed in a J.Young tube 
to give a 5 mM solution in each component. After the first measurement, the solution was evap-
orated and another equivalent of 19a in 0.5 ml solvent was added. 
 
Figure 7-12: Crossover experiment using ligands 19a and 19b in equimolar amounts. Top: 31P{1H}-NMR spectrum. 
Bottom: 1H-NMR spectrum with expansion of area of amide protons. 
 
Figure 7-13: 1H-NMR segment of proton H6. 1) 1:1 mixture of 19a and 19b gives a2:ab:b2 dimers in a ratio of 1:2:1 
with the mixed dimer bearing two diastereotopic protons H6 and H6’, thus yielding four signals of identical intensity. 
2) 2:1 mixture (a:b) gives dimers in 4:4:1 distribution, thus yielding four signals with 4:2:2:1 intensity (see below for 
kinetic considerations). 
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Assuming a similar behaviour of both compounds in terms of interaction, the dimerization be-
haviour can be described as follows: 
kAA ∼ [A]2 kBB ∼ [B]2 kAB = kBA ∼ 2[A][B] 
If [A] = [B] → kAA = kBB = ½ kAB = ½ kBA 
If [A] = 2[B] → kAA = 4[B]2 kBB = [B]2 kAB = kBA = 4[B]2 
7.2.12.2 BIPOL ligands 18a and 18b 
Diols 18a and 18b were mixed in dry CDCl3 to give a 5 mM in each component. NMR spectra 
were collected at -38 °C and compared to those of the isolated compounds under identical con-
ditions. Mixing the ligands gives rise to a variety of new (partially overlapping) signals that can 
be attributed to the formation of the heterodimeric compound. 
 
 Figure 7-14: Section of 1H NMR spectra of diols 18a, 18b and their respective 1:1 mixture in CDCl3 
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7.2.13 Temperature-dependent NMR measurements 
A sample of bisphosphine 7 (8 mM in dry and degassed CDCl3 or CDCl2CDCl2) was measured 
at diff erent temperatures from -38 to 80 °C. Strong line broadening was observed for the di-
merized ligand species with increasing temperature. 
 
Figure 7-15: Temperature-dependent 31P{1H} NMR spectra of bisphosphine 7 in CDCl3 (-40 °C – 50 °C) and 
CDCl2CDCl2 (80 °C). 
 
Samples of bisphosphinite 19a (8 mM in dry and degassed NMR solvent) were measured at 
diff erent temperatures from -38 to 50 °C (THF-d8) and from 20 to 100 °C (CDCl2CDCl2). 
 
Figure 7-16: Temperature-dependent shifts of amid protons of 19a are used to qualitatively asses binding strength on 
non-covalent interactions.  
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Figure 7-17: Temperature-dependent 31P{1H} NMR spectra of 19a in THF-d8 (bottom) and in CDCl2CDCl2 (top). 
New singlet species forms at 40 °C and above that vanishes when sample is measured again at room temperature 
afterwards. 
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Samples from crossover experiments exhibited a similar behaviour to samples containing one 
single ligand. A mixture of compounds 19a and 19b (5 mM solution in each compound in dry 
and degassed NMR solvent) were measured at diff erent temperatures from -38 to 50 °C (THF-
d8) and from 20 to 100 °C (CDCl2CDCl2). 
 
 
Figure 7-18: Temperature-dependent 31P{1H} NMR spectra of 19a and 19b in THF-d8 (bottom) and in CDCl2CDCl2 
(top). New singlet species forms at 40 °C and above that vanishes when sample is measured again at room temperature 
afterwards. 
7.2.14 Model structure model-19a and NOESY spectra of 19a 
7.2.14.1 Structure optimization 
The model structure model-19a for an illustrative analysis of NOESY spectra was generated 
with Gaussian 16, Revision A.03.[228] using the B3LYP functional[229] with Grimme’s D3BJ dis-
persion correction[230] and Dunning’s cc-pVDZ basis set[231] with additional diff use functions[232] 
on hetero atoms and on amide protons. The initial structure was based on the crystallographic 
data obtained for glycine-based phosphinite compound 19d and a variety of conformers were 
optimized to find the one of lowest energy. No imaginary frequencies were observed for the 
ground state and Gibbs free energies refer to standard temperature (298.15 K) and pressure (1 
atm). 
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Figure 7-19: Front view of calculated structure model-19a. The two molecular subunits of the dimer are coloured in 
light and dark grey. Protons are omitted for clarity. Nitrogen = blue, oxygen = red, phosphorus = orange. 
Energy: HF= -7510.9041682 
Cartesian coordinates (in Å): 
--------------------------------------------------------------------- 
Center     Atomic       Atomic Coordinates (Angstroms) 
Number     Number       Type             X           Y           Z 
 --------------------------------------------------------------------- 
      1         15           0       -5.379776    2.849292   -2.373805 
      2         15           0       -3.827478   -1.224812   -4.337429 
      3          8           0       -5.048477    1.142272   -2.299531 
      4          8           0       -7.414509    0.735718   -1.123386 
      5          8           0       -6.339024   -1.577080    3.316897 
      6          8           0       -3.125379   -1.282688   -2.753965 
      7          8           0       -0.797245   -0.838158   -4.070001 
      8          8           0        1.582826    2.737845   -1.422793 
      9          8           0        2.056704    1.970292    2.716085 
     10          7           0       -4.087312   -1.824043    3.315696 
     11          1           0       -3.179175   -1.625501    2.895978 
     12          7           0        0.495408    2.881041    0.562448 
     13          1           0       -0.286541    2.604634    1.161800 
     14          7           0        3.779181    3.185518    1.847619 
     15          1           0        4.000417    3.971503    1.234524 
     16          6           0       -6.026994    2.803766   -4.098241 
     17          6           0       -6.951567    1.803813   -4.443170 
     18          1           0       -7.199993    1.029439   -3.717994 
     19          6           0       -7.526947    1.791000   -5.714602 
     20          1           0       -8.232497    0.999419   -5.976487 
     21          6           0       -7.201877    2.780747   -6.647843 
     22          1           0       -7.654951    2.768503   -7.641597 
     23          6           0       -6.292367    3.784740   -6.304259 
     24          1           0       -6.028944    4.557667   -7.029779 
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     25          6           0       -5.705312    3.796788   -5.036075 
     26          1           0       -4.980473    4.572516   -4.781734 
     27          6           0       -3.668787    3.479292   -2.640892 
     28          6           0       -2.792413    2.932808   -3.594459 
     29          1           0       -3.128656    2.112138   -4.230511 
     30          6           0       -1.493184    3.422948   -3.707579 
     31          1           0       -0.806688    2.982435   -4.432569 
     32          6           0       -1.056794    4.464863   -2.879993 
     33          1           0       -0.032502    4.829065   -2.960928 
     34          6           0       -1.922484    5.015107   -1.934581 
     35          1           0       -1.582953    5.823873   -1.286712 
     36          6           0       -3.223115    4.515719   -1.808177 
     37          1           0       -3.896552    4.925305   -1.051187 
     38          6           0       -5.079882    0.542530   -1.071720 
     39          6           0       -6.318882    0.302183   -0.438147 
     40          6           0       -6.352970   -0.345428    0.795511 
     41          1           0       -7.284038   -0.540070    1.323112 
     42          6           0       -5.156554   -0.767958    1.398463 
     43          6           0       -3.936704   -0.538842    0.757388 
     44          1           0       -2.997314   -0.859810    1.196094 
     45          6           0       -3.888503    0.123340   -0.474226 
     46          6           0       -8.687038    0.535846   -0.525220 
     47          1           0       -9.416766    0.951574   -1.230784 
     48          1           0       -8.763322    1.062602    0.440718 
     49          1           0       -8.892135   -0.536588   -0.372492 
     50          6           0       -5.250956   -1.420752    2.744149 
     51          8           0       -3.764388   -0.263913    5.706357 
     52          7           0       -5.307942   -1.677541    6.614235 
     53          1           0       -5.835777   -2.516411    6.419618 
     54          6           0       -4.089731   -2.410992    4.637669 
     55          1           0       -4.885044   -3.172510    4.679133 
     56          6           0       -4.386865   -1.334481    5.693053 
     57          6           0       -5.717528   -0.887461    7.796752 
     58          6           0       -2.579096    0.374016   -1.135799 
     59          6           0       -2.258718   -0.320795   -2.306894 
     60          6           0       -1.014357   -0.115884   -2.936543 
     61          6           0       -0.102584    0.775444   -2.380127 
     62          1           0        0.865424    0.957499   -2.838029 
     63          6           0       -0.416187    1.470192   -1.202940 
     64          6           0       -1.651745    1.266241   -0.582312 
     65          1           0       -1.928038    1.809538    0.318278 
     66          6           0       -3.229622   -2.881433   -4.929369 
     67          6           0       -2.186092   -2.893938   -5.867452 
     68          1           0       -1.802871   -1.946583   -6.248918 
     69          6           0       -1.628416   -4.100237   -6.298298 
     70          1           0       -0.810239   -4.095053   -7.021711 
     71          6           0       -2.118280   -5.311704   -5.801561 
     72          1           0       -1.684572   -6.256259   -6.137512 
     73          6           0       -3.173445   -5.310890   -4.882907 
     74          1           0       -3.567311   -6.255653   -4.501111 
     75          6           0       -3.728046   -4.103751   -4.451763 
     76          1           0       -4.550334   -4.111657   -3.735270 
     77          6           0       -5.543520   -1.687463   -3.839543 
     78          6           0       -5.882062   -2.146551   -2.559252 
     79          1           0       -5.108214   -2.238466   -1.798633 
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     80          6           0       -7.208955   -2.461488   -2.255112 
     81          1           0       -7.460795   -2.805487   -1.249615 
     82          6           0       -8.206128   -2.328747   -3.224865 
     83          1           0       -9.242835   -2.573433   -2.983227 
     84          6           0       -7.872460   -1.876689   -4.506030 
     85          1           0       -8.647289   -1.766657   -5.268199 
     86          6           0       -6.548974   -1.551131   -4.808399 
     87          1           0       -6.295901   -1.170426   -5.801253 
     88          6           0        0.491591   -0.755301   -4.671349 
     89          1           0        0.488117   -1.488519   -5.486279 
     90          1           0        1.283077   -1.020210   -3.956490 
     91          1           0        0.674318    0.254121   -5.077186 
     92          6           0        0.622023    2.414145   -0.691806 
     93          6           0        1.498876    3.738212    1.173524 
     94          1           0        2.037998    4.263238    0.377131 
     95          6           0        2.482651    2.873163    1.974560 
     96          6           0        4.876283    2.637472    2.683743 
     97         15           0        5.394851   -2.818108    1.953285 
     98         15           0        2.879471   -3.647448   -3.327182 
     99          8           0        4.860952   -2.512408    0.328150 
    100          8           0        7.328561   -1.523554   -0.066044 
    101          8           0        6.584169    3.274138   -1.736549 
    102          8           0        4.203016    5.594879    0.213096 
    103          8           0        2.709571   -2.172535   -2.417058 
    104          8           0        0.193317   -3.146956   -2.224391 
    105          8           0       -1.439635   -1.583441    2.334150 
    106          8           0       -1.622646    2.664545    2.407774 
    107          7           0        4.328862    3.515096   -1.760025 
    108          1           0        3.405717    3.150571   -1.527729 
    109          7           0        5.774217    6.648669   -1.061175 
    110          1           0        6.259819    6.592029   -1.945098 
    111          7           0       -0.196736    0.269315    2.752892 
    112          1           0        0.603359    0.863264    2.518909 
    113          7           0       -3.325501    1.708029    3.581833 
    114          1           0       -3.545518    0.977426    4.261224 
    115          6           0        5.762695   -4.600460    1.641232 
    116          6           0        6.411144   -4.969991    0.450654 
    117          1           0        6.625578   -4.215278   -0.306383 
    118          6           0        6.743845   -6.305862    0.221310 
    119          1           0        7.221195   -6.583107   -0.720522 
    120          6           0        6.459883   -7.280973    1.182300 
    121          1           0        6.721463   -8.325201    0.998558 
    122          6           0        5.833442   -6.914644    2.377071 
    123          1           0        5.602952   -7.671543    3.130211 
    124          6           0        5.480623   -5.581482    2.604605 
    125          1           0        4.964393   -5.306354    3.526705 
    126          6           0        3.773041   -2.949231    2.827097 
    127          6           0        2.614449   -3.485657    2.244254 
    128          1           0        2.632968   -3.824871    1.211220 
    129          6           0        1.425661   -3.545949    2.970415 
    130          1           0        0.521581   -3.934564    2.500123 
    131          6           0        1.382480   -3.078591    4.288153 
    132          1           0        0.445054   -3.111933    4.846237 
    133          6           0        2.530344   -2.543351    4.877386 
    134          1           0        2.496290   -2.165127    5.900648 
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    135          6           0        3.718800   -2.467054    4.144313 
    136          1           0        4.610189   -2.020797    4.592849 
    137          6           0        5.001984   -1.247244   -0.174948 
    138          6           0        6.288097   -0.698972   -0.379284 
    139          6           0        6.418118    0.602307   -0.861153 
    140          1           0        7.387890    1.075928   -0.997817 
    141          6           0        5.271301    1.354098   -1.167231 
    142          6           0        4.007404    0.779952   -1.021789 
    143          1           0        3.100664    1.325108   -1.267417 
    144          6           0        3.864236   -0.515818   -0.516960 
    145          6           0        8.641993   -0.991568   -0.156547 
    146          1           0        9.313699   -1.798544    0.160819 
    147          1           0        8.767722   -0.120529    0.507981 
    148          1           0        8.885090   -0.694978   -1.190808 
    149          6           0        5.458337    2.780734   -1.582911 
    150          6           0        4.413300    4.917325   -2.101678 
    151          1           0        5.199315    5.036983   -2.863354 
    152          6           0        4.799052    5.740381   -0.862824 
    153          6           0        6.266925    7.648802   -0.087311 
    154          6           0        2.498480   -1.077085   -0.330305 
    155          6           0        1.966579   -1.935545   -1.301108 
    156          6           0        0.647647   -2.417959   -1.170769 
    157          6           0       -0.099244   -2.083484   -0.044377 
    158          1           0       -1.113544   -2.450594    0.087678 
    159          6           0        0.425073   -1.204954    0.917312 
    160          6           0        1.716357   -0.695068    0.764265 
    161          1           0        2.148692   -0.025328    1.504598 
    162          6           0        2.520227   -5.007323   -2.133665 
    163          6           0        3.200592   -5.152375   -0.916590 
    164          1           0        3.961738   -4.426887   -0.635614 
    165          6           0        2.910401   -6.226494   -0.073055 
    166          1           0        3.450171   -6.330809    0.868910 
    167          6           0        1.939924   -7.163195   -0.442374 
    168          1           0        1.717382   -8.005604    0.216552 
    169          6           0        1.257678   -7.026105   -1.655681 
    170          1           0        0.500041   -7.757434   -1.945857 
    171          6           0        1.545264   -5.948955   -2.497336 
    172          1           0        1.006361   -5.828260   -3.439859 
    173          6           0        4.735480   -3.667353   -3.239462 
    174          6           0        5.461414   -2.466489   -3.210857 
    175          1           0        4.933242   -1.515324   -3.157269 
    176          6           0        6.857907   -2.486468   -3.213850 
    177          1           0        7.405247   -1.542941   -3.172629 
    178          6           0        7.547880   -3.700267   -3.263005 
    179          1           0        8.639912   -3.712381   -3.262412 
    180          6           0        6.830951   -4.899730   -3.312842 
    181          1           0        7.360662   -5.854367   -3.353232 
    182          6           0        5.434405   -4.884258   -3.301064 
    183          1           0        4.886395   -5.828616   -3.314033 
    184          6           0       -1.054298   -3.823437   -2.090183 
    185          1           0       -1.206607   -4.352568   -3.036486 
    186          1           0       -1.879437   -3.112673   -1.947919 
    187          1           0       -1.015001   -4.543114   -1.256036 
    188          6           0       -0.461974   -0.853928    2.062358 
    189          6           0       -1.079622    0.768886    3.796600 
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    190          1           0       -1.648106   -0.073919    4.204625 
    191          6           0       -2.048562    1.794696    3.188712 
    192          6           0       -4.377983    2.715991    3.294042 
    193          6           0       -2.727012   -3.086416    4.920466 
    194          1           0       -1.951507   -2.321752    4.753041 
    195          6           0       -0.255687    1.424920    4.931628 
    196          1           0        0.342820    2.226356    4.470988 
    197          6           0        3.065272    5.402893   -2.683676 
    198          1           0        2.291339    5.173541   -1.932964 
    199          6           0        7.382233    8.418783   -0.803099 
    200          1           0        7.002329    8.907183   -1.715059 
    201          1           0        7.788406    9.199010   -0.143610 
    202          1           0        8.208040    7.744970   -1.082871 
    203          6           0        5.122663    8.600692    0.290814 
    204          1           0        4.744611    9.126108   -0.599655 
    205          1           0        4.294072    8.045364    0.750153 
    206          1           0        5.480881    9.352673    1.010567 
    207          6           0        6.826632    6.951593    1.160746 
    208          1           0        6.025567    6.433346    1.701890 
    209          1           0        7.594151    6.214371    0.881838 
    210          1           0        7.280634    7.696369    1.832538 
    211          6           0        6.175906    3.208888    2.107677 
    212          1           0        6.164147    4.307783    2.125585 
    213          1           0        7.032599    2.864310    2.704882 
    214          1           0        6.327661    2.886619    1.068153 
    215          6           0        4.685737    3.107278    4.134488 
    216          1           0        4.712247    4.206343    4.195816 
    217          1           0        3.723205    2.753735    4.529914 
    218          1           0        5.490600    2.706319    4.769899 
    219          6           0        4.913026    1.104188    2.619897 
    220          1           0        4.034401    0.659890    3.101799 
    221          1           0        4.947717    0.765580    1.579084 
    222          1           0        5.817485    0.736797    3.128624 
    223          6           0       -6.287478    0.470464    7.363089 
    224          1           0       -5.504220    1.084467    6.902411 
    225          1           0       -7.099058    0.335380    6.632758 
    226          1           0       -6.685245    1.006093    8.238910 
    227          6           0       -6.802058   -1.712372    8.498671 
    228          1           0       -6.416233   -2.701271    8.794862 
    229          1           0       -7.144584   -1.194851    9.406151 
    230          1           0       -7.673538   -1.857465    7.839983 
    231          6           0       -4.510377   -0.697563    8.726723 
    232          1           0       -4.806135   -0.115578    9.613097 
    233          1           0       -4.123872   -1.671421    9.064627 
    234          1           0       -3.705081   -0.159657    8.209046 
    235          6           0       -5.674963    2.160123    3.890351 
    236          1           0       -5.571358    1.997673    4.972350 
    237          1           0       -6.496199    2.872663    3.725892 
    238          1           0       -5.950531    1.202343    3.427157 
    239          6           0       -4.005139    4.041130    3.977670 
    240          1           0       -4.779680    4.798130    3.779815 
    241          1           0       -3.923575    3.907539    5.067539 
    242          1           0       -3.046256    4.416825    3.594361 
    243          6           0       -4.553702    2.926187    1.783407 
    244          1           0       -3.652058    3.356112    1.331789 
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    245          1           0       -4.777266    1.977639    1.283389 
    246          1           0       -5.396695    3.611805    1.606650 
    247          6           0        0.825556    4.776469    2.104372 
    248          1           0        0.260941    4.211089    2.862264 
    249          6           0        1.862962    5.656207    2.809151 
    250          1           0        1.355848    6.425900    3.411054 
    251          1           0        2.504019    5.074941    3.486964 
    252          1           0        2.517193    6.161240    2.080693 
    253          6           0       -0.169028    5.624785    1.309310 
    254          1           0        0.346148    6.187670    0.511944 
    255          1           0       -0.944220    5.000731    0.846189 
    256          1           0       -0.667469    6.351592    1.969730 
    257          6           0        3.066763    6.912998   -2.936135 
    258          1           0        2.111784    7.222256   -3.387298 
    259          1           0        3.200099    7.489978   -2.009617 
    260          1           0        3.871643    7.201164   -3.634336 
    261          6           0        2.735742    4.630026   -3.965087 
    262          1           0        3.514014    4.790321   -4.730227 
    263          1           0        2.649727    3.552228   -3.774301 
    264          1           0        1.778236    4.974930   -4.385601 
    265          6           0       -2.485104   -4.234974    3.935883 
    266          1           0       -3.246022   -5.023853    4.060790 
    267          1           0       -2.507470   -3.886384    2.895369 
    268          1           0       -1.497708   -4.688623    4.114722 
    269          6           0       -2.622334   -3.574117    6.368079 
    270          1           0       -2.678406   -2.747942    7.091382 
    271          1           0       -3.426120   -4.291087    6.608631 
    272          1           0       -1.662799   -4.090468    6.524029 
    273          6           0        0.707744    0.401250    5.533817 
    274          1           0        0.153958   -0.438779    5.987181 
    275          1           0        1.385797   -0.007935    4.774634 
    276          1           0        1.320332    0.867535    6.321496 
    277          6           0       -1.160584    2.034008    6.007205 
    278          1           0       -1.765200    2.864536    5.616143 
    279          1           0       -1.851958    1.281863    6.419366 
    280          1           0       -0.547834    2.429740    6.831794  
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7.2.14.2 NOESY spectra 
Spectra obtained for 19a (8 mM in THF-d8) show cross peaks between the ligand monomers in 
the hydrogen bond complex. Atoms X and X’ refer to inner and outer sphere atoms of the com-
plex. 
 
 
Figure 7-20: NOESY spectrum of 19a with annotated cross signals depicting vicinity of protons H4 and H6’ shown 
in the calculated structure model-19a below. For clarity reasons, irrelevant hydrogen atoms were omitted and OPPh2 
groups are represented by placeholder atoms. The two molecular subunits of the dimer are coloured in light and dark 
grey. Nitrogen = blue, oxygen = red, OPPh2 moiety = orange. 
H4 
H6’ 
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Figure 7-21: NOESY spectrum of 19a with annotated cross signals depicting vicinity of inner and outer sphere se-
lectors shown in structure model-19a below. For clarity reasons, irrelevant hydrogen atoms were omitted and OPPh2 
groups are represented by placeholder atoms. The two molecular subunits of the dimer are coloured in light and dark 
grey. Nitrogen = blue, oxygen = red, OPPh2 moiety = orange. 
H8’ 
H9 
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Figure 7-22: NOESY spectrum of 19a with annotated cross signals depicting vicinity of inner and outer sphere se-
lectors shown in the structure model-19a below. For clarity reasons, irrelevant hydrogen atoms were omitted and 
OPPh2 groups are represented by placeholder atoms. The two molecular subunits of the dimer are coloured in light 
and dark grey. Nitrogen = blue, oxygen = red, OPPh2 moiety = orange. 
  
H9 
H10’ 
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7.2.15 CD3OD titration experiments with BIPOL 18c 
Analyte solutions of compound 18c (20 mM) were prepared in solvent mixtures of CDCl3 and 
CD3OD with ratios 99:1, 90:10, 50:50 and 0:100 (v:v). Both methanol and chloroform was taken 
from a freshly opened bottle and the latter was passed twice through a plug of dry, basic alumina 
to remove traces of acid. Spectra were calibrated to the terminal tBu group at 0.94 ppm, which 
showed a negligible shift difference in all four spectra. 
 
Figure 7-23: Diol 18c in different mixtures of deuterated chloroform and methanol. 
7.2.16 HD exchange kinetics of BIPOL 18c 
Analyte solutions of 18c and (S)-25 with a concentration of 20 mM and 40 mM, respectively, in 
freshly opened methanol-d4 were prepared. With a final methanol concentration of 24.6 M, HD 
exchange was considered to proceed with pseudo-first-order kinetics. Spectra were collected 
periodically with intervals suitable for the speed of exchange. All acquired spectra were baseline 
and phase corrected. The decay of the signal was evaluated relatively to the non-exchanging 
methin proton in the chiral center, H9. Regression curves were generated using Origin 16’s quick 
fit functionality with the exponential decay function: 
𝑦 =  𝑦0 +  𝐴1 ∗ 𝑒𝑥𝑝(−(𝑥 − 𝑥0)/𝑡1) 
The y-intercept is taken to normalize the final data to start from 100%. For proton Ha4, full signal 
decay was observed within 30 sec when the first spectrum was measured. Half-life is thus esti-
mated based on a signal decay to 1% within 30 sec (equal to 6.65 half-lives): t1/2(Ha4) = 4.5 sec. 
Half-lives were read out and kinetic constants calculated according to first-order-kinetics: 
𝑡0.5 = ln(2) /𝑘𝑒𝑥 
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Figure 7-24: Deuterium exchange for amide protons of compounds 18c and 25. 
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Retardation factors describe slowdown of amide proton exchange compared to the model com-
pound. 
 
7.2.17 Hydrogenation experiments 
To evaluate the enantioselectivity of the ligand structure, enantiomers of precursor ligand 5 were 
separated using preparative HPLC and the Rh complex was generated in situ.  
As for ligand 7, samples of the equilibrated compound (2.00 mg, 2.04 µm) were placed in 
J.Young NMR tubes. Where the effect of additives was investigated, these and 0.4 ml dry and 
degassed CDCl3 were added. The mixture was re-equilibrated at 60 °C for 16 hours and the 
solvent subsequently removed under reduced pressure after determination of the ligand’s dr via 
31P{1H}-NMR spectroscopy. The Rh catalyst was generated in situ by evaporating the solution 
and adding equal amounts of Rh precursor [Rh(COD)2]BF4 in 0.5 ml dry and degassed CDCl3 
to the prepared ligand sample to give a clear yellow solution. Finally, methyl 2-acetamido acry-
late (20 eq.) was added.  
For ligands 19a-c and 23a-b, Rh complexes were prepared by adding equimolar amounts of 
[Rh(COD)2]BF4 to a solution of the ligand in dry and degassed DCM. After stirring the mixture 
for three hours, the solution was concentrated and addition of n-pentane gave yellow solids. The 
supernatant solution was removed using a filter-tipped cannula and precipitation was repeated 
another two times. Yellow solids were dried and 3.2 mM stock solutions in DCM were prepared 
from which 0.5 ml were taken and substrate (10 eq. for ligands 19a-c and 20 eq. for ligands 23a-
b) was added.  
The prepared solution was transferred into a nitrogen-filled stainless steel reactor loaded with a 
standard NMR tube and a small stirring bar and cooled in a bath of 2-propanol utilizing a cry-
ostatic temperature regulator, if necessary. The reactor was pressurized with hydrogen gas (20 
bar for the phosphine ligands, 95 bar for phosphinite ligands and 35 bar for the phosphoramidite 
ligands) to initiate the catalysis.  
The autoclave was re-opened after one or two days and the solution was passed through a short 
pipet filled with silica (ca. 3 cm) using ethyl acetate as eluent. Evaporation gave the hydrogena-
tion product as a yellow oil. Enantiomeric ratio was determined by chiral GC (compound 12: 
Table 7-3: Estimated half-life and exchange rates for HD exchange in methanol 
 
 Diol 18c Diamide 25 
 Ha Hb Ha’ Hb’ Ha Hb 
t1/2 
[102 min] 
1.91 253.3 1.80 201.6 0.0008a) 0.28 
kex 
[sec-1] 
6.03 · 10-5 4.56 · 10-7 6.41 · 10-5 5.72 · 10-7 1.54 · 10-1 4.18 · 10-4 
Retardation Factorb) 
2554 - 2402 - 1 - 
- 917 - 731 - 1 
a) Complete exchange was observed before after 30 second. Half-life time was estimated (see 
above). b) Retardation Factor = kex(HX25) / kex(HX18c) 
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Chirasil Val-C5: 110 °C, ksubst = 1.53, kR = 2.21, kS = 2.35,  = 1.06  or (6-TBDMS-2,3-Ac)-β-
CD: 130 °C, kR = 6.84, kS = 9.07,  = 1.33, both 25 m, i.d. 250 µm, film thickness 250 nm, 
prepared and coated in the Trapp group, 100 kPa helium; compound 22: (6-TBDMS-2,3-dime-
thyl)-β-CD, 120 °C, kR = 27.6, kR = 30.3,  = 1.10, 13 m, i.d. 250 µm, film thickness 250 nm, 
prepared and coated in the Trapp group, 100 kPa helium) or chiral HPLC (compound 20: Chi-
ralpak ODH, hexane:isopropanol:methanol 97:1.5:1.5, 1.5 ml/min, 20 °C, tR = 17.0 min and tS 
= 19.9 min; compound 21: Chiralpak IB, hexane:isopropanol 95:5, 1.0 ml/min, 20 °C, tR = 5.4 
min and tS = 6.3 min). Assignment of absolute configuration was accomplished by comparison 
of the elution order to known standards or literature values. All reactions showed full conversion. 
7.2.18 Enantioselective alkylation of aromatic aldehydes. 
7.2.18.1 Investigation of the Ti complex  
BIPOL 18c (10 mg, 13.5 µmol, 1.00 eq.) was dissolved in 0.5 ml dry and degassed DCM-d2 (1H 
NMR spectrum 1). Addition of Ti(OiPr)4 (4.1 µl, 13.5 µmol, 1.00 eq.) gave a yellow precipitate 
(spectrum 2). When another charge of Ti(OiPr)4 (24.6 µl, 81.0 µmol, 6.00 eq.) was added, solids 
re-dissolved and a clear, yellow solution formed (spectrum 3) Finally, Zn(Et)2 (135 µl, 1 M in 
hexane, 135 µmol, 10.0 eq.) was added (spectrum 4). 
 
Figure 7-25: Investigation of the interplay of BIPOL ligand 18c, titanium precursor Ti(OiPr)4 and Zn(Et)2. Structures 
on top are suggestions. To improve clarity, a different representation is chosen for ligand dimer 18c. 
7.2.18.2 Reaction setup 
In a typical procedure, a heat-gun dried Schlenk flask equipped with a magnetic stirring bar was 
charged with ligand (25 µmol) and titanium tetraisopropoxide (175 µmol). Dry and degassed 
solvent (1 ml) was added and the mixture was stirred for 10 min. Diethylzinc (375 µmol from a 
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1M solution in toluene) was added and stirring was continued for another 10 min. The temper-
ature of the mixture was subsequently adjusted, the substrate (125 µmol) was added and stirring 
was continued for 16 hours. The reaction was stopped by addition of saturated ammonium chlo-
ride solution (3 ml) and the product was extracted with ethyl acetate (2 x 3 ml). 
Combined organic layers were dried over sodium sulfate and conversion and enantioselectivity 
were determined by chiral GC (Chirasil--Dex, 25 m, i.d. 250 µm, film thickness 250 nm, pre-
pared and coated in the Trapp group, Reactions with benzaldehyde: 100 °C, 80 kPa He, ksubst = 
2.78, kR = 25.8, kS = 28.7,  = 1.11)) or HPLC (Chiralcel OD-H). Retention times and absolute 
configuration were assigned by comparison with GC traces in literature, of known compounds 
or by identification with GC-MS. 
7.3 Experimental data for chapter 3 
7.3.1 MOM-protected 2,2’-biphenol (27i) 
 
This compound was synthesized according to a known procedure.[159] 2,2’-biphenol (5.00 g, 
26.9 mmol, 1.00 equiv.) was dissolved in dry THF (40 ml). The solution was added to a stirred 
suspension of sodium hydride (1.42 g, 59.1 mmol, 2.20 eq.) in THF (90 ml) at 5 °C over 30 
minutes. The resulting mixture was kept stirring at low temperatures for one hour, warmed to 
room temperature for 15 minutes and cooled again in an ice bath. Chloromethyl methyl ether 
(4.28 ml, 56.4 mmol, 2.10 eq.) was added dropwise. The mixture turned yellow and solids 
formed. After warming to room temperature, the suspension was kept stirring overnight. For 
work-up, the mixture was quenched with saturated ammonium chloride (100 ml) and all volatiles 
were removed under reduced pressure. The residue was extracted with DCM (3 x 100 ml), com-
bined organic layers were washed with brine (1 x 100 ml), dried over sodium sulfate, filtered 
and evaporated to give the crude product as a yellow oil. Purification by column chromatography 
(silica, petrol ether:ethyl acetate 20:1 to 10:1, Rf = 0.38 in petrol ether:ethyl acetate 10:1) gave a 
colourless oil that transformed into a waxy solid after prolonged drying under high vacuum (4.50 
g, 16.4 mmol, 61%).  
 
1H-NMR (CDCl3, 400.33 MHz, 298 K): δ = 3.34 (s, 3H, H8), 5.07 (s, 2H, H7), 7.06-7.10 (m, 
1H, H4/H5), 7.21-7.34 (m, 3H, H3 and H4/H5 and H6) ppm. 
13C{1H}-NMR (CDCl3, 100.66 MHz, 289 K): δ = 56.0 (C8), 95.4 (C7), 115.8 (C3/C4/C5), 122.0 
(C4/C5), 128.8 (C3/C4/C5/C6), 129.4 (C1), 131.7 (C3/C4/C5/C6), 155.1 (C2) ppm. 
HRMS (ESI): m/z calcd. for C16H22NO4 [M+NH4]+: 292.15433; found: 292.15456. 
FTIR: ṽ = 750 (s), 920 (s), 984 (s), 1079 (s), 1149 (s), 1475 (s), 1593 (s), 2788 (w), 2823 (m), 
2903 (m), 2950 (m), 2973 (w), 2994 (w) cm-1. 
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7.3.2 3,3’-Dimethyl-2,2’-biphenol (28) 
 
This compound was synthesized according to a known procedure.[159] Methoxy methyl-protected 
biphenol 27i (5.00 g, 18.2 mmol, 1.00 eq.) was dissolved in dry THF (130 ml). Butyl lithium 
(1.6 M in hexane, 34.2 ml, 54.7 mmol, 3.00 eq.) was slowly added at room temperature and the 
resulting brown suspension warmed up slightly. Stirring was continued for one hour and the 
flask was subsequently placed in a water bath. Iodomethane (3.40 ml, 54.7 mmol, 3.00 eq.) was 
added and a clear, yellow solution formed, which was stirred for another hour. The mixture was 
subsequently quenched wit saturated Na2SO3 solution (130 ml) and ethyl acetate (180 ml) was 
added. Layers were separated and the aqueous layer was extracted twice more with ethyl acetate 
(150 ml each). Combined organic layers were dried over sodium sulfate, filtered and evaporated 
to give a yellow oil. Hydrochloric acid in isopropanol (5-6 M, 30 ml) was added and the solution 
instantly turned black. After 18 hours of stirring, the mixture was concentrated and the residue 
diluted with DCM (150 ml). The organic layer was washed sodium bicarbonate solution and 
brine. Evaporation gave a brown oil. Further purification by column chromatography (silica, 
petrol ether:ethyl acetate 20:1 to 10:1, Rf = 0.5 in petrol ether:ethyl acetate 10:1) gave an off-
white, crystalline solid that was washed with little n-pentane and finally dried in vacuo (1.5 g, 
7.00 mmol, 38%).  
 
1H-NMR (CDCl3, 400.33 MHz, 298 K): δ = 2.33 (s, 3H, H7), 5.20 (s, 1H, H8), 6.92-6.96 (m, 
1H, H5), 7.07-7.09 (m, 1H, H4/H6), 7.20-7.22 (m, 1H, H4/H6) ppm. 
13C{1H}-NMR (CDCl3, 100.66 MHz, 289 K): δ = 16.3 (C7), 121.4 (C5), 122.3 (C1), 125.7 (C3), 
128.5 (C4/C6), 131.6 (C4/C6), 151.7 (C2) ppm. 
HRMS (EI): m/z calcd. for C14H14O2 [M]+: 214.09938; found: 214.0989. 
FTIR: ṽ = 758 (s), 839 (m), 1087 (s), 1198 (s), 1239 (s), 1322 (s), 1450 (s), 1587 (w), 2520 (w), 
2579 (bw), 2921 (w), 2952 (bs), 3022(w) cm-1. 
 
7.3.3 3,3’-Dimethyl-5,5’-dinitro-2,2’-biphenol (29) 
 
This compound was synthesized according to a known procedure, which was slightly modi-
fied.[160] Biphenol 28 (400 mg, 1.87 mmol, 1.00 eq.) and sodium nitrate (476 mg, 5.60 mmol, 
3.00 eq.) were placed in a flask and dissolved in water:diethyl ether (50ml, 1:1 v:v). Concen-
trated hydrochloric acid (6.8 ml) was added and the mixture was stirred vigorously. After 16 
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hours, the etheric layer had turned slightly yellow while the aqueous layer remained clear. An-
other charge of hydrochloric acid (4 ml) was added in portions (0.8 ml each) over 10 hours, the 
mixture was kept stirring overnight and brown solid precipitated. The etheric layer was subse-
quently evaporated and the solids were filtered off. They were suspended in acetonitrile (5 ml) 
and the mixture was stirred for one hour. After placing the flask in the fridge for several hours 
to reduce loss of product, the product was filtered off, rinsed with small amounts of fresh ace-
tonitrile and dried in vacuo to yield the pure product as a brown powder (365 mg, 1.20 mmol, 
64%).  
 
1H-NMR (DMSO-d6, 300.18 MHz, 298 K): δ = 2.31 (s, 3H, H7), 7.91 (d, 1H, 4J(H,H) = 2.6 Hz, 
H6), 8.10 (d, 1H, 4J(H,H) = 2.6 Hz, H4), ppm. 
13C{1H}-NMR (DMSO-d6, 75.49 MHz, 289 K): δ = 16.8 (C7), 124.3 (C1), 125.2 (C6), 125.9 
(C4), 126.6 (C3), 139.2 (C5), 160.0 (C2) ppm. 
HRMS (ESI): m/z calcd. for C14H11N2O6 [M-H]-: 303.06226; found 303.06214. 
FTIR: ṽ = 651 (s), 746 (s), 904 (s), 1097 (s), 1189 (s), 1231 (s), 1322 (s), 1422 (s), 1502 (s), 
1583 (m), 2922 (w), 3084 (w), 3106 (w), 3446 (bs) cm-1. 
 
7.3.4 5,5’-DClB-selector modified 3,3’-dimethyl-2,2’-biphenol (30) 
 
This compound was synthesized according to a known procedure, which was slightly modi-
fied.[41] Substrate 29 (970 mg, 3.19 mmol, 1.00 eq.) and tin(II) chloride (6.04 g, 31.9 mmol, 10.0 
eq.) were placed in a Schlenk flask. Ethanol (24 ml) and hydrochloric acid (5-6 M in isopropanol, 
12 ml, 15.0 eq.) were added and the mixture was refluxed for seven hours. To the clear, yellow 
solution, DCM (30 ml) was added. It was cooled in an ice bath and subsequently treated first 
with triethylamine (7.11 ml, 51.0 mmol, 16.0 eq.) and then with dichlorobenzoyl chloride (2.67 
g, 12.75 mmol, 4.00 eq.) The ice bath was removed after 45 minutes and stirring was continued 
at room temperature for another five hours, then N,N-dimethylethylenediamine was added (13.9 
ml, 128 mmol, 40.0 eq.) and the mixture was kept stirring for yet another 16 hours. For work-
up, the clear solution was diluted with ethyl acetate (400 ml) and cautiously acidified with hy-
drochloric acid (3 M, 150 ml). Layers were separated and the organic layer was washed twice 
more with hydrochloric acid (3 M, 150 ml each), then with saturated sodium bicarbonate solution 
(2 x 150 ml) and finally with brine (1 x 150 ml). Any solids that formed during the washing 
process were discarded. The organic layer was finally dried over sodium sulfate and evaporated 
to give orange, waxy solids. Further purification by column chromatography (silica, DCM to 
ethyl acetate, Rf = 0.8 in ethyl acetate) gave yellow solids that were washed with little acetone 
and finally dried in vacuo at 60 °C to give the pure product 30 as an off-white solid (1.56 g, 2.64 
mmol, 83%).  
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1H-NMR (DMSO-d6, 400.33 MHz, 298 K): δ = 2.26 (s, 3H, H13), 7.47 (d, 1H, 4J(H,H) = 2.4 
Hz, H6), 7.53 (d, 1H, 4J(H,H) = 2.4 Hz, H4), 7.84 (t, 1H, 4J(H,H) = 1.9 Hz, H12), 7.97 (d, 2H, 
4J(H,H) = 1.9 Hz, H10), 10.23 (s, 1H, H7) ppm. 
13C{1H}-NMR (DMSO-d6, 100.66 MHz, 289 K): δ = 117.1 (C13), 121.5 (C6), 122.5 (C4), 125.6 
(C3), 126.4 (C10), 126.7 (C1), 130.6 (C5), 130.8 (C13), 134.4 (C11), 138.3 (C9), 149.1 (C2), 
162.1 (C9) ppm. 
HRMS (ESI): m/z calcd. for C28H19Cl4N2O4 [M-H]-: 587.01044; found: 587.01059. 
FTIR: ṽ = 803 (s), 864 (s), 1022 (m), 1108 (m), 1211 (bm), 1415 (m), 1477 (s), 1564 (s), 1647 
(s), 2918 (w), 2962 (w), 3078 (w), 3156 (bm), 3525 (bm) cm-1. 
 
7.3.5 3,5-Dichlorobenzoyl-selector modified 3,3’-dimethyl-2,2’-bisphosphinite (31) 
 
Selector-modified biphenol 30 (300 mg, 0.51 mmol, 1.00 eq.) and DABCO (228 mg, 2.03 mmol, 
4.00 eq.) were placed in a heat-gun dried Schlenk flask and dry, degassed and stabilized THF 
(10 ml) was added to give a clear, yellow solution. After cooling in an ice bath, chlorodiphe-
nylphosphine (0.35 ml, 2.03 mmol, 4.00 eq.) was added dropwise, during which the solution 
became colorless and white solids precipitated. Stirring was continued for 30 minutes at low 
temperatures and the for another two hours at room temperature. For work-up, the mixture was 
passed through a short pad of neutral alumina under inert conditions using THF as eluent (3 x 
10 ml). Evaporation gave amorphous solids that were re-precipitated three times from dry and 
degassed DCM/n-pentane (1:10 ml). Final drying gave the compound as a white solid (256 mg, 
0.37 mmol, 73%). The product decomposes in presence of air or moisture and should be stored 
in the freezer under an atmosphere of argon.  
 
1H-NMR (THF-d8, 400.33 MHz, 298 K): δ = 1.81 (s, 3H, H13), 7.15-7.19 (m, 3H, H21 and 
H19), 7.24-7.28 (m, 3H, H15 and H17), 7.29 (d, 1H, 4J(H,H) = 2.7 Hz, H6), 7.36 (d, 1H, 4J(H,H) 
= 2.7 Hz, H4), 7.36-7.40 (m, 2H, H20), 7.48-7.51 (m, 2H, H16), 7.66 (t, 1H, 4J(H,H) = 1.9 Hz, 
H12), 7.88 (d, 2H, 4J(H,H) = 1.9 Hz, H10), 9.25 (s, 1H, H7) ppm. 
13C{1H, 31P}-NMR (THF-d8, 150.93 MHz, 289 K): δ = 18.7 (C13), 122.1 (C6), 123.0 (C4), 
127.1 (C10), 128.5 (C19), 128.8 (C15), 129.7 (C21), 130.0 (C17), 131.0 (C20), 131.2 (C3), 
131.3 (C16), 131.6 (C12), 132.8 (C1), 134.9 (C5), 135.9 (C11), 140.0 (C9), 143.2 (C18), 144.0 
(C14), 151.3 (C2), 162.7 (C7) ppm. 
31P{1H}-NMR (THF-d8, 243.00 MHz, 289 K): δ = 114.0 (s) ppm. 
MS (MALDI): Anthracene matrix, m/z calcd. for C52H37Cl4N2O4P2 [M-H]-: 955.1; found: 955.1. 
FTIR: ṽ = 690 (s), 856 (s)m 1097 (s), 1201 (s), 1266 (s), 1434 (s), 1541 (s), 1644 (s), 2919 (w), 
2964 (w), 3016 (w), 3053 (w), 3068 (w), 3348 (bm) cm-1. 
7  Experimental section 
____________________________________________________________________________ 
- 127 - 
7.3.6 Rh complex of 3,5-dichlorobenzoyl selector-modified 3,3’-dimethyl-2,2’-bisphosphinite 
(32) 
 
The ligand 31 (100 mg, 104 µmol, 1.00 eq.) and [Rh(COD)2]BF4 (42.3 mg, 104 µmol, 1.00 eq.) 
were placed in a heat-gun dried Schlenk flask and dry and degassed DCM (8 ml) were added. 
The orange solution was stirred for 3 hours and subsequently concentrated. Addition of dry and 
degassed n-pentane (10 ml) produced yellow solids. The supernatant solution was removed us-
ing a filter-tipped cannula and re-precipitation was repeated twice. The solids were finally dried 
in vacuo to yield the complex as a yellow powder (93.0 mg, 74.0 µmol, 71%). The product 
decomposes in presence of air or moisture and should be stored in the freezer under an atmos-
phere of argon.  
 
1H-NMR (CDCl3, 600.25 MHz, 298 K): δ = 1.97 (s, 3H, H13), 2.30-2.50 (m, 4H, H16 and H17), 
4.58-4.59 (m, 1H, H15), 5.41-5.42 (m, 1H, H14), 6.71 (d, 1H, 4J(H,H) = 0.9 Hz, H6), 7.28-7.45 
(m, 10H, HAr), 7.46-7.48 (t, 1H, 4J(H,H) = 1.5 Hz, H12), 7.89 (d, 1H, 4J(H,H) = 0.9 Hz, H4), 
7.92 (d, 1H, 4J(H,H) = 1.5 Hz, H10), 8.79 (s, 1H, H7) ppm. 
13C{1H, 31P}-NMR (CDCl3, 150.93 MHz, 289 K): δ = 14.4 (C13), 30.2 (C16/C17), 30.3 
(C16/C17), 101.5 (C14), 106.7 (C15), 123.7 (C6), 124.3 (C4), 126.4 (C10), 129.0 (CHAr), 129.0 
(CHAr), 129.4 (CHAr), 130.0 (CHAr), 130.1 (C3), 130.6 (CHAr), 131.3 (C1/C5/C9), 131.4 
(C1/C5/C9), 131.9 (CHAr), 132.0 (C12), 135.5 (C1/C5/C9), 135.9 (C11), 137.4 (CqAr), 137.9 
(CqAr), 146.2 (C2), 163.3 (C8) ppm. 
31P{1H}-NMR (CDCl3, 243.00 MHz, 289 K): δ = 122.9 (d, 1J(P,Rh) = 178 Hz) ppm. 
HRMS (ESI): m/z calcd. for C60H50Cl4N2O4P2Rh [M-BF4]+: 1167.10495; found: 1167.1057. 
FTIR: ṽ = 692 (s), 867 (s), 1094 (s), 1200 (s), 1405 (m), 1435 (s), 1541 (s), 1564 (m), 1670 (m), 
2836 (w), 2881 (w), 2925 (w), 3076 (w), 3333 (bm) cm-1. 
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7.3.7 3,5-dichlorobenzoyl selector-modified 3,3’-dimethylphosphoramidite (33) 
 
Selector-modified biphenol 30 (400 mg, 678 µmol, 1.00 eq.) was suspended in dry and degassed 
toluene (5 ml). Tris(diethylamino)phosphine (370 µl, 1.36 mmol, 2.00 eq.) was added and the 
mixture was refluxed for three hours. All volatiles were subsequently removed and the residue 
was slurried in dry and degassed DCM (4 ml). After addition of dry and degassed n-pentane (15 
ml), stirring was continued to complete precipitation and the supernatant solution was subse-
quently removed using a filter-tipped cannula. Re-precipitation was repeated one more time and 
obtained solids were dried in vacuo yielding product 33 as a white powder (427 mg, 618 µmol, 
91%). The product decomposes in presence of air or moisture and should be stored in the freezer 
under an atmosphere of argon.  
 
For some atoms an additional signal splitting was observed. This is caused by the non-equiva-
lence of the two halves in the BIPOL-phosphoramidite, which has been previously observed for 
other chiral phosphoramidites.[233,234] Those signals are marked X and X’.  
1H-NMR (THF-d8, 400.22 MHz, 298 K): δ = 1.09 (t, 3H, 3J(H,H) = 7.0 Hz, H15), 2.36 (s, 3H, 
H13), 3.13 (dq, 2H, 3J(H,P) = 7.0 Hz, 3J(H,H) = 9.6 Hz, H14), 7.66 (t, 1H, 4J(H,H) = 1.9 Hz, 
H12), 7.68 (d, 1H, 4J(H,H) = 2.6 Hz, H4), 7.80 (d, 1H, 4J(H,H) = 2.6 Hz, H6), 7.93 (d, 1H, 
4J(H,H) = 2.6 Hz, H10) ppm. 
13C{1H}-NMR (THF-d8, 100.65 MHz, 289 K): δ = 15.4 (C15), 15.4 (C15’), 17.1 (C13), 39.3 
(C14), 39.5 (C14’), 119.8 (C6), 122.9 (C4), 127.1 (C10), 131.2 (C3), 131.7 (C12), 132.0 (C1), 
132.1 (C1’), 135.9 (C11), 139.8 (C9), 147.2 (C2), 147.3 (C2’), 163.2 (C8) ppm. No signal for 
C5 was observed. 
31P{1H}-NMR (THF-d8, 162.00 MHz, 289 K): δ = 146.5 (quint, 3J(P,H) = 10.3 Hz) ppm. 
HRMS (ESI), m/z calcd. for C32H32Cl4N4O4P [M+NH4]+: 707.09098; found: 707.09230. 
FTIR: ṽ = 668 (s), 752 (s), 833 (s), 851 (s), 1023 (s), 1203 (s), 1417 (s), 1507 (s), 1567 (s), 1652 
(s); 2869 (w), 2933 (w), 2971 (m), 3068 (m), 3347 (m), 3396 (m) cm-1. 
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7.3.8 rac-tBuNH-Phe-NH diol (meso-18c) 
 
Compound 16 (1.00 g, 2.99 mmol, 1.00 equiv.) and HOBt (1.01 g, 7.48 mmol, 2.50 equiv.) were 
placed in a heat-gun dried round-bottom flask and dissolved in dry DMF (35 ml) giving a clear 
solution. DIPEA (1.30 ml, 7.48 mmol, 2.50 equiv.) was added and the resulting slightly yellow 
solution was cooled in an ice bath. EDCIHCl (1.43 g, 7.48 mmol, 2.50 equiv.) was added. After 
15 min, an equimolar mixture of selector hydrochlorides (R)-S2c and (S)- S2c (1.92 g, 7.48 
mmol, 2.50 equiv. in total) was added. The reaction mixture was stirred at 0 °C for 30 min, 
afterwards overnight at room temperature. Subsequently, N,N-dimethylethylenediamine (13.2 
g, 16.3 ml, 0.15 mmol, 50.0 equiv.) was added slowly and the mixture was stirred at room tem-
perature for another 6.5 hours. For work-up, the reaction mixture was diluted with ethyl acetate 
(250 ml) and washed with HCl solution (2M, 3 x 250 ml), sat. NaHCO3 solution (3 x 50 ml) and 
brine (3 x 50 ml), during which some precipitate formed. The solids were filtered off and the 
organic phase was dried over Na2SO4, filtered again and concentrated under reduced pressure. 
The resulting crude product (separated solids and residue from organic phase) was purified by 
flash column chromatography (silica, DCM:acetone:ethyl acetate = 3:1:1 to pure acetone, Rf = 
0.34 DCM:acetone:ethyl acetate 2:1:1) to separate the diastereomers. Relevant fractions were 
combined and evaporated. Prolonged drying under high vacuum gave an off-white solid (716 
mg, 0.97 mmol, 65%).  
 
Due to molecular dynamic, the two sides of the molecule are represented by one single set of 
NMR signals. 
 
1H-NMR (DMSO-d6, 400.22 MHz, 298 K): δ = 1.23 (s, 9H, H18), 2.89-3.08 (m, 2H, H10), 3.84 
(s, 3H, H19), 4.67 (dt, 1H, 3J(H,H) = 8.9 Hz, 3J(H,H) = 5.5 Hz, H9), 7.11-7.15 (m, 1H, H14), 
7.21-7.25 (m, 2H, H13), 7.31-7.34 (m, 2H, H12), 7.35-7.38 (m, 2H, H4 and H6), 7.57 (m, 1H, 
H16), 8.19 (d, 1H, 3J(H,H) = 8.4 Hz, H8) ppm. 
13C{1H}-NMR (DMSO-d6, 100.65 MHz, 289 K): δ = 28.5 (C18), 37.9 (C10), 50.2 (C17), 55.0 
(C9), 56.0 (C19), 109.7 (C4), 123.1 (C6), 125.6 (C5), 126.2 (C14), 128.0 (C13), 129.4 (C12), 
138.4 (C11), 147.7 (C3), 149.0 (C2), 166.0 (C7), 171.0 (C15) ppm. 
HRMS (ESI): m/z calcd. for C42H51N4O8 [MH]+: 739.37014; found: 739.35975. 
FTIR: ṽ = 3368 (w), 3298 (s), 3083 (w), 3065 (w), 3030 (w), 2933 (w), 2870 (w), 1661 (w), 
1639 (s), 1596 (m), 1541 (s), 1486 (s), 1453 (s), 1414 (m), 1392 (w), 1320 (w), 1365 (s), 1303 
(m), 1287 (w), 1263 (w), 1246 (w), 1216 (s), 1192 (w), 1152 (m), 1130 (m), 1085 (w), 1067 (m), 
1044 (s), 1003 (w), 986 (w), 955 (w), 940 (w), 922 (m), 909 (w), 886 (m), 846 (w), 800 (m), 
758(w), 742(m), 698(s) cm-1. 
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7.3.9 rac-tBuNH-Phe-NH bisphosphinite (meso-19c) 
 
Compound meso-18c (300 mg, 0.41 mmol, 1.00 equiv.) was dissolved in dry and degassed THF 
(4 ml, stabilized with 250 ppm BHT) to give a yellow suspension and NEt3 (185 mg, 0.26 ml, 
18.3 μmol, 4.50 equiv.) was added. The reaction mixture was cooled to 0 °C, PPh2Cl (296 mg, 
0.23 ml, 13.4 μmol, 3.30 equiv.) was added dropwise and the resulting solution was stirred at 
0 °C for 15 min, afterwards at room temperature for two hours. Precipitated NEt3HCl was sub-
sequently filtered off using a filter-tipped cannula. The solvent was removed in high vacuum, 
the resulting residue was dissolved in dry and degassed DCM (2 ml) and the product precipitated 
by addition of dry and degassed n-pentane (20 ml). After removing the solution via filter-tipped 
cannula, the precipitation was repeated two times. The resulting solid was dried in high vacuum 
giving a white powder (302 mg, 0.27 mmol, 67%). 
 
Due to residual molecular dynamic, significant line broadening was observed in 1H and 13C 
spectra rendering them uninterpretable even at lower temperatures.   
31P-NMR (THF-d8, 161.98 MHz, 295.0 K)  120.6 (bs) ppm. 
HR-MS (ESI): m/z calcd. For C66H69N4O8P2 [MH]+: 1107.45851; found: 1107.45756. 
IR (FT-ATR, cm-1) ν = 3406 (m), 3298 (s), 3058 (m), 3028 (w), 3002 (w), 2967 (m), 2930 (w), 
2865 (w), 1660 (m), 1628 (vs), 1081 (s), 1542 (s), 1507 (w), 1498 (w), 1471 (w), 1459 (w), 1436 
(w), 1418 (w), 1392 (m), 1359 (m), 1312 (m), 1279 (w), 1129 (m), 1091 (s), 1046 (m), 1029 
(w), 999 (w), 957 (w), 937 (w), 911 (w), 860 (vs), 827 (w), 809 (m), 782 (w), 776 (w), 762 (w), 
749 (m), 736 (s), 692 (vs), 664 (w) cm-1. 
 
7.3.10 Rh-complex of rac-tBuNH-Phe-NH bisphosphinite (Rh-meso-19c) 
 
Compound meso-19c (150.0 mg, 135.5 mmol, 1.00 equiv.) and [Rh(COD)2]BF4 (55.0 mg, 
136 mmol, 1.00 equiv.) were dissolved in DCM (1.5 ml, dry and degassed) and stirred overnight 
at room temperature. The solvent was removed in high vacuum and the residue was dissolved 
in DCM (2 ml, dry and degassed) and the complex precipitated with pentane (15 ml, dry and 
degassed). The solvent was removed via filter-tipped cannula and the procedure was repeated 
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three times. The obtained yellow powder was dried for 2 days and gave the catalyst complex in 
quantitative yield. 
 
31P-NMR (CDCl3, 162 MHz, CDCl3, 293 K)  126.8 (d, 1J(P,Rh) = 187.4 Hz), 127.9 (d, 
1J(P,Rh) = 187.4 Hz) ppm.  (CDCl3, 162 MHz, CDCl3, 293 K)  126.47 (dd, 1J(P,Rh) = 178.2, 
2J(P,P) = 19.8 Hz), 128.29 (dd, 1J(P,P) = 180.3, 2J(P,P) = 20.9 Hz) ppm. 
HR-MS (ESI+): m/z calcd. for C74H80N4O8P2Rh,  [MBF4]+: 1317.45009; found: 1317.45416. 
 
7.3.11 Seeding and hydrogenation experiments 
For catalysts 32, complex, substrate 20 and AcNH-(S)Phe- NHMe (S)-8 (5 eq.) were dissolved 
in dry and degassed CDCl3 to give a 3.2 mM catalyst solution. For the respective phospho-
ramidite complex, ligand 33, [Rh(COD)2]BF4 (1 eq.), substrate 20 and AcNH-(S)Phe- NHMe 
(S)-8 (5 eq.) were dissolved in dry and degassed THF-d8 to give a 3.2 mM catalyst solution. The 
yellow solution was subsequently transferred into a stainless steel reactor loaded with a standard 
NMR tube and a small stirring bar and cooled to -20°C in a cooling bath. After an equilibration 
time of 15 min, 95 bar hydrogen was applied. 
 
For ligands 19d and meso-19c, stock solutions (4.9 mM) in dry and degassed CDCl3 of the 
complex were prepared or a stock solution of the ligand was treated with [Rh(COD)2]BF4 from 
which 0.5 ml were added to a J. Young NMR tube that had been placed under an atmosphere of 
argon and charged with a chiral additive. The solution was left standing at room temperature for 
16 hours to complete re-equilibration and afterwards, substrate 12 (20 eq. to catalyst) was added. 
The resulting mixture was transferred into a nitrogen-filled stainless steel reactor and cooled in 
a bath of 2-propanol utilizing a cryostatic temperature regulator, if necessary. The reactor was 
pressurized with hydrogen gas (20 bar for the phosphine ligands, 50 bar for catalyst 32) to initiate 
the catalysis.  
 
The autoclave was reopened after one day and the solution was passed through a short pipet 
filled with silica (ca. 3 cm) using ethyl acetate as eluent. Evaporation gave the hydrogenation 
product as a yellow oil. Enantiomeric ratio was determined by chiral GC (compound 13: (6-
TBDMS-2,3-Ac)-β-CD, 25 m, i.d. 250 µm, film thickness 250 nm, prepared and coated in the 
Trapp group, 100 kPa helium, 130 °C, kR = 6.84, kS = 9.07,  = 1.33). Assignment of absolute 
configuration was accomplished by comparison of the elution order to known standards or liter-
ature values. All reactions showed full conversion. 
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7.4 Experimental data for chapter 4 
7.4.1 Allyl-protected 3,3’-methoxy-5,5’-bis(methyloxycarbonyl)-2,2’-biphenol (37)  
 
This compound was prepared according to a known procedure.[191] Diol 15 (8.00 g, 22.1 mmol, 
1.00 eq.) and potassium carbonate (30.5 g, 221 mmol, 10.0 eq.) were suspended in 2-butanone 
(250 ml). Allyl bromide (9.55 ml, 110 mmol, 5.00 eq.) was added and the mixture was refluxed 
for 24 hours. All volatiles were subsequently evaporated and the solid residue was heated to 70 
°C for one hour under vacuum to remove residual allyl bromide. Solids were then partitioned 
between ethyl acetate (200 ml) and water (200 ml), layers were separated and the aqueous layer 
was re-extracted with more ethyl acetate (twice with 100 ml each). Combined organic layers 
were washed with brine (100 ml), dried over sodium sulfate and evaporated to give a yellow oil, 
which crystallized into an off-white solid upon prolonged drying in high vacuum (9.46 g, 22.1 
mmol, 97%). 
 
1H NMR (CDCl3, 598.76 MHz, 300 K): δ = 3.88 (s, 3H, H8), 3.93 (s, 6H, H9), 4.43-4.45 (m, 
2H, H10), 4.99-5.02 (m, 1H, H12), 5.05-5.09 (m, 1H, H12’), 5.71-5.79 (m, 1H, H11), 7.60 (d, 
1H, 4J(H,H) = 2.0 Hz, H6), 7.61 (d, 1H, 4J(H,H) = 2.0 Hz, H4) ppm. 
13C{1H} NMR (CDCl3, 150.57 MHz, 300 K): δ = 52.2 (C8), 56.2 (C9), 74.1 (C10), 113.0 (C4), 
117.5 (C12), 125.2 (C1), 125.3 (C6), 132.3 (C5), 134.0 (C11), 150.1 (C2), 152.6 (C3), 166.8 
(C7) ppm. 
HRMS (ESI): m/z calcd. for C24H30N1O8 [M+NH4]+: 460.19659; found: 460.19712. 
FTIR: ṽ = 761 (s), 981 (s), 1042 (s), 1173 (s), 1222 (s), 1286 (s), 1714 (s), 2845 (w), 2870 (w), 
2951 (m), 3015 (w), 3090 (w) cm-1. 
 
7.4.2 Allyl-protected dicarboxylic acid (38)  
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Diester 37 (9.40g, 21.2 mmol, 1.00 eq.) and sodium hydroxide (8.50 g, 212 mmol, 10.0 eq.) 
were dissolved in a mixture of water (110 ml) and THF (110 ml) and the biphasic system was 
refluxed under vigorous stirring for 14 hours. For work-up, THF was evaporated and the aqueous 
orange solution was acidified with conc. HCl solution (6 M) until pH 1 was reached and a thick, 
white precipitate formed. The solids were filtered off and washed with more water to neutrality. 
Freeze-drying afforded product 38 as a white powder (8.80 g, 21.2 mmol, 99%). 
 
1H NMR (CDCl3, 800.34 MHz, 300 K): δ = 3.90 (s, 3H, H9), 4.37-4.38 (m, 2H, H10), 4.99-5.01 
(m, 1H, H12), 5.04-5.06 (m, 1H, H12’), 5.68-5.73 (m, 1H, H11), 7.41 (d, 1H, 4J(H,H) = 2.0 Hz, 
H6), 7.57 (d, 1H, 4J(H,H) = 2.0 Hz, H4), 12.91 (bs, 1H, H8) ppm. 
13C{1H} NMR (CDCl3, 201.24 MHz, 300 K): δ = 55.9 (C9), 73.2 (C10), 112.8 (C4), 117.1 
(C12), 124.3 (C6), 125.7 (C5), 131.5 (C1), 134.1 (C11), 149.0 (C2), 152.1 (C3), 166.8 (C7) 
ppm. 
HRMS (ESI): m/z calcd. for C22H26NO8 [M+NH4]+: 432.16529; found: 432.16564. 
FTIR: ṽ = 759 (s), 980 (s), 1040 (s), 1179 (s), 1218 (s), 1285 (s), 1404 (s), 1577 (s), 1677 (s), 
2519 (bm), 2837 (bm), 2970 (bm), 3063 (w) cm-1. 
 
7.4.3 Allyl-protected dicarboxylic acid chloride (38i)  
 
Dicarboxylic acid 38 (4.00 g, 9.65 mmol, 1.00 eq.) was placed in a dried Schlenk flask with 
reflux condenser and overpressure ventilation and thionyl chloride (30 ml) was added. The mix-
ture was refluxed for seven hours and turned unto a clear, brown solution within minutes. Sub-
sequently, thionyl chloride was removed in vacuo, residual solids were suspended in dry toluene 
(15 ml) and all volatiles were removed again. The last two steps were repeated another two times 
and after drying, the product was obtained as a grey solid (4.36 g, 9.65 mmol, 99%). 
 
1H NMR (CDCl3, 598.76 MHz, 300 K): δ = 3.96 (s, 3H, H9), 4.50-4.54 (m, 2H, H9), 4.05-5.12 
(m, 2H, H11 and H11’) 5.73-5.79 (m, 1H, H10), 7.64 (d, 1H, 4J(H,H) = 2.2 Hz, H6), 7.73 (d, 
1H, 4J(H,H) = 2.2 Hz, H4) ppm. 
13C{1H} NMR (CDCl3, 150.57 MHz, 300 K): δ = 56.3 (C8), 74.4 (C9), 114.2 (C6), 118.2 (C11), 
128.0 (C1), 128.1 (C4), 131.9 (C5), 133.5 (C10), 152.2 (C2), 152.8 (C3), 167.6 (C7) ppm. 
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7.4.4 Allyl–protected tBuO-(S)Phe-NH biphenol (39a)  
 
Allyl-protected acid chloride 38i (800 mg, 4.43 mmol, 2.50 eq.) was dissolved in dry DCM (4 
ml). In a separate flask, phenylalanine tert-butyl ester hydrochloride (1.14 g, 4.43 mmol, 2.50 
eq.) was mixed with DIPEA (1.54 ml, 8.86 mmol, 5.00 eq.) in dry DCM (10 ml) to give a clear 
solution. Both mixtures were cooled in an ice bath and the acid chloride was subsequently added 
dropwise to the selector solution. The resulting orange solution was slowly warmed to room 
temperature and stirring was continued for 18 hours. For work-up, the mixture was diluted with 
ethyl acetate (120 ml) and subsequently washed with HCl solution (2M, 3 x 120 ml), saturated 
bicarbonate solution (2 x 120 ml) and brine (120 ml), dried over sodium sulfate and evaporated 
to yield the product as a brown powder (1.33 g, 1.62 mmol, 91%). 
 
1H NMR (CDCl3, 598.47 MHz, 300 K): δ = 1.39 (s, 9H, H17), 3.14-3.26 (m, 2H, H10 and H10’), 
3.89 (s, 3H, H18), 4.35-4.36 (m, 2H, H19), 4.96-5.05 (m, 2H, H21 and H21’), 5.05 (s, 1H, H9), 
5.70-5.77 (m, 1H, H20), 7.16-7.28 (m, 6H, H6 and H12 and H13 and H14), 7.43 (s, 1H, H4) 
ppm. The NH proton was not observed. 
13C{1H} NMR (CDCl3, 150.57 MHz, 300 K): δ = 28.1 (C17), 28.3 (C10), 54.5 (C9), 56.1 (C18), 
74.1 (C19), 82.3 (C16), 111.7 (C4), 117.5 (C21), 121.2 (C6), 127.0 (14), 128.3 (C13), 128.8 
(C5), 129.5 (C12), 132.1 (C1), 134.0 (C20), 136.7 (C11), 148.7 (C2), 152.9 (C3), 166.2 (C7), 
171.6 (C15) ppm. 
HRMS (ESI): m/z calcd. for C48H57N2O10 [M+H]+: 821.4008; found: 821.40258. 
FTIR: ṽ = 698 (s), 982 (s), 1151 (s), 1219 (s), 1366 (s), 1537 (s), 1639 (s), 1706 (s), 2867 (w), 
2935 (w), 2978 (w), 3029 (w), 3062 (w), 3344 (bm) cm-1. 
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7.4.5 tBuO-(S)Phe-NH biphenol (40a)  
 
The deprotection was done by a known procedure, which was slightly modified.[235] To remove 
the allyl groups, substrate 39a (750 mg, 914 mmol, 1.00 eq.), palladium acetate (10.2 mg, 45.7 
µmol, 0.05 eq.) and (4-dimethylaminophenyl)diphenylphosphine (140 mg, 457 µmol, 0.50 eq.) 
were dissolved in dry ethyl acetate (18 ml) and the suspension was stirred for 15 min. The re-
sulting solution was treated with formic acid (0.20 ml, 5.30 mmol, 5.80 eq.) and the orange 
mixture was subsequently refluxed. It quickly turned brown and gas evolved. After two hours, 
the mixture was cooled to room temperature and diluted with ethyl acetate (80 ml). The organic 
layer was washed with HCl solution (2M, 4 x 100 ml), saturated bicarbonate solution (3 x 100 
ml) and brine (1 x 100 ml), dried over sodium sulfate and evaporated. Purification by column 
chromatography (silica, n-pentane:ethyl acetate 1:2, Rf = 0.4). Appropriate fractions were evap-
orated and the residue precipitated from ethyl acetate:n-pentane to yield the desired diol 40a as 
an off-white powder (481 mg, 649 µmol, 71%). 
 
 1H NMR (CDCl3, 598.74 MHz, 300 K): δ = 1.39 (s, 9H, H9), 3.13-3.23 (m, 2H, H10 and H10’), 
3.90 (s, 3H, H18), 5.03-5.04 (m, 1H, H9), 6.20 (bs, 1H, H19), 7.17-7.23 (m, 5H, H12 and H13 
and H14), 7.27 (s, 1H, H8), 7.30 (s, 1H, H6), 7.39 (s, 1H, H4) ppm. 
13C{1H} NMR (CDCl3, 150.57 MHz, 300 K): δ = 55.9 (C9), 73.2 (C10), 112.8 (C4), 117.1 
(C12), 124.3 (C6), 125.7 (C5), 131.5 (C1), 134.1 (C11), 149.0 (C2), 152.1 (C3), 166.8 (C7) 
ppm. 
HRMS (ESI): m/z calcd. for C42H49N2O10 [M+H]+: 741.3382; found: 741.33910. 
FTIR: ṽ = 698 (s), 1042 (s), 1086 (s), 1150 (s), 1220 (s), 1366 (s), 1487 (s), 1593 (s), 1636 (s), 
1710 (s), 2933 (m), 2977 (m), 3029 (w), 3330 (bm), 3508 (bw) cm-1. 
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7.4.6  tBuO-(S)Phe-NH bisphosphinite (41a)  
 
Selector-modified diol 40a (350 mg, 472 µmol, 1.00 eq.) and DABCO (212 mg, 1.89 mmol, 
4.00 eq.) were placed in a dried Schlenk flask and dissolved in dry and degassed DCM (10 ml). 
The solution was cooled in an ice bath and PPh2Cl (326 µl, 1.89 mmol, 4.00 eq.) was added. 
After 15 minutes, the ice bath was removed and stirring was continued at room temperature for 
another two hours. For work-up, all volatiles were removed and the off-white residue was sus-
pended in dry, degassed and stabilized THF (5 ml). The suspension was filtered through an inert 
pad of neutral alumina and the product was eluated with more THF. Combined fractions were 
evaporated to give a white foam. Re-precipitation from DCM:n-pentane (4x 1:10 ml) gave the 
desired phosphinite 41a as a white powder (105 mg, 94.8 mmol, 20%). 
 
The compound exists as two interconverting rotamers. The minor isomer (A, Sax) shows sharp 
NMR signals in 31P, 1H and 13C NMR spectra.  For the major rotamer (B, Rax), significant line 
broadening was detected in 31P and 1H NMR spectra and even with concentrated samples, almost 
no peaks could be detected in the 13C{1H} NMR spectrum. 
1H NMR (THF-d8, 400.22 MHz, 300 K): δ = 1.37 (s, H17, B), 1.39 (s, H17, A), 3.04-3.09 (m, 
H10, A), 3.12 (bs, H10, B), 3.14-3.19 (m, H10’, A), 3.27 (bs, H10’, B), 3.53 (bs, H18’, B), 3.59 
(s, H18, A), 4.75-4.81 (m, H9, A) 4.86 (bs, H9, B), 6.91 (bs, HAr B), 7.04-7.26 (m, HAr, A and 
B), 7.12 (m, H6, A), 7.28-7.35 (m, HAr, A), 7.35 (d, 4J(H,H) = 1.9 Hz, H4, A), 7.40 (d, 3J(H,H) 
= 7.7 Hz, H8, A), 7.48 (bs, HAr, B), 8.47 (bs, H8, B) ppm. 
13C{1H} NMR (THF-d8, 100.54 MHz, 300 K): δ = 27.2 (C17, A), 37.5 (C10), 54.4 (C9, A), 54.7 
(C18, A), 54.9 (C18, B), 80.5 (C16, A), 111.8 (C4, A), 121.1 (C6, A), 120.8 (C6, B), 126.3 (CAr), 
126.2 (CAr), 127.3 (CAr), 127.3 (CAr), 127.4 (CAr), 127.5 (CAr), 127.5 (CAr), 127.5 (CAr), 127.9 
(CAr), 129.1 (C12, A), 129.2 (CAr), 129.3 (CAr), 129.5 (CAr), 129.5 (C13, A), 129.7 (CAr), 130.3 
(CAr), 130.5 (CAr), 130.6 (CAr), 130.7 (CAr), 131.3 (C1, A), 137.7 (C11, A), 138.0 (CArq, B), 142.5 
(CArq, B), 142.7 (CArq, B), 143.0 (CArq, A), 143.1 (CArq, A), 147.5 (C2, A), 151.2 (C3, A), 165.0 
(C7, A), 165.1 (C7, B), 170.8 (C14, A) ppm. 
31P{1H} NMR (THF-d8, 161.85 MHz, 300K): δ = 118.4 (bs, 1P, B), 121.1 (s, 1P, A), 121.1 (bs, 
1P, B) ppm. 
HRMS (ESI): m/z calcd. for C66H67N2O10P2 [M+H]+: 1109.4271; found: 1109.42863. 
FTIR: ṽ = 694 (s), 863 (m), 1094 (s), 1152 (s), 1367 (s), 1476 (s), 1642 (s), 1707 (s), 2859 (w), 
1933 (w), 2977 (w), 3054 (w), 3349 (bm) cm-1. 
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7.4.7 Rh complex of tBuO-(S)Phe-NH bisphosphinite (42a)  
 
Bisphosphinite 41a (53 mg, 47.8 µmol, 1.00 eq.) and [Rh(COD)2]BF4 (19.4 mg, 47.8 µmol, 
1.00 eq.) were placed in a dried Schlenk flask and dissolved in dry and degassed DCM (3.5 ml). 
The clear orange solution was stirred for two hours at room temperature and then concentrated 
to 1.0 ml. Addition of dry and degassed pentane (10 ml) gave an orange precipitate. The super-
natant solution was removed using a filter-tipped cannula and re-precipitation was repeated an-
other two times. The solids were finally dried in high vacuum to give the desired Rh complex as 
a yellow powder (61.0 mg, 43.4 µmol, 91%). 
 
The compound exists as two interconverting rotamers.  
31P{1H} NMR (CDCl3, 161.98 MHz, 300K): δ = 127.91 (d, 1J(P,Rh) = 179.9 Hz, Sax), 128.02 
(d, 1J(P,Rh) = 181.3 Hz, Rax) ppm. 
EA (CHNS): calcd. for C74H78N2O10P2RhBF4: C: 63.17, H: 5.59, N: 1.99; found: C: 61.24, H: 
5.48, N: 1.93. 
HRMS (ESI): m/z calcd. for C74H78N2O10P2Rh [M-BF4]+: 1319.41813; found: 1319.41751. 
 
7.4.8 Allyl-protected tBuNH-(S)Phe-O biphenol (39b)  
 
Dicarboxylic acid 38 (1.00 g, 2.41 mmol, 1.00 eq.), amido alcohol S3 (2.14 g, 9.56 mmol, 4.00 
eq.) and dimethylaminopyridine (59.0 mg, 482 µmol, 0.20 eq.) were mixed in dry DCM (40 ml) 
and cooled in an ice bath. EDCI.HCl (1.16 g, 6.03 mmol, 2.50 eq.) was added and the yellow 
solution was left stirring to warm to room temperature overnight. After 18 hours, the mixture 
was diluted with ethyl acetate (200 ml) and subsequently washed with HCl solution (2 M, 3 x 
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180 ml), saturated bicarbonate solution (2 x 180 ml) and brine (180 ml), dried over sodium 
sulfate and evaporated. Purification by column chromatography (neutral alumina, diethyl 
ether:toluene 3:1, Rf = 0.6) yielded the product as a white solid (1.00 g, 1.22 mmol, 50%). 
 
1H NMR (CDCl3, 598.74 MHz, 300 K): δ = 1.24 (s, 9H, H17), 3.26-3.28 (m, 2H, H9), 3.92 (s, 
3H, H18), 4.42-4.43 (m, 2H, H19), 4.99-5.08 (m, 2H, H21 and H21’), 5.43-5.45 (m, 1H, H8), 
5.58 (s, 1H, H15), 5.71-5.77 (m, 1H, H20), 7.19-7.22 (m, 1H, H13), 7.22-7.29 (m, 4H, H11 and 
H12), 7.53 (d, 1H, 4J(H,H) = 2.0 Hz, H4), 7.55 (d, 1H, 4J(H,H) = 2.0 Hz, H6) ppm. 
13C{1H} NMR (CDCl3, 150.57 MHz, 300 K): δ = 28.7 (C17), 38.0 (C9), 51.3 (C16), 56.2 (C18), 
74.2 (C19), 75.3 (C8), 113.2 (C4), 117.7 (C21), 124.3 (C5), 125.4 (C6), 127.1 (C13), 128.5 
(C12), 130.0 (C11), 132.3 (C1), 133.9 (C20), 136.2 (C10), 150.6 (C2), 152.7 (C3), 164.9 (C7), 
168.0 (C14) ppm. 
HRMS (ESI): m/z calcd. for C48H60N3O10 [M+NH4]+: 838.4273; found: 838.42788. 
FTIR: ṽ = 696 (s), 979 (s), 1169 (s), 1217 (s), 1657 (s), 1711 (s), 2867 (w), 2966 (w), 3029 (w), 
3088 (w), 3291 (bm) cm-1. 
 
7.4.9 tBuNH-(S)Phe-O biphenol (40b)  
 
The deprotection was done by a known procedure, which was slightly modified.[235] To remove 
the allyl groups, substrate 39b (890 mg, 1.08 mmol, 1.00 eq.), palladium acetate (12.2 mg, 54.2 
µmol, 0.05 eq.) and (4-dimethylaminophenyl)diphenylphosphine (166 mg, 542 µmol, 0.50 eq.) 
were dissolved in dry ethyl acetate (18 ml) and the suspension was stirred for 15 min. The re-
sulting solution was treated with formic acid (0.24 ml, 6.29 mmol, 5.80 eq.) and the orange 
mixture was subsequently refluxed. It quickly lost its colour and gas evolved. After one hours, 
the mixture was cooled to room temperature and diluted with ethyl acetate (100 ml). The organic 
layer was washed with HCl solution (2 M, 4 x 100 ml), saturated bicarbonate solution (2 x 100 
ml) and brine (1 x 100 ml), dried over sodium sulfate and evaporated. The residue was precipi-
tated from ethyl acetate:n-pentane to yield the desired diol 40b as an off-white powder (745 mg, 
1.01 mmol , 93%). 
 
1H NMR (CDCl3, 598.47 MHz, 300 K): δ = 1.25 (s, 9H, H17), 3.27 (d, 2H, 3J(H,H) = 5.9 Hz, 
H9), 3.98 (s, 3H, H18), 5.46 (t, 1H, 3J(H,H) = 5.9 Hz, H8), 5.63 (s, 1H, H15), 6.39 (s, 1H, H19), 
7.19-7.21 (m, 1H, H13), 7.23-7.26 (m, 4H, H11 and H12), 7.49 (d, 1H, 4J(H,H) = 1.9 Hz, H4), 
7.71 (d, 1H, 4J(H,H) = 1.9 Hz, H6) ppm. 
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13C{1H} NMR (CDCl3, 150.57 MHz, 300 K): δ = 28.7 (C17), 38.00 (C9), 51.4 (C16), 56.5 
(C18), 75.0 (C8), 111.2 (C4), 121.0 (C5), 122.8 (C1), 126.4 (C6), 127.0 (C13), 128.4 (C12/C13), 
130.0 (C12/C13), 136.3 (C10), 146.8 (C3), 148.0 (C2), 164.9 (C7), 168.2 (C14) ppm. 
HRMS (ESI): m/z calcd. for C42H52N3O10 [M+NH4]+: 758.3647; found: 758.36497. 
FTIR: ṽ = 699 (s), 740 (m), 1039 (m), 1208 (s), 1277 (s), 1454 (m), 1669 (s), 2868 (w), 2933 
(w), 2965 (m), 3027 (w), 3065 (w), 3317 (bm), 3407 (w) cm-1. 
 
7.4.10 tBuNH-(S)Phe-O bisphosphinite (41b)  
 
Selector-modified diol 40b (50.0 mg, 67.5 µmol, 1.00 eq.) was dissolved in dry, degassed and 
stabilized THF (2 ml) and triethylamine (23.5 µl, 168 µmol, 2.50 eq.) was added. The mixture 
was cooled in an ice bath and chlorodiphenylphosphine (24.2 µl, 142 µmol, 2.10 eq.) was added. 
After two hours, the mixture was filtered through a filter-tipped cannula and residual solids 
rinsed with more THF (2 x 2 ml). Combined organic washings were evaporated and the resulting 
white crude product was washed with n-pentane (5 x 2 ml) to give the product as a white solid 
(52.0 mg, 46.9 µmol, 69%). Traces of Ph2P(O)PPh2 (side product) still remained and could not 
be removed without significant loss of product. 
 
For some atoms an additional signal splitting was observed. Those signals are marked X and X’. 
1H NMR (THF-d8, 399.78 MHz, 300 K): δ = 1.25 (s, 9H, H13), 3.17 (dd, 2H, 2J(H,H) = 14.8 
Hz, 3J(H,H) =, 6.6 Hz, H9), 3.63 (s, 3H, H18), 5.20 (q, 3J(H,H) = 6.3 Hz, H8), 6.53 (s, 1H, H11), 
7.03-7.32 (m, 15H, Har), 7.30 (s, 1H, H6), 7.38 (d, 1H, 4J(H,H) = 2.0 Hz, H4) ppm. 
13C{1H} NMR (THF-d8, 100.54 MHz, 300 K): δ = 27.8 (C13), 37.8 (C9/C9’), 50.3 (C12), 54.9 
(C14), 75.1 (C8), 75.2 (C8’), 112.9 (C4), 124.4 (C6), 124.7 (3J(C,P) = 4.6 Hz, C1), 126.3 (J(C,P) 
= 11.4 Hz, Cartert), 127.4 (J(C,P) = 7.4 Hz, Cartert), 127.6 (J(C,P) = 8.3 Hz, Cartert), 127.9 (J(C,P) = 
4.6 Hz, Cartert), 128.3 (J(C,P) = 7.4 Hz, Cartert), 128.8 (J(C,P) = 5.5 Hz, Cartert), 129.4 (C5), 129.5 
(J(C,P) = 5.8 Hz, Cartert), 129.7 (J(C,P) = 11.5 Hz, Cartert), 130.3 (J(C,P) = 12.9 Hz, Cartert), 130.5 
(J(C,P) = 12.9 Hz, Cartert), 131.3 (C5), 137.0 ((J(C,P) = 11.4 Hz, Carq/ Carq’), 142.5 (J(C,P) = 17.8 
Hz, Carq), 142.7 (J(C,P) = 16.6 Hz, Carq), 149.0 (J(C,P) = 7.3 Hz, C2/C2’), 151.1 (J(C,P) = 7.4 
Hz, C3), 164.2 (C7), 167.5 (C10), 167.6 (C10’)  ppm. 
31P{1H} NMR (THF-d8, 161.85 MHz, 300 K): δ = 122.4 (s, 1P), 122.5 (s, 1P) ppm. 
HRMS (ESI): m/z calcd. for C66H67N2O10P2 [M+H]+: 1109.42655; found: 1109.42479. 
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FTIR: ṽ = 692 (s), 1166 (s), 1211 (m), 1453 (m), 1657 (s), 1723 (m), 2867 (w), 2930 (m), 2965 
(m), 3002 (w), 3056 (w), 3291 (bm) cm-1. 
 
7.4.11 Rh complex of tBuNH-(S)Phe-O bisphosphinite (42b)  
 
Bisphosphinite 41b (33.0 mg, 29.8 µmol, 1.00 eq.) and [Rh(COD)2]BF4 (9.10 mg, 22.3 µmol, 
1.00 eq.) were placed in a dried Schlenk flask and dissolved in dry and degassed DCM (2.0 ml). 
The clear orange solution was stirred for two hours at room temperature and then concentrated 
to 0.5 ml. Addition of dry and degassed n-pentane (5.0 ml) gave an orange precipitate. The 
supernatant solution was removed using a filter-tipped cannula and re-precipitation was repeated 
another two times. The solids were finally dried in high vacuum to give the desired Rh complex 
as a yellow powder (23.3 mg, 16.6 µmol, 74%). 
 
The compound exists as two rotamers A and B.  
31P{1H} NMR (CDCl3, 161.98 MHz, 300K): δ = 129.00 (d, 1J(P,Rh) = 179.9 Hz, A), 129.19 (d, 
1J(P,Rh) = 179.8 Hz, B) ppm. 
HRMS (ESI): m/z calcd. for C68H69N3O10P2Rh [M-COD-BF4+CH3CN]+: 1252.35077; found: 
1252.34933. 
 
7.4.12 tBuO-(S)Phe-NH phosphoramidite (44)  
 
Selector-modified diol 40a (100 mg, 135 µmol, 1.00 eq.) was dissolved in dry, degassed and 
stabilized THF (2 ml) and triethylamine (54.6 µl, 391 µmol, 2.90 eq.) was added. The mixture 
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was cooled in an ice bath and diethylaminophosphoramidous dichloride (22.5 µl, 155 µmol, 1.15 
eq.) was added dropwise. The mixture was warmed to room temperature and stirred for 18 hours. 
For work-up, the mixture was filtered through a filter-tipped cannula and residual solids were 
rinsed with more THF (2 x 2 ml). Combined organic washings were evaporated and the crude 
product was washed with n-pentane (3 x3 ml) to give complex 44 as a white solid (87.0 mg, 103 
µmol, 77%). 
 
For some atoms an additional signal splitting was observed. This is caused by the non-equiva-
lence of the two halves in the BIPOL-phosphoramidite, which has been previously observed for 
other chiral phosphoramidites.[233,234] Those signals are marked X and X’.  
1H NMR (THF-d8, 400.22 MHz, 300 K): δ = 1.05 (t, 3H, 3J(H,H) = 7.0 Hz, H20), 1.40 (s, 9H, 
H17), 3.05 (dd, 2H, 3J(P,H) = 10.8 Hz, 3J(H,H) = 7.0 Hz, H19), 3.10 (dd, 1H, 2J(H,H) = 13.8 
Hz,  3J(H,H) = 8.2 Hz, H10), 3.18 (dd, 1H, 2J(H,H) = 13.8 Hz,  3J(H,H) = 6.5 Hz, H10’), 3.87 (s, 
3H, H18), 4.78-4.84 (m, 1H, H9), 7.14-7.18 (m, 1H, H14), 7.23-7.29 (m, 4H, H12 and H13), 
7.48-7.49 (m, 1H, H4/H4’), 7.58-7.59 (m, 1H, H6), 7.81-7.84 (m, 1H, H8/H8’) ppm. 
13C{1H} NMR (THF-d8, 100.65 MHz, 300 K): δ = 14.7 (C20), 28.1 (C17), 38.6 (C10), 38.8 
(C16), 55.7 (C9), 56.2 (C18), 81.5 (C16), 111.9 (d, 4J(P,C) = 9.6 Hz, C4), 121.0 (d, 4J(P,C) = 
12.4 Hz, C6), 127.3 (C14), 129.0 (C13), 130.2 (C12), 131.8 (C5), 132.0 (m, C1/C1’), 138.6 
(C11), 144.3 (m, C2/C2’) 152.9 (C3), 166.6 (C7), 171.8 (C15) ppm. 
31P{1H} NMR (THF-d8, 162.00 MHz, 300 K): δ = 150.9 (quint, 3J(P,H) = 10.8 Hz) ppm. 
HRMS (ESI): m/z calcd. for C46H57N3O10P [M+H]+: 842.37761; found: 842.37727. 
FTIR: ṽ = 697 (s), 740 (s), 843 (s), 1022 (s), 1089 (s), 1151 (s), 1366 (s), 1456 (s), 1533 (m), 
1585 (m), 1640 (m), 1733 (m), 2868 (w), 2933 (w), 2974 (m), 3028 (w), 3064 (w), 3088 (w), 
3330 (bm) cm-1. 
 
7.4.13 Rh complex of tBuO-(S)Phe-NH phosphoramidite (45)  
 
Phosphoramidite 44 (150 mg, 178 µmol, 1.00 eq.) and [Rh(COD)2]BF4 (36.2 mg, 89.1 µmol, 
0.50 eq.) were dissolved in dry and degassed DCM (5 ml). The orange solution was stirred for 
18 hours and subsequently concentrated to 0.5 ml. Addition of n-pentane (4 ml) gave the com-
plex as a yellow precipitated. The supernatant solution was removed using a filter-tipped cannula 
and the product was re-precipitated another two times. Subsequent drying gave the product as a 
yellow powder. (141 mg, 71.1 µmol, 80%). 
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Due to high molecular dynamics, very broad signals where observed in 1H, 13C{1H} NMR spec-
tra which made peak assignment impossible. 31P{1H} NMR spectrum shows various signals 
which is in line with the nature of previously investigated Rh complexes of similar nature.[40] 
31P{1H} NMR (CDCl3, 162.00 MHz, 300 K): δ = 137.6, 138.2, 138.6. 139.3, 140.6, 142.3, 
143.7 ppm. 
  
HRMS (ESI): m/z calcd. for C100H124N6O20P2Rh [M-BF4-]+: 1894.74287; found: 1894.74635. 
EA (CHNS): calcd. for C100H124N6O20P2RhBF4: C: 60.61, H: 6.31, N: 4.24; found: C: 58.42, H: 
6.13, N: 4.23. 
FTIR: ṽ = 697 (s), 879 (m), 1022 (s), 1153 (s), 1367 (s), 1456 (m), 1527 (m), 1663 (m), 1728 
(m), 2872 (w), 2933 (w), 2975 (w), 3314 (bw) cm-1. 
 
7.4.14 (Z)-4-benzylidene-2-phenyloxazol-5(4H)-one (46) 
 
Hippuric acid (25 g, 139 mmol, 1 eq.), benzaldehyde (21.9 g, 2.07 mmol, 1.48 eq.), sodium 
acetate (8.47 g, 103 mmol, 0.74 eq.) and acetic anhydride (33.0 ml, 349 mmol, 2.50 eq.) were 
mixed and heated to 140 °C for two hours and yellow solid formed. The product was filtered 
off, washed with water (3 x 75 ml) and recrystallized from methanol to yield the product as a 
yellow solid (21.5 g, 86.3 mmol, 62 %). 
 
1H NMR (CDCl3, 400.22 MHz, 300 K): δ = 7.25 (s, 1H, H4), 7.46-7.55 (m, 5H, H7 and H8 and 
H11), 7.60-7.64 (m, 1H, H12), 8.18-8.22 (m, 4H, H6 and H10) ppm. 
13C{1H} NMR (CDCl3, 100.65 MHz, 300 K): δ = 125.7 (C2), 128.5 (C10), 129.0 (C11/C7), 
129.1 (C11/C7), 131.4 (C8), 131.9 (C4), 132.6 (C6), 133.4 (C5), 133.5 (C12), 133.6 (C9), 163.6 
(C1), 167.8 (C3) ppm. 
HRMS (ESI): m/z calcd. for C16H12NO2 [M+H]+: 250.08626; found: 250.08642. 
FTIR: ṽ = 684 (s), 766 (s), 983 (s), 1294 (s), 1448 (s), 1651 (s), 1791 (s), 3028 (w), 3242 (w) 
cm-1. 
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7.4.15 PhCO-Phe-NHtBu (47a) 
  
Azlactone 46 (800 mg, 3.21 mmol, 1.00 eq.) was dissolved in chloroform (20 ml). The clear 
solution was cooled in an ice bath and treated with tert-butylamine (3.37 ml, 32.1 mmol, 10.0 
eq.). The clear solution was subsequently stirred at 40 °C for 72 hours. For work-up, all volatiles 
were removed in vacuo and residual off-white solids where recrystallized from acetone:hexane 
to give the product as a white solid (702 mg, 2.18 mmol, 68%). 
 
1H NMR (CDCl3, 400.22 MHz, 300 K): δ = 1.30 (s, 9H, H16), 6.17 (s, 1H, H14), 6.73 (s, 1H, 
H8), 7.13-7.22 (m, 3H, H11 and H12), 7.28-7.34 (m, 4H, H2 and H10), 7.40-7.44 (m, 1H, H1), 
7.74 (d, 2H, 3J(H,H) = 7.3 Hz, H3), 8.08 (s, 1H, H6) ppm. 
13C{1H} NMR (CDCl3, 100.65 MHz, 300 K): δ = 28.7 (C16), 51.8 (C15), 125.3 (C8), 127.8 
(C3), 128.7 (C12), 128.8 (C2/C11), 128.9 (C2/C11), 129.1 (C10), 131.1 (C7), 132.3 (C1), 133.2 
(C4), 134.1 (C9), 165.5 (C13), 166.3 (C5) ppm. 
HRMS (ESI): m/z calcd. for C20H22N2O2 [M]+: 322.16813; found: 322.1678. 
FTIR: ṽ = 688 (s), 1223 (s), 1281 (s), 1475 (s), 1627 (s), 1642 (s), 2871 (w), 2826 (w), 2967 
(m), 3029 (w), 3059 (m), 3238 (bm) cm-1. 
 
7.4.16 PhCO-Phe-NHiPr (47b) 
  
Azlactone 46 (200 mg, 0.80 mmol, 1.00 eq.) was dissolved in chloroform (5 ml). The clear 
solution was cooled in an ice bath and treated with isopropyl amine (245 µl, 4.01 mmol, 5.00 
eq.). White solids precipitated soon after. Stirring was continued at room temperature for 72 
hours. All volatiles were subsequently removed and residual solids were dissolved in acetone 
and precipitated with n-pentane to give the product as a white powder (171 mg, 556 µmol, 69%). 
 
1H NMR (CDCl3, 598.61 MHz, 300 K): δ = 1.22 (d, 6H, 3J(H,H) = 6.6 Hz, H16, H16’), 4.16 
(ds, 1H, 3J(H,H) = 6.7Hz, 3J(H,H) = 6.9 Hz, H15), 6.20 (d, 1H, 3J(H,H) = 6.8 Hz, H14), 6.97 (s, 
1H, H8), 7.26-7.29 (m, 1H, H12), 7.31-7.34 (m, 2H, H11), 7.40-7.41 (m, 2H, H10), 7.44-7.46 
(m, 2H, H2), 7.53-7.56 (m, 1H, H1), 7.84-7.85 (m, 2H, H3), 7.92 (s, 1H, H6) ppm. 
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13C{1H} NMR (CDCl3, 150.54 MHz, 300 K): δ = 22.8 (C16), 42.3 (C15), 126.2 (C8), 127.7 
(C3), 128.9 (C2), 128.9 (C12), 129.0 (C11), 129.2 (C10), 130.2 C7), 132.5 (C1), 133.2 (C4), 
134.0 (C9), 165.1 (C13), 166.3 (C5) ppm. 
HRMS (ESI): m/z calcd. for C19H19N2O2 [M-H]-: 307.14520; found: 307.14531. 
FTIR: ṽ = 687.5 (s), 902 (m), 1277 (s), 1479 (s), 1512 (s), 1621 (s), 2873 (w), 2935 (w), 2969 
(m), 3056 (m), 3214 (bs) cm-1. 
 
7.4.17 PhCO-Phe-NHEt (47c) 
  
Azlactone 46 (200 mg, 0.80 mmol, 1.00 eq.) was dissolved in chloroform (5 ml). The clear 
solution was cooled in an ice bath and treated with ethylamine (2 M in ethanol, 2.00 ml, 4.00 
mmol, 5.00 eq.) and white solids precipitated soon after. Stirring was continued at room tem-
perature for 16 hours. All volatiles were subsequently removed and residual solids were washed 
with ethyl acetate (10 ml) to give the product as a white powder (172 mg, 583 µmol, 73%). 
 
 1H NMR (CDCl3, 399.87 MHz, 300 K): δ = 1.18 (t, 3H, 3J(H,H) = 7.2 Hz, H16), 3.37 (dt, 1H, 
3J(H,H) = 13.1 Hz, 3J(H,H) = 7.1 Hz, H15), 6.50 (s, 1H, H14), 6.99 (s, 1H, H8), 7.28-7.33 (m, 
3H, H11 and H12), 7.38-7.43 (m, 2H, H10), 7.44-7.47 (m, 2H, H2), 7.54 (t, 1H, 3J(H,H) = 7.5 
Hz, H1), 7.85 (d, 2H, 3J(H,H) = 8.3 Hz, H3), 8.05 (s, 1H, H6) ppm. 
13C{1H} NMR (CDCl3, 100.54 MHz, 300 K): δ = 14.8 (C16), 35.1 (C15), 126.9 (C8), 127.7 
(C3), 128.9 (C2), 128.9 (C11), 129.0 (C12), 129.2 (C10), 130.1 (C7), 132.4 (C1), 133.1 (C4), 
134.0 (C9), 166.0 (C13), 166.5 (C5) ppm. 
HRMS (ESI): m/z calcd. for C18H17N2O2 [M-H]-: 293.12955; found: 293.12964. 
FTIR: ṽ = 686 (s), 903 (m), 1274 (s), 1482 (s), 1482 (s), 1520 (s), 1630 (s), 2870 (w), 2932 (m), 
2971 (m), 3073 (m), 3205 (bs), 3249 (bm) cm-1. 
 
7.4.18 Seeding experiments with bisphosphinite ligand 41a 
A solution of ligand 41a in dry and degassed THF-d8 was prepared and appropriate amounts of 
additive were added. For spectrum e), an aliquot of the final solution was taken and diluted. 
The pure ligand shows similar properties to previously investigated bis(diamido)-substituted 
bisphosphine ligand. Two sets of signals, one sharp singlet and two broad singlets of equal in-
tensity were found. In accordance with results from previous studies on the bisphosphine, it was 
concluded that they represent a monomeric ligand rotamer (Sax)-41a (sharp singlet) and a dimer-
ized rotamer (Rax)-41a (two broad singlets). Addition of the additive substantially diminishes 
the Sax rotamer, while the Rax rotamer accumulates (newly formed singlet signal). 
7  Experimental section 
____________________________________________________________________________ 
- 145 - 
 
Figure 7-26: Interactions studies of ligand 41a with different equivalents of diamide (S)-25. 
7.4.19 Seeding experiments with bisphosphinite complex 42a 
A solution of complex 42a (4.3 mM) in dry and degassed CDCl3 was prepared. For each seeding 
experiment, one additive was added in excess (5 eq. for compound 24, 10 eq. for all other com-
pounds) and clear solutions formed for all mixtures, but those containing compounds (S)-9 and 
(S)-35, where the diamide only partly dissolved. Re-equilibration was monitored by 31P NMR 
spectroscopy. All mixtures were found to reach their new equilibrium in less than 20 hours. 
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Figure 7-27: Equilibration of complex 42a in presence of various amino acid-derived additives. 
  
(S)-43 
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7.4.20 Seeding experiments with bisphosphinite complex 42b 
A solution of complex 42b (4.3 mM) in dry and degassed CDCl3 was prepared. For each seeding 
experiment, one additive was added in excess (5 eq. for compound 24, 10 eq. for the other com-
pounds) and clear solutions formed for all mixtures, except for compound (S)-9, where the dia-
mide only partly dissolved. Re-equilibration was monitored by 31P NMR spectroscopy and all 
spectra shown below depict fully equilibrated mixtures. No significant change for the distribu-
tion of ligand rotamer species could be detected with any of the employed additives. 
 
Figure 7-28: Equilibration of complex 42b in presence of various amino acid derivatives. 
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7.4.21 Seeding experiments with phosphoramidite complex 45 
A solution of complex 45 (4.3 mM) in dry and degassed CDCl3 was prepared. For each seeding 
experiment, the appropriate amount of additive was added and clear solutions formed. The NMR 
spectrum of the pure complex shows a variety of signals which is in accordance with previously 
reported complexes of similar nature and potentially arises due to fast interconversion of differ-
ent rotamers. See SI of this reference for further information.[40]  
Addition of the S enantiomer of the chiral additive shows a distinct change of the spectrum, 
where the multitude of small signals is replaced by two potential doublets of different intensity. 
This also happens when a racemic mixture of the additive is employed, which proves that enan-
tioselective interactions occur for this ligand, as well. 
 
Figure 7-29: Interaction studies between phosphoramidite complex 45 and additives (S)- and (R)-25. 
 
7.4.22 Hydrogenation experiments 
For hydrogenation experiments with bisphosphinite catalysts 42a and 42b, methyl 2-acetam-
idoacrylate 12 (6.10 mg, 42.6 µmol, 20 eq. with respect to catalyst) was added to the equilibrated 
mixtures from the seeding experiments.  
For hydrogenation experiments with phosphoramidite catalyst 45, a J.Young NMR tube was 
charged with the appropriate amount of substrate and additive. The catalyst was added from a 
stock solution.  
The prepared solution was transferred into a nitrogen-filled stainless steel reactor loaded with a 
standard NMR tube and a small stirring bar. The reactor was pressurized with hydrogen gas (50 
bar in case of bisphosphinite complexes, 5 bar in case of phosphoramidite complexes, unless 
noted otherwise) to initiate the catalysis.  
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The autoclave was reopened after one day (two days in case of low catalyst concentrations). The 
solution was passed through a short pipet filled with silica (ca. 3 cm) using ethyl acetate as 
eluent. Evaporation gave the hydrogenation product as a yellow oil. Enantiomeric ratio was de-
termined by chiral GC (compound 12: (6-TBDMS-2,3-Ac)-β-CD, 25 m, i.d. 250 µm, film thick-
ness 250 nm, prepared and coated in the Trapp group, 100 kPa helium, 130 °C, FID detection, 
kR = 6.84, kS = 9.07,  = 1.33) or chiral HPLC (compound 47a: Chiralpak IE, hexane:isopropa-
nol: 80:20, 1.0 ml/min, 20 °C, 254 nm, tS = 5.2 min and tR = 5.8 min; compound 47b: Chiralpak 
IE, hexane:isopropanol: 80:20, 0.5 ml/min, 20 °C, 254 nm, tS = 6.6 min and tR = 7.2 min; 47c: 
Chiralpak IC, hexane:isopropanol: 80:20, 1.0 ml/min, 10 °C, 254 nm,  tS = 7.2 min and tR = 7.9 
min;). Assignment of absolute configuration was accomplished by comparing measurements to 
those of previously prepared enantiopure samples. All reactions showed full conversion. 
7.5 Experimental data for chapter 5 
7.5.1 tBuNH-(S)Phe-NH fumarate (51) 
 
Fumaric acid (50.0 mg, 431 µmol 1.00 eq.) and HOBt (145 mg, 1.08 mmol, 2.50 eq.) were 
dissolved dry DMF (2 ml) and DIPEA (188 µl, 1.08 mmol, 2.50 eq.) was added. The clear solu-
tion was cooled in an ice bath and EDCI.HCl (206 mg, 1.08 mmol, 2.50 eq.) was added. Stirring 
was continued for 15 minutes and the solution turned orange. (S)-Phenylalanine tert-butylamide 
hydrochloride S2c (277 mg, 1.08 mmol, 2.50 eq.) was added and after another 15 minutes, the 
clear, orange solution was warmed to room temperature and stirring was continued. After 16 
hours, the mixture was diluted with 25 ml ethyl acetate (25 ml) and solids precipitated. Solids 
were filtered off and washed with small quantities of fresh ethyl acetate. The organic layer was 
washed with HCl solution (2 x 25 ml), sat. NaHCO3 solution (2 x 25 ml) and brine (1 x 25 ml). 
It was dried over sodium sulfate, filtrated and evaporated to give more white solids. Combined 
solids were finally dried at 50 °C in vacuo to yield the product as a beige solid (169 mg, 324 
µmol, 75%). 
 
1H-NMR (DMSO-d6, 400 MHz, 298 K)   1.20 (s, 9H, H1), 2.75 (dd, 1H, 2J(H,H) = 13.6 Hz, 
3J(H,H) = 9.3, H6a), 2.75 (dd, 1H, 2J(H,H) = 13.6 Hz, 3J(H,H) = 5.4, H6b), 4.56 (dt, 1H, 3J(H,H) 
= 8.9 Hz, 3J(H,H) = 5.3, H5), 6.80 (s, 1H, H10), 7.14-7.26 (m, 5H, H7), 7.58 (s, 1H, H2), 8.53 
(d, 1H, 3J(H,H) = 8.6 Hz, H8) ppm.  
13C{1H}-NMR (DMSO-d6, 100 MHz, 298 K)   28.4 (C1), 38.2 (C6), 50.1 (C2), 54.4 (C5), 
126.2 (C7p), 127.9 (C7o/m), 129.2 (C7o/m), 132.7 (C10), 137.7 (C7i), 163.2 (C9), 170.0 (C4) ppm.  
HR-MS (ESI): m/z calcd. for C30H41N4O4+, [M+H]+: 521.31223; found: 521.31193. 
FTIR: ṽ = 698 (s), 1224 (m), 1512 (s), 1632 (s), 2928 (w), 2967 (w), 3064 (w), 3281 (bm) cm-
1
. 
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7.5.2 tBuNH-(S)Phe-NH meso-2,3-dibromo succinic amide (52) 
 
Alkene 51 (123 mg, 236 µmol 1.00 eq.) was suspended in chloroform (6 ml). Bromine was 
added and the suspension was stirred in the dark for 60 hours. The resulting clear solution was 
evaporated and the residue was dissolved in ethyl acetate:chloroform (1:1, 5 ml) and passed 
through a short pad of silica using ethyl acetate as eluent. The collected fraction was concen-
trated. Addition of n-hexane gave white solids that were dried in vacuo (159 mg, 235 µmol, 
99%). 
 
Additional splitting was observed for some signals, which is caused by the non-equivalence of 
both molecular halves. Respective signals are indicated as X and X’. 
1H-NMR (DMSO-d6, 400 MHz, 298 K)   1.18 (s, 9H, H1), 1.19 (s, H9, H1’), 2.78 (dd, 2H, 
2J(H,H) = 13.7 Hz, 3J(H,H) = 8.4, H6a), 2.90 (dd, 2H, 2J(H,H) = 13.7 Hz, 3J(H,H) = 5.9, H6b), 
4.74 (dt, 1H, 3J(H,H) = 8.4 Hz, 3J(H,H) = 5.9, H5), 4.52 (dt, 1H, 3J(H,H) = 8.4 Hz, 3J(H,H) = 
5.9, H5), 4.89 (s, 2H, H10), 7.14-7.22 (m, 10H, H7), 7.36 (s, 1H, H3), 7.43 (s, 1H, H3’), 8.82 
(d, 1H, 3J(H,H) = 8.4 Hz, H8), 8.83 (d, 1H, 3J(H,H) = 8.4 Hz, H8’) ppm.  
13C{1H}-NMR (DMSO-d6, 100 MHz, 298 K)   38.2 (C1), 28.3 (C1’), 37.6 (C6), 38.0 (C6’), 
44.7 (C10), 45.3 (C10’), 50.2 (C2), 54.2 (C5), 54.4 (C5’), 126.1 (C7p), 126.2 (C7p’), 127.9 
(C7o/m), 127.9 (C7o/m’), 137.2 (C7i), 137.2 (C7i’), 165.4  (C9),165.4 (C9’), 169.2 (C4), 169.2 
(C4’) ppm.  
HR-MS (ESI): m/z calcd. for C30H41Br792N4O4+, [M+H]+: 679.14891; found: 679.14965. m/z 
calcd. for C30H41Br812N4O4+, [M+H]+: 681.14716; found: 681.14686. 
 
7.5.3 Oxazoline-protected fumaric acid (53) 
 
Fumaric acid (1.50 g, 12.9 mmol 1.00 eq.) was suspended in dry DCM (15 ml) and 15 drops of 
dry DMF were added. The suspension was treated with oxalyl chloride (2.77 ml, 32.3 mmol, 
2.50 eq.) and gas evolved. The mixture was stirred at room temperature and a clear, orange 
solution had formed after 16 hours. In a separate, heat-gun dried flask, 2-amino-2,2-dimethyleth-
anol was dissolved in dry DCM (15 ml) and cooled in an ice bath. The solution with the carbox-
ylic acid chloride was added dropwise, upon which the solution turned yellow and thick solids 
formed. The suspension was subsequently warmed to room temperature and allowed to stir for 
another three hours. All volatiles were subsequently removed, residual white solids were placed 
on a plug of silica and the diol intermediate was eluated with tetrahydrofuran (1.5 L). Evapora-
tion gave white solids.  
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Formation of the bisoxazoline was done according to a published procedure.[218] The isolated 
diol (500 mg, 1.94 mmol, 1.00 eq.) was suspended in dry THF (25 ml) and cooled to -78 °C. 
DAST was added dropwise and the mixture was kept stirring for four hours. For work-up, po-
tassium carbonate (802 mg, 5.81 mmol, 3.00 eq.) was added, the mixture was warmed to room 
temperature and slowly poured into sat. NaHCO3 solution (100 ml). The aqueous layer was ex-
tracted with DCM (3x 100 ml) Combined organic layers were dried over sodium sulfate and 
evaporated to give a beige solid. Further purification by column chromatography (silica, n-pen-
tane:diethyl ether 1:1, Rf = 0.23) gave the product as a white solid (236 mg, 1.06 mmol, 25% 
over two steps). 
 
1H-NMR (CD2Cl2, 600 MHz, 298 K)   1.27 (s, 6H, H1), 3.99 (s, 2H, H3), 6.69 (s, 1H, H5) 
ppm.  
13C{1H}-NMR (CD2Cl2, 150 MHz, 298 K)   28.31 (C1), 68.3 (C2), 79.3 (C3), 126.7 (C5), 
160.6 (C4) ppm.  
HR-MS (ESI): m/z calcd. for C12H19N2O2+, [M+H]+: 223.14410; found: 223.14392.  
FTIR:  ṽ = 726 (m), 989 (s), 1298 (s), 1637 (s), 2871 (w), 2894 (w), 2969 (s), 3053 (s) cm-1. 
 
7.5.4 Meso-2,3-diacetoxysuccinic acid (54) 
 
This compound was synthesized according to a known procedure, which was slightly 
adapted.[222] Meso-tartaric acid (1.00 g, 6.66 mmol, 1.00 eq.) and acetyl chloride (467 mg, 59.5 
mmol, 42.5 ml, 10.0 eq.) were placed in a heat-gun dried round bottom flask and refluxed for 48 
hours. After cooling to room temperature, all volatiles were removed under high vacuum. Last 
traces of solvent were then evaporated during three freeze-pump-thaw cycles to give the acetyl-
protected anhydride as a yellow oil. It was dissolved in THF/H2O (5:1, 24.0 ml) and stirred 
overnight at room temperature. The solvent was removed under high vacuum once more and the 
residue was washed with DCM to give the product as a beige solid that was dried at 50 °C in 
vacuo (1.49 g, 6.36 mmol, 96%). 
 
1H-NMR (DMSO-d6, 400 MHz, 298 K)   2.10 (s, 3H, H5), 5.43 (s, 1H, H3) ppm. Carboxylic 
acid protons were not observed.  
13C{1H}-NMR (DMSO-d6, 400 MHz, 298 K)   20.4 (C5), 70.9 (C3), 167. (C2), 169.5 (C4) 
ppm.  
HR-MS (ESI): m/z calcd. for C8H9O8, [MH]: 233.03029; found: 233.03024. 
FTIR:  ṽ = 656 (s), 683 (s), 769 (s), 805 (w), 879 (s), 923 (m), 1005 (w), 1046 (w), 1078 (s), 
1210 (vs), 1277 (s), 1339 (m), 1375 (s), 1437 (m), 1720 (vs), 1738 (vs), 2539 (w), 2595 (w), 
2650 (w), 2775 (w), 2874 (w), 2991 (w) cm-1 
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7.5.5 tBuNH-(S)Phe-NH meso-2,3-diacetyloxy succinic amide (55) 
 
This compound was synthesized according to a known procedure.[223] Compound 54 (200 mg, 
0.85 mmol, 1.00 eq.) was dissolved in DCM (2 ml, dry and degassed) and dry DMF (8 drops) 
were added. The clear solution was subsequently treated with oxalyl chloride (325 mg, 0.22 ml, 
2.56 mmol, 3.00 eq.) under evolution of gas. After two hours, all volatiles were removed in 
vacuo and the residue was re-dissolved in DCM (2 ml, dry and degassed). In a second heat-gun 
dried flask, (S)-phenylalanine tert-butylamide hydrochloride S2c (548 mg, 2.14 mmol, 2.50 eq.) 
was dissolved in DCM (3 ml, dry and degassed) and DIPEA (662 mg, 0.89 ml, 5.12 mmol, 
6.00 eq.) was added. The acetylated succinic acid chloride solution was subsequently added 
dropwise to the selector solution under formation of fumes. The reaction mixture was stirred for 
four hours at room temperature, then diluted with ethyl acetate (35 ml), washed with HCl solu-
tion (2M, 3 x 35 ml), sat. NaHCO3 solution (2 x 35 ml) and brine (1 x 35 ml), dried over Na2SO4, 
filtered and finally concentrated under reduced pressure to give yellowish solids. These were re-
dissolved in DCM and precipitated with n-pentane yielding compound 55 as a white powder 
(309 mg, 0.48 mmol, 57%).  
 
Additional splitting was observed for some signals, which is caused by the non-equivalence of 
both molecular halves. Respective signals are indicated as X and X’. 
1H-NMR (CDCl3, 600 MHz, 298 K)   1.13 (s, 9H, H1), 1.31 (s, 9H, H1’), 2.04 (s, 3H, H12), 
2.13 (s, 3H, H12’), 2.80 (dd, 1H, 2J(H,H) = 13.5 Hz, 3J(H,H) = 9.8 Hz, H6a’), 2.93 (dd, 1H, 
2J(H,H) = 13.8 Hz, 3J(H,H) = 7.4 Hz, H6a), 3.23 (dd, 1H, 2J(H,H) = 13.5 Hz, 3J(H,H) = 5.1 Hz, 
H6b’), 3.34 (dd, 1H, 2J(H,H) = 13.8 Hz, 3J(H,H) = 6.0 Hz, H6b), 4.33 (ddd, 1H, 3J(H,H) = 9.8 
Hz, 3J(H,H) = 7.3 Hz, 3J(H,H) = 5.1 Hz, H5’), 4.54 (dt, 1H, 3J(H,H) = 7.6 Hz, 3J(H,H) = 5.9 Hz, 
H5), 4.83 (s, 1H, H3), 5.61 (d, 1H, 3J(H,H) = 2.1 Hz, H10), 5.67 (d, 1H, 3J(H,H) = 2.1 Hz, H10’), 
6.06 (s, H, H3’), 6.90 (d, 1H, 3J(H,H) = 7.9 Hz, H8), 7.19-7.34 (m, 10H, H7 and H7’), 7.46 (d, 
1H, 3J(H,H) = 7.4 Hz, H8’) ppm. 
13C{1H}-NMR (CDCl3, 150 MHz, 298 K)   20.6 (C12), 20.7 (C12’), 28.4 (C1), 28.6 (C1’), 
37.6 (C6), 38.8 (C6’), 51.5 (C2), 51.6 (C2’), 54.5 (C5), 55.5 (C5’), 72.9 (C10), 127.1 (C7p), 
127.2 (C7p’), 128.7 (C7o/m), 128.8 (C7o/m’), 129.4 (C7o/m), 129.4 (C7o/m’), 136.7 (C7i), 136.9 
(C7i’), 165.1 (C9), 165.9 (C9’), 168.7 (C11), 168.9 (C4), 168.9 (C11’), 169.5 (C4’) ppm.  
HR-MS (ESI): m/z calcd. for C34H47N4O8+, [M+H]+: 639.33884; found: 639.33901. 
FTIR:  ṽ = 679 (w), 698 (s), 742 (s), 800 (m), 758 (w), 846 (w), 886 (m), 909 (w), 922 (m), 986 
(w), 1003 (w), 1044 (m), 1067 (w), 1085 (w), 1130 (m), 1152 (w), 1192 (w), 1216 (s), 1246 (w), 
1263 (w), 1287 (w), 1303 (w), 1320 (w), 1365 (m), 1392 (w), 1414 (w), 1453 (s), 1486 (s), 1541 
(s), 1596 (m), 1639 (s), 1661 (w), 2870 (w), 2933 (m), 2967 (m), 3030 (w), 3065 (w), 3083 (w), 
3298 (s), 3368 (w) cm-1. 
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7.5.6 tBuNH-(S)Phe-NH meso-2,3-dihydroxy succinic amide (56)  
 
Deprotection was done according to a known protocol with a modified work-up procedure.[236] 
Compound 55 (500 mg, 783 µmol, 1.00 eq.) was dissolved in methanol (10 ml). K2CO3 (1.08 g, 
7.83 mmol, 10.0 eq.) was added and the suspension was stirred at 40 °C for 1.5 hours. The 
suspension was poured onto a short plug of silica and the product was eluated with ethanol. 
Evaporation gave the desired diol 56 as a white solid (430 mg,780 µmol, quant).  
 
Additional splitting was observed for some signals, which is caused by the non-equivalence of 
both molecular halves. Respective signals are indicated as X and X’. 
1H-NMR (DMSO-d6, 600 MHz, 298 K)   1.13 (s, 9H, H1), 1.27 (s, 9H, H1’), 2.81 (dd, 1H, 
2J(H,H) = 13.6 Hz, 3J(H,H) = 6.7 Hz, H6a), 2.96 (dd, 1H, 2J(H,H) = 13.6 Hz, 3J(H,H) = 6.1 Hz, 
H6b), 2.99-3.05 (m, 2H, H6a’ and H6b’), 4.11 (s, 1H, H10’), 4.19 (s, 1H, H10), 4.36-4.43 (m, 
2H, H5 and H5’), 6.62 (bs, 2H, H11 and H11’), 7.16-7.25 (m, 10H, H7 and H7’), 7.41 (s, 1H, 
H3), 7.48 (s, 1H, H3’), 7.52 (d, 1H, 3J(H,H) = 8.1 Hz, H8), 7.60 (d, 1H, 3J(H,H) = 8.6 Hz, H8’) 
ppm. 
13C{1H}-NMR (DMSO-d6, 100 MHz, 298 K)   28.3 (C1), 28.5 (C1’), 37.1 (C6’), 38.3 (C6), 
50.2 (C2), 50.4 (C2’), 53.3 (C5), 73.8 (C10’), 74.1 (C10), 126.2 (C7p), 126.2 (C7p’), 127.8 
(C7o/m), 128.1 (C7o/m’), 129.2 (C7o/m), 129.6 (C7o/m’), 137.1 (C7i), 137.9 (C7i’), 169.0 (C4), 169.7 
(C4’), 170.1 (C9’), 170.6 (C9) ppm.  
HR-MS (ESI): m/z calcd. for C30H43N4O6+, [M+H]+: 555.31771; found: 555.31750. 
FTIR:  ṽ = 741 (s), 913 (m), 1080 (s), 1222 (s), 1364 (s), 1454 (s), 1514 (s), 1644 (s), 2873 (w), 
2929 (w), 2969 (m), 3031 (w), 3064 (w), 3088 (w), 3308 (bs) cm-1. 
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7.5.7 tBuNH-(S)Phe-NH meso-tartaric acid-derived bisphosphinite (49)  
 
Long term experiment: Compound 56 (20.0 mg, 36.1 µmol, 1.00 eq.) and 4-dimethylamino-
pyridine (881 µg, 7.21 µmol, 0.20 eq.) were placed in a J. Young NMR tube and dissolved in 
dry and degassed THF-d8 (0.5 ml). Diethylamino diphenylphosphine (35.7 µl, 144.2 µmol, 4.00 
eq.) was added and the mixture was heated to 70 °C and NMR spectra were collected periodi-
cally until no further reaction was observed.  
Synthesis: Compound 56 (50.0 mg, 90.1 µmol, 1.00 eq.) was dissolved in dry and degassed THF 
(1.0 ml). Triethylamine (56.5 µl, 406 µmol, 4.50 eq.) was added and the mixture was cooled in 
an ice bath. Chlorodiphenylphosphine (50.9 µl, 297 µmol, 3.30 eq.) was added dropwise. The 
suspension was slowly warmed to room temperature and stirring was continued for another three 
hours. All volatiles were subsequently removed and crude solids washed with n-pentane (5 x 2 
ml) to yield a grey powder. Traces of Ph2P(O)PPh2 (side product) still remained and could not 
be removed without significant loss of product. 
 
31P-NMR (THF-d8, 161.98 MHz, 295.0 K)  124.5 (s), 123.8 (bs) ppm. 
7.6 Selector Preparation 
7.6.1 General procedure for the preparation of selector amine hydrochlorides 
The N-protected amino acid (1.00 eq.) was placed in a dried Schlenk tube and dissolved in dry 
DMF (about 4 ml/mmol amino acid). DIPEA (2.00 eq.) and the corresponding primary amine 
(1.10 eq.) were added and the clear solution was cooled in an ice bath. Addition of COMU (1.10 
eq.) gave a bright yellow solution that was left stirring to slowly warm to room temperature 
overnight. For work-up, the solution was diluted with ethyl acetate (10 times the volume of 
DMF) and the organic layer was washed consecutively with HCl solution (1M, three times), 
saturated NaHCO3 solution (two times) and brine (two times), dried over sodium sulfate and 
evaporated. Purification by column chromatography gave the BOC-protected amide as a white 
solid.  
In order to ensure that no racemization occurred during amide formation, enantiopurity of the 
chiral amides was determined using chiral HPLC (Chiralpak IE, hexane:isopropanol 95:5). All 
coupling products were obtained with purities >99% ee. 
For removal of the BOC group, the protected amide (1.00 eq.) was dissolved in THF (about 1 
ml/mmol) and HCl in isopropanol (5 M, 10 eq.) was added slowly. The clear solution was stirred 
at room temperature for 20 hours. After all volatiles were removed, the residual oil was stirred 
in diethyl ether (100 ml) to give white solids that were filtered off , washed another two times 
with diethyl ether (100 ml each) and were finally dried in vacuo. 
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7.6.1.1 tBuNH-(S)Val-NH selector ((S)-S2a) 
 
The compound was synthesized according to the general procedure described above using (tert-
butoxycarbonyl)-L-valine (5.00 g, 23.0 mmol). After column chromatography (silica, n-pen-
tane:ethyl acetate 3:1, Rf = 0.12), BOC-protected valine tert-butyl amide (S)-S1a was obtained 
as a white solid (4.20 g, 15.4 mmol, 67%). 
 
Deprotection (4.20 g, 15.4 mmol) gave the corresponding amine hydrochloride (S)-S2a as a 
white, fluff y solid (3.12 g, 15.00 mmol, 97%). 
 
Analytics for BOC protected amide: 
1H-NMR (CDCl3, 400.13 MHz, 298 K): δ = 0.90 (d, 3H, 3J(H,H) = 6.8 Hz, H7), 0.94 (d, 3H, 
3J(H,H) = 6.8 Hz, H8), 1.34 (s, 9H, H1), 1.43 (s, 9H, H12), 1.90-2.11 (m, 1H, H6), 3.70 (dd, 1H, 
3J(H,H) = 6.5 Hz, 3J(H,H) = 8.8Hz, H5), 5.08 (s, 1H, H4), 5.69 (s, 1H, H10) ppm. 
13C{1H}-NMR (CDCl3, 100.66 MHz, 298 K): δ = 18.1 (C7), 19.4 (C8), 31.2 (C6), 51.6 (C11), 
60.7 (C5), 1179.8 (C3), 156.1 (C3), 170.9 (C9) ppm. 
HRMS (ESI): m/z calcd. for C14H28N2NaO3 [M+Na]+: 295.19921; found: 295.19922. 
FTIR: ṽ = 881 (w), 1010 (m), 1168 (s), 1251 (s), 1299 (s), 1364 (s), 1527 (s), 1650 (s), 2874 
(w), 2933 (w), 2989 (m), 3295 (bs) cm-1. 
[α]D20 -13.1 (c 1%, CHCl3). 
 
Analytics for hydrochloride: 
1H-NMR (DMSO-d6, 400.33 MHz, 300 K): δ = 0.92 (d, 3H, 3J(H,H) = 6.9 Hz, H4), 0.93 (d, 
3H, 3J(H,H) = 6.9 Hz, H5), 1.28 (s, 9H, H9), 2.01-2.12 (m, 1H, H3), 3.55 (d, 1H, 3J(H,H) = 5.9 
Hz, H2), 8.14 (s, 1H, H7), 8.17 (s, 3H, H1) ppm. 
13C{1H}-NMR (DMSO-d6, 100.66 MHz, 300 K): δ = 17.9 (C4), 18.3 (C5), 28.3 (C9), 29.8 (C3), 
50.7 (C8), 57.4 (C2), 167.0 (C6) ppm. 
HRMS (ESI): m/z calcd. for C9H21N2O [M-Cl]+: 173.16484; found: 173.14938. 
FTIR: ṽ = 905 (w), 1029 (w), 1224 (s), 1362 (s), 1493 (s), 1544 (s), 1684 (s), 2878 (bs), 2967 
(bs), 3028 (bs), 3300 (bw), 3412 (bw) cm-1. 
[α]D20 +30.6 (c 1%, MeOH). 
  
7.6  Selector Preparation 
____________________________________________________________________________ 
- 158 - 
7.6.1.2 1-AdNH-(S)Val-NH selector ((S)-S2b) 
 
The compound was synthesized according to the general procedure described above using (tert-
butoxycarbonyl)-L-valine (3.00 g, 13.8 mmol). After column chromatography (silica, n-pen-
tane:diethyl ether 3:1, Rf = 0.19), BOC-protected valine adamantyl amide (S)-S1b was obtained 
as a white solid (3.78 g, 10.78 mmol, 78%). 
 
Deprotection (3.60 g, 10.3 mmol) gave the corresponding amine hydrochloride (S)-S2b as a 
white, fluff y solid (2.74 g, 9.55 mmol, 87%). 
 
Analytics for BOC protected amide: 
1H-NMR (CDCl3, 400.13 MHz, 298 K): δ = 0.84 (d, 3H, 3J(H,H) = 6.3 Hz, H8), 0.88 (d, 3H, 
3J(H,H) = 6.3 Hz, H7), 1.38 (s, 9H, H1), 1.58-1.63 (m, 6H, H14), 1.53-1.72 (m, 1H, H5), 1.91-
1.96 (m, 6H, H12), 1.98-2.05 (m, 3H, H13), 3.58-3.74 (m, 1H, H5), 5.02 (s, 1H, H10), 5.42 (s, 
1H, H4) ppm. 
13C{1H}-NMR (CDCl3, 100.66 MHz, 298 K): δ = 18.0 (C8), 19.3 (C7), 28.3 (C1), 29.4 (C13), 
36.3 (C14), 41.6 (C14), 52.2 (C11), 60.5 (C5), 79.7 (C2), 155.9 (C3), 170.6 (C9) ppm. 
HRMS (ESI): m/z calcd. for C36H56N4NaO6 [2M+Na]+: 723.5031; found: 723.5035. 
FTIR: ṽ = 881.3 (w), 1170 (s), 1242 (m), 1364 (m), 1522 (bm), 1647 (s), 1682 (m), 2852 (w), 
2905 (s), 2972 (w), 3083 (w), 3292 (bs) cm-1. 
[α]D20 -18.9 (c 1%, CHCl3). 
 
Analytics for hydrochloride: 
1H-NMR (CD3OD, 400.33 MHz, 300 K): δ = 1.04 (d, 3H, 3J(H,H) = 6.9 Hz, H4), 1.06 (d, 3H, 
3J(H,H) = 6.9 Hz, H5), 1.70-1.78 (m, 6H, H8), 2.04-2.09 (m, 9H, H10 and H11), 2.09-2.17 (m, 
1H, H3), 3.51 (d, 1H, 3J(H,H) = 5.94 Hz, H2) ppm. No NH protons were observed due to rapid 
HD exchange. 
13C{1H}-NMR (CD3OD, 100.66 MHz, 300 K): δ = 17.9 (C4), 19.0 (C5), 30.9 (C11), 31.7 (C3), 
37.9 (C10), 42.3 (C9), 53.5 (C8), 60.0 (C2), 168.4 (C6) ppm. 
HRMS (ESI): m/z calcd. for C15H27N2O [M-Cl]+: 251.2188; found: 251.2144. 
FTIR: ṽ = 742 (m), 899 (m), 1091 (s), 1395 (s), 1452 (s), 1507 (s), 1647 (s), 2849 (s), 2902 (s), 
3366 (bw) 3428 (bw) cm-1. 
[α]D20 +22.8 (c 1%, MeOH). 
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7.6.1.3 tBu-(S)Phe-NH selector ((S)-S2c) 
 
The compound was synthesized according to the general procedure described above using (tert-
butoxycarbonyl)-L-phenylalanine (4.10 g, 15.5 mmol). After column chromatography (silica, n-
pentane:diethyl ether 4:1, Rf = 0.14), BOC-protected phenylalanine tert-butyl amide (S)-S1c was 
obtained as a white solid (4.80 g, 15.0 mmol, 97%). 
 
Deprotection (4.80 g, 15.0 mmol) gave the corresponding amine hydrochloride (S)-S2c as a 
white, fluff y solid (3.35 g, 13.0 mmol, 87%). 
 
Analytics for BOC protected amide: 
1H-NMR (CDCl3, 400.33 MHz, 298 K): δ = 1.20 (s, 9H, H14), 1.43 (s, 9H, H1), 2.91 (dd, 1H, 
3J(H,H) = 8.33 Hz, 2J(H,H) = 13.45 Hz, H6a), 3.10 (dd, 1H, 3J(H,H) = 5.72 Hz, 2J(H,H) = 13.45 
Hz, H6b), 4.14 (m, 1H, H5), 5.16 (bs, 1H, H4), 5.26 (bs, 1H, H12), 7.20-7.21 (m, 3H, H9 and 
H10), 7.28-7.32 (m, 2H, H8) ppm. 
13C{1H}-NMR (CDCl3, 100.66 MHz, 298 K): δ = 28.5 (C1), 28.7 (C14), 39.3 (C6), 51.4 (C13), 
56.7 (C5), 80.2 (C2), 127.1 (C10), 128.8 (C9), 129.6 (C8), 137.3 (C7), 155.5 (C3), 170.1 (C11) 
ppm. 
HRMS (ESI): m/z calcd. for C36H56N4NaO6 [2M+Na]+: 663.4092; found: 663.4092. 
FTIR: ṽ = 696 (s), 1021 (m), 1170 (s), 1363 (s), 1539 (s), 1653 (s), 2868 (w), 2931 (w), 2972 
(m), 3066 (w), 3304 (bs) cm-1. 
[α]D20 +8.7 (c 1%, CHCl3). 
 
Analytics for hydrochloride: 
1H-NMR (CDCl3, 150.93 MHz, 298 K): δ = 1.15 (s, 9H, H14), 3.18-3.22 (m, 1H, H3a), 3.50-
3.58 (m, 1H, H3b), 4.48-4.52 (m, 1H, H2), 6.46 (s, 1H, H9), 7.20-7.25 (m, 1H, H7), 7.26-7.35 
(m, 2H, H6), 7.31-7.45 (m, 2H, H5), 8.54 (bs, 3H, H1) ppm. 
13C{1H}-NMR (CDCl3, 100.66 MHz, 298 K): δ = 28.6 (C11), 37.8 (C3), 52.1 (C10), 55.3 (C2), 
127.6 (C7), 129.0 (C6), 130.1 (C5), 135.0 (C4), 167.1 (C8) ppm. 
HRMS (ESI): m/z calcd. for C13H21N2O [M-Cl]+ : 221.1648; found: 221.1647. 
FTIR: ṽ = 698 (s), 740 (s), 1221 (s), 1456 (s), 1295 (s), 1688 (s), 2899 (bs), 2969 (bs), 3209 (w) 
3309 (w) cm-1. 
[α]D20 +64.6 (c 1%, CHCl3). 
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7.6.1.4 tBu-(R)Phe-NH selector ((R)-S2c) 
 
The compound was synthesized according to the general procedure described above using (tert-
butoxycarbonyl)-D-phenylalanine (3.95 g, 14.9 mmol). After column chromatography (silica, n-
pentane:diethyl ether 4:1, Rf = 0.14), BOC-protected phenylalanine tert-butyl amide (R)-S1c 
was obtained as a white solid (4.21 g, 13.1 mmol, 88%). 
 
Deprotection (4.21 g, 13.1 mmol) gave the corresponding amine hydrochloride (R)-S2c as a 
white, fluff y solid (3.18 g, 12.3 mmol, 94%). 
 
Analytical NMR, HR-MS and IR data was identical to that of the enantiomers.  
 
Analytics for BOC protected amide: 
 [α]D20 +8.7 (c 1%, CHCl3). 
 
Analytics for hydrochloride: 
 [α]D20 +64.6 (c 1%, CHCl3). 
 
7.6.1.5 tBuNH-Gly-NH selector (S2d) 
 
The compound was synthesized according to the general procedure described above using (tert-
butoxycarbonyl)-glycine (4.92 g, 28.1 mmol). BOC protected glycine tert-butyl amide S1d was 
obtained as a white solid. 
 
Deprotection of the amine gave the corresponding hydrochloride S2d as a white, fluff y solid 
(3.70 g, 22.2 mmol, 79% over two steps). 
 
Analytics for crude BOC protected amide: 
1H-NMR (CDCl3, 300.51 MHz, 298 K): δ = 1.35 (s, 9H, H9), 1.45 (s, 9H, H1), 3.67 (m, 2H, 
H5), 5.1 (bs, 1H, H4), 5.80 (s, 1H, H7) ppm. 
 
Analytics for hydrochloride: 
1H-NMR (DMSO-d6, 400.13 MHz, 298 K): δ = 1.27 (s, 9H, H6), 3.44 (s, 2H, H2), 8.17 (bs, 
3H, H1), 8.19 (s, 1H, H4) ppm. 
13C{1H}-NMR (DMSO-d6, 100.66 MHz, 298 K): δ = 18.4 (C6), 30.3 (C5), 40.6 (C2), 155.0 
(C3) ppm. 
HRMS (EI): m/z calcd. for C6H15N2O [M-Cl]+ : 131.11789; found: 131.11790. 
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FTIR: ṽ = 705 (s), 925 (s), 1365 (s), 1488 (s), 1560 (s), 1678 (s), 2618 (m), 2680 (m), 2841 
(bm), 3060 (bm), 3224 (w) cm-1. 
 
7.6.2 tBuNH-(S)Phe-O selector (S3)  
 
(S)-3-Phenyl lactic acid (5.00 g, 30.1 mmol, 1.00 eq.) and HOBt (4.47 g, 33.1 mmol, 1.10 eq.) 
were dissolved in dry DMF (60 ml). DIPEA (10.5 ml, 60.2 mmol, 2.00 eq.) was added, the 
solution was cooled in an ice bath and EDCI.HCl (6.34 g, 33.1 mmol, 1.10 eq.) was added. After 
15 min, all solids had dissolved and the solution was treated with tert-butyl amine (3.48 ml, 33.1 
mmol, 1.10 eq.). After 30 minutes at lower temperatures, the mixture was warmed to room tem-
perature again and stirring was continued for 18 hours. The mixture was subsequently diluted 
with ethyl acetate (500 ml) and washed with HCl solution (2M, 3 x 300 ml), saturated bicar-
bonate solution (3 x 300 ml) and brine (1 x 300 ml), dried over sodium sulfate and evaporated 
to give the product as a yellow oil, that crystallized into an amorphous solid after prolonged 
drying (4.57 g, 20.7 mmol, 69%). 
 
1H NMR (CDCl3, 800.34 MHz, 300 K): δ = 1.29 (s, 9H, H10), 2.78 (bs, 1H, H11), 2.93 (dd, 1H, 
2J(H,H) = 13.9 Hz, 3J(H,H) = 7.6 Hz, H5’), 3.12 (dd, 1H, 2J(H,H) = 13.9 Hz, 3J(H,H) = 4.8 Hz, 
H5), 4.16 (dd, 1H, 3J(H,H) = 7.6 Hz, 3J(H,H) = 4.9 Hz, H6), 6.13 (s, 1H, H8), 7.24-7.26 (m, 3H, 
H3 and H1), 7.30-7.32 (m, 2H, H2) ppm. 
13C{1H} NMR (CDCl3, 201.24 MHz, 300 K): δ = 28.7 (C10), 41.1 (C5), 51.1 (C9), 72.9 (C6), 
127.1 (C1), 128.8 (C2), 129.8 (C3), 137.1 (C4), 172.0 (C7) ppm. 
HRMS (ESI): m/z calcd. for C13H18NO2 [M+H]+: 220.1343; found: 220.13439. 
FTIR: ṽ = 697 (s), 742 (s), 1089 (s), 1186 (s), 1223 (s), 1454 (s), 1528 (s), 1642 (s), 1743 (s), 
2929 (m), 2968 (m), 3030 (w), 3063 (w), 3088 (w), 3225 (bs), 3335 (w), 3397 (w) cm-1. 
[α]D20 -56.5 (c 1%, CHCl3). 
 
7.7 Preparation of additives for chiral alignment 
Additives (S)- and (R)-AcNH-Phe-NHMe (8) as well as AcNH-(S)Ala-NHMe (13) are known 
compounds and were prepared according to published protocols.[237] Similarly, Ac-(S)Phe-OMe 
(43)[237]  and (3,5-dinitrobenzoyl)-(S)Leu-NMe2 (36)[77] have previously been described else-
where.  
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7.7.1 AcNH-(S)Ala-NH(3,5-dichlorophenyl) ((S)-9)  
 
(S)-N-Acetyl alanine (200 mg, 1.53 mmol, 1.00 eq.) was suspended in dry DCM (5 ml). 
EDCI.HCl (322 mg, 1.68 mmol, 1.10 eq.) was added and the mixture was stirred for 15 min to 
give a clear solution. Subsequently, 3,5-dichloroaniline (260 mg, 1.60 mmol, 1.05 eq.) was 
added as a solid to give a dark purple solution from which solids precipitated shortly after. After 
16 hours, the solids were collected by filtration. The mother liquor was evaporated and the res-
idue slurried in warm acetonitrile from which another batch of solids was obtained. The com-
bined crude product was finally dissolved in ethyl acetate (10 ml) at 65 °C and crystallized in 
the freezer. This was repeated twice to give the enantiomerically pure product (S)-9 as a white, 
crystalline solid (150 mg, 1.53 mmol, 36%).  
 
The enantiopurity of the compound was verified by chiral HPLC (Chiralpak IA, hexane:isopro-
panol 80:20, 1.0 ml/min, tS = 5.10 min) and was found to be >99% ee.  
 
1H-NMR (CD3OD, 600.24 MHz, 300 K): δ = 1.26 (d, 3H, 3J(H,H) = 7.0 Hz, H5), 1.85 (s, 3H, 
H1), 4.31 (dt, 1H, 3J(H,H) = 7.0Hz, 3J(H,NH) = 6.9 Hz, H4), 7.27 (t, 1H, 3J(H,H) = 1.8 Hz, H11), 
7.67 (d, 2H, 3J(H,H) = 1.8 Hz, H9), 8.24 (d, 1H, 3J(H,H) = 6.9 Hz, H3), 10.33 (s, 1H, H7) ppm. 
13C{1H}-NMR (CD3OD, 150.93 MHz, 300 K): δ = 17.7 (C5), 22.4 (C1), 49.3 (C4), 117.4 (C9), 
122.6 (C11), 134.1 (C10), 141.3 (C8), 169.4 (C2), 172.4 (C6) ppm. 
HRMS (ESI): m/z calcd. for C11H12Cl2N2NaO2 [M+Na]+: 297.0168; found: 297.0170. 
FTIR: ṽ = 668 (s), 1153 (s), 1409 (s), 1436 (s), 1526 (s), 1586 (s), 1642 (s), 2978 (w), 3086 (w), 
3117 (w), 3181 (w), 3257 (w), 3343, (m) cm-1. 
[α]D20 -34.9 (c 0.5%, MeOH). 
 
7.7.2 O,O’-methylated tBuNH-(S)Phe-NH biphenol (24)  
 
Compound 18c (180 mg, 244 µmol, 1.00 eq.) was dissolved in dry acetone (20 ml). Caesium 
carbonate (188 mg, 975 µmol, 4.00 eq.) was added and the mixture was cooled in an ice bath. 
The cool solution was treated with iodomethane (303 µl, 4.87 mmol, 20.0 eq.) and turned into a 
gel-like mass. Stirring was continued at room temperature, the gel dissolved overtime and solids 
formed.  After 72 hours, all volatiles were removed and the crude mix was partitioned between 
water and DCM (20 ml each). Layers were separated and the aqueous layer was extracted with 
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DCM (20 ml) another two times. Combined organic layers were subsequently washed with 
brine, dried over sodium sulfate and evaporated to give the methylated compound 24 as a white 
solid (160 mg, 209 µmol, 86%). 
 
1H-NMR (CDCl3, 600.24 MHz, 298 K): δ = 0.98 (s, 9H, H18), 1.26 (s, 9H, H18‘), 2.98 (dd, 1H, 
2J(H,H) = 13.6 Hz, 3J(H,H) = 10.0 Hz, H10b‘), 3.13-3.19 (m, 2H, H10a‘ and H10b), 3.43 (s, 3H, 
H20‘), 3.44-3.48 (m, 1H, H10a), 3.65 (s, 3H, H19), 3.72 (s, 3H, H20), 3.94 (s, 3H, H19‘), 4.47-
4.51 (m, 1H, H9‘), 5.25 (s, 1H, H16‘), 5.54-5.58 (m, 1H, H9), 6.92 (d, 1H, 4J(H,H) = 2.0 Hz,  
H4), 7.03-7.06 (m, 1H, H14), 7.09-7.12 (m, 2H, H13), 7.19-7.21 (m, 1H, H14‘), 7.23-7.24 (m, 
1H, H6), 7.27-7.29 (m, 2H, H12‘ and H13‘), 7.67-7.68 (m, 2H, H12), 7.73 (d, 1H, 4J(H,H) = 2.1 
Hz, H6‘), 7.79 (d, 1H, 3J(H,H) = 2.1 Hz, H4‘), 8.21 (s, 1H, H16), 9.34 (d, 1H, 3J(H,H) = 6.3 Hz, 
H8‘), 9.89 (d, 1H, 3J(H,H) = 9.2 Hz, H8) ppm. 
13C{1H}-NMR (CDCl3, 150.93 MHz, 289 K): δ = 27.9 (C18), 28.9 (C18‘), 38.3 (C10‘), 39.0 
(C10), 51.0 (C17), 51.6 (C17‘), 55.3 (C19), 56.3 (C9), 56.3 (C19‘), 58.5 (C9‘), 60.7 (C20), 60.8 
(C20‘), 111.5 (C4), 112.7 (C4‘), 119.7 (C6), 122.5 (C5‘), 126.4 (C14), 126.9 (C14‘), 127.9 
(C13), 128.4 (C5), 128.5 (C13’), 128.8 (C5‘), 129.8 (C12‘), 130.2 (C12), 131.3 (C1‘), 133.2 
(C1), 138.0 (C11‘), 139.3 (C11), 148.9 (C2), 150.1 (C2‘), 152.1 (C3), 152.8 (C3‘), 166.0 (C7’), 
166.2 (C7), 172.5 (C15‘), 173.7 (C15) ppm. 
HRMS (ESI): m/z calcd. for C44H55N4O8 [M+H]+: 767.40144; found: 767.40033. 
FTIR: ṽ = 697 (s), 1003 (s), 1223 (s), 1483 (s), 1543 (s), 1627 (s), 2837 (w), 2933 (m), 2967 
(m), 3064 (w), 3284 (bm) cm-1.  
 
7.7.3 PhCO-(S)Phe-NHtBu ((S)-25) 
 
Benzoyl chloride (100 µl, 854 µmol, 1.00 eq.) and DIPEA (327 µl, 1.88 µmol, 2.20 eq.) were 
mixed in dry DCM (5 ml) and cooled in an ice bath. (S)-2c (241 mg, 939 µmol, 1.10 eq.) was 
added as a solid and the clear mixture was subsequently stirred at room temperature for 18 hours. 
For work-up, the clear solution was diluted in ethyl acetate (40 ml) and the organic layer was 
washed with HCl solution (40 ml, 2 M, three times), saturated bicarbonate solution (40 ml, two 
times) and brine (40 ml, once). Drying over sodium sulfate and evaporation gave the diamide 
(S)-25 as a white, fluffy solid (257 mg, 792 µmol, 93%) 
 
Enantiopurity of the compound was confirmed by chiral HPLC (Chiralpak IE, hexane:isopropa-
nol 80:20, 1.0 ml/min, 20 °C, tR = 5.2 min). 
 
1H-NMR (CDCl3, 598.17 MHz, 298 K): δ = 1.19 (s, 9H, H16), 2.96 (dd, 1H, 3J(H,H) = 9.3 Hz, 
2J(H,H) = 13.4 Hz, H8b), 3.31 (dd, 1H, 3J(H,H) = 5.2 Hz, 2J(H,H) = 13.4 Hz, H8a), 4.66 (ddd, 
1H, 3J(H,H) = 9.3 Hz, 3J(H,H) = 7.3 Hz, 3J(H,H) = 5.2 Hz, H7), 5.17 (s, 1H, H14), 7.98 (d, 1H, 
3J(H,H) = 7.3 Hz, H6), 7.25-7.28 (m, 1H, H12), 7.30-7.35 (m, 4H, H10 and H14), 7.41-7.44 (m, 
2H, H2), 7.49-7.52 (m, 1H, H1),  7.78-7.80 (m, 2H, H3) ppm. 
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13C{1H}-NMR (CDCl3, 150.65 MHz, 298 K): δ = 28.6 (C16), 39.6 (C8), 51.6 (C15), 55.7 (C7), 
127.2 (C3), 127.2 (C12), 128.7 (C2), 128.9 (C11), 129.7 (C10), 131.9 (C1), 134.1 (C4), 137.2 
(C9), 166.9 (C5), 169.6 (C13) ppm. 
HRMS (ESI): m/z calcd. for C20H23N2O2 [M-H]-: 323.17650; found: 323.17682. 
FTIR: ṽ = 687 (s), 1224 (m), 1543 (s), 1636 (s), 2923 (w), 2970 (m), 3066 (bw), 3278 (bs) cm-
1. 
[α]D20 +7.01 (c 1 %, CHCl3). 
 
7.7.4 PhCO-(R)Phe-NHtBu ((R)-25) 
 
This compound was prepared according to the same procedure as its enantiomer using (R)-S2c 
(200 mg, 0.78 mmol) as substrate. The product was obtained as a white solid (230.9 mg, 
0.71 mmol, quant.) 
 
Analytical NMR, MS and IR data was identical to that of the enantiomers.  
 
Analytics for diamide: 
[]D20 -7.2 (c 1% in CHCl3) 
 
7.7.5 AcNH-(S)Ala-NH(3-nitrophenyl) ((S)-35) 
 
(S)-N-acetyl alanine (400 mg, 3.05 mmol, 1.00 eq.) was placed in a dried Schlenk flask and 
suspended in dry DCM (2 ml). The mixture was cooled in an ice bath and EDCI-HCl (643 mg, 
3.36 mmol, 1.10 eq.) was added as a solid. After 15 minutes, all solids had dissolved and 3-
nitroaniline (421 mg, 3.05 mmol, 1.00 eq.) was added. After stirring was continued for another 
18 hours at room temperature, the solution was diluted more DCM (50 ml). The organic layer 
was washed with HCl solution (2 M, 3 x 50 ml), saturated bicarbonate solution (2 x 50 ml) and 
brine (1 x 50 ml), dried over sodium sulfate and evaporated. Resulting solids were recrystallized 
four times from hot ethyl acetate at 60 °C to give the enantiopure product as a white powder 
(300 mg, 1.19 mmol, 39 %).  
 
Enantiopurity of the compound was confirmed by chiral HPLC (Chiralpak IE, hexane:isopropa-
nol 80:20, 1.0 ml/min, 20 °C, tS = 8.3 min).  
 
1H NMR (DMSO-d6, 400.33 MHz, 300 K): δ = 1.30 (d, 3H, 3J(H,H) = 7.1 Hz, H5), 1.87 (s, 3H, 
H1), 4.37 (dq, 1H, 3J(H,H) = 7.1 Hz, 3J(H,H) = 7.0 Hz, H4), 7.60 (t, 1H, 3J(H,H) = 8.2 Hz, H12), 
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7.89-7.94 (m, 2H, H11 and H13), 8.23 (d, 1H, 3J(H,H) = 6.9 Hz, H3), 8.64 (t, 1H, 4J(H,H) = 2.2 
Hz, H9), 10.46 (s, 1H, H7) ppm. 
13C{1H} NMR (DMSO-d6, 100.66 MHz, 300 K): δ = 17.7 (C5), 22.4 (C1), 49.3 (C4), 113.3 
(C9), 117.8 (C13), 125.2 (C11), 130.2 (C12), 140.1 (C8), 148.0 (C10), 169.4 (C2), 172.3 (C6) 
ppm. 
HRMS (ESI): m/z calcd. for C22H26N6NaO8 [M+Na]+ 525.17043; found: 525.17131. 
FTIR: ṽ = 729 (s), 740 (s), 820 (s), 1209 (s), 1294 (s), 1345 (s), 1526 (s), 1599 (s), 1647 (s), 
1686 (s), 2950 (w), 3001 (w), 3103 (bm), 3136 (w), 3246 (m) cm-1. 
[α]880nm 20 -1.3 (c 1%, MeOH). 
 
7.7.6 PhCO-(S)Phe-OMe (57) 
 
This compound was prepared according to the same procedure as PhCO-Phe-NHtBu 25. Using 
(S)-phenylalanine methyl ester (1.10g, 5.09 mmol, 1.10 eq.), DIPEA (537 µl, 4.62 mmol, 2.20 
eq.) and benzoic acid chloride (650 mg, 4.62 mmol, 1.00 eq.), the desired amido ester 57 was 
obtained as a white, waxy solid (1.15 g, 4.06 mmol, 88%). 
 
1H NMR (CDCl3, 589.67 MHz, 300 K): δ = 3.23 (dd, 1H, 2J(H,H) = 13.9 Hz, 3J(H,H) = 5.4 Hz, 
H8’), 3.30 (dd, 1H, 2J(H,H) = 13.9 Hz, 3J(H,H) = 5.8 Hz, H8) 3.77 (s, 3H, H14), 5.10 (dt, 1H, 
3J(H,H) = 7.6 Hz, , 3J(H,H) = 5.6 Hz, H7), 6.57 (d, 1H, 3J(H,H) = 7.5 Hz, H6), 7.13-7.14 (m, 
2H, H10), 7.25-7.27 (m, 1H, H12), 7.28-7.31 (m, 2H, H11), 7.41-7.44 (m, 2H, H2), 7.49-7.52 
(m, 1H, H1), 7.71-7.73 (m, 2H, H3) ppm. 
13C{1H} NMR (CDCl3, 150.55 MHz, 300 K): δ = 37.9 (C8), 52.4 (C14), 53.5 (C7), 127.0 (C8), 
127.2 (C12), 128.6 (C11 and C2), 129.3 (C10), 131.8 (C1), 133.9 (C4), 135.8 (C9), 166.8 (C5), 
172.0 (C13) ppm. 
HRMS (ESI): m/z calcd. for C17H18NO3 [M+H]+: 284.12812; found: 284.12797. 
FTIR: ṽ = 693 (s), 1172 (s), 1214 (s), 1638 (s), 1739 (s), 2885 (w), 2950 (m), 3031 (w), 3063 
(w), 3305 (bs) cm-1. 
[α]D20 +105.5 (c 1%, CHCl3). 
 
7.7.7 PhCO-(S)Phe-NHEt (58) 
 
Amido ester 57 (100 mg, 353 µmol, 1.00 eq.) was dissolved in methanol (1 ml) and a solution 
of ethylamine in methanol (2 M, 1.8 ml) was added. The clear mixture was stirred for 72 hours 
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and white solids precipitated. All volatiles were subsequently removed and residual solids were 
re-precipitated from DCM:n-pentane to give the pure product as a white, fluffy solid (87.0 mg, 
0.29 mmol, 83%). 
 
Enantiopurity of the compound was confirmed by chiral HPLC (Chiralpak IE, hexane:isopropa-
nol 80:20, 1 ml/min, 20 °C, tR = 8.4 min).  
 
 1H NMR (CDCl3, 400.22 MHz, 300 K): δ = 1.01 (t, 3H, 3J(H,H) = 7.3 Hz, H16), 3.08-3.32 (m, 
4H, H8 and H8’and H15), 4.81 (dt, 1H, 3J(H,H) = 8.1, 3J(H,H) = 5.9 Hz, H7), 5.81 (s, 1H, H14), 
7.04 (d, 1H, 3J(H,H) = 7.7 Hz, H6), 7.25-7.34 (m, 5H, H10 and H11 and H12), 7.42-7.46 (m, 
2H, H3), 7.51-7.53 (m, 1H, H1), 7.76-7.78 (m, 2H, H2) ppm. 
13C{1H} NMR (CDCl3, 100.65 MHz, 300 K): δ = 14.7 (C16), 34.6 (C15), 39.1 (C8), 55.3 (C7), 
127.2 (C2), 128.7 (C3), 128.8 (C11), 129.5 (C10), 131.9 (C1), 133.9 (C4), 137.0 (C9), 167.2 
(C5), 170.6 (C13) ppm. 
HRMS (ESI): m/z calcd. for C18H19N2O2 [M-H]-: 295.14520; found: 295.14539. 
FTIR: ṽ = 699 (s), 1232 (m), 1291 (s), 1527 (s), 1634 (s), 2868 (w), 2929 (m), 2967 (m), 3031 
(w), 3063 (w), 3264 (s), 3307 (s) cm-1. 
[α]D20 -12.3 (c 1%, CHCl3). 
 
1.1.1 PhCO-(S)Phe-NHiPr (59) 
 
Amido ester 57 (100 mg, 353 µmol , 1.00 eq.) was dissolved in methanol (1 ml) and isopropyl-
amine (0.60 ml, 7.06 mmol, 20.0 eq.) was added. The mixture was stirred at 50 °C for 7 days 
until no more substrate could be detected by TLC. After cooling to room temperature, all vola-
tiles were removed and residual solids re-precipitated from ethyl acetate:n-pentane to give the 
product as a white solid (83.0 mg, 267 µmol, 76%). 
 
Enantiopurity of the compound was confirmed by chiral HPLC (Chiralpak IE, hexane:isopropa-
nol 80:20, 0.5 ml/min, 20 °C, tR = 6.55 min).  
 
1H NMR (CDCl3, 598.61 MHz, 300 K): δ = 0.94 (d, 3H, 3J(H,H) = 6.6 Hz, H16), 0.96 (d, 3H, 
3J(H,H) = 6.6 Hz, H16’),  3.03 (ddd, 1H, 2J(H,H) = 13.5, 3J(H,H) = 8.9, 4J(H,H) = 1.9 Hz, 8H), 
3.26 (ddd, 1H, 2J(H,H) = 13.5, 3J(H,H) = 5.7, 4J(H,H) = 3.3 Hz, H8’), 3.92-4.00 (m, 1H, H15), 
4.77 (tdd, 1H, 3J(H,H) = 8.3, 3J(H,H) = 5.6, 3J(H,H) = 2.7 Hz, H7), 5.54-5.62(m, 1H, H14), 7.07-
7.08 (m, 1H, H6), 7.22-7.31 (m, 5H, H10 and H11 and H12), 7.41-7.44 (m, 2H, H2), 7.49-7.52 
(m, 1H, H19, 7.76-7.78 (m, 2H, H3) ppm. 
13C{1H} NMR (CDCl3, 150.54 MHz, 300 K): δ = 22.5 (C16), 22.6 (C16’), 39.4 (C8), 44.7 (C15), 
55.4 (C7), 127.2 (C12), 127.2 (C3), 128.7 (C11), 128.8 (C2), 129.6 (C10), 131.9 (C1), 134.0 
(C4), 137.0 (C9), 167.0 (C5), 169.8 (C13) ppm. 
HRMS (ESI): m/z calcd. for C19H21N2O2 [M+H]+: 309.16085; found: 309.16095. 
7  Experimental section 
____________________________________________________________________________ 
- 167 - 
FTIR: ṽ = 690 (s), 1255 (m), 1327 (m), 1536 (s), 1630 (s), 2872 (w), 2926 (w), 2971 (m), 3023 
(w), 2061 (m), 3284 (bs) cm-1. 
[α]880nm20 +1.6 (c 1%, MeOH). 
7.8 Crystallographic data 
7.8.1 Compound (Rax)-7 
 
Identification code jfs2sq 
Empirical formula C60.73H66.74Cl8.21N4O6P2 
Formula weight 1301.63 
Temperature 200(2) K 
Wavelength 0.71073 Å 
Crystal system monoclinic 
Space group P21 
Z 4 
Unit cell dimensions  
a =  17.729(3) Å  = 90 deg. 
b =  17.746(4) Å  = 96.724(5) deg. 
c =  24.008(5) Å  = 90 deg. 
Volume 7501(3) Å3 
Density (calculated) 1.15 g/cm3 
Absorption coefficient 0.40 mm-1 
Crystal shape polyhedron 
Crystal size 0.170 x 0.160 x 0.160 mm3 
Crystal colour colourless 
Theta range for data collection 1.6 to 17.4 deg. 
Index ranges -14h14, -14k13, -20l18 
Reflections collected 21959 
Independent reflections 8569 (R(int) = 0.1005) 
Observed reflections 5441 (I > 2(I)) 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.95 and 0.84 
Refinement method Full-matrix least-squares on F2 
Data/restraints/parameters 8569 / 2858 / 1482 
Goodness-of-fit on F2 1.02 
Final R indices (I>2sigma(I)) R1 = 0.095, wR2 = 0.226 
Absolute structure parameter 0.12(8) 
Largest diff. peak and hole 0.36 and -0.34 eÅ-3 
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7.8.2 Compound (S)-9 
 
ID xv019_trapp  refls. measured 37014 
net formula C11H12Cl2N2O2  Rint 0.0544 
Mr/g mol−1 275.13  mean σ(I)/I 0.0351 
crystal size/mm 0.100 × 0.030 × 0.020  θ range 2.860–27.101 
T/K 110.(2)  observed refls. 5024 
radiation MoKα  x, y (weighting scheme) 
0.0248, 
0.8813 
diffractometer 'Bruker D8 Venture TXS'  hydrogen refinement 
H(C) constr, 
H(N) refall 
crystal system orthorhombic  Flack parameter 0.00(2) 
space group 'P 21 21 21'  refls in refinement 5515 
a/Å 9.4676(3)  parameters 327 
b/Å 12.6190(4)  restraints 0 
c/Å 20.9371(8)  R(Fobs) 0.0302 
α/° 90  Rw(F2) 0.0721 
β/° 90  S 1.054 
γ/° 90  shift/errormax 0.001 
V/Å3 2501.39(15)  max electron density/e Å−3 0.240 
Z 8    
calc. density/g cm−3 1.461    
μ/mm−1 0.510    
absorption correction Multi-Scan    
transmission factor range 0.82–0.99    
 
 
7  Experimental section 
____________________________________________________________________________ 
- 169 - 
7.8.3 Compound 19d 
 
ID vv186_trapp  refls. measured 43408 
net formula C53.75H58N4O8P2  Rint 0.0623 
Mr/g mol−1 949.98  mean σ(I)/I 0.0941 
crystal size/mm 0.100 × 0.080 × 0.050  θ range 3.143–25.338 
T/K 100.(2)  observed refls. 23005 
radiation MoKα  x, y (weighting scheme) 
0.2000, 
0.0000 
diffractometer 'Bruker D8 Venture TXS'  hydrogen refinement constr 
crystal system triclinic  refls in refinement 43408 
space group 'P -1'  parameters 2376 
a/Å 18.7366(15)  restraints 132 
b/Å 25.531(2)  R(Fobs) 0.1038 
c/Å 27.891(2)  Rw(F2) 0.3365 
α/° 65.696(3)  S 1.090 
β/° 82.215(3)  shift/errormax 0.001 
γ/° 80.709(3)  max electron density/e Å−3 1.466 
V/Å3 11964.7(17)  min electron density/e Å−3 −1.151 
Z 8    
calc. density/g cm−3 1.055    
μ/mm−1 0.121    
absorption correction Multi-Scan    
transmission factor range 0.8989–0.9705    
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7.8.4 Compound 24 
 
ID wq035_trapp  absorption correction Multi-Scan 
net formula C47.15H57.60N4O8  transmission factor range 0.93–1.00 
Mr/g mol−1 808.37  refls. measured 41085 
crystal size/mm 0.100 × 0.090 × 0.040  Rint 0.0508 
T/K 296.(2)  mean σ(I)/I 0.0648 
radiation MoKα  θ range 2.332–25.350 
diffractometer 'Bruker D8Quest'  observed refls. 10885 
crystal system orthorhombic  x, y (weighting scheme) 0.0573, 2.1296 
space group 'P 21 21 21'  hydrogen refinement constr 
a/Å 17.3902(6)  Flack parameter −1.0(6) 
b/Å 22.2927(10)  refls in refinement 16733 
c/Å 23.9010(11)  parameters 1114 
α/° 90  restraints 54 
β/° 90  R(Fobs) 0.0612 
γ/° 90  Rw(F2) 0.1504 
V/Å3 9265.8(7)  S 1.024 
Z 8  shift/errormax 0.001 
calc. density/g 
cm−3 
1.159  max electron density/e Å−3 0.291 
μ/mm−1 0.079  min electron density/e Å−3 −0.296 
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7.8.5 Compound (S)-25 
 
ID wv089_trapp  absorption correction Multi-Scan 
net formula C20H24N2O2  transmission factor range 0.95–1.00 
Mr/g mol−1 324.41  refls. measured 47885 
crystal size/mm 0.100 × 0.020 × 0.020  Rint 0.0488 
T/K 100.(2)  mean σ(I)/I 0.0635 
radiation MoKα  θ range 3.136–25.348 
diffractometer 'Bruker D8 Venture TXS'  observed refls. 13654 
crystal system monoclinic  x, y (weighting scheme) 0.0343, 0.2107 
space group 'P 1 21 1'  hydrogen refinement H(C) constr, 
H(N) restr 
a/Å 20.9315(6)  Flack parameter −0.4(4) 
b/Å 10.3250(3)  refls in refinement 17123 
c/Å 22.0184(6)  parameters 1136 
α/° 90  restraints 46 
β/° 99.6730(10)  R(Fobs) 0.0428 
γ/° 90  Rw(F2) 0.0848 
V/Å3 4690.9(2)  S 1.036 
Z 10  shift/errormax 0.001 
calc. density/g 
cm−3 
1.148  max electron density/e Å−3 0.158 
μ/mm−1 0.074  min electron density/e Å−3 −0.204 
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7.8.6 Compound 47a 
 
 
ID  vv796_trapp  absorption correction Multi-Scan 
net formula C20H22N2O2  
transmission factor 
range 
0.92–1.00 
Mr/g mol−1 322.39  refls. measured 4157 
crystal size/mm 0.100 × 0.030 × 0.030  Rint 0.0517 
T/K 103.(2)  mean σ(I)/I 0.0412 
radiation MoKα  θ range 3.271–26.367 
diffractometer 'Bruker D8 Venture TXS'  observed refls. 3601 
crystal system tetragonal  x, y (weighting scheme) 0.0517, 3.3665 
space group 'I 41 c d'  hydrogen refinement H(C) constr, H(N) refall 
a/Å 23.7003(9)  Flack parameter 0.5 
b/Å 23.7003(9)  refls in refinement 4157 
c/Å 14.6413(7)  parameters 228 
α/° 90  restraints 1 
β/° 90  R(Fobs) 0.0443 
γ/° 90  Rw(F2) 0.1074 
V/Å3 8224.1(7)  S 1.074 
Z 16  shift/errormax 0.001 
calc. density/g cm−3 1.042  
max electron density/e 
Å−3 
0.234 
μ/mm−1 0.068  
min electron density/e 
Å−3 
−0.183 
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7.8.7 Compound 47c 
 
ID wv096_trapp  absorption correction Multi-Scan 
net formula C19H19Cl3N2O2  transmission factor range 0.91–0.98 
Mr/g mol−1 413.71  refls. measured 20081 
crystal size/mm 0.100 × 0.050 × 0.040  Rint 0.0392 
T/K 100.(2)  mean σ(I)/I 0.0343 
radiation MoKα  θ range 3.217–26.363 
diffractometer 'Bruker D8 Venture TXS'  observed refls. 3209 
crystal system tetragonal  x, y (weighting scheme) 
0.0286, 
9.6216 
space group 'I 41/a'  hydrogen refinement 
H(C) constr, 
H(N) refall 
a/Å 23.4372(6)  refls in refinement 4211 
b/Å 23.4372(6)  parameters 244 
c/Å 15.0532(4)  restraints 0 
α/° 90  R(Fobs) 0.0389 
β/° 90  Rw(F2) 0.0860 
γ/° 90  S 1.030 
V/Å3 8268.8(5)  shift/errormax 0.001 
Z 16  max electron density/e Å−3 0.406 
calc. density/g 
cm−3 
1.329  min electron density/e Å−3 −0.380 
μ/mm−1 0.458    
 
7.8  Crystallographic data 
____________________________________________________________________________ 
- 174 - 
7.8.8 Compound 51 
 
ID wv070_trapp  absorption correction Multi-Scan 
net formula C30H40N4O4  transmission factor range 0.88–1.00 
Mr/g mol−1 520.66  refls. measured 51785 
crystal size/mm 0.100 × 0.030 × 0.020  Rint 0.1049 
T/K 100.(2)  mean σ(I)/I 0.1514 
radiation MoKα  θ range 3.141–25.137 
diffractometer 'Bruker D8 Venture TXS'  observed refls. 12450 
crystal system monoclinic  x, y (weighting scheme) 0.0633, 
space group 'P 1 21 1'  hydrogen refinement constr 
a/Å 9.7167(7)  Flack parameter −1.0(8) 
b/Å 33.897(2)  refls in refinement 19807 
c/Å 17.4040(10)  parameters 1394 
α/° 90  restraints 13 
β/° 90.041(3)  R(Fobs) 0.0665 
γ/° 90  Rw(F2) 0.1611 
V/Å3 5732.3(6)  S 1.007 
Z 8  shift/errormax 0.001 
calc. density/g 
cm−3 
1.207  max electron density/e Å−3 0.353 
μ/mm−1 0.081  min electron density/e Å−3 −0.296 
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7.8.9 Compound 59 
 
ID wv422_trapp  absorption correction Multi-Scan 
net formula C19H22N2O2  transmission factor range 0.96–1.00 
Mr/g mol−1 310.38  refls. measured 18067 
crystal size/mm 0.060 × 0.040 × 0.030  Rint 0.0461 
T/K 110.(2)  mean σ(I)/I 0.0589 
radiation MoKα  θ range 2.890–26.372 
diffractometer 'Bruker D8 Venture TXS'  observed refls. 5263 
crystal system triclinic  x, y (weighting scheme) 0.0327, 0.7272 
space group 'P -1'  hydrogen refinement 
H(C) constr, 
H(N) refall 
a/Å 10.8890(15)  refls in refinement 6961 
b/Å 11.6708(16)  parameters 430 
c/Å 15.8451(15)  restraints 1 
α/° 73.396(4)  R(Fobs) 0.0470 
β/° 78.461(3)  Rw(F2) 0.1145 
γ/° 62.592(4)  S 1.043 
V/Å3 1707.5(4)  shift/errormax 0.001 
Z 4  max electron density/e Å−3 0.237 
calc. density/g 
cm−3 
1.207  min electron density/e Å−3 −0.246 
μ/mm−1 0.079    
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